






ANTIMICROBIAL BACTERIAL CELLULOSE AND ITS 
DERIVED SOFT GELS DEVELOPED FROM SMECTITE 















A thesis submitted in partial fulfilment of the requirements of Nottingham Trent 

















This work is the intellectual property of the author and supervisors: Fengge Gao 
and Michael Loughlin. You may copy up to 5% of this work for private study, or 
personal, non-commercial research. Any re-use of the information contained 
within this document should be fully referenced, quoting the author, title, 
university, degree level and pagination. Queries or requests for any other use, or 
if a more substantial copy is required, should be directed in the owner of the 



























Bacterial cellulose (BC) is a homopolysaccharide synthesised mainly by species 
of the genera Acetobacter. Due to the porous matrix, BC possesses high water-
absorption and -holding capacities. This non-toxic, biodegradable and 
biocompatible material is widely used in medical, cosmological, textile and food 
industries. In the medical field, BC has found potential in wound, burn and 
reconstructive surgeries. However, the major drawback of BC is that it does not 
provide a barrier against infections. Infections are one of the most challenging 
aspects of burn recovery and wound healing systems that can delay a healing 
process due to contamination by foreign bodies, such as bacteria. There is, thus, 
a need to generate BC with additional antibacterial activity. While most 
antibacterial agents are harmful to mammalian cells, they can also leach, which 
causes the uncontrolled release of the agents into the environment. 
 
Therefore, the overall aim of this project was to use nanofillers such as smectite 
clay and natural biocides such as chitosan to give BC permanent, non-toxic, 
antimicrobial properties without biocide leaching. This research has made three 
major findings that are based on natural and non-toxic minerals or biomaterials. 
One of the major results obtained was that natural Cloisite Na+ and synthetic 
SWN clays showed antibacterial activity against both Gram-positive MRSA and 
Gram-negative E. coli bacteria in its exfoliated state. Exfoliated clays were then 
incorporated into BC to provide such antibacterial properties to the final 
composite. Another major finding was the synthesis of new BC-based material, 
named bacterial chitosan. Bacterial chitosan was developed using chitosan as 
the main carbon source. This material showed antibacterial activity against 
MRSA and E. coli. Bacterial chitosan cannot be dissolved in acid. This can solve 
problems associated with using chitosan in antibacterial applications. The third 
major finding was the enhancement of antibacterial activity of BC/chitosan hybrid 
hydro and hydrated gels by using exfoliated Cloisite Na+ clay. In addition to these 






chitosan as biocides. Some of these synthesised materials had strong 
antibacterial activity. However, the leaching behaviour of biocides may have 
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ATP: Adenosine triphosphate 
BC-CH: Bacterial chitosan 
BC: Bacterial cellulose 
CFs: Cotton fibers 
CFU: Colony-forming unit 
CH: Chitosan 
DDA: Degree of deacetylation 
DLS Dynamic laser scattering 
DMEM: Dulbecco’s modified Eagle’s medium 
DMSO: Dimethyl sulfoxide 
DSA: Drop shape analyser 
FBS: Fetal bovine serum 
FT-IR Fourier Transform Infrared spectroscopy 
G. xylinus: Gluconacetobacter xylinus 
HS: Hestrin Schramm 
IM: Isolated microorganisms 
KB: Kombucha beverage 
KC: Kombucha cellulose 
kDa: Kilodalton 
LPS: Lipopolysaccharides 
MRSA: Methicillin resistant Staphylococcus aureus 
MTT: MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium 
Bromide) 
MW: Molecular weight 
N/A Not available 









OD: Optical density 
Ox: Oxidised 
P. aeruginosa: Pseudomonas aeruginosa 
PBS: Phosphate buffered saline 
QAC: Quaternary ammonium compounds 
RCF: Relative centrifugal force 
RIU: Reflective index unit 
RPM: Revolutions per minute 
SCOBY Symbiotic culture of bacteria and yeasts 
SEM: Scanning electron microscopy 
SWN: Lithium magnesium sodium silicate  
TSA: Tryptic soy agar 
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Chapter 1. Introduction 
 
The introduction covers the current state-of-the-art progress in the synthesis of 
BC-based composites with antibacterial properties. The first Section will review 
the fundamental knowledge on BC structure, properties and applications, 
including modification and examples of BC-based composites with various 
antibacterial agents. Since clays were used as antibacterial agents in this project, 
the second Section will focus specifically on clay and BC/clay composites with 
antibacterial properties and their applications in wound healing. Thereafter, the 
third Section will be based on chitosan, which has also been used as an 
antibacterial agent in this current study, its antibacterial properties and potential 
for antibacterial BC/chitosan composites. The next part will review the progress 
in Kombucha cellulose as an alternative for conventional BC. The last Section 
will summarise the literature review, explain the need for the research, the 
hypothesis and experimental aim.  
 
1.1. Bacterial cellulose  
1.1.1. Structure of bacterial cellulose 
 
Cellulose (C6H10O5)n is a homopolysaccharide formed by a linear chain of 
monosaccharide β-d-glucose residues linked by β(1 → 4) bonds to form β-1,4 
glucan chains[1, 2]. Linear β-1,4-glucan chains are secreted outside the cells 
through a linear row of pores located on the bacterial outer membrane[3]. In 
addition to β-1,4 covalent bonds, each d-glucose subunit also has hydrogen 
bonds between d-glucose monomers[1]. The glucan chains are held together by 
inter- and intra-hydrogen bonding (Fig. 1)[1].  The interchain hydrogen bonding is 
located between the exposed hydroxyl groups of the aligned chains. 
 






Figure 1. Inter- and intra-hydrogen bonding of bacterial cellulose[1]. 
In BC, each glucose residue has one intermolecular (O6–H⋯O3) and two 
intramolecular hydrogen bonds (O6⋯H–O2) and (O3–H⋯O ring). 
 
The subsequent assembly of the β-1,4-glucan chains leads to the formation of 
sub-fibrils. Each sub-fibril consists of 10–15 nascent β-1,4-glucan chains and has 
a width of approximately 1.5 nm[1, 4]  Sub-fibrils are crystallised into microfibrils 
that then form bundles and ribbons. The ribbon is composed of approximately 
1000 individual glucan chains[1]. This process results in the formation of a thick, 
porous membrane in static culture conditions (Fig. 2). The matrix of BC consists 
of uniaxially orientated fibres with a diameter of 3-8 nm[1]. 






Figure 2. Schematic representation of bacterial cellulose organisation[4]. 
 
1.1.2. Synthesis of bacterial cellulose  
 
BC is synthesised mainly by two genera of acetic acid bacteria: Acetobacter and 
Gluconacetober [5]. Gluconacetobacter xylinus (G. xylinus) is one of the most 
efficient cellulose producers[5]. It can utilise different types of carbon sources such 
as glucose, galactose, fructose, sucrose, lactose, maltose, glycerol, 
dihydroxyacetone, pyruvate and dicarboxylic acids[6]. During BC formation, 
glucose monomers are covalently attached to a linear chain by cellulose synthase 
enzymes[1].  
 
1.1.2.1. Acetic acid bacteria: genus Gluconacetobacter  
 
Acetic acid bacteria are so named because of their ability to oxidise ethanol into 
acetic acid. The Acetobacteraceae family consists of strictly aerobic, Gram-
negative acetic acid bacteria with the ability to oxidise alcohols, carbohydrates 
and sugar alcohol into acetic acid and other organic acids such as fumaric, 





ketones, gluconic, citric and oxoacids[5]. The genus Gluconacetobacter is one of 
the most efficient cellulose producers amongst acetic acid bacteria. G. xylinus is 
non-pathogenic bacterium, which is a common contaminant of beer and wine and 
is found on the surface of leaves, flowers and fruits[1, 5].  The cellulose produced 
by G. xylinus protects bacteria from harsh environmental conditions such as 
toxins, including antibiotics and UV radiation, and helps to retain moisture[5]. For 
example, the biofilm produced by G. xylinum promotes bacterial colonisation 
while inhibiting colonisation of competing organisms on fruits[5]. In addition, 
cellulose, which is produced in liquid environments, floats and allows the bacteria 
to stay near the oxygen-rich surface. However, in a natural environment, the 
cellulose does not reach the same thickness of the fibres as those obtained on 
the surface of liquid broth in a laboratory environment[1]. 
 
1.1.3. The process of BC biosynthesis  
 
The biosynthesis of cellulose is a multi-step reaction, which contains four key 
enzymatic steps (Fig. 3):  
 
 
Figure 3. A schematic representation of the biosynthesis of cellulose by Acetobacter 
xylinus[7]. 





The first step is phosphorylation of glucose to glucose-6-phosphate (Glc-6-P) by 
enzyme glucokinase[7]. This is followed by the isomerisation of glucose-6-
phosphate to glucose-1-phosphate (Glc-1-P) by phosphoglucomutase[7]. Glc-1-P 
is then converted to UDP- glucose by UDPG-pyrophosphorylase (UGPase)[7]. 
UPD-glucose monomers subsequently bind with each other to form cellulose, 
further forming a linear chain[1]. Thus, bacterial cellulose is a polymer synthesised 
from UDP-glucose monomers[1]. Cellulose synthase is the key enzyme involved 
in the formation of cellulose because it catalyses the covalent attachment of 
glucose monomers into a linear chain[1]. This enzyme is encoded by the genes of 
the bacterial cellulose synthase (bcs or axcs) operon[5]. Cellulose synthase 
operates with endo-b-1,4-glucanase (CMCAx), cellulose complementing factor 
(CcpAx) and b-glucosidase (BglAx). Their genes are located in the operon 
flanking regions. This operon comprises three (bcsAB, bcsC, and bcsD) or four 
(bcsA, bcsB, bcsC, and bcsD) genes, encoding the subunits BcsA, BcsB, BcsC, 
and BcsD (Fig.4)[5].  
 
 
Figure 4. Organisation of cellulose synthase operon of the genus Gluconacetobacter[3]. 
BcsA, bcsB, and bcsC genes of the bcs operon are characteristic of known 
microorganisms that produce cellulose. Regarding Gluconacetobacter, the most 
conserved gene is bcsD, followed by bcsA and bcsB, whereas the bcsC 
sequence contains the greatest number of mutations[5]. BC is formed between 
the cytoplasm and outer membranes of the cell. The cellulose molecules, which 
are synthesised inside the bacteria, are then spun through cellulose export 











1.1.4. Transport of cellulose through the membrane 
 
The synthesis and transport of cellulose through the membrane is mediated by 
the cellulose synthase complex that contains a membrane-integrated catalytic 
BcsA subunit and a periplasmic, membrane-anchored BcsB domain (Fig. 5)[8].  
 
 
Figure 5. BcsA-BcsB complex[9]. 
The membrane-integrated BcsA subunit, which is located on the inner 
membrane, is the catalytically active protein. BcsA subunit mediates both 
transport and synthesis of cellulose through the inner membrane[8]. The subunit 
is connected to the cytoplasmic membrane by 8 transmembrane (TM) helices, 
which are flanked by 3 amphipathic helices (IF1-3) that are located at the 
cytosolic water–lipid interface parallel to the membrane[9]. The cytoplasmic region 
of the BcsA subunit consists of a catalytic domain with glucosyltransferase (GT) 
activity that uses UDP-glucose as a precursor of the β-1,4-glucan chain and a 
PilZ regulatory domain that binds a specific allosteric activator to the c-di-GMP 
molecule[9]. 
 
BcsB is the periplasmic domain that is anchored to the inner membrane by a 
single, carboxy-terminal transmembrane helix. BcsB consists of two periplasmic 
carbohydrate-binding domains that are connected to two α/β-domains (FD1 and 





FD2) (Fig.5)[10]. BcsB domain transports a newly synthesised β-1,4-glucan chain 
from the cytoplasm through the periplasmic space[10]. The BcsA subunit and BcsB 
domain form the core of the cellulose synthase complex[9]. This complex is crucial 
for the synthesis of BC both in vitro and in vivo.  
 
The exact mechanism of cellulose translocation is currently unknown[11]. 
However, a model of cellulose transport was proposed by Morgan et al.[10]. In this 
model, the newly added glucose molecule might rotate around the acetal linkage 
to align with the glucan in the channel, where the allosteric interactions could 
guide the direction of the rotation[10]. This might lead to the formation of the β-1,4 
glucan with an intramolecular O3-H••O5 hydrogen bond. Moreover, the glucan 
might translocate into the channel during a relaxation[11]. This process can be 
repeated in a second for UDP-glucose, but the rotation would be in the opposite 
direction due to steric constraints[10]. 
 
Cellulose might be moved by one glucose unit each round of catalysis via the 
cellulose synthase complex: thus, newly added glucose unit can be positioned to 
become an acceptor in the subsequent reaction. Therefore, the translocation can 
be coupled with conformational changes at the active site followed by relaxation 
of the newly added glucose into the plane of the cellulose[11]. Interaction of the 
cellulose subunits should be dynamic allowing either the protein to slide along 
rigid cellulose fibres or isolation of glucan chains to pass through pores[11].  
 
Furthermore, the BcsC subunit is predicted to form an 18-stranded β-barrel in the 
outer membrane[11]. The BcsC subunit is followed by a large periplasmic domain 
that contains tetratricopeptide repeats that might be involved in the complex 
assembly. This subunit is required for the synthesis of cellulose in vivo, but not in 
vitro. Furthermore, BcsC might create pores in the outer cell membrane and be 
involved in the export of synthesised polysaccharides outside the cell[11]. An 
interaction of the inner BcsA subunit and BcsB domain with the outer membrane 





BcsC subunit is still unknown[11]. It is also unknown how cellulose enters the 
channels in the outer membrane[11].  
 
Bacteria usually contain an additional BcsD subunit, which is a small periplasmic 
protein with approximately 160 residues[11]. BcsD is located in the periplasm 
between BcsA and BcsB units[11]. BcsD might be responsible for the formation of 
crystalline regions of the cellulose chain by facilitating a formation of hydrogen 
bonds between the four newly established chains of β-1,4-glucan[9]. However, the 
exact function of this subunit is unknown[11]. A direct interaction between BcsD 
and the membrane-associated BcsA and BcsB subunits has not yet been 
demonstrated[11].  
 
1.1.5. The comparison of BC and cotton fibres 
 
BC can be compared to cotton fibres (CFs) that are made up of nearly 90% 
cellulose[12].  The cellulose in both BC and CF cellulose is chemically identical, 
as both are type I cellulose (insoluble in both water and the most common organic 
solvents)[13]. However, at a macroscopic level, they differ, as BC is rich in triclinic 
structure Ia whereas CFs are predominantly monoclinic structure Ib[14].  
 
BC is synthesised in a pure state and found external to the bacteria[13]. Fibres of 
BC are uniaxially orientated and create a well-separated, highly porous matrix[15] 
(Fig. 6).  






Figure 6. SEM image showing a coherent 3-D network of BC[16]. 
CFs are found in both primary and secondary plant cell walls. A primary cell wall 
includes cellulose in addition to proteins (1.0–1.9%), waxes (0.4–1.2%), pectins 
(0.4–1.2%), inorganics (0.7–1.6%) and other substances (0.5–8.0%)[12, 17]. The 
secondary cell wall contains fewer non-cellulose constituents[12]. Fig. 7 shows 
SEM image of CFs. 
 
 
Figure 7. SEM image of cotton fibres[12]. 





Both BC and cotton fibres show a high crystallinity, 89% and 70-80%, 
respectively, suggesting a similarly packed fibre structure[13, 18, 19]. Both BC and 
CFs have a porous matrix. However, the porosity of BC is 28.3% whereas the 
porosity of CFs has been found to be 11.36%[3, 17]. Porosity greatly affects the 
water absorption capacity of cellulose. The water holding capacity of BC is 142%, 
which is far greater than the 9.5% of CFs[16, 18]. According to the aforementioned 
differences, BC seems to be more promising material than CFs for a variety of 
applications that are detailed below. 
 
1.1.6. Applications of bacterial cellulose 
 
Due to high in vivo biocompatibility, the ability to provide a three-dimensional 
substrate for the attachment of cells as well as flexibility, high water-holding 
capacity and gas exchange, BC has a wide range of applications. For example, 
BC can be used in the food industry as a thickening agent in pastry condiments, 
gelation agent in tofu and stabilising agent in ice creams[20]. A product containing 
BC as a stabilising agent may retain its moisture for at least a month during 
storage as well as keep its shape[21].  Adding BC to ice cream can make the 
shape of ice cream remain the same for at least 60 minutes after removing it from 
a freezer[21]. As a gelling agent, BC significantly increases the strength of tofu by 
0.2–0.3% and provides better texture and firmness[21]. Additionally, BC helps to 
produce low-cholesterol and low-calorie food ingredients. Introducing BC to 
monascus, which is a natural red pigment, leads to the formation of a dietary 
complex with meat flavour[21]. Moreover, BC is used in food packaging. The 
addition of BC increases transparency and thermostability and reduces the 
diffusion of gases[20]. For example, a BC-reinforced PLA composite results in 
improved transparency and mechanical properties that might be ideal for food 
packaging applications[20].  
 
Due to high purity, BC has a low endotoxin unit (EU) level (<20 EU/g), which is 
required by the Food and Drug Administration (FDA)[22]. Endotoxins are 





lipopolysaccharides, which are potential inducers of inflammation. The endotoxin 
values measured on the purified BC membrane have been shown to be 0.3-3 
EU/g[23, 24]. In contrast, cellulose obtained from wood and ultrapure cellulose 
nanofibrils (CNF) have endotoxins level of around 100 EU/g and 50 EU/g, 
respectively[25]. Because of its non-toxicity, BC has the potential to be used as 
artificial skin, in vivo implants and artificial blood vessels[22]. Furthermore, BC can 
be produced in different sizes and shapes without significantly affecting its 
properties. BC consists of a number of almost parallel, thin cellulose layers[1]. 
Each new layer is formed at the upper film surface, resulting in increased 
thickness over time[1]. Therefore, it is possible to reform the pellicles into a 
desirable shape. Nimeskern et al. have designed an implant for the replacement 
of ear cartilage using BC[26]. Fig. 8 shows different shapes of BC produced for a 
variety of applications, such as vascular graft, burn dressing material and a 
meniscus implant[1]. 
 
Figure 8.  BC produced in various shapes. Tube to be used as a vascular graft (a), 
membrane to be used as burn dressing (b), and meniscus implant (c)[1]. 





Due to the extracellular production of BC and the fact that it can be extracted 
without lipopolysaccharide (endotoxin) contamination, bacterial cellulose can be 
used in vivo as blood vessels. Scherner et al. investigated the possibility of using 
BC tubes as in vivo replacements of blood vessels in ten sheep for three 
months[27]. In this study, BC showed good blood compatibility, no changes in 
blood cells and minimal inflammatory response compared to the control group[27]. 
Furthermore, BC has the potential to be used as a scaffold in tissue engineering 
due to biocompatibility, which is a crucial property for implantation. The 
biocompatibility of BC was evaluated using Wistar rats by Helenius et al.[28]. In 
this study, BC was implanted in rats for one, four and 12 weeks, respectively. By 
the end of the experiment, there were no microscopic signs of inflammation and 
an absence of fibrotic or giant cells[28].  
 
BC is widely used as a wound-healing material. Wound healing is a biological 
process, which consists of four basic phases: hemostasis, inflammation, 
proliferation and maturation[29]. Wounds secrete exudate, which is liquid 
produced from wounds and released during the inflammation and proliferation 
phases, providing moisture to a wound, which leads to a healing process[30]. 
However, a high level of exudate decreases the concentration of proteinase 
inhibitors and growth factors, which subsequently results in the degradation of 
tissue and retards the healing process[29, 30]. Generation of a moist environment 
is crucial for controlling the level of exudates and, therefore, is beneficial for 
enhancing re-epithelialisation and reducing scar formation[30]. Hence BC, as a 
wound dressing system can provide a moist environment, absorb excessive 
exudates, offer transparency for a wound inspection, provide mechanical strength 
and prevent fluid loss. BC can also improve the interaction of living cells with 
moisture and support cell migration, which results in the replacement of lost tissue 
in burn surgery[29]. Due to its high water-holding capacity, BC increases healing 
rates and reduces pain[29]. Its ability to retain a moist environment can also 
prevent wounds from drying as well as sticking to wound dressings. In addition, 





its water-absorption and -holding capacities may be beneficial when incorporating 
drugs or bioactive components[29]. 
 
However, the major drawback of BC as a wound-healing material is the lack of a 
barrier between a wound and infections. Long-term chronic wounds can be 
contaminated by foreign bodies, such as bacteria, which induce inflammatory 
responses[29]. As a consequence, more than 50% of diabetic chronic ulcers 
become infected[29]. The infections are one of the most challenging issues in burn 
recovery as they can delay the healing process due to patient’s adversely 
affected immune system together with the extensive disruption of the physical 
skin barrier. In order to prevent an infection, BC can be modified using different 
materials with antimicrobial properties. Application in other areas is becoming 
more popular, while its use in even broader areas may be possibly the 
enhancement of its properties in the future. 
 
1.2. Bacterial cellulose-based composites 
1.2.1. Modification of BC 
 
BC is typically modified to improve its properties, usually to introduce 
antimicrobial properties and enhance biocompatibility and its liquid-holding and -
realising capacities. Modification of BC can be achieved through an adjustment 
of the BC structure during the biosynthesis process (in situ) or post-synthesis (ex 
situ) (Fig. 9).  
 






Figure 9. Schematic representation of BC modification methods. (a) In situ modification 
of BC, where additive/reinforcement material is added directly into the culture medium. 
(b) Ex situ modification, where BC is modified by chemical treatment or absorption of 
other materials (immersion)[2]. 
Various BC-based composites have been designed to introduce different 
properties into BC, such as antibacterial properties, and to improve mechanical 
properties in different biomedical applications. Fig. 10 summarises a range of 
biomedical applications of BC-based composites.  
 






Figure 10. Summary of various biomedical and pharmaceutical applications of BC-based 
nanocomposites[29]. 
Thus, BC-based nanocomposites can be used as antimicrobial/antiviral films and 
in wound dressing systems, bioengineering, drug delivery systems, ophthalmic 
and skeletal systems and cardiovascular system[29]. 
 
1.2.2. Overview of in situ modification of BC 
 
The in situ methods are based on the utilisation of additive material in medium at 
the beginning of bacterial cultivation. This material can be added directly to the 
culture medium prior to or during the synthesis of cellulose to generate BC with 
novel properties by modifying the intrinsic biophysical properties. These additives 
then become a part of the BC nano- or micro-fibril networks, usually by interacting 
with -OH moieties of glucose and subsequently building new interconnected 
hydrogen bridges[20]. Hydrophilic and water-soluble materials are mainly chosen 
for such a modification. For example, in order to improve the rehydration ability 
of BC, 1% of hydroxypropylmethyl cellulose (HPMC) is added to the culture 





medium[31]. As a result, the rehydration ratio increases twice compare to the 
original BC. Another example is the synthesis of BC with carboxymethyl cellulose 
(CMC) for the biofiltration of blood proteins[32]. BC produced in a CMC 
environment shows reduced irreversible structural changes of the network during 
the process of drying[20, 32]. 
 
BC has also been modified specifically for bone tissue engineering applications[33, 
34]. In order to enhance the porosity of BC and prepare a BC scaffold for bone 
regeneration, paraffin microspheres were added into the culture medium[35]. The 
research showed that the synthesised BC scaffold significantly enhanced cell 
infiltration[35]. In another example, hydroxyapatite nanoparticles (HA - 
Ca5(PO4)3(OH)) were added into the BC culture medium for the fabrication of 
scaffolds for bone regeneration[2, 36, 37]. The results of the Stumpf et al. study 
showed a lack of inflammatory reaction, as well as bone defects filled with new 
bone tissues after four weeks[2]. Barreiro et al. added a sand dollar skeleton (from 
Clypeaster subdepressus), composed of CaMg(CO3)2, into Gluconacetobacter 
hansenii culture medium[38]. The resulting material had 3.6 ± 0.8 MPa 
compressive strength and apatite particles deposited over the BC surface[38].  
 
Materials with antibacterial properties have also been used for in situ BC 
modification. Danuta Ciechańska added chitosan acetate and chitosan lactate 
into the culture medium[39]. The developed BC/chitosan composites, which 
had N-acetylglucosamine and glucosamine units, showed antibacterial activity 
against E. coli and Staphylococcus aureus (S. aureus)[39]. Moreover, 0.5% 
concentration of poly (vinyl alcohol) (PVA) compounded with chitosan can 
improve the mechanical properties of BC as well as introduce additional 
antimicrobial properties[29]. This BC composite showed antibacterial activity 
against E. coli. Another example is the study by Yang et al., where silver 
nanoparticles were added into the culture medium with different carbon sources 
such as glucose, maltose and sucrose. The results showed that sucrose-derived 
BC possessed the lowest crystallinity and exhibited the highest silver content, 





whereas maltose-derived BC showed more than 99.99% antibacterial activity 
against E. coli after 18 hours[40].  
 
1.2.3. Ex situ modification of BC with antibacterial metal particles 
 
BC can also be modified after the synthesis. This type of modification is called ex 
situ modification. Ex situ modification is based on adding materials once the BC 
has been produced and purified[20, 22]. This type of modification might be 
beneficial in the cases that there is a need to keep the original BC structure. There 
are several ways of achieving BC ex situ modification. One of the common 
methods is an immersion of purified BC into a solution or suspension, where BC 
can interact with exogenous molecules (also known as accessory materials)[20]. 
Secondly, BC may also be stirred with an accessory material. The third method 
is the incorporation of an accessory material inside the BC network using laser 
or vacuum[41]. For instance, Dinca et al. incorporated ZnO nanoparticles into BC 
using the matrix-assisted pulsed laser evaporation (MAPLE) method with a laser 
wavelength of 266 nm, 6 ns pulse duration and 10 Hz repetition rate[41].  
 
Due to the lack of antimicrobial activity, BC alone does not provide a barrier 
between a wound and infection. This means that introducing antimicrobial 
properties to BC can increase the material’s diabetic efficiency in the treatment 
of extremely severe cases such as chronic wounds, ulcers and burns. Therefore, 
it would be useful to synthesise BC-based composites with antimicrobial 
properties. For example, metal nanoparticles such as ZnO, gold, silver and 
copper can be incorporated into BC and provide antimicrobial activity to the 











1.2.3.1. Gram-positive and Gram-negative bacteria 
 
Most bacteria can be divided into two groups based on their stainability: Gram-
positive and Gram-negative bacteria. A difference in stainability between these 
groups is based on the structure of their cell walls. Gram-positive bacteria have 
just one cell wall, whereas Gram-negative bacteria have an additional outer 
membrane[43]. Cell walls of both Gram-positive and Gram-negative bacteria 
contain peptidoglycan. Peptidoglycan is composed of a glycan backbone of N-
acetylglucosamine and N-acetylmuramic acid that form long chains[43]. The layers 
of peptidoglycan represent a cross-linked matrix consisting of linear glucan 
chains that are linked via covalent bonds[43].  
 
The chains of glucan are highly cross-linked by bridges of tetra-peptides in Gram-
positive bacteria (for instance, Staphylococcus aureus) or partially cross-linked 
in Gram-negative bacteria (for example, Escherichia coli)[43]. However, the layer 
of peptidoglycan in Gram-positive bacteria is much thicker than that in the Gram-
negative bacteria. For instance, approximately 50% of the cell wall of Gram-
positive bacteria is composed of peptidoglycan[44]. Due to the lack of the outer 
membrane, cell walls of Gram-positive bacteria are much more penetrable than 
those of Gram-negative bacteria[44]. The structure of the cell walls of both Gram-
positive and Gram-negative bacteria is shown in Fig. 11[44]. As seen in Fig. 11, 
the cell wall of Gram-positive bacteria has several layers of peptidoglycan. The 
thick layers of peptidoglycan help to support the cell and result in retaining most 
of the crystal violet dye after Gram staining, causing bacteria to appear purple.  
 






Figure 11. The structure of the cell walls of Gram-negative (top) and Gram-positive 
(bottom) bacteria[44]. 
The remaining 50% of the cell wall of Gram-positive bacteria is composed of a 
variety of polymers such as teichoic acids[44]. Teichoic acids are polyol phosphate 
polymers consisting of small repeating units of glycerol phosphate, glucosyl 
phosphate or ribitol phosphate that are linked via phosphodiester bonds[43]. 
Teichoic acids are extended from the plasma membrane through a layer of 
peptidoglycan[45]. There are two main groups of teichoic acids: lipoteichoic acids 
(LTA), which are anchored in a membrane via a glycolipid, and wall teichoic acids 
(WTA) that are covalently linked to peptidoglycan[45]. WTA consist of a chain 
polymer of phosphodiester-linked polyol repeat units and a disaccharide linkage 
unit. The phosphodiester-linked polyol repeat units of WTA are extended from 
the glycerol-3-phosphate end of the linkage unit[45]. One or two glycerol-3-
phosphate units are attached to the C4 oxygen[45]. The disaccharide linkage unit 
is composed of N-acetylmannosamine (β1→4) N-acetylglucosamine-1-
phosphate[45]. The anomeric phosphate of the linkage unit is covalently attached 
Gram-negative 
Gram-positive 





to peptidoglycan through a phosphodiester bond. Teichoic acids are present just 
in the cell wall of Gram-positive bacteria and help the cell to maintain its shape, 
play a role in cell division as well as to infect and cause disease[43].  
Gram-negative bacteria have a thin layer of peptidoglycan (10-20%) in their cell 
walls that is surrounded by an outer membrane containing lipopolysaccharides 
(LPS), which are not found in Gram-positive bacteria[44]. Each LPS is a complex 
molecule consisting of a polysaccharide core, a lipid A and chains of 
carbohydrates. Lipid A is composed of fatty acids and anchors the LPS structure 
to the membrane[43]. Core carbohydrates, which are connected to lipid A, consist 
of octanoic and ketodeoxytonic acids as well as heptose[43]. Core carbohydrates 
may also represent up to 40 sugars and cover the surface of the cell wall[43].  
 
Furthermore, in Gram-negative bacteria, the outer membrane involves two 
classes of proteins such as β-barrel proteins and lipoproteins. β-barrel proteins 
(porins) represent β sheets that are wrapped into cylinders[46]. In order to allow 
low molecular weight compounds to pass through a cell wall via slow diffusion, 
several porins or proteins are located on the membrane[43]. For instance, the 
function of OmpF and OmpC porins is to allow the passive diffusion of small 
molecules such as amino acids, mono- and disaccharides across the outer 
membrane[43]. LamB and PhoE porins allow the diffusion of maltose, anions and 
maltodextrins[43]. These porins have 16 transmembrane β strands[43]. 
Furthermore, lipoproteins consist of lipid moieties that embed lipoproteins in the 
leaf of the outer membrane through the attachment to the amine terminal cysteine 
residue[43]. For instance, the cells of Escherichia coli (E. coli), have about 100 
lipoproteins in their outer membrane[43]. Therefore, the structure of the outer 
membrane of Gram-negative bacteria may show a greater resistance to 










1.2.3.2. Antibacterial activity against Gram-positive and Gram-
negative bacteria 
 
Due to the difference in structures of cell walls, antibacterial agents might affect 
Gram-positive and Gram-negative bacteria in different ways. Antibacterial agents 
such as amine groups, nanoparticles and quaternary ammonium compounds 
(QAC) can influence the permeability of a cell wall, penetrate into the cytoplasm 
and/or affect bacterial DNA[47]. The antibacterial action of nanoparticles against a 
bacterial cell is shown in Fig. 12[47]. 
 
 
Figure 12. The mechanism of antibacterial action of nanoparticles[47]. 
As shown in Fig. 12, nanoparticles can interact with a cell wall, penetrate it and 
affect DNA and proteins. The interaction of nanoparticles with ribosomes, 
lysosomes and enzymes can lead to oxidative stress, enzyme inhibition, 
disruption of electrolyte balance and deactivation of proteins[47].  
 





The mechanism of antibacterial action is mainly based on electrostatic 
interactions[48]. In order to possess antibacterial activity, nanoparticles need to be 
in contact with a bacterial cell wall. Nanoparticles and other antibacterial agents 
can electrostatically bind to negatively charged components on a bacterial cell 
wall and, as a result, change the penetrability of the cell wall. The antibacterial 
effect of different nanoparticles may vary among Gram-positive and Gram-
negative bacteria. Surface charge, hydrophobicity, molecular weight and size of 
nanoparticles can affect their antibacterial activity[49]. Both LPS in Gram-negative 
bacteria and teichoic acids in Gram-positive bacteria are negatively charged, 
whereas most of antibacterial agents are positively charged[50-52].  
 
The cell wall of Gram-positive bacteria consists of layers of peptidoglycan and 
teichoic acid as well as abundant pores that allow foreign molecules to penetrate 
and cause damage[47]. A number of studies have reported that nanoparticles 
possess a greater antibacterial activity against Gram-positive bacteria than 
against Gram-negative bacteria due to the presence of an additional outer 
membrane in Gram-negative bacteria that is composed of LPS, phospholipids, 
porins and lipoproteins and forms a penetration barrier, which allows the entrance 
of only macromolecules[47, 50-52]. For instance, hydroxyapatite whisker/nano-zinc 
oxide showed a stronger antibacterial activity against Gram-positive S. mutans 
and S. aureus than Gram-negative E. coli [47]. Moreover, LPS, phospholipids and 
lipoproteins are connected with divalent cations that are required to stabilise the 
outer membrane of Gram-negative bacteria by electrostatic interactions[53]. The 
packing of LPS molecules is tight and, therefore, LPS could provide an effective 
permeability barrier[54]. For example, the outer membrane of E. coli contains from 
hundreds to thousands of LPS molecules[54]. This LPS barrier might, however, 
not be effective against amine groups. Amine groups can bind to negatively 
charged O-specific oligosaccharide units of LPS and, thus, disturb the integrity of 
the outer membrane[53]. Furthermore, amine groups that bind either to lipid A or 
divalent cations could also increase the permeability of the outer membrane[53].  
In addition, Amro et al. showed that the depletion of metal can cause the 





formation of irregular-shaped pits in the outer membrane followed by changing 
the permeability of the membrane and, subsequently, a progressive release of 
LPS molecules and membrane proteins[54, 55]. Moreover, in Gram-negative 
bacteria, Al2O3 nanoparticles may interact with LPS through hydrogen bonding 
and ligand exchange. As a result, such structural changes might lead to the loss 
of molecules, destruction of the cell wall and cytoplasmic leakage[47]. 
 
The charge of a bacterial cell wall also plays a crucial role in the antibacterial 
activity. For instance, the cell wall of Listeria innocua contains lysine-derived 
phospholipids that do not possess a strong net negative charge with zeta-
potential being around -20 mV[47, 56]. Whereas, the zeta potential of E. coli could 
be around -44.2 mV[57]. The difference in the zeta potential may be due to the 
additional layer of negatively charged LPS in the cell wall of E. coli. This could 
make the cell wall of Gram-positive bacteria such as L. innocua more permeable 
than Gram-negative E. coli [47]. 
 
Another possible reason for different sensitivities of bacteria to antibacterial 
agents is the thickness of the bacterial cell wall. For example, polymyxin 
polypeptides may affect LPS in Gram-negative bacteria followed by changing the 
structure of the cell wall and disruption of the osmotic balance[58]. Furthermore, 
polymyxin can increase water uptake and discharge molecules from the interior 
of the cell[58]. However, polymyxin does not affect the cell walls of Gram-positive 
bacteria, because their cell wall is too thick due to layers of peptidoglycan[58].  
 
Porins, which allow diffusion of molecules smaller than 600 Da, are the main 
channels for the movement of foreign molecules into and out of a bacterial cell 
wall[47]. Hydrophilic antibiotics (β-lactams and fluoroquinolones) might enter 
Gram-negative bacteria via porin channels[59]. However, bacteria such as 
Pseudomonas and Acinetobacter exhibit a low membrane permeability due to a 
different structure of their porins. For example, OprF is the major outer membrane 
porin of Pseudomonas aeruginosa (P. aeruginosa)[50]. The diffusion of different 





molecules through this channel is approximately two orders of magnitude slower 
than through the OmpA porin of E. coli [50]. This is one reason why Pseudomonas 
shows higher intrinsic resistance to many antibacterial agents[60].  
One of the crucial functions of a cell wall is the respiratory activity of bacteria[47]. 
Nanoparticles can disrupt the respiratory activity of a bacterial cell wall, which 
might be analysed by detecting a reduction in 2,3,5-triphenyltetrazolium chloride 
or O2[47]. TiO2 nanoparticles might adhere to the surface of a bacterial cell and 
produce reactive oxygen species (ROS) followed by damaging the structure, 
composition of a cell wall and leakage of cellular contents[47]. ROS are chemically 
reactive species that have a strong positive redox potential[47]. Therefore, the 
oxidative stress can be one of the key contributors to altered permeability of the 
cell wall[47]. Moreover, the binding of TiO2 to DNA could lead to DNA 
degeneration, compression and fragmentation[47].  
Metal ions, which can be released slowly from a metal oxide, might be absorbed 
through the cell wall[55]. This leads to the direct interaction of ions with functional 
groups of nucleic acids and proteins followed by changing the structure of cells, 
damaging enzyme activity, affecting the normal physiological processes and 
ultimately inhibiting the growth of microorganisms[55]. MRSA might be inactivated 
by the generation of a large amount of hydroxyl radicals and diffusion of graphene 
oxide or iron oxide nanoparticles[47]. Both hydroxyl radicals and hydrogen 
peroxide can penetrate cell walls[47].  
Many antibacterial agents can inhibit the growth of both Gram-positive and Gram-
negative bacteria. Silver is one of the most studied materials for introducing 
antimicrobial properties against a wide spectrum of pathogens such as S. aureus, 
Bacillus subtilis (B. subtilis), Klebsiella pneumoniae (K. pneumoniae), P. 
aeruginosa and E. coli as well as fungi and viruses[22, 41]. For instance, silver ions 
can bind to the bacterial cell wall, damage proteins, alter the function of bacteria 
by interacting with the thiol groups of enzymes or affect bacterial cells from the 
inside[61]. Silver ions can inhibit the growth of both S. aureus and E. coli by 





binding to functional groups of enzymes, causing the release of K+ ions[62]. For 
example, Thawatchai et al. have introduced antimicrobial properties into BC by 
incorporating silver nanoparticles through immersion[63]. The material produced 
showed antibacterial activity against both E. coli and S. aureus[63]. Tabaii et al. 
have also synthesised BC/silver composites through immersion that inhibited E. 
coli and S. aureus by 100% and 99.99%, respectively[64]. Additionally, BC/sodium 
alginate with silver sulfadiazine composites showed strong antimicrobial 
properties against E. coli and S. aureus bacteria as well as Candida albicans (C. 
albicans) yeast[65]. In Gram-negative E. coli, nanosized silver particles can cause 
both structural changes and death[55]. After contact with silver nanoparticles, the 
cell walls of E. coli exhibited a significant increase in permeability, impaired 
transport regulation through the walls followed by cell death[66]. Bacterial cell walls 
appeared to shrink and were separated from the cell followed by cell 
degradation[62]. Silver ions can penetrate the cell wall of Gram-positive bacteria 
and bind to DNA, which then loses its replication ability, cellular and functional 
proteins followed by protein denaturation[55]. Furthermore, small size silver 
nanoparticles (<10 nm) might pass through pores in the cell membrane[47]. Silver 
nanoparticles could be involved in a species-specific mechanism of upregulation 
of several antioxidant genes and genes coding for proteins involved in metal 
transport, metal reduction and ATPase pumps[47].  
 
ZnO, CuO and FeO might be more effective against Gram-positive bacteria B. 
subtilis and S. aureus than Gram-negative bacterial strains of E. coli and P. 
aeruginosa[67]. ZnO nanoparticles may possess antibacterial activity through 
releasing Zn ions in a manner that disrupts transport of amino acids, metabolism 
and causes disruption of an enzyme system in both S. aureus and 
Saccharomyces cerevisiae[68]. ZnO might affect the cell wall of Gram-negative 
bacteria externally due to particle size that could penetrate neither the cell 
membrane nor cell wall[68, 69]. Furthermore, ZnO nanoparticles can also be 
incorporated in BC and provide antimicrobial activity against K. pneumoniae 
and S. aureus[41]. In addition, copper exhibits antibacterial activity against 





Salmonella typhimurium (S. typhimurium), Listeria monocytogenes (L. 
monocytogenes), Salmonella enterica (S. enterica) and Campylobacter jejuni (C. 
jejuni)[42]. Araujo et al. reported that BC synthesised with copper and copper alloy 
(CuxOy) nanoparticles by immersion possessed antimicrobial activity against E. 
coli, S. aureus, S. enterica and C. albicans[42].  
 
Bacterial resistance can be developed against different antibacterial effects. 
Mechanisms of resistance can include expression of enzymes that might degrade 
or modify antibiotics[47]. However, most of mechanisms of resistance could be 
irrelevant to nanoparticles, because most nanoparticles might affect bacterial 
growth externally, without penetrating the cell wall[47].  
 
1.2.4. Limitations of the current BC modification techniques 
 
There are a number of limitations of the current BC modification techniques. One 
of the main challenges is controlling the amount of incorporated material into BC. 
For instance, the study by Grade et al. showed that 22% of hydroxyapatite was 
not integrated into the final in situ synthesised BC/hydroxyapatite composite[37]. 
Another study by Thawatchai et al. showed that both the size and amount of silver 
nanoparticles inside BC increased after the ex situ incorporation[63]. In addition, 
the incorporation of nanoparticles into BC can result in non-uniform distribution 
or accumulation of particles on the surface[63].  The study by Lvov et al. used raw 
halloysite clay nanotubes added directly into the culture medium. The results 
showed that clay particles were aggregated and subsequently settled at the 
bottom of the medium after cultivation[70]. This variation of concentration of 
nanoparticles within the BC matrix means that a varied dose of an antibacterial 
agent will be encountered by bacteria. 
 
Excessive use of the same antibacterial agent may lead to bacterial mutations. 
There is evidence that bacteria can mutate and develop resistance to an 
antibacterial agent[61]. These mutations can occur in normal cellular genes, 





plasmids or transposons[61]. For instance, plasmid-mediated biocide resistance 
to silver was documented in S. aureus and members of Enterobacteriaceae and 
Pseudomonas[61]. This means that excessive and uncontrolled use of silver might 
result in more bacterial resistance.  
 
Besides strong antibacterial activity, some metal nanoparticles such as silver and 
copper might have adverse effects on human health. For example, silver 
nanoparticles can inhibit cell viability, increase reactive oxygen species (ROS) in 
mitochondria and lactate dehydrogenase release activity[71]. Silver ions might 
result in a number of negative effects on human health such as genotoxicity, 
cytotoxicity, immunological responses and cell death[71-73]. Silver ions may also 
pass through tissues, such as the blood-brain barrier[71]. Moreover, one study 
showed that 30% of patients with burns who were treated with silver nanoparticles 
experienced the reversible hepatotoxicity and argyria-like symptoms[29]. Cu 
nanoparticles can also release toxicity on somatosensory neurons of rats and 
livers of juvenile fish[29]. Another example is that titanium dioxide (TiO2) may 
induce ROS and initiate lipid peroxidation, DNA degradation and protein 
disruption in the mouse brain[71, 74].  
 
Different size and shapes of metal nanoparticles can exhibit different levels of 
cytotoxicity on mammalian cell lines. Dermal toxicity and irritation might be worse 
with smaller size particles, because smaller gold and silver particles penetrate 
deeper, while the larger ones accumulate in the superficial epidermis or 
dermis[29]. The results of Carlson et al. showed that 15 nm hydrocarbon-coated 
silver nanoparticles induced more ROS generation than 55 nm in macrophage 
cell lines[75]. Another study by Liu et al. was focused on using 5 nm, 20 nm and 
50 nm silver nanoparticles and four different cell lines, A549, HepG2, MCF-7, 
SGC-7901[76]. The results showed that 5 nm silver nanoparticles exhibited more 
cytotoxicity than the 20 nm and 50 nm particles[76]. Moreover, Wang et al. 
reported that 20 nm citrate-coated silver nanoparticles showed greater 
cytotoxicity followed by neutrophilic inflammation in the lungs of mice than 110 





nm silver nanoparticles[71, 77]. However, Kaba et al. showed that smaller silver 
particles have not affected the viability of HeLa and U937 tumour cells[71, 78]. 
Therefore, small silver nanoparticles can inhibit cytotoxicity in specific cell types.  
 
The shape of nanoparticles can also influence cytotoxicity parameters. For 
instance, spherical silver particles do not show a cytotoxicity effect on A549 cells, 
whereas wires have been shown to be toxic[71]. Due to a variety of cell lines, which 
are sensitive to specific morphological characteristics of nanoparticles, the overall 
toxicity examination system was developed. This system is called the toxicity 
threshold (TT)[71]. TT is the minimum dose of any material that starts to result in 
cytotoxicity[71]. TT can vary even within the same cell line. For instance, TT value 
of silver nanoparticles in an A431 cell line is between 1.51 µg/ml and 50 µg/ml, 
but the TT value in A549 cells is from 0.5 µg/mL to 50 µg/ml[71]. 
 
Based on the above-mentioned evidence, there is a need to develop a BC-based 
composite combining both antibacterial and healing properties. The ideal material 
will possess all crucial features of BC and include additional antibacterial activity 
but not be toxic to mammalian cells. Such material will be suitable for medical 
applications such as wound and burns therapy. In order to synthesise such a BC-
based composite, non-toxic materials need to be chosen. In order to do so, this 
research is focused on natural and organically modified clay and chitosan. 
Therefore, clay and chitosan will be reviewed further.  
 
1.3.  Bacterial cellulose composites with clay particles and their 
applications 
1.3.1.  Smectite clay 
 
Clay can be described as fine-grained rocks and soil components. Clay minerals 
are small, hydrated silicate sheets. Most clay minerals are made by a stack of 
tetrahedral (T) and octahedral (O) sheets. The main types of clay can be 
discerned by the arrangement of these layers. For instance, the structure of 





kaolinite and serpentine clay is represented by a combination of a tetrahedral and 
an octahedral sheet (TO or 1:1 combination)[79]. Smectite, vermiculite and illite 
groups have TOT or 2:1 structure, whereas chlorite has a TOTO structure[79, 80]. 
Different types of clay have different properties and applications. Kaolinite is used 
in ceramic applications, whereas the serpentine group is used as a source of 
magnesium and asbestos as well as decorative stone[80]. Smectites are applied 
in foundry, oil well drilling, wine and feed pelletising industries[81]. Clay can also 
be used as antibacterial and sterilising agents as well as for adsorption of toxins 
and membrane coating[79].  
 
Smectites have TOT or 2:1 structure with a single octahedral and two tetrahedral 
sheets. The net positive charge deficiency is balanced by exchangeable cations 
that are absorbed between the unit layers and on the edges[82].  
 
1.3.1.1. Montmorillonite (MMT) clay 
 
Montmorillonite (MMT) clay was named after the Montmorillon region in France 
where the clay was discovered[83]. Sodium MMT clay is obtained from glassy 
igneous material such as volcanic ash or tuff.  
The structure of MMT consists of two building blocks: the tetrahedral sheet, which 
is composed of siloxane (Si2O5-2), and octahedral sheet, which consists of 















                     Tetrahedral Silica                            Octahedral Alumina 
 
Figure 13. Schematic presentation of silica tetrahedron and alumina octahedron. A 
silicone atom bonds four oxygen atoms in the tetrahedral sheets, whereas in an 
octahedral sheet, an alumina atom bonds six oxygen atoms[83]. 
 
Octahedral layers are constituted by six OH groups, whereas OH groups are 
replaced with the apical oxygen atoms in tetrahedrons[84]. Tetrahedra link to 
neighbouring tetrahedra by sharing three corners with oxygen, resulting in a 
hexagonal network (Fig. 14)[85]. The fourth corner with oxygen is then adjusted to 
an octahedral sheet.  
 
 
Figure 14. Chemical structure of montmorillonite[85]. 





Each layer is 50-200 nm long (Fig. 15)[83]. The space between TOT layers is 
called the interlayer spacing or gallery[79]. The thickness of each clay layer with 






Figure 15. The structure of MMT. Figure showing the size of the layers[83]. 
While the sheets together form a single layer, several layers can also be joined 
by interlayer cations and van der Waals force[82]. Each layer has an excess 
negative charge due to the isomorphic substitution of Si4+ by Al3+ in the 
tetrahedral sheet and of Al3+ by Mg2+ ions in the octahedral sheet[83]. The charge 
imbalance in smectite is about 0.66 per unit cell[82]. The negative charge is 
compensated by counter-cations, which can be located either in the interlayer 
space or on the outer basal surfaces (Fig. 14). The interlayer cations are called 
exchangeable cations due to their ability to be replaced with other materials[82]. 
Cation exchange capacity (CEC) is a parameter used to measure the ability of 
clay to exchange its interlayer cations. It is inhibited in milliequivalents per 100 g 
of calcined clay[79]. CEC of NaMMT is 92.6 meq/100 g[86]. The CEC is one of the 
essential parameters for a modification of natural clay.  
 





MMT clay can be organically modified with quaternary ammonium salts[87]. For 
instance, the quaternary ammonium salt in Cloisite 30B clay is methyl tallow bis-
2-hydroxyethyl quaternary ammonium chloride[86, 87]. The size of organic cations 
is larger than compensating cations due to the presence of a long alkyl chain[87]. 
This results in an increase in the basal distance in organically modified clay 
(organoclay)[84, 88]. For example, d(001) spacing in NaMMT is 1.17 nm, whereas 
d(001) spacing in Cloisite 15A can reach 3.15 nm[86]. Regarding Cloisite 30B, the 
surface modifier is quaternary ammonium salt consisting of hydroxyl groups, 
which allows hydrogen binding with carbonyl groups[89]. The enhancement of the 
interlayer space results in hydrophobicity[87].  
 
1.3.2. Properties of MMT 
1.3.2.1. Physical properties of MMT 
 
Smectites have reactive edges on individual layers and an ability to interact with 
a wide range of natural and synthetic organic compounds[90]. The large surface 
area of MMT clay is effective for the absorption of organic compounds. For 
example, the surface area of MMT clay is 650–800 m2/g[91]. Organic compounds, 
which react with clay, have access to tetrahedral and octahedral sheets as well 
as metal ions inside interlayer spaces. As a result, clay may rearrange or swell[90]. 
MMT is hydrophilic clay, possessing high swelling behaviour in water. The ability 
of clay to absorb a large amount of water and swell can be caused by two factors. 
The first factor is a large number of hydrophilic-compensating cations on the large 
surface area. The second is the flexibility of sheets, which creates pores within 
sheets, particles and aggregates[91].  Porosity in smectite clay can be modulated 
by a variety of shapes, sizes and concentrations of intercalated materials as well 
as by partial exchange of inorganic cations or by modifying the interlayer charge 
density[91].  
 





Clay also have high facture toughness, high modulus and fire resistance[92]. 
These properties allow clay to be used as an enhancement material in developing 
polymer/clay composites.  
  
1.3.2.2. Antimicrobial properties of MMT 
 
Natural unmodified MMT clay does not show any antimicrobial activity, but 
organic modification of MMT results in antibacterial and antifungal properties 
being introduced[88, 93-95]. For instance, organoclays that are quaternary 
ammonium surfactant-based can show antimicrobial activity against both Gram-
positive and Gram-negative bacteria[88, 94, 96]. The interaction of a quaternary 
ammonium group of organoclay with bacterial cells can disrupt cell membranes 
and cause death[97]. Quaternary ammonium compounds disturb the structure of 
cell membrane through physical interaction with the membrane components, 
allowing vital cell content to be released[98, 99]. For instance, the alkyl chain of 
quaternary ammonium compounds reacts with fatty acid chains of membrane 
lipids and destabilises interactions between phospholipids and proteins[98]. Due 
to their organophilic nature, organoclays can also penetrate the membrane of 
bacteria. A low concentration of quaternary ammonium compounds leads to 
membrane damage and leakage of cytoplasmic constituents, whereas high 
concentrations cause coagulation of the cytoplasm, presumably through 
denaturation of proteins[98]. For example, Cloisite 20A and Cloisite 30B have been 
shown to have strong antibacterial activity against Gram-positive S. aureus and 
L. monocytogenes and Gram-negative and E. coli and S. typhimurium[97]. 
Moreover, Cloisite 10A and 15A have also shown antibacterial activity against S. 
aureus[100]. In addition, quaternary ammonium compounds can disorganise the 










1.3.3. Mammalian toxicity of MMT clay 
 
The cytotoxicity of MMT has been investigated by a number of cell research 
groups, but results vary significantly due to factors such as clay concentration, 
type of cells and composition of culture medium. Thus, the concentration up to 
31 μg/ml of natural NaMMT did not show any cytotoxicity for Caco-2 and HepG2 
(liver) cell lines in previous studies[101-103]. Maisanaba et al. reported no 
cytotoxicity effect of NaMMT at 31.25 μg/ml concentration on Caco-2 cells[78]. 
However, cell viability decreased with a higher concentration of NaMMT (31.25–
125 μg/ml)[78]. Maisanaba et al. tested the viability of human umbilical vein 
endothelial cells (HUVEC) in the presence of 0-125 μg/ml ultrasound-treated 
NaMMT suspension[104]. The results showed that NaMMT did not exhibit any 
cytotoxicity[104].  Furthermore, Lordan et al. reported that NaMMT inhibited HepG2 
cell growth, which then resulted in cell necrosis at all used concentrations from 1 
to 1000 μg/mL[105]. However, Maisanaba et al. had completely opposite results, 
where NaMMT suspension did not exhibit any cytotoxicity towards HepG2 cells 
at 0-62.5 μg/mL concentration[78]. One of the main differences between these two 
studies was medium type. Lordan et al. used DMEM with 10% fetal bovine serum 
(FBS), whilst Maisanaba et al. used EMEM with 10% FBS[80, 105]. Therefore, the 
composition of tissue culture medium might also influence a cytotoxicity assay. 
Lordan et al. analysed the effect of different fetal calf serum (FCS) serum 
concentrations along with 1 mg/ml NaMMT on human monocytic U937 cells[106]. 
The results showed that NaMMT suspension had a detrimental effect on the cells 
in serum-free medium, whereas clay did not inhibit any cytotoxicity in medium 
with 5% and 2.5% of FCS[106]. This might be due to clay particle agglomeration in 
the medium-containing serum, but the dispersion of particles in serum-free 
medium[106]. Moreover, 1 mg/ml may also be a very high concentration, which 
could affect the viscosity of the medium and subsequent penetration of oxygen.  
 
The cytotoxicity of different concentrations of organoclay has also been 
investigated. For example, Cloisite 20A at a concentration ranging from 0 to 65 





μg/ml of did not show any cytotoxicity for Caco-2 and HepG2 cell lines after 24 
and 48 hours, respectively[101]. In contrast, Cloisite 30B can damage DNA of 
Caco-2 cells at concentration 170 μg/ml after 24 hours[102, 104]. Furthermore, 
Cloisite 30B showed cytotoxicity at 125 μg/ml against HepG2[102]. The study by 
Sharma et al. showed that a 226 μg/ml concentration of Cloisite 30B induced 40% 
cytotoxicity in Caco-2 cells[102]. In addition, 250 μg/ml of Cloisite 30B was toxic for 
HUVEC cells[104].  Cloisite 93A reduced the viability of HepG2 cells to 37% at 
1000 μg/mL concentration[105]. The toxicity of organoclay can also be caused by 
the surfactants. However, organo-modifiers such as amine or carboxyl groups 
have shown low cytotoxicity and DNA damage[104] . Thus, the type of the cell line 
and the modifier plays a crucial role in toxicity testing.  
 
The toxicity of MMT on animal organs and the whole body has also been 
analysed. For instance, Mitchell et al. tested the toxicity effect of 0.75-1.5 grams 
of solid MMT particles, which were applied directly on to rabbit eyes[107]. The 
results showed no damage to the organ[107]. MMT was also injected and orally 
tested using Wistar rats as an in vivo model for 72 hours[108]. The results showed 
a lack of MMT toxicity on healthy rats, but there was toxicity on the rats with 
cardio-vascular diseases[108]. This might be due to the penetration of particles into 
already clogged blood vessels, which caused additional blockage. Furthermore, 
Lee at al. reported non-toxic behaviour of MMT after oral administration in 
rats[108]. In addition, Wiles et al. orally tested MMT clay on pregnant Sprague-
Dawley rats for 16 days[109]. The results showed an absence of any negative 
effects on rats or embryos as well as on normal tissue weights and maternal body 
gain[109]. Mitchell et al. confirmed that 1.5 g/day oral dose of purified CaMMT is 
safe for children at least for a period of 14 days[107]. Furthermore, 5 wt.% of 
NaMMT per day is considered safe and can act positively on bone mineralisation 









1.3.4. Current progress on BC/MMT composites  
 
Due to the presence of active functional hydroxyl groups, BC can be combined 
with inorganic nanoparticles such as clay[111]. The porous matrix of BC is 
beneficial for the synthesis of nanocomposites due to its biodegradability and 
considerable mechanical properties. The mechanical properties of BC can also 
be further modified via incorporation of different fillers such as clay. The addition 
of well-exfoliated MMT nanoparticles can improve thermostability and the 
mechanical, barrier and antimicrobial properties of BC[112]. For example, MMT 
can improve the mechanical properties of composites up to 10 times[112]. Another 
advantage is that BC/MMT composites can be synthesised without any toxic and 
expensive organic solvents. As with other additive materials, MMT clay particles 
can be introduced to BC by in situ or ex situ methods (Section 1.2).  
 
Using in situ modification, the structure, shape and properties of BC/MMT 
composites can be easily adjusted[113]. The BC/MMT in situ growth conditions can 
be either static or agitated, which may influence the structure and crystallinity of 
the composite as well as dispersion of particles during biosynthesis[113]. Non-
exfoliated particles might not fully attach to BC fibres during the static cultivation 
due to settling, whereas formation of BC occurs on the top of the medium[114]. 
Alternatively, BC/MMT can be synthesised in agitated culture, where the 
movement of medium lets particles penetrate into the BC[113]. However, the 
continuous movement of the medium might affect the structure and porosity of 
BC.  
 
The ex situ method allows incorporation of particles into BC without affecting its 
initial structure. The ex situ method is usually performed using the solution 
impregnation technique, which is the immersion of BC matrix into a clay 
suspension[113]. This immersion method also has limitations. Firstly, due to the 
hydrophilic nature of BC, the incorporation of organophilic oil-dispersible clay is 
a challenge. Secondly, only submicron and nano-sized particles can penetrate 





the BC matrix, because the size of the largest pores of BC can vary from 4 to 
1000 μm in diameter[115]. Therefore, exfoliation state and concentration of clay 
are crucial factors for achieving desirable properties in the final BC/MMT 
composites. A high concentration of clay can lead to particle agglomeration, 
which can adversely affect the composite properties[116]. For instance, Ul-Islam 
et al. 2012 stirred BC with 1 wt.%, 2 wt.% and 4 wt.% MTT clay suspensions, 
respectively, for 24 hours at 150 rpm[112]. The results showed that the number of 
particles absorbed by BC increased with increasing clay concentrations[112]. 
Thus, 25.72%, 40.36% and 45.06% of MMT particles from 1 wt.%, 2 wt.% and 4 
wt.% concentrations were absorbed by BC, respectively[112]. However, the final 
weight of BC/MMT composites was not significantly increased from the 2 wt.% to 
4 wt.% of clay concentration[112]. This might be due to particle agglomeration and 
subsequent lack of proper binding to BC fibres, which then resulted in clay 
leaching. 
 
1.3.5. BC/MMT composites for wound healing applications 
 
MMT clay has been used in therapeutic applications including wound healing due 
to its ability to inhibit bacterial growth, protect the skin, improve blood clotting and 
control haemorrhage in trauma patients[112, 117]. The possible mechanism 
triggering clay antibacterial activity may be the destruction of the cell membranes, 
enzyme inhibition, physical adsorption of bacteria or cation release from the 
clay[111, 118, 119]. The common bacterial species that cause wound infections are 
S. aureus, P. aeruginosa and methicillin-resistant S. aureus (MRSA)[120]. Thus, 
different BC/MMT composites such as BC/NaMMT, BC/CaMMT and BC/CuMMT 
have been tested against these species. The antibacterial activity of different 
freeze-dried BC/MMT composites was analysed by zone inhibition assay. For 
instance, Ul-Islam et al. immersed BC into 2 wt.% and 4 wt.% of NaMMT, CaMMT 
and CuMMT suspensions, respectively, in order to develop films with potential 
antibacterial activity[118]. Freeze-dried BC/CuMMT composites, which were 
placed directly on the TSA agar, showed 20 mm inhibition zones against E. coli 





and 9 nm against S. aureus[118]. Sajjad et al. tested the antibacterial activity of ex 
situ synthesised BC/NaMMT, BC/CuMMT and BC/CaMMT composites against 
MRSA, S. aureus, E. coli, P. aeruginosa, S. typhimurium and Citrus fruendii (C. 
fruendii)[94]. The results showed that BC/NaMMT composite produced a 43.6 mm 
zone against E. coli and 34 mm zone against both MRSA and S. aureus[94]. There 
was no antibacterial activity of BC/NaMMT against P. aeruginosa, S. typhimurium 
and C. fruendii [94]. Furthermore, BC/CaMMT resulted in 30, 25, 22 mm zones 
against S. aureus, E. coli and C. fruendii, respectively[94]. The zones of inhibition 
for S. typhimurium, E. coli, S. aureus were 34, 33 and 36 mm, respectively, using 
freeze-dried BC/CuMMT[94].  
 
However, while zone assays can give preliminary information about the 
antibacterial activity of composites, the determination of the viability of bacteria 
could be more accurately assessed in terms of efficiency of concentration and 
time. For instance, freeze-dried BC/NaMMT, BC/CaMMT, BC/CuMMT 
composites prepared ex situ with 2 wt.% of clay suspension showed a reduction 
of E. coli to 85, 80 and 22%, respectively, after 24 hours[118]. Furthermore, 
BC/NaMMT, BC/CaMMT, BC/CuMMT composites prepared with 4 wt.% clay 
suspensions reduced the viability of E. coli to 81, 75 and 1% and S. aureus to 84, 
80 and 20% after 24 hours, respectively[118].  
 
Although copper itself has proven antibacterial properties, the mechanism behind 
the antibacterial activity of BC/NaMMT and BC/CaMMT is still uncertain[121]. 
According to Cabezas-Pizarro et al., sodium salts destabilise the permeability of 
the cytoplasmic membrane and inhibit enzymes, which can lead to the death of 
Salmonella enteritidis (S. enteritidis), P. aeruginosa, Enterococcus faecalis (E. 
faecalis) and C. albicans[121]. Sodium cations can bind to the negatively charged 
lipopolysaccharides (LPS) in Gram-negative bacteria[122]. Moreover, Jantsch et 
al. noticed that infected areas in a wound display remarkable Na+ accumulation, 
which reduces after antibiotic treatment[123]. Sodium cations can be stored inside 
or directly under the epidermis and generate osmotic conditions in healthy 





tissues. Results showed that osmotic stress within Na+ cation loaded interstitial 
fluid boosts the host’s defence against bacteria and, therefore, strengthens the 
anti-infectious barrier function of the skin[123]. 
 
The antibacterial activity of different BC/MMT composites can also be stronger 
than other BC/metal particles composites. For instance, BC/NaMMT and 
BC/CaMMT composites showed antibacterial activity against MRSA and, in case 
of BC/CuMMT, against S. typhimurium, whereas BC/ZnO nanocomposites did 
not exhibit any antibacterial activity against these pathogens[94, 124]. According to 
Agnihotri et al., S. aureus and C. fruendii are the most common pathogens 
associated with burns[125]. Therefore, modified BC/MMT composites may perhaps 
be used to control infections caused by these pathogens.  
 
Tissue regeneration properties of BC along with healing capabilities of MMT can 
also be exploited for developing materials for treating burn wounds. In the study 
by Sajjad et al., BC/NaMMT, BC/CuMMT and BC/CaMMT composites were used 
to treat wounds in 35 mice, which were divided into five groups including groups 
with pure BC and positive control with silver sulfadiazine (standard topical 
cream)[94]. The results showed that the best healing rate was observed with silver 
cream (76%) and BC/CuMMT (75%), then BC/NaMMT (64%), BC/CaMMT (55%) 
and pure BC (38%) (Fig. 16)[94].  
 






Figure 16. Representative wound photographs of BC/CuMMT, BC/NaMMTC and 
BC/CaMMT treated group, negative control (without BC), pure BC, unmodified MMT-BC 
group and positive control group (silver sulfadiazine) during the course of treatment[94].  
As shown in Fig. 13, BC/CuMMT showed the highest healing rate among the 
other composites. Copper and copper oxide can play an important role in the 
inhibition of extracellular matrix proteins and promotion of angiogenic factors[94]. 
Borkow et al. found enhanced healing and wound closure in diabetic mice using 
copper [126]. However, copper can also be toxic to mammalian cells. For instance, 
Assadian et al. reported that CuO nanoparticles affected the mitochondrial 
membrane and resulted in lysosome leakiness of human blood lymphocytes at 
382 μM concentration[127]. On the other hand, BC/NaMMT composite, which 
showed 64% healing rate, did not exhibit any cytotoxicity to mammalian cells[94]. 





According to Sajjad et al., BC/NaMMT composites showed smooth healing of the 
wound without obvious signs of infection.  
 
The healing effect of BC/NaMMT composites was also investigated using 
haemotoxylin and eosin (H&E) histological strains of tissues. Tissue groups 
treated with BC/NaMMT showed better wound healing with healthy re-
epithelisation than the control group without any treatments[94]. Similarly, Ji et al. 
showed that sodium humate composites promote wound healing in the rat model 
due to the acceleration of wound contraction and increasing hydroxyproline 
content[128]. As the skin epidermis plays a crucial role in preventing 
transepidermal water loss, active transport of Na+ cations can create a 
physiological fluid as the additional barrier. Thus, the increased concentration of 
Na+ cations can promote the healing of the wounds[123]. 
 
1.4. BC/chitosan composites 
1.4.1.  Chitosan overview 
1.4.1.1. Chitosan as chitin derivative 
 
Chitosan is a natural, linear polysaccharide, which can be obtained from partial 
or full deacetylation of chitin[129]. Chitin, which is poly(β-(1→4)-N-acetyl-d-
glucosamine), is the second most abundant polymer after cellulose[130]. In nature, 
chitin occurs as ordered crystalline microfibres that form structural components 
in the cell walls of fungi, yeast and in the exoskeleton of arthropods[131]. The main 
commercial sources of chitin are crab and shrimp waste shells[132]. Chitin shows 
low toxicity to mammalian cells, is biodegradable and has antibacterial 
properties[133]. For example, chitin can inhibit the growth of E. coli and suppress 
the growth of tumour cells in mice[133]. Moreover, chitin may also accelerate 
wound healing[133]. However, the major drawback of chitin is its insolubility in 
water and other organic solvents, therefore the applications of chitin are 
limited[133].   
 





In order to achieve solubility, chitin can be deacetylated to chitosan. Firstly, chitin 
is extracted from crustaceans by using acids in order to dissolve the calcium 
carbonate[134]. The acid treatment is followed by solubilising the proteins under 
an alkaline wash. Partial deacetylation with concentrated NaOH or enzymatic 
hydrolysis leads to the final product, which is chitosan[131]. Deacetylation results 
in the removal of the acetyl group of the glucosamine unit and the formation of 
the amino group[132], [135] (Fig. 17). 
 
 
Figure 17. Effect of conversion of chitin into chitosan on the molecular structure through 
four steps: deproteinisation, demineralisation, decolourisation, deacetylation[135].  
Chitin can undergo additional steps for final removal of residual proteins and 
pigments that could cause problems in biomedical applications. 
 
Thus, the polymer is called chitosan when the fraction of glucosamine units is 
greater than 50%, whereas chitin has greater than 50% of the fraction of N-acetyl 
glucosamine[136]. The number of glucosamine units reflecting the degree of 
deacetylation (DDA), while the N-acetyl glucosamine units indicated the degree 
of acetylation (DA)[136]. 





1.4.2. Structure and properties of chitosan  
 
Chitosan consists of β-(1–4)-2-acetamido-2-deoxy-D-glucose and β-(1–4)-2-
amido-D-glucose units linked by β-(1→4) glycosidic bonds (Fig. 18)[129, 136]. β-(1–
4)-2-acetamido-2-deoxy-D-glucose is the sugar unit GlcNAc (N-acetyl-D- 
glucosamine unit) or A-unit, whereas 2-amino-2-deoxy-D-glucose is the positively 
charged sugar unit GlcN (deacetylated D-glucosamine) or D-unit[137, 138].  
Chitosan varies in the wide range of A-unit fractions (FA) and chain lengths[137]. 
The value of FA units can vary from ca. 0.7 (70% acetylated) to 0 (0% acetylated, 
which means that all units are charged). Chitosan can be considered to be an 
ampholyte due to enrichment in A-unit fractions[137]. The amino-groups of D-unit 
are predominantly positively charged at pH-values lower than 6.5. A- and D-units 
are randomly distributed along the chitosan chain[139]. 
 
 
Figure 18. Schematic molecular structure of chitosan [137]. 
 
The semi-crystalline polymer structure of chitosan results in strong inter- and 
intra-molecular hydrogen bonds[140]. Chitosan can be described in terms of the 
DDA and average molecular weight (MW)[141]. As was mentioned above, DDA is 
the percentage of N-glucosamine[142, 143].  
 
Depending on the preparation procedure and a source, MW of chitosan may vary 
up to 1000 kD with DDA from 30 to 95%[144]. Chitosan with MW of 8.6 kDa or 
more along with DDA of 75-88% has shown the highest aggregation of whole 
blood, washed platelets and erythrocytes in platelet-rich plasma[145]. Furthermore, 
a high concentration of high MW of chitosan (for example, 247 kDa) may cause 





the aggregation of whole blood, PRP and washed erythrocytes[145]. However, MW 
of chitosan can be modified by chemical, enzymatic or mechanical degradation 
methods such as shearing, ultrasound and microfluidisation[146].  
 
Chitosan has three types of reactive functional groups: an amine group, and a 
primary and secondary hydroxyl group[140, 144]. These groups allow modification 
of chitosan for specific applications such as covalent, ionic modifications for 
mechanical and biological properties.  
 
1.4.2.1. Solubility of chitosan  
 
Due to a semi-crystalline structure, which is derived mainly from intra- and 
intermolecular hydrogen bonds, chitosan becomes soluble only at pH lower than 
6 in aqueous acidic environment made of acetic, formic, lactic and hydrochloric 
acids[140]. In such an environment, amine groups of chitosan can be 
protonated[140]. Once the amine groups get protonated, they become positively 
charged and facilitate the solubility of chitosan in diluted acids that makes 
chitosan a water-soluble cationic polyelectrolyte[144]. If pH increases above 6, 
amine groups become deprotonated, therefore, chitosan loses its charge and 
becomes insoluble[147]. A transition state between soluble and insoluble chitosan 
occurs at pH between 6 and 6.5[147]. The concentration of ions can also affect the 
form of chitosan in solution[148].  
 
The following equilibrium reaction describes the state of ionisation, when chitosan 
is dispersed in an acetic acid solution: 
1. 𝐶𝐻!𝐶𝑂𝑂𝐻 + 𝐻"𝑂 ↔ 𝐶𝐻!𝐶𝑂𝑂# + 𝐻!𝑂$ 
2. 𝐶ℎ𝑖𝑡𝑜𝑠𝑎𝑛 − 𝑁𝐻" + 𝐻!𝑂$ ↔ 𝐶ℎ𝑖𝑡𝑜𝑠𝑎𝑛 − 𝑁𝐻!$ + 𝐻"𝑂[148] 
 
The concentration of hydrogen ions in the solution is determined by acetic acid.  
Once chitosan is dispersed in the acid solution, free amine groups start to bind 





hydrogen ions to form cations[148]. A solubilisation occurs when approximately 
50% of all glucosamine units are protonated[148].  
 
The solubility of chitosan may be associated with the degree of deacetylation 
(DDA)[140]. A structure with a DDA value of less than 60% (chitin) is insoluble in 
acidic solutions, whereas DDA at over 60% is defined as chitosan and can be 
water-soluble[149]. The condensation of protonated charge occurs in a chitosan 
solution with DDA over 75% due to a large charge density that leads to both high 
solubility and electrostatic repulsion[149]. A decrease of DDA (<50%) shows the 
largest number of N-acetyl-d-glucosamine units and leads to the hydrophobic 
nature of the polymer chains[149]. Therefore, the fraction of N-acetyl-d-
glucosamine units have a high influence on the solubility of chitosan[149]. 
 
In addition to DDA and pH, molecular weight (MW) can also affect the solubility 
of chitosan. Chitosan with lower MW is more soluble in the acidic medium than 
chitosan with a higher MW[150]. High MW chitosan (MW <300 kDa) might promote 
the formation of aggregations[149]. Such aggregations may occur due to both 
reduction of hydrogen bonds between macromolecules and lack of free amine 
groups for the formation of intermolecular hydrogen bonds[149]. Furthermore, 
aggregation could appear by a loss of conformational entropy due to the 
arrangement of the molecular chains in a regular crystalline array[149]. This loss 
of entropy is compensated by the release of water during the aggregation of a 
chain.  
 
1.4.3. Antimicrobial properties of chitosan  
 
Chitosan can possess antibacterial properties against both Gram-positive and 
Gram-negative bacteria. However, the mode of antibacterial action of chitosan 
may vary between Gram-positive and Gram-negative bacteria due to the 
difference in the structures of their cell walls (Section 1.2.3.1)[151]. 
 





1.4.3.1. Mechanism of antibacterial action of chitosan 
 
The antibacterial activity of chitosan occurs due to the presence of the amine 
groups. The antibacterial mechanism of chitosan is not well understood; however, 
several theories have been proposed[53, 152].  The most accepted theory is based 
on a mechanism involving electrostatic interaction between positively charged 
chitosan and the negatively charged bacterial cell wall, which leads to the 
alteration of cell permeability and lysis. As described in Section 1.4.2.1, chitosan 
becomes soluble in an acid aqueous environment, where the amine groups get 
protonated and, therefore, are positively charged. This means that the –NH2 
groups are converted to a soluble protonated form −NH3+ [46]. The structure of 
Gram-positive bacteria carries a large net negative charge due to phosphate 
groups in teichoic acids, whereas LPS are negatively charged in the outer 
membrane of Gram-negative bacteria[43]. Fig. 19 shows a schematic 




Figure 19. Interactions between bacterial cell walls and chitosan[46].  
For example, the interaction of chitosan and Gram-positive bacteria, such as S. 
aureus, can result in electrostatic binding to the negatively charged teichoic acids 





and approximately 100% inhibition of bacterial growth[151]. Tantala et al. showed 
the alteration of the cell wall of Listeria innocua (L. innocua) bacteria treated with 
0.25 and 0.5 wt.% of high MW chitosan, respectively[152]. The accumulation of 
chitosan around the cell walls of L. innocua was observed by transmission 
electron microscopy (TEM)[152]. TEM results showed that the cell walls of L. 
innocua were covered with chitosan[152]. This might be due to the high MW of 
chitosan making it unable to penetrate the cell walls.  
 
The ability of chitosan to interact with LPS caused changes in the permeability of 
the bacterial membrane, therefore enhancing both non-protein nitrogenous 
substance uptake and release of LPS from the cell surface[131, 151]. The binding of 
chitosan to the outer membrane of Gram-negative bacteria leads to a vesicular 
structure on the cell surface, disruption of the outer membrane and, 
subsequently, results in the loss of cell membrane barrier properties[53, 152].   
 
In Gram-negative bacteria, proteins and LPS are held together by electrostatic 
interactions with divalent cations in order to stabilise the outer membrane. 
Replacement of Mg2+ and Ca2+ ions present in the cell wall may disrupt the 
integrity of the cell wall or influence the activity of degradative enzymes. Chitosan 
may bind to metal ions such as Ni2+, Fe2+ or Cu2+ that are present in the cell and 
play an essential role in cell viability and, therefore, can also inhibit the cell 
growth[132]. The metal-binding capacities of chitosan are stronger at a lower pH 
(below 6.0)[46]. Li et al. reported FTIR spectra and kinetic traces results showing 
that chitosan rapidly attacks the cell wall of E. coli [53]. The cell wall was 
damaged[53]. The leakage of cytoplasm as well as release of DNA and proteins 
were measured by absorbance at 260 nm and 280 nm[53]. Furthermore, TEM 
results showed an alteration of the outer membrane that was coupled with the 
coagulation of cytosolic components after 24 hours[53]. In addition, porins, which 
are located inside the cell wall of Gram-negative bacteria and responsible for the 
uptake of nutrients, could interact with the amine groups thus leading to blockage 





of nutrients exchange due to the formation a polymer layer over the surface of 
bacterial cells[46]. 
 
In Gram-positive bacteria, teichoic acids along with Mg2+ and Ca2+ cations help 
to maintain the integrity and enzymatic functions of the cell wall[46]. The absence 
of these divalent cations could lead to the sensitivity of the cell wall to chemical 
and antibacterial components[46]. Raafat el al. reported ultrastructural changes in 
S. simulans that were exposed to chitosan[131]. It was possible to identify chitosan 
molecules attached to the cell walls using TEM[131]. In addition, Mansilla et al. 
added Mg2+ and Ca2+ cations to the medium and showed an increase in a positive 
charge of the bacterial cell wall that subsequently weakened the antibacterial 
activity of chitosan[46, 131]. 
 
To summarise the comments made above, the interaction between chitosan and 
a bacterial cell wall can cause chelation of trace metal cations, which are 
necessary for the growth of bacteria, breaking down the bacterial cell wall 
followed by the leakage of proteinaceous and other intracellular constituents of 
the cytoplasm[132, 153, 154]. Furthermore, the electrostatic interaction between 
chitosan and the bacterial cell may result in an imbalance of internal osmosis and 
consequently inhibit the growth of microorganisms[131]. In addition, chitosan can 
form a layer over the cell that can subsequently affect the absorption of 
nutrients[53, 132].   
 
Another proposed theory is based on an intracellular mode of antibacterial action 
of chitosan. Chitosan might penetrate a bacterial cell wall and bind to DNA, which 
is negatively charged due to the presence of phosphate groups[155]. However, the 
mechanism of interaction of chitosan with bacterial DNA is not well 
understood[155]. Due to the cationic nature of chitosan and anionic nature of DNA, 
such a binding interaction might be pH dependent and, thus, stronger at a lower 
pH[156]. Chitosan is capable of forming hydrogen bonds with A-T base pairs that 
might lead to a breakage of the Watson Crick hydrogen bonds, whereas the 





Watson Crick hydrogen bonds between G-C nucleotides could exhibit a higher 
stability and restrain diffusion of chitosan[156]. The binding of chitosan to bacterial 
DNA can prevent DNA transcription, mRNA synthesis and interrupts protein 
synthesis[131]. For example, chitosan oligomers were found inside E. coli using a 
confocal laser microscope and caused the prevention of DNA transcription[53]. 
Moreover, chitosan may cause both restraining of motion and structural 
distortions of DNA that could lead to a transformation of DNA into a compact 
structure[156]. It is still unknown whether chitosan interacts with DNA in a specific 
binding manner[156]. However, it might be difficult for chitosan to pass through the 
outer membrane of Gram-negative bacteria[53]. It has been concluded that 
chitosan reacts mostly with the cell walls and proteinaceous content rather than 
DNA or RNA[53]. It has been stated that even though this mechanism is accepted, 
the probability of chitosan passing through cell walls and bind DNA is rather low[53, 
131]. Therefore, explaining these mechanisms is another aspect that has become 
an important and a great challenge.  
 
1.4.3.2. Effect of DDA of chitosan on antibacterial activity  
 
The ability of chitosan to penetrate a bacterial cell wall depends on DDA and MW. 
The DDA of chitosan might affect the antimicrobial properties due to a number of 
amine groups, which are directly involved in at least one of the proposed 
antibacterial mechanisms (Section 1.4.3.1.)[132]. An increase in DDA was reported 
to result in a stronger antimicrobial activity due to the presence of the free amine 
groups[132]. Moreover, the binding activity of chitosan is also stronger at a higher 
DDA[156]. For example, higher DDA showed a stronger DNA binding capacity and 
ability to cause condensation[156]. Furthermore, high DDA could restrain the 
global motion of DNA[156]. Once DNA binds with chitosan, its surface collapses 
which might subsequently lead to a dehydration of DNA[156]. Chitosan with higher 
DDA showed a quicker ability to form a stable complex than low DDA[156]. In 
addition, the Coulombic energy between chitosan and DNA becomes weaker 
when DDA decreases[156]. 





Li et al. found that minimal inhibitory concentration (MIC) of chitosan (DDA 51% 
and 61%, MW > 1000 kDa) was 0.25% against both E. coli and S. aureus, 
whereas increasing DDA to 76.98% resulted in a decrease of MIC to 0.1250%[157]. 
Chitosan with 82% and 100% DDA showed a MIC of 0.0625% and 0.0313% 
against both E. coli and S. aureus, respectively, after 24 hours[157]. According to 
Li et al., the bacterial activity increased as DDA increased from 51% to 81% but 
remained stable after further increasing of DDA[157]. Moreover, Chung et al. 
reported that increasing DDA of chitosan from 75% to 95% leads to increased 
antimicrobial activity against S. aureus and E. coli through nucleotide leakage[158]. 
Similarly, Takahashi et al. showed that 2 wt.% low MW chitosan with increased 
DDA from 89% to 92% could enhance antibacterial properties and fully inhibit the 
growth of both E. coli and S. aureus[159].  
 
1.4.3.3. Effect of molecular weight on antibacterial activity  
 
There are different molecular weights (MW) of chitosan. Low MW chitosan has 
MW<190 kDA, medium MW is 190-310 kDA and high MW >310 kDA[160]. The 
exact antibacterial mechanism of different molecular weights of chitosan against 
both Gram-positive and Gram-negative bacteria is still unknown[161]. Low MW 
chitosan might penetrate bacterial cell walls and enter bacterial cells[161]. As 
Gram-positive bacteria have a thicker layer of peptidoglycan (20-80 nm), chitosan 
might not be able to penetrate the cell wall, but could form a bilayer over the 
surface of a cell[132, 162]. However, low MW chitosan might penetrate the outer 
membrane of Gram-negative bacteria, which is the relatively thin (7-8 nm)[162]. 
Therefore, the thickness of peptidoglycan might play an important role in 
penetration of chitosan into the cell[161, 163]. The studies reported that low MW 
chitosan possessed higher antibacterial activity against Gram-negative bacteria 
than Gram-positive bacteria[164]. Low molecular weight chitosan was found to be 
more effective for E. coli, K. pneumoniae and P. aeruginosa, whereas high 
molecular weight chitosan was more effective against Gram-positive bacteria[165].  





It has also been reported that chitosan with high MW might show reduced 
antibacterial activity against E. coli due to the formation of intramolecular 
hydrogen bonds that prevents amine groups from being available to attach to 
bacterial cells or blocks the entry of chitosan[151]. Such a trend was not observed 
with Gram-positive bacteria, where MW of chitosan higher than 100kDa might 
form a film that inhibits the absorption of nutrients[151]. 
 
Furthermore, it has been demonstrated that hydrophilicity of Gram-positive 
bacteria is lower than in Gram-negative, which makes the latter more sensitive to 
chitosan. As MW decreases chitosan can pass through the channels into cell[166]. 
Low molecular weight chitosan might also bind to DNA and inhibit RNA 
replication[46]. Inside a bacterial cell, low MW chitosan may affect the mobility of 
nucleic acids[132, 162]. Xing et al. showed the interaction of the positively charged 
amine groups in oleoyl-chitosan nanoparticles at a concentration of 1 g/l with the 
negatively charged phosphate groups in the chains of nucleic acids such as DNA 
and RNA of E. coli [46]. Li et al. tested different MW of chitosan using OD610 and 
reported that MW of 50kDA showed higher inhibitory activity than MW of 
1000kDA[53].  Another method of testing was based on measuring the leaching of 
DNA and RNA from the cells at OD260 and OD280[53]. MW of 50 kDA resulted in 
the highest release of nucleic acids after 40 minutes[53]. Furthermore, the cell wall 
of E. coli appeared to be more damaged with low MW chitosan than with high 
MW chitosan[53]. TEM analysis showed that the cell walls of E. coli treated with 
low MW chitosan was disrupted after 24 hours[53]. The cytoplasmic membrane 
was separated from the cell envelope followed by lysis[53]. According to the study, 
low MW chitosan caused disruption of the outer membrane and separation of the 
cytoplasmic membrane, which resulted in a disruption of function, permeability of 
cell walls and leakage of intracellular components followed by the ultimate lysis 
of the cells[53].  
 
However, too low MW chitosan could also negatively affect the antibacterial 
activity. For instance, MW below 40kDa showed a weak antibacterial activity 





against both E. coli and S. aureus[164]. Jeon et al. reported that MW of chitosan 
should be higher than 10kDA for an effective inhibition of bacterial growth[167].  
 
As was stated previously, high MW chitosan may form a dense polymer film on 
the cell surface and prevent nutrients and oxygen from passing through the wall. 
This might inhibit the growth of aerobic bacteria[46]. A number of research studies 
observed bacterial cells such as E. coli and S. typhimurium covered with chitosan 
using electron, fluorescence and transmission microscopes[46, 168]. Cell walls 
appeared thicker due to being coated with chitosan[46]. However, the effect of 
chitosan might also depend on the type of bacteria. For instance, low MW 
chitosan (50 kDa) was effective against Gram-negative E. coli, E. coli O-157, 
Salmonella enterica, Bacillus cereus, B. subtilis, Listeria monocytogenes 
Klebsiella pneumoniae and S. typhi, but not P. aeruginosa[131, 167]. P. aeruginosa 
apperead to be the most resistant microorganism to low MW chitosan in the 
research obtained elsewhere[165]. Furthermore, Streptococcus sobrinus was 
sensitive to both high and low MW chitosan, whereas high molecular weight 
chitosan showed higher antibacterial activity against S. mutans[169]. Therefore, 
the modes of action of different MW chitosan against both Gram-positive and 
Gram-negative bacteria need to be investigated further. 
 
Zheng et al. showed that decreasing the molecular weight of chitosan (MW <5 
kDa, DDA 75-85%) using 0.25 wt.% concentration enhances antibacterial activity 
by 50% against E. coli after 20 hours[162]. Cruz-Romero et al. reported that 1 wt.% 
of both low and medium MW chitosan fully inhibited the growth of Bacillus cereus, 
S. aureus, Pseudomonas fluorescens and E. coli at 0.010 and 0.015 wt.% 
chitosan concentration, respectively, after 20 hours[170]. Therefore, low MW 
chitosan has shown higher antibacterial activity than both medium and high MW 
chitosan[170].   
 
Liu et al. have reported that MW lower than 500 kDa of chitosan along with 80% 
DDA has been effective in the inhibition of growth of E. coli [171]. According to 





Benhabiles et al., the minimum inhibitory concentration using low MW chitosan 
(12 kDa, DDA 80%) at 0.1 wt.% concentration showed complete antibacterial 
activity against E. coli and B. subtilis, whereas 0.3 wt.% was effective against S. 
typhimurium and S. aureus[172]. The concentration 0.5 wt.% of low MW chitosan 
inhibited the growth of P. aeruginosa after 4 hours[172]. Moreover, Jeon et al. 
showed that 1 wt.% of chitosan (MW >10 kDa) caused 100% bacterial growth 
reduction of Streptococcus mutans, S. aureus, Lactobacillus bulgaricus, 
Lactobacillus fermentum and Streptococcus faecalis and 99% against E. coli, E. 
coli O-157, Salmonella typhi and Staphylococcus epidermidis, respectively[167]. In 
addition, 40 kDa MW chitosan could inhibit 90% of S. aureus and E. coli at a 
concentration of 0.5 wt.%[162]. Jeon et al. has claimed that increasing MW of 
chitosan to MW > 10 kDa is more effective against E. coli than MW <10 kDa[167].  
However, it was found that 305 kDa MW chitosan at 0.25 wt.% concentration 
shows 99% antimicrobial activity against S. aureus after 20 hours[162]. According 
to Zheng et al., the antibacterial activity against Gram-positive bacteria such as 
S. aureus can increase with increasing molecular weight, whereas decreasing 
the MW of chitosan can enhance antibacterial properties against Gram-negative 
bacteria such as E. coli [164].  
 
The pH of the chitosan solution can also affect the antibacterial assay. According 
to Li et al., the bactericidal effect of chitosan against E. coli and S. aureus was 
stronger in an acidic solution than in neutral and alkaline solutions[157]. The reason 
for this may be due to the solubility of chitosan in an acidic environment, where 
the amine group of chitosan may be changed to -NH3+ and therefore have 
cationic characteristics. Li et al. reported that pH6 is optimal for the investigation 
of the antibacterial activity because bactericidal activity using chitosan solution at 
a pH below or above pH5 might also come from the effects of acids and alkali[157]. 
For example, Chang et al. used fixed MW chitosan (MW 300 kDa, DDA 95%) 
against both E. coli and S. aureus for 24 hours, but at pH5 and pH6, 
respectively[173]. The results showed that bacterial response and inhibition of 





bacterial growth was increased at pH5, which might be due to either released 
amine groups or acidic stress[173]. 
 
Chitosan also possesses antifungal properties. The interaction between the 
cation chain of chitosan and negatively charged macromolecules on the fungal 
cell membrane leads to leakage of intercellular electrolytes and other 
constitutes[132]. Furthermore, chitosan can affect the morphogenesis of the chitin 
cell wall by acting with enzymes responsible for fungal growth. For instance, low 
MW chitosan can penetrate the hyphae of Fulvia fulva, resulting in growth 
inhibition[132]. Chitosan with MW of 7.6 kDa has been shown to be more effective 
than MW 700 kDa against Botrytis cinerea and Colletotrichum lagenarium, 
respectively[174]. This might be due to the ability of lower molecular weight 
chitosan to penetrate the fungal cell more easily than medium or high MW 
chitosan. Moreover, Marquez et al. showed the membrane disruptive ability of 
low MW chitosan (75-85% DDA) on 31% of haploid deletion mutants of 
Saccharomyces cerevisiae[175]. In addition, Hernandez-Lauzardo et al. showed 
the antifungal effect of different MW chitosan (17-30 kDa) against Rhizopus 
stolonifer in various stages of fungal development[176]. The results show that 
chitosan with MW of 17 kDa is more effective in the inhibition of mycelial growth, 
whereas chitosan with MW of 30 kDa influenced sporulation and germination[176]. 
Therefore, chitosan can be beneficial for introducing antimicrobial properties into 
BC for a number of potential wound healing applications. 
 
1.4.4. BC/chitosan composites for wound dressing applications 
 
The presence of O-H and N-H groups in chitosan may lead to strong chemical 
binding to BC[177]. As chitosan can be beneficial in wound healing systems due to 
its antimicrobial properties, ability to absorb the wound exudates and lack of 
mammalian cytotoxicity, the possibility of incorporation of chitosan into BC for 
wound healing properties has been investigated.  





In one case study, 0.1 wt.% chitosan (MW 30 and 80 kDa, DDA 85%) was added 
to coconut water, which contained 5 wt.% sucrose, in order to produce in situ a 
BC/chitosan composite. The composite was incubated for 5 days at 30°C. The 
results showed that the addition of chitosan to the medium inhibits the growth of 
BC [138]. The final BC/chitosan composite had a denser fibre structure and smaller 
pore diameter than pure BC[138]. Wahid et al. synthesised ex situ semi-
interpenetrating BC/chitosan hydrogels with antibacterial properties against E. 
coli and S. aureus[178]. In order to prepare the composite, BC was incubated using 
HS medium for 7 days at 30°C[178]. Then, 1% of homogenised BC was mixed with 
both 2 wt.% of low MW chitosan solution and 2% glutaraldehyde as a cross-
linking agent at 80 °C for 4 hours [178]. The antibacterial properties were analysed 
through the colony-forming unit (CFU) method. BC/chitosan hydrogel reduced 
the population of S. aureus and E. coli by 88% and 98%, respectively[178]. A 
similar antibacterial effect was observed by Wu et al., where chitosan and 
synthesised BC were dissolved in 2 vol.% acetic acid and then mixed at ratio 1:1, 
1:3 (1 part chitosan to 3 BC) and 3:1 (3 parts chitosan to 1 BC)[179]. Then, all BC 
samples were placed in 24-well plates with bacteria, respectively, for 1, 2, 3 and 
4 hours[179]. After incubation, both BC and bacteria were sonicated for 75 seconds 
at 64 kHz [179]. The bacteria were then plated on agar plates for 24 hours at 
37°C[179]. The results showed full inhibition of E. coli growth using 3:1 BC and 1:1 
ratio, whereas the viability of bacteria was 5% with 1:3 ratio composite[179]. The 
most effective ratio for inhibition of S. aureus growth was 3:1 (98%), then 1:1 
(95%). Least effective was 1:3 (40% of bacterial viability)[179]. Lin et al. immersed 
BC into 0.6 wt.% chitosan solution for 12 hours and then freeze-dried the 
composite for antibacterial agar diffusion assay[180]. The results showed 99% 
reduction of both E. coli and S. aureus growth[180].  
 
1.4.4.1. Mammalian toxicity of BC/chitosan composites  
 
The cytotoxicity of BC/chitosan composites has also been investigated. The 
cytotoxicity of the BC/0.6 wt.% chitosan composites, which were synthesised by 





the immersion, were analysed using mouse skin fibroblast cells (L929) in the 
presence of DMEM and 10% FBS medium[180]. The results showed that 
BC/chitosan composites do not affect cell viability[180]. Similarly, Kingkaew et al. 
showed no cytotoxicity of BC/chitosan composite, which was synthesised by 
immersion of BC into 1 wt.% chitosan (MW 30 and 80 kDA)[181]. Even though the 
growth of human skin keratinocytes and fibroblasts was similar within pure BC 
and the BC/chitosan composite, cell adhesion and spreading were improved 
within BC/chitosan material[181]. Moreover, the results did not show any 
differences in cytotoxicity to fibroblasts between 30 kDA and 80 kDA MW chitosan 
in BC/chitosan composites on the cytotoxicity[181].  
 
Another investigation of the cytotoxicity of BC/chitosan composite used 1 wt.% 
chitosan solution that was mixed with 1g of BC in order to synthesise BC/chitosan 
composites at 1:1 ratio[182]. The composite was air-dried and applied to L929 
cells, which were maintained in DMEM medium for 24 hours. The results showed 
that cell viability using BC/chitosan composite was 90% compared to the control 
after 24 hours[182]. Kim et al. compared 3t3 fibroblasts cell attachment to the fibres 
of pure BC and BC/chitosan composite, which was produced by immersion of BC 
into 1 wt.% chitosan solution, by seeding the cells on the surface of cellulose in 
DMEM for 48 hours[183]. The results showed that cells that were attached to pure 
BC remained round-shaped, but the cells that were attached to BC/chitosan 
adhered with many pseudopodia, proliferated and almost completely spread over 
the surface[183]. This might be due to better biocompatibility of BC/chitosan 
composite than pure BC.  
 
The synthesised BC/chitosan composite has also been tested as a wound 
healing material on 18 8-weeks-old male Sprague Dawley rats, where pure BC 
and BC/chitosan dressings were compared to the commercial Tegaderm™ [180]. 
According to Lin et al., both BC membranes showed rapid healing and 85% 
wound closure on the 8th day followed by complete healing on the 13th day, 
whereas Tegaderm™ showed lower epithelisation rate and complete healing on 





the 14th day[180]. Moreover, the average contraction of the wound was greater with 
BC/chitosan than pure BC. Furthermore, the keratin production was more 
integrated with BC/chitosan composite than pure BC on day 7[180]. Due to the 
generation of type IV collagen, the epidermis and dermis were anchored tightly 
in the wounds treated with BC/chitosan[180]. Chitosan can also increase the 
production of collagen type III. For example, in one study, 15-month old female 
beagles, weighing 8-10 kg, were wounded; one group was treated with 0.5 wt.% 
chitosan fibres for 15 days (MW 30kDA, DDA 18%) [184]. It was found that chitosan 
promotes the granulation phase of healing by increasing the production of 
collagen type III[184]. The chitosan-treated wounds showed major infiltration of 
polymorphonuclear leukocytes compare to the control group on the 3rd day[184]. 
The increase of polymorphonuclear leukocytes led to the production of 
osteopontin, which is a glycosylated phosphoprotein that promotes the 
attachment and spread of cells[185].  
 
Chitosan can also accelerate the migration of macrophages. As chitosan consists 
of GlcN and GlcNA units, macrophages can inhibit the receptors for mannose- 
and GlcNa-glycoproteins, which then mediate the uptake of glycoprotein into 
macrophages[185]. Therefore, GlcNA units of chitosan can bind to macrophage-
specific receptors, which then leads to the release of various biological mediators 
and fast wound healing [185]. In addition, chitosan can degrade in vivo mainly by 
enzymatic hydrolysis[144]. Highly deacetylated chitosan (DDA > 85%) possesses 
a low degradation rate in vivo, which may last for several months, whereas lower 
DDA degrades more rapidly[144]. Moreover, chitosan can also evoke a minimal 
foreign body reaction, which is beneficial for wound healing applications[144]. 
 
1.5.  Kombucha as an alternative to conventional BC 
 
Another type of bacterial cellulose is Kombucha cellulose (KC). Similar to 
conventional BC, cellulose pellicles of KC are formed on the top of the growth 
medium, which is usually black tea, due to the presence of Acetobacteraceae. 





1.5.1. The structure of Kombucha cellulose 
 
The structure of KC is similar to conventional BC. The fibres of KC are less than 
100 nm in diameter and composed of ribbon-like fibre bundles, which are 20–70 
nm in width (Fig. 20)[162]. These fibre bundles consist of 3–10 fibrils with a 
diameter of approximately 7-10 nm[162]. 
 
Figure 20. TEM image showing the structure of the KC matrix and fibres [162]. 
As shown in Fig. 21, the 3-D matrix of KC is translucent, with numerous pores of 
different sizes [162].  
 






Figure 21. SEM images showing the structure KC matrix. A and c demonstrate the dense 
surface, whereas b and d show the enlarged porous matrix [162].  
 
Therefore, KC and conventional BC have a similar 3-D structure, which suggests 
that KC can be used as an alternative due to the simpler fermentation process, 
which involves mainly microorganisms such as bacteria and yeasts, tea and 
sugar. 
1.5.2. Microbial composition of Kombucha  
 
Kombucha is a beverage prepared by fermenting mainly black tea and sugar 
along with a symbiotic culture of bacterial and yeast (SCOBY)[186]. The SCOBY 
is a composition of microorganisms resembling a mushroom cap, which then 
starts the brew. The SCOBY consists of various acetic acid bacteria such as G. 
xylinus, Acetobacter pasteurianus, Gluconobacter oxydans and Acetobacter 
aceti and yeast such as Saccharomyces species, Zygosaccharimyces 
kombuchaensis and Zygosacharomyces bailii [186, 187]. De Filippis et al. reported 
that the concertation of acetic acid bacteria (AAB) increased to 1.5 log and 5.5 
log CFU/ml after 7 and 21 days, respectively, of cultivation at 20°C, whereas the 
initial concentration of AAB increased to 8.5 log CFU/g during the same period of 
time at 30°C[188]. In addition, the genus Gluconacetobacter reached 90% in total 





among all bacterial population after 7 days, while Acetobacter decreased to 3-
5% after 21 days[188]. Therefore, Gluconacetobacter is found to be the prevalent 
genus for production of Kombucha. 
 
1.5.3. Fermentation of Kombucha cellulose 
 
Kombucha cultivation can be achieved by placing SCOBY into a sugared tea 
broth. Fermented Kombucha beverage (KB) can consist of sugars, tea 
polyphenols, fibre, ethanol, acids such as acetic, glucuronic, lactic and gluconic, 
Ni, Mn, Fe, Cu, vitamins such as C and B, hydrolytic enzymes and carbon dioxide 
after fermentation[189, 190]. For example, Kombucha that has been fermented for 
14 days, has the concentration of 6.38 mg/ml and 1.34 mg/ml of gluconic acid 
and d-saccharic acid-1,4-lactone (DLS), respectively[191, 192]. Furthermore, the 
concentration of ethanol increased within the time and reached 0.28 ± 0.014 g/L 
on the 7th day of fermentation, which then decreased to about 0.073 ± 0.003 g/L 
after 21 days of fermentation[193]. This might be due to the utilisation of ethanol 
by AAB in order to produce acetic acid. 
 
1.5.4. Benefits of Kombucha beverage 
 
The FDA has not found any pathogenic organisms in Kombucha cellulose and 
Kombucha tea[191]. Therefore, Kombucha is a safe product, which has been 
already commercially available. Kombucha has not shown any toxic signs in 
albino Witsar rats after feeding them orally with Kombucha at 2.5 ml/kg of their 
body weight for 60 days[192]. Furthermore, Kombucha tea at a mass of 60 μg has 
not shown any cytotoxicity against hepatocytes liver cells after 24 hours 
maintained in DMEM[194]. Due to antioxidant activity, Kombucha tea can modulate 
the oxidative stress in hepatocytes via mitochondrial-dependent pathways[194]. 
This might be beneficial against liver diseases. 
 





Kombucha components such as tea polyphenols, acids such as ascorbic and 
vitamins might result in the antioxidant potential of KB. Due to the benefits of such 
components on health, Kombucha can also reduce cholesterol level, blood 
pressure and inflammation, provide an antibiotic effect and generally enhance 
metabolism[189]. The antioxidant properties of black tea have been compared to 
KB. Four-weeks-old Swiss albino male rats, weighing approximately 180-200 
grams, were, in additional to their normal diet, fed with 150 mg/kg black tea and 
Kombucha, respectively, for 14 days[191]. In this study, Kombucha was brewed 
with black tea containing 10 vol.% sucrose for 14 days. The results showed that 
the total phenol and flavonoid content, which contained a high level of 
antioxidants, owing to their ability to scavenge free radicals, increased in 
Kombucha by 27.2% and 75%, respectively, compared to black tea[191]. The 
reason for this might be the presence of enzymes and other components such as 
organic acids, which are produced by bacteria and yeasts during Kombucha 
fermentation. 
 
1.5.5. Antimicrobial properties of Kombucha beverage 
 
The KB can exhibit antimicrobial activity against bacteria such as E. coli, S. 
aureus, S. typhi, S. epidermis [195-197]. The antibacterial activity of KB may be 
inhibited by the presence of acids such as acetic acid inside the Kombucha broth. 
During fermentation, the pH of KB can go from initial 5 to 2-3 on the 7th day of 
fermentation[198, 199]. The decrease of pH was not continuous and went down to 
maximum pH2-1.88 by the 21st day[188]. 
 
An accurate antibacterial analysis can be obtained at a fixed pH. For example, 
Battikh et al. reported antibacterial properties of KB with pH was fixed at pH2, 
which had been brewed in black tea containing 20 g/L sucrose for 21 days, 
against S. epidermis, S. aureus, Micrococcus luteus (M. luteus), S. typhimurium, 
L. monocytogenes, E. coli and P. aeruginosa [198]. The results showed that the 
largest inhibition zones were 18.5 ± 2.1 mm diameter for S. epidermis and 19.0 





± 1.4 mm for P. aeruginosa , followed by 14.5 ± 2.1 mm for S. aureus, 16.5 ± 0.7 
mm for M. luteus and 14.0 ± 1.4 mm for S. typhimurium[198]. The smallest zone of 
inhibition was 11.0 ± 1.4 mm for E. coli [198].  
 
Furthermore, the antibacterial activity of KB against E. coli, S. typhi, P. 
aeruginosa, S. aureus, Shigella sonnei (S. sonnei) and Microsporum canis (M. 
canis), was evaluated by Santos et al. The KB was prepared using 0.5 wt.% mate 
tea containing 35 wt.% sucrose[199]. The antibacterial effect of KB in volume of 50 
μl, but at different fermentation times was evaluated at a fixed pH4[199]. The 
results showed the antibacterial activity of KB against M. canis after 14 days of 
fermentation, where zones of inhibition were from 24 to 28 mm in diameter[199]. 
Fermented KB inhibited the growth of E. coli in 12-16 mm zones after 14 days 
[199]. KB showed antibacterial activity against S. typhi on the 21th day of the 
fermentation, where the zones of inhibition were 30 mm in diameter[199]. However, 
KB did not show any antibacterial activity against P. aeruginosa, S. aureus or S. 
sonnei [199]. 
 
The antibacterial properties of KB prepared with black tea and 100 g/L sucrose 
for 9 days were also analysed against S. aureus, E. coli, B. cereus, Salmonella 
choleraesuis (S. choleraesuis) and C. albicans [200]. In this research, KB pH was 
fixed at 7, subsequently absorbed by the sterile cotton pad and placed on the top 
of agar with freshly spread bacteria [200]. Zones of inhibition for S. aureus were 
1.2-1.4 mm, 1.5-1.6 mm for E. coli and 0.3-0.4 mm for B. cereus [200]. Moreover, 
1.2-1.5 mm zones were observed for S. choleraesuis, whereas C. albicans did 
not show any zones of inhibition [200].  
 
In addition, Ashrafi et al. mixed from 1 vol.% to 3 vol.% of KB that was produced 
in black tea containing 100 g/L sucrose for 18 days with 0.5 wt.% chitosan 
solution (MW 310-375 kDa, DDA 75-85%). The composite was then air-dried, cut 
into 1 x 4 cm strips and subsequently placed on the top of agar plates containing 
bacteria [201]. The results from antibacterial assay showed that inhibitory zones for 





S. aureus were 13.2 mm, 15.2 mm and 17.6 mm using chitosan/1 vol.% KB, 
chitosan/2 vol.% KB and chitosan/3 vol.% KB, respectively[201]. The inhibitory 
zones using chitosan itself were 8.66 mm in diameter for S. aureus and 6.21 mm 
for E. coli [201]. Chitosan/1 vol.% KB, chitosan/2 vol.% KB and chitosan/3 vol.% 
KB showed 15.3, 20.1, 20.1 mm in diameter zones of inhibition against E. coli, 
respectively[201]. While untreated KB has antibacterial properties, treated KC did 
not show any bactericidal activity[202].  
 
1.6. Need for the research 
 
There are limitations associated with biomedical applications of BC, especially in 
wound and burn surgeries. One of the major drawbacks of BC is the lack of innate 
antibacterial properties. The presence of antibacterial activity in BC is crucial, 
because infections are one of the most challenging issues in burn recovery, as 
they can delay the healing process by adversely affecting the patient’s immune 
system and extensively disrupting the physical skin barrier. In order to prevent 
infections, BC can be modified using different materials with antimicrobial 
properties. However, another drawback is that most of antibacterial agents, such 
as silver, copper or TiO2 might have adverse effects on human health[71]. In 
addition, due to toxicity of those antibacterial agents, there is a challenge in 
controlling the amount of incorporated material into BC. The incorporation of 
antibacterial compounds into BC can result in a non-uniform distribution or 
accumulation of particles on its surface[63].  This variation of concentration of 
nanoparticles within the BC matrix means that a varied dose of an antibacterial 
agent will be encountered by bacteria. The uncontrolled leaching of toxic 
additives can lead to relatively strong adverse effects on human health. 
 
Based on the above-mentioned limitations, there is a need to develop a BC-
based composite with permanent antibacterial and non-toxic to mammalian cells 
properties. This material might be suitable for medical applications such as 
wound and burns therapies. In order to fill the need, the current research is 





focused on the use of BC and its derived soft gels with smectite clay and chitosan, 
to develop an antibacterial film that is non-toxic to mammalian cells and exhibits 
low levels of biocide leaching.  
 
1.7. Aim and objectives of the study 
 
The overall aim of the project is to use nanofillers to develop BC-based gels with 
permanent antimicrobial properties without biocide leaching. Such a material 
would be ideal for wound dressing, artificial skin and cosmetic applications. The 
aim was achieved by introducing the antimicrobial, natural and non-toxic towards 
mammalian cells materials into BC. These natural biocides were incorporated 
into BC through both in situ and ex situ modification.  
 
In order to achieve the objective, natural Cloisite Na+ and synthetic SWN (lithium 
magnesium sodium silicate) clays were exfoliated and incorporated in situ and ex 
situ into the BC matrix. Moreover, the novel BC-based material, which was named 
bacterial chitosan, was developed using chitosan as the main carbon source. The 
antibacterial activity of bacterial chitosan was investigated against both MRSA 
and E. coli. The solubility of bacterial chitosan was evaluated by immersion of the 
material into vinegar for 48 hours. Furthermore, the modification ex situ was 
carried out by introducing either clay or chitosan into already formed BC gels. 
The antimicrobial behaviour of a hybrid structure of chemically cross-linked 
chitosan hydrogel and BC hydrated gel was also investigated. The enhancement 
of the antibacterial activity of BC/chitosan hybrid hydro and hydrated gels was 
obtained by using exfoliated clay. Organoclays containing QAC, which exhibit 
antibacterial properties, were incorporated into BC. In addition, antibacterial 
activity was provided to Kombucha, which is a mixture of organisms, using natural 
biocides. This demonstrates that the new materials can be produced in domestic 
environments, which may offer potential for future commercialisation and the 
creation of new industries. 
 





This thesis is divided into eleven parts. The next Section is an experimental 
methodology that covers the materials and techniques used during the project. 
The results and discussion are presented in chapters 3-8. The 9th Section is the 
final discussion. The last two chapters conclude the results obtained and provide 
ideas for future work. 
 
  





Chapter 2. Experimental Methodology  
 
2.1. Materials used in the current study 
 
Gluconacetobacter xylinus (G. xylinus) (ATCC 53524), which was used for the 
synthesis of BC, was supplied by LGC Ltd. Chosen bacteria for the antibacterial 
assay were methicillin-resistant Staphylococcus aureus (MRSA) NCTC 10418 
and Escherichia coli (E. coli) NCTC 12493 that were obtained from the National 
Collection of Types Culture (NCTC). Pseudomonas aeruginosa (P. aeruginosa) 
ATCC 15442 was supplied by American Type Culture Collection (ATCC).  
 
Bacteriological peptone (code 70175), citric acid (code 251275), disodium 
phosphate (code S7907), yeast extract (code Y1625), microbiology agar #3  
(code A5306), D-(+)-glucose (code G8270), skimmed milk powder (code 70166), 
tryptic soy agar (TSA, code 22091), tryptic soy broth (TSB, code 22092) and 
phosphate buffered saline (PBS, code P4417) were purchased from Sigma 
Aldrich. 
 
NIH 3t3 Swiss mouse embryo fibroblast cells (code 93061524) were purchased 
from Sigma Aldrich and used for the mammalian cytotoxicity assay. Dulbecco’s 
modified Eagle’s medium (DMEM, code 11965084) containing both glucose and 
L-glutamine was purchased from ThermoFisher Scientific. Dimethyl sulfoxide 
(DMSO, code 10103483) and fetal bovine serum (FBS, code 11563397) were 
manufactured by Gibco and were obtained from ThermoFisher Scientific. MTT 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) with the product 
code of M6494 and penicillin-streptomycin (code 11548876) were purchased 
from ThermoFisher Scientific. Dulbecco’s phosphate buffered saline (D8662) was 
purchased from Sigma Aldrich. 
 
Black Yorkshire tea (code B07JXK2C7V) was produced by Taylors of Harrogate 
and obtained from Amazon. Kombucha SCOBY was supplied by Amazon with 





the Amazon standard identification number (ASIN) of B00H9I80C6 and 
manufactured by Happy Kombucha. 
 
Natural NaMMT (Cloisite Na+) and Cloisite 10A, Cloisite 15A, Cloisite 20A, 
Cloisite 30B and Cloisite 93A organoclay were purchased from Southern Clay 
Products, USA. Organoclay are MMT clay that were organically-modified by 
incorporating quaternary ammonium cations into the clay structure. 
 
LucentiteTM (SWN) was obtained from COOP, Japan. SWN is a synthetic, 
commercial smectite clay. SWN is a lithium magnesium sodium silicate and has 
a TOT structure similar to natural MMT. Si ions are located in tetrahedral sheets, 
whereas Mg ions can remain or be replaced with Li in an octahedral sheet (Fig. 
22). SWN consists of silicate nanolayers with the dimension of height to length 
approximately 1:300 nm[204]. The silicate nanolayers have diameter of 25 cm and 
thickness of 1 nm[204]. This means that even SWN and Cloisite Na+ have similar 
structure, but the aspect ratio is smaller in SWN clay.  
 
 
Figure 22. Schematic structure of synthetic SWN clay[205]. 
 





Low molecular weight (MW) chitosan (product code 448869) with MW of 50-190 
kDa and 75-85% degree of deacetylation (DDA). It was purchased from Sigma 
Aldrich. Medium MW chitosan (code 448877) with MW of 190-310 kDa and 75-
85% DDA was also obtained from Sigma Aldrich. Widely-available (WA) chitosan 
with the Amazon standard identification number (ASIN) of B008TO725K was 
purchased from Amazon and produced by BioOrigins. Sodium metaperiodate 
(product code S878), which was used for the oxidation of BC, was obtained from 
Sigma Aldrich. 
 
All materials were sterilised by either autoclaving at 121oC for 15 min at 100 
kPa (15 psi) pressure or passing through 0.2 μm pore size filters (Fisher 
Scientific). 
 
2.2. Synthesis of BC 
2.2.1. Maintenance of bacterial species 
 
For long-term storage, colonies from agar plates with G. xylinus were re-
suspended in the solution that consisted of 3 grams of TSB, 2 grams of biology 
purpose skimmed milk powder, 0.5 grams of glucose powder, 4 ml of glycerol 
made up to 100 ml in total before sterilising. The bacteria were then stored at -
80°C. 
 
Hestrin Schramm (HS) medium was used for the growth of G. xylinus either on 
agar plates or in liquid broth. The medium consisted of 5 grams of bacteriological 
peptone, 5 grams of yeast extract, 1.15 grams of citric acid, 2.7 grams of disodium 
phosphate.  If agar was required, 15 grams of microbiology agar #3 was added 
at this point. The medium was, then, adjusted to pH5 using 0.1M of hydrochloric 
acid and filled up to 960 ml by adding distilled water. The medium was then 
sterilised in an autoclave. Subsequently, 40 ml of 50 wt.% glucose solution, which 
was sterilised by the filter pore size of 0.2 µm, was added to either broth or agar 
after autoclaving to give a final concentration of 2 wt.%.  





Prior to any experiment, bacteria were streaked from the frozen culture to HS 
agar and incubated for 48 hours at 30°C. These bacteria could then be stored for 
up to 2 weeks at 4-8°C.  
 
2.2.2. Incubation of bacteria in liquid medium  
 
Bacteria, that had been incubated on HS agar for 48 hours at 30°C, were 
aseptically re-suspended in sterile PBS. This bacterial solution was added to HS 
medium and inoculated on either small or large scale. For the small scale 
production, the bacterial suspension was adjusted to 0.1 OD600 and then 
inoculated into 3 ml of HS medium. This small scale production continued by 
subsequent incubation of the bacteria in 6 well sterile polystyrene plates 
(Sarstedt, 3.5 cm diameter x 2 cm depth) statically at 30°C for up to 72 hours.  
 
The large scale production was carried out by the diluting the bacterial 
suspension into 200 ml of HS medium. The bacteria were incubated statically 
inside sterile pyrex dishes (27 cm height x 35 cm width x 6 cm depth), which were 
sealed with aluminium foil, at 30°C for up to 96 hours.  
 
The temperature, duration of incubation, medium type and carbon sources varied 
as detailed in subsequent experiments. 
 
2.2.3. Treatment of BC after incubation 
 
The synthesised BC was treated by submerging statically within 0.1M NaOH at 
80°C for an hour, and then, washed with distilled water until pH reached 7. A 
sterility check by incubation of a portion of BC after the treatment was carried out 
in both HS and tissue culture medium. If no contamination was observed, BC was 
then termed as pure BC, which was the basis for further treatments and 
characterisation.  
 





2.3. Optimisation of BC growing conditions 
 
The growing conditions of BC were optimised on both small and large scales. 
The effect of temperature, time and concentration of a carbon source were 
analysed. 
 
2.3.1 The effect of optical density  
 
The effect of optical density on the synthesis of BC was investigated by 
inoculation of G. xylinus at 0.001-0.5 OD600 with 3 ml of HS medium, respectively, 
at 30°C for 48 hours. The experiment was carried out on a small scale in 6 well 
sterile polystyrene plates (Sarstedt, 3.5 cm diameter x 2 cm depth). The produced 
BC was dried for 48 hours at 37°C. The growth of BC was evaluated by the mass 
yield of dried BC.  
 
2.3.2 The effect of temperature  
 
In order to investigate the optimal temperature for BC growth, 0.1 OD600 of PBS-
resuspended bacteria were inoculated with 3 ml of HS medium at 25°C, 30°C 
and 37°C, respectively, for 48 hours. The experiment was carried out on a small 
scale in 6 well sterile polystyrene plates (Sarstedt, 3.5 cm diameter x 2 cm depth). 
The growth of BC was evaluated by the mass yield of wet and dried BC. The wet 
mass was obtained by placing the produced wet BC into a centrifuge tube and 
sedimentation at 150xg followed by discarding the supernatant. This process was 
repeated three times. The dried mass was obtained by drying centrifuged BC 
pellet for 48 hours at 37°C.  
 
2.3.3 The duration of incubation 
 
The duration of incubation on the synthesis of BC was investigated by inoculation 
of G. xylinus at a concentration of 0.1 OD600 for 24, 48 and 72 hours, respectively, 





on a small scale at 30°C. The bacteria were also inoculated for 24, 48, 72 and 96 
hours at 30°C on a large scale in sterile pyrex dishes (27 cm height x 35 cm width 
x 6 cm depth). The growth of BC was evaluated by the mass yield of wet and 
dried BC. The wet mass was obtained by placing the produced wet BC into a 
centrifuge tube and spinning the tube at 150xg followed by discarding of the 
liquid. This process was repeated three times. The dried mass was obtained by 
drying centrifuged BC pellet for 48 hours at 37°C.  
 
2.3.4 The effect of carbon source  
 
The effect of a reduction of a carbon source on the production of BC was 
investigated on a small scale in 6 well sterile polystyrene plates (Sarstedt, 3.5 cm 
diameter x 2cm depth). The bacteria at a concentration of 0.1 OD600 were 
inoculated with 3 ml of HS medium containing from 2 wt.% (standard) to 1 wt.% 
glucose. The incubation was carried out for 48 hours at 30°C. The BC produced 
was then dried for 48 hours at 37°C. The growth of BC was evaluated by the 
mass yield of dried BC. 
 
2.4. The growth of BC in a clay environment  
 
Exfoliated and non-exfoliated Cloisite Na+ and SWN clay suspensions were 
mixed with HS medium at concentrations from 0.09 mg/ml to 3 mg/ml, 
respectively. The bacteria at the concentration of 0.1 OD600 was added to HS/clay 
suspensions and inoculated on a small scale for 48 hours at 30°C. For the large 
scale production, both exfoliated and non-exfoliated Cloisite Na+ and SWN clay 
suspensions were used at the concentration of 3 mg/ml, respectively. 
 
2.4.1. Preparation of clay suspensions 
 
A stock solution containing 6 mg/ml of either Cloisite Na+ or SWN suspensions 
was prepared in a total of 100 ml by mixing the clay powder in distilled water, 





respectively, and defined as non-exfoliated. Exfoliated suspensions were 
obtained using a blender (Tefal Fruit Sensation blender) for 16 minutes (for 
Cloisite Na+) and 10 minutes (for SWN) at speed 1, respectively. All clay 
suspensions were sterilised through autoclaving at 121°C for 15 minutes. 
 
2.4.1.1. Exfoliation of clay suspensions 
 
Both Cloisite Na+ and SWN clay suspensions were treated using ultrasound, 
magnetic stir and the Tefal blender, respectively. The treatment was based on 
disassociating of clay particles in 100 ml of each stock of clay suspensions for 16 
minutes for Cloisite Na+ and 10 minutes for SWN, respectively.  
 
In order to treat the clay using ultrasound, 100 ml of aqueous Cloisite Na+ and 
SWN clay suspensions were sonicated (Missonix) at 85% amplitude for 16 and 
10 minutes, respectively. In order to prevent overheating of solutions, sonication 
occurred at intervals of 5 minutes, followed by a minute cooling period at 25oC.   
Cloisite Na+ and SWN suspensions at the concentration of 6 mg/ml in the volume 
of 100 ml being stirred using plastic covered stir bar for 16 and 10 minutes, 
respectively, at 800 rpm speed and at 25oC.  
 
Aqueous suspensions of Cloisite Na+ and SWN clay were also exfoliated using 
the Tefal blender for 16 and 10 minutes, respectively, at speed 1. The effect of 
the coffee grinder and chopper blades on the exfoliation of the clay were 
investigated.  
 
All suspensions were stored at 25°C for no longer than a day until incorporation 
into BC or further characterisation. The characterisation of the exfoliation state of 
the suspensions was carried out using dynamic laser scattering (DLS). 
 
 





2.4.1.2. Characterisation of exfoliation state of the clay suspensions 
using dynamic laser scattering 
 
Measurements of size, volume and number distribution of clay particles or 
aggregations were carried out using dynamic laser light scattering (DLS, supplied 
by Malvern N4). A cuvette containing 1 ml of each suspension was analysed at 
25°C using a 90-degree beam angle and 5 minute equilibration time. The data 
obtained were observed by three mean parameters: numbers, volume and 
intensity. The measurements were repeated up to four times. 
 
2.4.2. The rheological characterisation of gel formation  
Non-exfoliated and exfoliated by the Tefal blender as described in Section 
2.4.1.1. Cloisite Na+ and SWN suspensions at the concentration of 3 mg/ml were 
mixed with HS medium, respectively. The gel formation measurements were 
carried out at 0 and 48 hours, respectively, using a rheometer (supplied by Bohlin 
Instruments). Each sample with volume of 1.2 ml was sandwiched between the 
plates. The measurements carried out by rotating an upper plate and a fixed lower 
plate with the sample present between them. The working gap between the plates 
was 400 µm. The type of the upper plate used was PP40. The measurements of 
both viscous and elastic modulus were carried out at the frequency ranging from 
0.01 to 10Hz for 21 minutes at 25oC. After 0 hours measurement, the samples 
were stored for 48 hours at 30°C incubator.  
2.4.3. Inoculation of G. xylinus with clay suspensions on a small scale 
 
The small scale production was carried out by the adding exfoliated and non-
exfoliated Cloisite Na+ and SWN clay suspensions to HS medium with a final 
concentration of the clay ranging between 0.09-3 mg/ml, respectively. Inoculation 
of bacteria was carried out by adding 100 µl of 0.1 OD600 PBS re-suspended 
bacteria to 3 ml of HS/Clay suspensions. The inoculum was incubated in 6 well 
plates (Sarstedt, 3.5 cm diameter x 2 cm depth) at 30°C for 48 hours. The BC 





produced was dried for 48 hours at 37°C. The growth of BC was evaluated by the 
mass yield of dried BC.  
 
2.4.4. Inoculation of G. xylinus with clay suspensions on a large scale 
 
The large scale production was carried out by adding exfoliated and non-
exfoliated Cloisite Na+ and SWN clay suspensions to HS medium to a final 
concentration of clay of 3 mg/ml, respectively. Then, 200 ml of HS/Clay medium 
was aseptically poured into sterile pyrex dishes (27 cm height x 35 cm width x 6 
cm depth). The bacteria in the volume of 50 ml of 0.1 OD600 was added to HS/clay 
medium, sealed with a foil and incubated at 30°C for 48 hours.  Subsequently, 
the wet mass was obtained by placing the produced wet BC/clay composite into 
a centrifuge tube and spinning the tube at 150xg followed by discarding of the 
liquid. This process was repeated three times. The growth of BC was evaluated 
by the mass yield of wet and centrifuged BC. 
 
2.4.5. Investigation of leaching behaviour 
 
The leaching behaviour of clay from BC/clay composite produced in situ started 
with obtaining the calibration curves measuring the absorbances of different 
concentrations of Cloisite Na+ and SWN clay, respectively. For this, the stock clay 
suspensions were diluted to the concentration ranging from 0.6 to 0.0019 mg/ml. 
The absorption values of the characteristic peak at the wavelength of 211 nm of 
each concentration were measured. Then, the graph showing the absorption 
versus the concentration was obtained.  
 
BC/Cloisite Na+ and BC/SWN composites produced in situ using the large scale 
method were placed into a centrifuge tube containing 20 ml of distilled water, 
respectively. The tubes were shaken using the plate shaker at the speed of 140 
rpm for 24 hours. The measurements were taken from 0 to 24 hours.  
 





2.5. Growth of BC in chitosan environment  
 
There were two ways to grow BC in situ with chitosan. Firstly, 0.5 wt.% of WA 
chitosan solution was added to HS medium, which already had 2 wt.% of glucose. 
Secondly, glucose was replaced with 0.5 wt.% of WA chitosan solution, which 
was then used as the main carbon source.  
 
2.5.1. Preparation of chitosan solutions 
 
The stock of 0.5 wt.% of chitosan solution was prepared in either 0.1M of acetic 
acid or in 10 vol.% of vinegar (obtained from Morrison’s) both adjusted to pH3. 
Chitosan solution was stirred (Stuart US152) at 880 rpm and 25°C for 24 hours 
to ensure full dissolution. Prior to the addition to the medium, chitosan solutions 
were filter-sterilised by passing through 0.2 μm pore size filter.  
 
2.5.2. Replacing glucose with a chitosan solution in HS medium 
 
HS medium was produced and sterilised as described previously, but the sterile 
glucose solution was replaced with an equal volume of filter-sterilised chitosan 
solution, which was prepared using 0.1M of acetic acid, to giving a final 
concentration of chitosan inside HS medium of 0.25%. 
 
2.5.2.1. Inoculation of G. xylinus with modified HS medium 
 
The bacteria inoculum at a concentration of 0.1 OD600 was added to either HS 
medium containing both glucose and 0.5 wt.% of WA chitosan solutions, or to the 
modified HS medium that consisted of 0.5 wt.% WA chitosan as the main carbon 
source. The inoculation was carried out on a large scale at pH5 for 48 hours at 
30°C. The produced material was then called bacterial chitosan (BC-CH). 
 





For the incubation of bacteria with WA chitosan as the main carbon source, the 
variety of pH ranging from 6 to 2 was adjusted using either sterile 0.1M sodium 
hydroxide or 0.1M acetic acid in order to increase or decrease the pH, 
respectively.  
 
2.5.2.2. Investigation of leaching behaviour of BC/chitosan 
composites 
 
The leaching behaviour of chitosan from the BC/chitosan composite, which was 
produced in situ using both chitosan and glucose, started with obtaining a 
calibration curve for chitosan. The chitosan solution was diluted to the 
concentration ranging from 0.5 to 0.0019 mg/ml. The absorption values of the 
characteristic peak at wavelength of 325 nm for each concentration were 
measured. Then, the graph showing the absorption versus the concentration was 
obtained.  
 
Then, the BC/chitosan composite was placed into a centrifuge tube containing 20 
ml of distilled water. The tubes were shaken using the plate shaker at the speed 
140 rpm for 80 hours. Measurements of absorbances at 325 nm were taken from 
1 to 80 hours.  
 
2.5.3. Investigation of solubility of BC-CH 
 
In order to investigate the solubility of BC-CH, 3 grams of the material were 
placed into the centrifuge tube containing 20 ml of vinegar at pH2. The tube was 
then shaken using the shaking plate at a speed of 140 rpm for 48 hours. After 48 
hours, 1 ml of washing vinegar from the tube was measured using UV-VIS. The 









2.6. Ex situ modification of BC  
 
Pure BC was modified ex situ using clay suspensions, chitosan solutions and 
chitosan/genipin hydrogel, respectively. The modification of BC was carried out 
by either immersion or vacuum self-assembly methods.  
 
2.6.1. Oxidation of BC 
 
In order to improve the attachment of chitosan to BC, 6 grams of pure BC were 
immersed into 100 ml of the oxidising solution that consisted of 0.5 wt.% of 
sodium metaperiodate for 20 minutes at 25oC. The beaker was covered with 
aluminium foil to allow sufficient oxidation to occur without significant effects on 
the crystallinity. Subsequently, oxidised BC was rinsed with distilled water to 
remove excess oxidant and then dried for 24 hours at 25°C before placing on 
Buchner funnel and treated as described Section 2.6.3.1. 
 
2.6.2. Preparation of additive materials  
2.6.2.1. Preparation of clay suspensions 
 
Non-exfoliated and exfoliated by the Tefal blender SWN and Cloisite Na+ clay 
suspensions at a concentration of 6 mg/ml were prepared as described in Section 
2.4.1. 
 
Cloisite 10A, 15A, 20A, 30B and 93A organoclay with the concentration of 6 
mg/ml were mixed in acetone and treated in the same way as the other non-
exfoliated suspensions. Each of the clay suspensions was then incorporated into 










2.6.2.2. Preparation of chitosan solutions  
 
Each type of chitosan of low, medium molecular weight and WA chitosan were 
prepared with at 0.1M acetic acid as described in Section 2.5.1. WA chitosan was 
also dissolved in 10 vol.% of vinegar at a final pH3 using the same method as 
detailed in Section 2.5.1. All chitosan solutions were stored at 25oC until used.  
 
2.6.2.3. Preparation of chitosan hydrogels 
 
Once 0.5 wt.% of WA chitosan was dissolved in 100 ml of distilled water 
containing 10 vol.% of vinegar at pH3, 5.5 mg of genipin was added into the 
solution. Subsequently, the solution was stirred at 880 rpm speed for an hour. 
The solution was pumped through pure BC to allow hydrogel to form the matrix 
of BC (Section 2.6.3.1). 
 
2.6.2.4. Introducing exfoliated Cloisite Na+ clay to chitosan hydrogels 
 
After dissolving 0.5 wt.% of WA chitosan in 100 ml of distilled water containing 
10 vol.% of vinegar at pH3, 50 ml of the chitosan solution were mixed with 50 ml 
of exfoliated by the Tefal blender for 16 minutes Cloisite Na+ clay suspension at 
a concentration of 3 mg/ml at ration 1:1. Then, 5.5 mg of genipin was added into 
the chitosan/clay mixture. Subsequently, the solution was stirred at 880 rpm for 
an hour. The solution was pumped through pure BC to allow hydrogel formed 
within the matrix of BC (Section 2.6.3.1). 
 
2.6.3. Incorporation of additive materials into pure BC 
 
The clay suspensions and chitosan hydrogel were incorporated into the matrix of 
BC by using vacuum self-assembly method, respectively. All chitosan solutions 
were incorporated into non-oxidised and oxidised BC using immersion and 
vacuum self-assembly techniques, respectively. 





2.6.3.1. Vacuum self-assembly method 
 
The following method allowed incorporation of a range of additives into already 
produced pure BC. These additives were: SWN, Cloisite Na+, Cloisites 10A, 15A, 
20A, 30B and 93A organoclay, low, medium MW and WA chitosan solutions, 
chitosan/genipin and chitosan/genipin/clay hydrogels.  
 
Pure bacterial cellulose was produced on a large scale and treated as described 
in Sections 2.2.2 and 2.2.3. A circle of pure BC measured 10 cm diameter, 
weighing approximately 6 grams, was aseptically cut and placed onto the wetted 
filter paper in a Buchner funnel to ensure equal absorption of the treatments into 
BC.  Firstly, the circle was rinsed with 10 ml of distilled water. Then, clay 
suspensions, chitosan solutions, chitosan/genipin and chitosan/genipin/clay 
hydrogels were slowly passed through the BC matrix, respectively, under a 
vacuum. Genipin, 10 vol.% of vinegar, 0.1M of acetic acid and acetone were also 
passed through the BC, respectively. Once all the solutions or suspensions went 
through, the BC was rinsed with 10 ml of distilled water. Synthesised BC 
composites were aseptically cut into 2x2 cm squares and sterilised by 
autoclaving.  
 
2.6.3.2. The immersion method 
 
Samples of oxidised and non-oxidised BC were immersed into each type of 0.5 
wt.% chitosan solution, respectively, for 30 minutes to allow chitosan to penetrate 
BC matrix. BC was removed from the solutions and gently washed with 10 ml of 
distilled water for either antibacterial assay experiment or left to dry for 24 hours 










2.7. Antibacterial activity of modified bacterial cellulose 
2.7.1. Bacterial strains used in antibacterial assays 
 
A total of three isolates were used to test the antibacterial properties of all 
synthesised BC materials. These were methicillin-resistant Staphylococcus 
aureus (MRSA), Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. 
aeruginosa). The experiments also included analysis of pure BC and oxidised BC 
as well as BC treated with 0.1M acetic acid, 10 vol.% vinegar and acetone, 
respectively, in order to investigate any antibacterial effect of different solvents, 
which were used to dissolve chitosan and disperse organoclay. 
 
2.7.2. Production of bacterial lawns 
 
Frozen culture of E. coli, MRSA and P. aeruginosa were maintained as described 
in Section 2.2.1. In order to produce the population for the experiments, the 
isolates were incubated from the frozen state onto TSA for 24 hours at 37°C. The 
obtained colonies were re-suspended in 10 ml of TSB. The bacterial suspensions 
were subsequently incubated by shaking (at 150 rpm) for 16-20 hours at 37oC. 
These overnight cultures were then diluted in phosphate buffered saline to a 
concentration of 0.1 OD600 for all further experiments.  
2.7.3. Antibacterial assay of the components incorporated into BC 
 
The antibacterial activity of Cloisite Na+, SWN and WA chitosan alone was 
investigated against E. coli and MRSA, respectively. Due to their organophilic 
nature, organoclay cannot be dispersed in water. Therefore, the antibacterial 
properties of Cloisite 10A, Cloisite 15A, Cloisite 20A, Cloisite 30B and Cloisite 
93A organoclay were studied against E. coli, MRSA and P. aeruginosa, 









2.7.3.1. Antibacterial assay using clay suspensions 
 
Once the overnight cultures of MRSA and E. coli were prepared as detailed in 
Section 2.7.2. The bacteria were re-suspended in PBS at a final concentration of 
0.1 OD600. Both sterile non-exfoliated and exfoliated by the Tefal blender Cloisite 
Na+ and SWN clay suspensions were added to the wells of a 96-well plate in the 
volume of 75 µl, respectively. Then, 75 µl of PBS-resuspended MRSA or E. coli 
were mixed with 75 µl of each type of clay. The final concentration of Cloisite Na+ 
and SWN within the bacterial suspension was 3 mg/ml, respectively. The control 
MRSA and E. coli in a total volume of 150 µl were added, respectively, into 
separate wells. Then, the controls and clay/bacteria suspensions were serially 
diluted in sterile PBS and incubated for 24 hours at 37oC temperature. After 24 
hours, an amount of 20 µl of each dilution was placed on the surface of a TSA 
plate in triplicate and incubated at 37oC temperature for 24 hours. After 24 hours, 
a number of colonies were calculated in each dilution Section. In order to 
calculate CFU, the number of colonies obtained was multiplied by both the 
dilution factor and by 50 and, subsequently converted to percentage. 
2.7.3.2. The disc diffusion method using compressed powder 
handmade discs  
 
This method focused on using organoclay clay powder as discs due to the high 
organophilic nature of the clay. Powders of Cloisites 10A, 15A, 20A, 30B and 93A 
organoclay were pressed into discs by a hydraulic press (Specac’s Atlas Series 
Manual Hydraulic Press) using 5-ton load configurations and subsequently stored 
at 25oC.  The discs, which contained 2 grams of each type of clay, were 
subsequently sterilised using dry heat at 120oC for 15 minutes.  Bacterial lawns 
were produced as described in Section 2.7.2. Each disc was aseptically placed 
on each TSA plate containing bacteria. The plates were incubated for 24 hours 
at 37oC. The zones of inhibition were subsequently determined.  
 





2.7.3.3. Antibacterial activity of chitosan 
 
WA chitosan solution at a concentration of 0.5 wt.% was prepared using 10 vol.% 
of vinegar as detailed in Section 2.5.1. Sterile glass cover slips were coated with 
the chitosan solution and air-dried for 24 hours at 25oC to allow acetic acid from 
the vinegar to evaporate. Subsequently, the cover slip coated with chitosan was 
further dried and sterilised using UV-Ozone (supplied by BioForce nanosciences) 
for an hour. Each cover slip was placed inside an empty petri dish.  
 
Overnight bacterial cultures were obtained as described in Section 2.7.2. 
Overnight cultures of MRSA and E. coli (100 µl) were placed on the surface of 
the cover slip and covered with 2 × 2 cm sterile plastic lid, respectively. The lid 
was sterilised prior to the experiment by immersion into 100 vol.% ethanol for an 
hour and subsequently dried inside the plate drier at “full” power. For the control, 
a sample of each type of the bacterium in a volume of 100 µl was placed on the 
surface of an empty sterile cover slip and covered with the lid. Then, the petri 
dishes with all cover slips were stationary incubated in a humid environment in a 
sterile pyrex glass dish, which was covered with aluminium foil for 24 hours at 
37oC. After 24 hours, the bacteria were washed from the cover slips using 3 ml 
of sterile PBS and serially diluted. An amount of 20 µl of each dilution was placed 
on the surface of a TSA plate in triplicate and incubated at 37oC temperature for 
24 hours. After 24 hours, a number of colonies were calculated in each dilution 
Section. In order to calculate CFU, the number of colonies obtained was 
multiplied by both the dilution factor and by 50 and, subsequently converted to 
percentage. In each case, the number of the pre-treatment bacteria was 
determined in CFU/ml concentration.  
 
2.7.4. Antibacterial activity of synthesised BC-based materials 
 
Sterile 2 cm × 2 cm squares of both in situ and ex situ modified BC were placed 
into empty, without agar sterile petri dishes. The bacterial culture produced as 





described in Section 2.7.2 in a volume of 100 µl were gently placed on the surface 
of cellulose and covered with a 2 cm × 2 cm plastic lid, which was sterilised by 
ethanol prior to the experiment. The control bacteria in the same volume of 100 
µl were placed on the surface of the empty, without agar petri dish and covered 
with the lid. All petri dishes were stationary located in a humid environment in a 
sterile pyrex glass dish, which was covered with aluminium foil. The dishes were 
stored at 37oC for 24 hours.  
 
After 24 hours, petri dishes containing bacteria and cellulose were then washed 
by adding 3 ml of PBS. Subsequently, bacterial culture, cellulose and the lids 
were placed into a sterile stomacher bag and mixed by Stomacher (Seward) at 
“normal setting” for a minute. Bacterial suspensions from the stomacher bag were 
then serially diluted in fresh PBS in 1:10 fold dilution. Then, the bacterial 
suspensions from each dilution was placed on a surface of a TSA plate in a 
volume of 20 µl and incubated at 37oC temperature for 24 hours. After 24 hours, 
a number of colonies were calculated in each dilution Section. In order to 
calculate CFU, the number of colonies obtained was multiplied by both the 
dilution factor and by 50 and, subsequently converted to percentage. In each 
case, the number of the pre-treatment bacteria was determined.  
2.8.  Synthesis of Kombucha cellulose 
 
The washed culture was derived from Kombucha by placing 6 grams of SCOBY 
into a sterile stomacher bag and mixed by Stomacher (Seward) at “normal 
setting” for a minute. The washed isolated culture of microorganisms (IM) was 
used for the growth of Kombucha cellulose (KC) in further experiments. 
 
2.8.1. Optimisation of KC growing conditions  
 
The growing conditions of KC were optimised in both small and large scales. The 
small scale experiments were carried out using 24 well plates (Sarstedt, 1.55 mm 
diameter). Sterile pyrex dishes (27 cm height x 35 cm width x 6 cm depth) were 





used for the large scale production. The effect of optical density, temperature, 
concentration of tea and type of a carbon source on the production of KC were 
analysed.  
 
2.8.2. Preparation of tea 
 
A teabag of Yorkshire tea was added to 200 ml of boiling water for 6 minutes. 
Tea was quantified by pH, ultraviolet-visible spectrophotometry (UV-VIS) and 
optical reflective index. Prepared tea was then autoclaved at 121oC for 15 
minutes before mixing with either glucose or chitosan solution. After the addition 
of carbon source, tea was then called the tea broth. 
 
2.8.3. Effect of OD on the growth of KC 
 
The effect of optical density on the growth of KC was investigated by inoculation 
of IM at 0.1-2 OD600 concentration with 1 ml of the tea broth containing 2 wt.% of 
glucose solution, respectively, at 25°C for 48 hours. The experiment was carried 
out on a small scale. Produced KC was centrifuged tube at 150xg followed by 
discarding of the excess liquid. This was repeated three times. The growth of KC 
was evaluated by the mass yield of wet and centrifuged produced KC.  
 
2.8.4. The effect of temperature on the growth of KC 
 
The effect of temperature on the synthesis of KC was investigated using IM at 
concentration of 2 OD600. The IM suspension was inoculated with tea containing 
2 wt.% of glucose solution at 25°C, 30°C and 37°C for 48 hours. The experiment 
was carried out on a small scale in 24 (1.55 mm diameter) sterile polystyrene 









2.8.5. Effect of tea concentration on the growth of KC 
 
Black tea was prepared as described in Section 2.8.2. The tea stock was diluted 
from 100 vol.% to 0 vol.% with sterile distilled water. Subsequently, 2 wt.% of 
glucose was added into each dilution. IM at a concentration of 2 OD600 was 
inoculated with each tea concentration on a small scale for 48 hours at 25°C. The 
growth of KC was evaluated by the mass yield of produced wet and centrifuged 
KC. 
 
For the large scale production, 50 ml of 2 OD600 PBS re-suspended IM was mixed 
with 200 ml of either 75% of the tea broth or sterile distilled water. The dishes 
were subsequently covered with aluminium foil and incubated statically at 25oC 
for 48 hours. 
 
2.8.6. Effect of pH on the growth of KC 
 
The effect of pH on the synthesis of KC was investigated using IM at 
concentration of 2 OD600. The IM suspension was inoculated with the tea broth 
containing 2 wt.% of glucose solution at pH ranging from 6 to 2, which were 
adjusted using either sterile 0.1M NaOH or 10 vol.% of filter-sterilised vinegar 
solution, at 25°C for 48 hours on a small scale. The growth of KC was evaluated 
by the mass yield of wet and centrifuged KC. 
 
2.8.7. Effect of carbon source 
 
IM at concentration of 2 OD600 was inoculated into 75% of the tea broth containing 
either 2 wt.% of filter sterilised glucose or 0.5 wt.% of WA chitosan solutions, 
respectively. The inoculation of IM was carried out on both small and large scales. 
The plates were covered either with filter paper or the foil for the small or large 
scale experiments, respectively, and incubated for up to 48 hours at 25°C. The 
growth of KC was evaluated by the mass yield of wet and centrifuged KC. 





2.8.8. Treatment of KC after incubation 
 
KC produced on a small and large scales was treated by submerging statically 
within 0.1M NaOH at 80°C for an hour, and then, washed with distilled water until 
pH reached 7.  
 
2.9. Growth of Kombucha in clay environment 
 
The growth of KC in a clay environment was carried out using 75% of the tea 
broth containing either 2 wt.% of glucose or 0.5 wt.% of chitosan solutions as the 
main carbon sources. Each type of the tea broth was mixed with either non-
exfoliated or exfoliated Cloisite Na+ or SWN suspensions at clay concentration of 
3 mg/ml, respectively. IM at concentration of 2 OD600 were inoculated with the tea 
broths, respectively, for 48 hours at 25°C in both small and large scales. 
 
2.9.1. Inoculation of Kombucha with clay suspensions on a small scale 
 
Each type of non-exfoliated and exfoliated clay suspensions at a final 
concentration of 3 mg/ml was mixed with the tea broth.  Inoculation of IM was 
carried out by adding 100 µl of PBS re-suspended IM at 2 OD600 to 3 ml of tea/clay 
suspensions. The inoculation was carried out in 24 well plates at 25°C for 48 
hours. The growth of KC/clay composite was evaluated by the mass yield of wet 
and centrifuged material. 
 
2.9.2. Inoculation of Kombucha with clay suspensions on a large scale 
 
The large scale production was carried out by mixing a non-exfoliated suspension 
and the suspension exfoliated by the Tefal blender of Cloisite Na+ and SWN clay 
with 200 ml of the tea broth, respectively, at a final concentration of clay of 3 
mg/ml. Inoculation of IM was carried out by adding 50ml of 2 OD600 PBS re-
suspended IM to the tea/clay suspensions and incubating into sterile pyrex dishes 





(27 cm height x 35 cm width x 6 cm depth) that were sealed by aluminium foil at 
25°C for 48 hours. The growth of KC/clay composite was evaluated by the mass 
yield of wet and centrifuged material. 
 
2.9.3. Antibacterial activity of synthesised KC-based materials 
 
The antibacterial activity of synthesised pure KC, KC/chitosan, KC/clay, 
KC/chitosan/clay composites were investigated against MRSA, E. coli and P. 
aeruginosa, respectively, as described in Section 2.7.3. 
 
2.10. Characterisation of developed materials 
2.10.1. Surface energy measurement 
 
In order to determine surface energy, hydrophilic or hydrophobic nature and, 
therefore, leaching behaviour of pressed organoclay discs using for antibacterial 
assay (Section 2.7.3.2.), the contact angle of each material was investigated 
using sessile drop method by drop shape analyser (DSA, supplied by Kruss). 
Each pressed disc was placed on a stage of DSA. A drop with 4 µl of distilled 
water was added to the surface on the discs. The dynamic contact angle was 
recorded for 100 seconds. The experiment was carried out once. 
 
2.10.2. Characterisation of chemical structure using Fourier Transform-
Infrared spectroscopy (FT-IR)  
 
The FT-IR equipment (Agilent Technologies, USA) was used to determine 
functional groups in the solid samples as well as to provide qualitative analysis of 
the presence of the additive material inside the final composites (Wavenumber 
region 650-4000 cm-1). Each experiment started with the baseline correction. 
Dried solid samples were then suspended on the equipment surface for analysis. 
The analysis was repeated two times.  
 





2.10.3. Powder X-Ray diffraction analysis 
 
X-ray diffraction analysis (PAnalytical, UK) was used to characterise the crystal 
structure of pure BC, BC-CH and chitosan powder. Operating conditions for each 
test were 40kV volts (X-ray beam), 35 mA current and 0o - 120o scanning angle 
range with a step of 0.0167. Prior to the experiment, samples were dried for 24 
hours at 25oC and then compressed into plate holders, suspended on a stage 
and analysed with the powder diffractometer. The analysis was done once. 
 
2.10.4. Solid state UV-VIS-NIR spectroscopy 
 
The solid-state UV-VIS equipment (Jasco V, model V-670, serial number 
A018261154) used to determine the change in chemical structure in various 
samples in the region of 190-2500 nm. Solid materials were dried for 24 hours at 
25oC and then placed inside the sample holder, which was closed tightly, and 
analysed. The experiment conditions included baseline correction with scanning 
speed of 1000 nm/min. The analysis was repeated three times. 
 
2.10.5. Scanning electron microscopy 
 
The microstructure and morphology of nanoparticles, BC, KC and their 
composites were investigated using scanning electron microscopy (SEM, JEOL).  
Samples were placed in a freeze dryer (Modulyo) submerged in liquid nitrogen 
and exposed to a vacuum pressure 4 atmospheres for up to 3 days (72 hours). 
Each freeze-dried sample was subsequently coated with 10 mm gold. The 
samples were analysed at different working distance from 10 mm to 4 mm. The 
experimental conditions included 6.5 mm working distance and 10.0 kV of 









2.11. Investigation of mammalian cell cytotoxicity of developed 
materials 
 
The mammalian cytotoxicity of non-exfoliated and exfoliated Cloisite Na+ and 
SWN suspensions, organoclay, chitosan and BC-based materials was 
investigated using NIH 3t3 cells. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) tetrazolium reduction assay was the main 
cytotoxicity assay. The MTT assay is a colorimetric assay that measures the 
metabolic activity of cells[207]. The assay is based on the ability of nicotine adenine 
dinucleotide (NADPH)-dependent cellular oxidoreductase enzymes to reduce the 
tetrazolium dye MTT to its insoluble formazan (Fig. 23)[207].  
 
 
Figure 23. Reduction of MTT to formazan[207]. 
During the assay, MTT enters the cells and becomes reduced by mitochondrial 
enzymes and lysosomal/endosomal compartments[208]. Subsequently, MTT is 
transported to the surfaces of the cells to form needle-like MTT formazans[207]. 
The quantity of formazan can be measured by the absorbance at 570 nm using 
a plate reading spectrophotometer[207]. Dead cells lose their ability to convert MTT 
into formazan, therefore a difference in colour might be an indicator of the altered 
metabolic activity of cells. Metabolic active cells had dark purple colour, whereas 
non-active cells were colourless[208]. However, the MTT reduction assay reflects 










2.11.1. Maintenance of NIH 3t3 cells  
 
The short-term storage of 3t3 cells was performed -80oC. The cell pellets that 
were produced by centrifugation for 5 minutes at 150xg were re-suspended into 
1 ml of the solution consisted of 900 µl of fetal bovine serum (FBS) and 100 µl of 
dimethyl sulfoxide (DMSO).  
 
Dulbecco′s modified medium (DMEM) was used to maintain 3t3 cells. DMEM was 
supplemented with a mixture of fetal bovine serum and penicillin-streptomycin 
antibiotic to give a final concentration of 10 vol.% and 1 vol.%, respectively.  
 
2.11.2. Reviving 3t3 cells from frozen 
 
Frozen 3t3 cells were thawed and diluted to 1:10 using the growth medium 
(DMEM). The cells were subsequently centrifuged at 150xg for 5 minutes. After 
centrifugation, cell pellets were re-suspended into 1 ml of fresh DMEM and then 
diluted to 1:6 using fresh DMEM.  The cells were incubated in 25 cm2 tissue 
culture flasks for up to 72 hours at 37oC.  
 
2.11.3. Passaging of 3t3 cells  
 
The passaging of 3t3 cells started with discarding the spent medium from flasks. 
Cells were subsequently washed once with sterile PBS and 1 ml of trypsin was 
added into the flask. The cells were then incubated for 5 minutes at 37oC. After 5 
minutes of incubation, 9 ml of fresh DMEM was transferred into the flask. The 
cells were centrifuged at 150xg for 5 minutes. Cell pellets were re-suspended into 
1 ml of fresh DMEM. Further passaging was carried out by diluting cells to 1:6 in 
fresh DMEM and incubating at 37oC.  
 
Prior to the experiments, 3t3 cells were counted using a haemocytometer directly 
after centrifugation and re-suspension of cell pellets into 1 ml of fresh DMEM, but 





before the passaging. After counting, the cells were seeded into sterile 
plasticware at appropriate concentrations, where 25,000 cell/ml was used for 
experiments in both 96-well plates and 24-well plates, respectively, whereas 
350,000 cells/ml was used for the experiments in 6-well plates.  
 
All biological waste was treated with 5 vol.% Trigene for 24 hours before 
autoclaving.  
 
2.12. Mammalian cell cytotoxicity 
2.12.1. MTT reduction assay 
 
The metabolic activity of cells was determined by MTT reduction assay[209].  MTT 
(3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) reagent was 
added to cells to a final concentration of 0.5 mg/ml. Cells were incubated for an 
hour at 37oC. Medium with MTT was then replaced with dimethyl sulfoxide 
(DMSO). Absorbance was measured using Gen5 plate reader and Gen5 software 
at 570 nm absorbance. Metabolically active cells were purple, whereas 
metabolically non-active cells were colourless. Therefore, this assay measures 
cell viability in terms of reduction of MTT as enzymatic conversion of the 
tetrazolium compound to formazan by dehydrogenases that occurs in the 
mitochondria of living cells[208]. 
 
2.12.2. Effect of non-exfoliated clay suspensions on NIH 3t3 cells  
 
NIH 3t3 cells were seeded at a concentration of 25,000 cells/ml in a volume of 
100 µl per well in 96 well plates. Sterile 10A, 15A, 20A, 30B, 93A, SWN and 
Cloisite Na+ clay powders were added directly to the medium at a concentration 
from 0.09 to 6 mg/ml. The cells were incubated at 37oC for 24, 48 and 72 hours. 
The control without any treatments was also set up for each time frame. Metabolic 
activity of cells was measured by MTT reduction assay. 
 





2.12.3. Effect of exfoliated clay suspensions on MTT reduction in 3T3 cells 
 
Medium was mixed with Cloisite Na+ and SWN exfoliated clay suspensions in a 
volume of 100 µl per well at final concentrations of clay from 0.09 to 3 mg/ml, 
respectively. NIH 3t3 cells were seeded at a concentration of 25,000 cells/ml in 
96-well plates. Cells were then incubated for up to 72 hours at 37oC. The 
metabolic activity of 3t3 cells was determined every 24 hours by MTT reduction 
assay and compared to untreated cells. Medium containing clay suspensions 
alone without the cells was also examined by the plate reader spectrometer. The 
effect of medium reduction on the MTT reduction of cells was measured by 
replacing medium with sterile PBS at the same dilution as with clay suspensions.  
 
2.12.4. Effect of nanoparticles on 3T3 cell using coated slides 
 
Glass coverslips were coated with 6 mg/ml of Cloisite 10A, 15A, 20A, 30B, 93A 
clay, respectively, and dried following sterilisation using UV-Ozone. Each coated 
slide was placed into each well of 6-well plates. A volume of 1 ml of NIH 3t3 cells 
at concentration 350,000 cells/ml were placed on the top of the cover slips and 
covered with 3 ml of fresh medium. Cells were incubated for 24 hours at 37oC. 
The metabolic activity of cells was measured by MTT reduction assay after 24 
hours. The control was obtained by seeding the cells inside the empty wells of 6 
well plates. The cells were also seeded on the top of the clear untreated cover 
glass. 
 
2.12.5.  Effect of chitosan on 3t3 cells 
2.12.5.1. Addition of chitosan to culture medium 
 
NIH 3t3 cells were seeded at a concentration of 25,000 cells/ml in a volume of 
100 µl per well in 96 well plates. Sterile WA chitosan powder was added directly 
to the medium at a concentration of 5 mg/ml. The cells were incubated for 24 and 
48 hours. Metabolic activity of the cells was measured by MTT reduction assay. 






2.12.5.2. Effect of chitosan on 3T3 cell using coated slides 
 
Cover slips were coated with 2 ml of 0.5 wt.% of WA chitosan solution, air-dried 
for 24 hours at 25°C and then dried for additional 6 hours using UV-Ozone 
(supplied by BioForce nanosciences). The cells were incubated with the coated 
cover slips for 24 and 48 hours at 37oC. The metabolic activity of cells was 
measured using MTT assay every 24 hours. The control was obtained by seeding 
the cells on the top of the clear untreated cover glass. 
 
2.12.6. Effect of pure and modified BC on 3T3 cells 
 
Sterile 1x1 cm squares of sterile pure BC and BC composites were soaked in 1 
ml of fresh medium in 24 well plates for 24 hours prior to the actual experiment. 
Then, the medium was replaced with 1 ml per well of fresh medium containing 
25, 000 cell/ml of 3t3 cells and incubated for up to 72 hours. The control was 
obtained by seeding the cells without any treatments. A metabolic activity of cells 
was measured by the MTT reduction assay every 24 hours. 
 
2.13. Statistical analysis 
 
Data were statistically analysed using Minitab software (Minitab, LLC, State 
College, Pennsylvania, USA; version 19.2.0.0). Statistical analysis was 
performed using either one-way ANOVA and Tukey test or a two-way ANOVA. 
A P-value of <0.05 was considered as statistically significant. Data represent the 
mean of experiments ± standard deviation.





Chapter 3. The growth of BC in clay environment 
 
BC/clay composites were synthesised in situ by inoculating Gluconacetobacter 
xylinus (G. xylinus) ACCT53524 into HS medium containing one of two types of 
clay: Cloisite Na+ and SWN, respectively. Firstly, the growth conditions of pure 
BC were optimised on a small and large scales as described in Section 2.3. Then, 
exfoliated and non-exfoliated clay suspensions were added into the medium, 
respectively, inoculated with bacteria and incubated for 48 hours at 30°C. The 
synthesised BC/clay composites were investigated by the mass yield and UV-
VIS-NIR (near IR) spectroscopy. The antibacterial activities of clay and BC/clay 
composites were studied against MRSA and E. coli (NCTC 12493). The 
cytotoxicity of clay and the composites were investigated using 3t3 fibroblast 
cells. 
 
3.1.  Results 
3.1.1. Optimisation of BC growing conditions on a small scale 
 
The first stage of synthesis of BC was the optimisation of initial bacterial inoculum. 
In order to achieve this, the bacteria were diluted in a range from 0.1 to 1.9 OD600 
of G. xylinus using PBS and streaked onto on HS agar plates. The bacterial 
colonies started to appear on the agar after 48 hours. Subsequently, the 
concentration of bacteria was calculated. A calibration curve was obtained (Fig. 
24). The purpose of the calibration curve was to quantify the concentration of 
bacteria and to obtain the reproducible data. R2 was 96%, which means that the 
relatively good linear relationships were obtained. This curve was used for the 
subsequent experiments to determine bacterial concentration. 
 






Figure 24. The relationship between OD600 and concentration of Gluconacetobacter 
xylinus. The bacteria were incubated on HS plates for 48 hours at 30°C. 
The wavelength of 600 nm of optical density was chosen because this 
wavelength is a relatively safe for bacterial cells[210]. Due to the limited space of 
the 6-well plate and the concentration of nutrients, a relatively high bacterial 
number could have a negative effect on BC growth. An increase in the population 
of bacteria can lead to depletion of nutrients with time. It has been reported that 
the bacteria exhibited chemotaxic behaviour and started to move towards the 
regions with higher nutrient concentration, which were observed to be at the 
edges of the medium, leaving the dead or dying cells behind in the centre[211]. 
Because of this, the range from 0.001 to 0.5 OD600 of G. xylinus was chosen for 
further investigation. 
 
The synthesis of BC was carried out for 48 hours at 30°C. After the synthesis, BC 
(a pellicle) was aseptically transferred into plastic weighing boats and dried for 





































Wet BC produced on a small scale 
 
Dried BC produced on a small scale 
Figure 25. Images of wet (left) and dried (right) BC. BC was produced using an inoculum 
of 7.9´107 CFU/ml bacterial concentration at 30°C on a small scale for 48 hours. 
 
The mass of dried BC at concentrations ranging from 0.001 to 0.5 OD600 was 
measured with the results shown in Fig. 26. There was little change in cellulose 
production from 0.001 to 0.005 OD600, where the mass of synthesised BC was 
0.06 grams. However, starting from 0.1 OD600, the mass of BC increased. The 
mass of dried BC was greater for 0.1 and 0.5 OD600 and corresponded to 0.7 and 
0.8 grams, respectively. In order to be conservative and avoid overpopulation of 
the bacteria in further experiments, the optical density of 0.1 OD600, which 










Figure 26. The effect of bacterial density on BC growth. The suspension of G. xylinus at 
0.5-0.001 OD600 was incubated in HS medium on a small scale for 48 hours at 30oC. 
Data shown represent the mean of three independent experiments with error bars of 
standard deviation. The mass obtained using 0.001 OD bacterial suspensions was 
compared to other OD. There is no statistically significant difference in data presented. 
 
The effect of temperature on BC growth was investigated. G. xylinus was 
inoculated at a concentration of approximately 7.9´107 CFU/ml on a small scale 
at 25oC, 30oC and 37oC temperature. The BC produced was measured at both 
wet and dried states (Figs. 27-28). According to Fig. 27, the most effective 
temperature for BC growth was 30oC with the mass reaching 2.7 grams. 
Whereas, the mass of wet BC produced at 25oC and the 37oC temperature was 
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Figure 27. The mass of wet BC produced at 25oC, 30oC and 37oC temperature on a small 
scale.  BC was produced using an inoculum of approximately 7.9´107 CFU/ml bacterial 
concentration. The bacteria were incubated for 48 hours on a small scale. Data shown 
represent the mean of three independent experiments with error bars of standard 
deviation. Temperature of 25oC was compared to either 30oC or 37oC. There is no 
significant difference between the temperatures.  
The mass of dried BC produced at 25oC, 30oC and 37oC temperature is shown 
in Fig. 28. Similar to wet BC, the mass of dried BC produced at 30oC was the 
heaviest and reached 0.07 grams. Whereas the mass of BC synthesised at 25oC 
and 37oC was 0.023 grams and 0.056 grams, respectively. Therefore, the 
optimum temperature for BC growth was found to be 30°C. The temperature of 
25°C has less extent of decrease in the mass of synthesised BC, whereas 
increasing the temperature to 37°C has pronounced negative effect on the growth 
of cellulose. Henceforth, bacteria at a concentration of approximately 7.9´107 




























Figure 28. The effect of temperature on the mass of dried BC. BC was produced using 
an inoculum of approximately 7.9´107 CFU/ml bacterial concentration. The bacteria were 
incubated for 48 hours on a small scale. Data shown represent the mean of three 
independent experiments with error bars of standard deviation. The data of either 30oC 
or 37oC was compared to 25 oC. Data obtained at 30oC and 37oC are significantly 
different from 25 oC (P-value <0.01).  
 
The effect of time of incubation on the synthesis of BC was also investigated. The 
bacteria at a concentration of 7.9´107 CFU/ml were inoculated at 30°C for 24, 48 
and 72 hours. The mass of wet and dried BC was measured in different times 
(Figs. 29-30). As shown in Fig. 29, the heaviest mass of wet BC was 2.43 grams 
after 48 hours. The lightest mass of BC was 2.08 grams after 24 hours. The mass 






























Figure 29. The mass of wet BC produced after 24, 48 and 72 hours on a small scale. BC 
was produced using an inoculum of approximately 7.9´107 CFU/ml at 30°C. Data shown 
represent the mean of three independent experiments with error bars of standard 
deviation. The mass obtained after 24 hours was compared to mass produced after 
either 48 or 72 hours. The data are not significantly different. 
 
As shown in Fig. 30 of the dried samples, the mass of dried BC was 0.06 grams 
after 24 hours. The mass increased to 0.07 grams after 48 hours and remained 
almost unchanged for 72 hours. Therefore, the minimum mass of BC was 
observed after 24 hours, which might be due to the growth process not yet being 
completed. The synthesis of BC on a small scale was most productive after 48 
hours. However, the formation of BC stopped after 48 hours due to the fact that 
there was no further increase in dried mass at 72 hours. Therefore, 48 hours of 
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Figure 30. The mass of dried BC produced after 24, 48 and 72 hours on a small scale. 
BC was produced using an inoculum of approximately 7.9´107 CFU/ml at 30°C. The data 
shown represent the mean of three independent experiments. Data shown represent the 
mean of three independent experiments with error bars of standard deviation. The mass 
obtained after 24 hours was compared to mass produced after either 48 or 72 hours. 
The data are not significantly different. 
Due to the variation of the standard carbon source in the subsequent experiments, the 
effect of concentration of glucose on the formation of BC was studied by replacing it with 
distilled water. As standard medium contains 2 wt.% of glucose, this concentration was 
chosen as the control. According to Fig. 31, the reduction of concentration of carbon 
source to 50%, which was corresponded to 1 wt.% of glucose inside the medium, has 
affected the BC growth. The formation of BC decreased rapidly within the reduction of 
concentration of carbon source under the constant amount of nitrogen source. As shown 
in Fig. 26, the reduction of glucose to 1.94 wt.% has not affected the biosynthesis of BC. 
The concentration of 1 wt.% of glucose resulted in a reduction of a mass of a pellicle 
from the control of 0.07 grams to 0.02 grams. This confirms the results obtained in Figs. 
29-30, in which the growth of BC has stopped after 48 hours. The lack of sufficient carbon 
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Figure 31. Effect of glucose on BC growth. Glucose was reduced from 2 wt.% of the 
standard (control) to 1 wt.%. Bacteria were incubated on a small scale using 7´107 
CFU/ml inoculum concentration at 30°C for 48 hours. Data shown represent the mean 
of three independent experiments with error bars of standard deviation. The control (2 
wt.%) is significantly different to both 1.5% and 1% treatments with P-value<0.01, 
respectively.  
The parameters for the synthesis of BC were optimised in small scale 
experiments. The chosen bacterial concentration was 7.9´107 CFU/ml. The 
incubation parameters were: 30°C temperature, 48 hours of incubation and HS 
medium containing 2 wt.% glucose. Based on the obtained results, the 
concentration of glucose for the synthesis of the original BC was chosen to be 2 
wt.% for further experiments. 
 
3.1.2. Synthesis of BC on a large scale 
 
The effect of 24, 48, 72 and 96 hours of incubation on the growth of BC was 
investigated on a large scale using fixed parameters such as approximately 



















Reduction of glucose as main carbon source from standard high to 
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2 wt.% of glucose. As shown in Fig. 32, the BC yield increased from 24 to 96 
hours. The pellicle, which was produced within 24 hours, was thin and did not 
cover the whole surface. The structure of cellulose was not robust enough after 
24 hours. Starting from 48 hours, BC reached sufficient thickness. BC was much 










Figure 32. The effect of the time of incubation on the synthesis of BC on a large scale 
using 7.9´107 CFU/ml bacterial concentration at 30oC. 
 
The yield of wet BC was measured. As shown in Fig. 33, the mass of wet BC was 
140 grams after 48 hours, then increased to 182 grams and 196 grams after 72 
and 96 hours, respectively.   






Figure 33. The effect of incubation time on the mass of wet BC on a large scale. BC was 
produced using an inoculum of 7.9´107 CFU/ml at 30°C for 48, 72 and 96 hours. Data 
shown represent the mean of a single experiment. 
 
3.1.3. Investigation of clay suspensions for in situ modification of BC 
 
Both Cloisite Na+ and SWN clay suspensions were used for in situ modification 
of BC. Each suspension contained 6 mg/ml of a clay. The suspensions were used 
at either non-exfoliated or exfoliated states. In order to obtain a uniform exfoliated 
suspension, clay exfoliation was investigated using magnetic stirring, 
ultrasonication and blending techniques, respectively. 
 
3.1.3.1. The morphology of the clay 
 
The morphology of Cloisite Na+ and SWN were studied using SEM as detailed in 
Section 2.10.5. Fig. 34 shows SEM images of dispersed and then freeze-dried 
clay particles. Both clays had similar layered structure, but different in aspect 
































Figure 34. SEM images of a) Cloisite Na+ and b) SWN clay. The bars represent a 
distance in 100 µm. 
 
3.1.3.2. Exfoliation of Cloisite Na+ clay suspensions  
 
The process of exfoliation was based on disassociating aggregates of clay 
particles followed by breaking van der Waals and electrostatic forces between 
the layered structure in order to obtain individual delaminated silicate layers. 
Cloisite Na+ clay suspensions at a fixed concentration of 6 mg/ml were 
investigated using mechanical exfoliation methods by applying magnetic stirring, 
ultrasound and a Tefal blender, respectively. The extent of clay exfoliation was 
studied by DLS (Dynamic Laser Scattering). The success of these techniques on 
achieving the exfoliated state of the suspension was evaluated.  
 
3.1.3.2.1. Analysis of Cloisite Na+ clay suspensions without exfoliation 
treatment 
 
The exfoliation of Cloisite Na+ suspensions started with an analysis of the non-
exfoliated state of the clay, which was prepared as described in Section 2.4.1. 
This allowed the comparison of the efficiency of different exfoliating techniques.  
Fig. 35 shows DLS results of Cloisite Na+ clay suspension without exfoliation 
treatment. The 43% and 42% of the total volume of particles were in 1584 and 
1165 nm size range, respectively. The results indicated that the suspension was 
b) a) 





non-uniform with extensive aggregation of micro-sized particles. An aggregation 
is a cluster of particles.   
 
 
Figure 35. The particle size distribution of Cloisite Na+ clay suspension at concentration 
of 6 mg/ml without exfoliation treatment. 
 
3.1.3.2.2. Exfoliation of Cloisite Na+ suspension through magnetic stirring 
 
The suspension was then stirred for 16 minutes using magnetic stirring at speed 
of 880 rpm. As shown in Fig. 36, the differences in number and volume frequency 
became less broad compared to the control (Fig. 35). The number and volume 
distribution were similar range close to 857 nm. This means that micro-sized clay 
particle aggregations have disappeared. The suspension was more homogenous 
























Figure 36. The particle size distribution of Cloisite Na+ suspension exfoliated using 
magnetic stirring. The suspension at 6 mg/ml concentration of clay was stirred at 880 
rpm for 16 minutes at 25°C.  
 
3.1.3.2.3. Exfoliation of Cloisite Na+ suspension through high power 
sonication 
 
The next technique applied was ultrasonication of the initial suspension for 16 
minutes using the amplitude of 85%. The process of ultrasonication was based 
on cavitation, which may break the layered structure of nanoparticles. As shown 
in Fig. 37, there were two peaks in volume distribution, second of which indicated 
the presence of micro-sized clay particle aggregations ranging from 1164 and 
1584 nm. The results showed that number distribution of particles has 
significantly reduced compared to the control. However, the suspension was not 

























Figure 37. The particle size distribution of Cloisite Na+ suspension exfoliated using 
ultrasound. The suspension at 6 mg/ml concentration of clay was sonicated for 16 
minutes.  
3.1.3.2.4. Exfoliation of Cloisite Na+ suspension through blender 
 
Cloisite Na+ suspensions were exfoliated using a Tefal blender as described in 
Section 2.4.1.1. The Tefal blender came with several attachable grinders. In the 
current research, two types of grinder were used: a chopper grinder (red) and 
coffee grinder (brown) (Fig. 38). The coffee grinder had the double-pronged blade 
at the bottom, whereas the chopper’s blade had horizontal Z-shape. The 




















Figure 38. The structure of blades of the chopper grinder (red; left picture) and coffee 
grinder (brown; right picture). 
Firstly, the clay suspension was treated using the red chopper grinder. As shown 
in Fig. 39, the total number of particles were in the range from 135 nm to 1165 
nm. The total volume consisted of particles of size from 185 nm to 1165 nm. This 
means that the suspension contained micro-particle aggregations. 
 
 
Figure 39. The particle size distribution of Cloisite Na+ suspension exfoliated using Tefal 
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The effect of the coffee grinder on exfoliation of the clay was studied. Figs. 40a 
and 40b shows the same DLS result of Cloisite Na+ suspension treated with the 
coffee grinder for 16 minutes at speed 1. As shown in Fig. 35b, 16 minutes was 
enough in order to achieve the uniformly exfoliated suspension, where 85.3% of 
the total volume consisted of particles at a size of 2.5 nm. The results showed 
that micro-sized clay particle aggregations have disappeared.  The suspension 
was fully exfoliated. According to Figs. 39 and 40, the coffee grinder was more 
effective in exfoliation of the clay than the chopper. 
 
 
Figure 40a. The particle size distribution of Cloisite Na+ suspension exfoliated by using 
the coffee grinder. The suspension at 6 mg/ml concentration of clay was blended for 16 






















Figure 40b. The particle size distribution of Cloisite Na+ suspension exfoliated by using 
the coffee grinder. The suspension at 6 mg/ml concentration of clay was blended for 16 
minutes at speed 1. The graph shows x-axis from 0 to 10 nm size.  
3.1.3.3. Exfoliation of SWN clay suspensions  
 
Similar to Cloisite Na+ clay suspension, exfoliation of SWN suspensions at a 
concentration of 6 mg/ml were investigated using magnetic stir, ultrasound and 
the Tefal blender. The comparison of these methods for achieving the exfoliation 
was made based on the results of DLS. Due to the exfoliation of SWN obtained 
by the Tefal blender after 10 minutes, this time was chosen for the comparison of 
the techniques. 
 
3.1.3.3.1. Analysis of SWN suspension without exfoliation treatment 
 
Prior to the actual exfoliation, SWN suspension without exfoliation treatment was 
analysed. The non-exfoliated SWN suspension was prepared as described in 
Section 2.4.1. Figs. 41a and 41b show the same DLS results of the particle size 
distribution of the SWN suspension without exfoliated treatment. According to 






















smaller than the size of Cloisite Na+ due to the smaller aspect ratio. As shown in 
Fig. 41b, there were two broad peaks of volume distribution indicating particle 




Figure 41a. The particle size distribution of non-exfoliated SWN suspension. A 
concentration of SWN in the suspension was 6 mg/ml. The graph shows x-axis from 0 






















Figure 41b. The particle size distribution of non-exfoliated SWN suspension. A 
concentration of SWN in the suspension was 6 mg/ml. The graph shows x-axis from 0 
to 80 nm size. 
 
3.1.3.3.2. Exfoliation of SWN suspension through magnetic stirring 
 
SWN suspension was stirred using the magnetic stir for 10 minutes at 880 rpm 
speed (Figs. 42a and 42b). As shown in Fig. 42a, there were no micro-size 
particles due to smaller aspect ratio. However, there were two broad peaks of 
volume ranging from 3 to 29 nm particle size, which indicated aggregation (Fig. 
42b). In addition, there were differences in number and volume frequency. A 
possible reason behind this might be the non-sufficient shear stress applied for 
























Figure 42a. The particle size distribution of SWN suspension exfoliated using magnetic 
stirring (Stuard). The suspension at a concentration of 6mg/ml of clay was stirred at 880 
rpm for 10 minutes at 25°C. The graph shows x-axis from 0 to 3000 nm size.  
 
Figure 42b. The particle size distribution of SWN suspension exfoliated using magnetic 
stirring (Stuard). The suspension at a concentration of 6mg/ml of clay was stirred at 880 






































3.1.3.3.3. Exfoliation of SWN suspension through high power sonication 
 
The next method of exfoliation of SWN suspension was ultrasonication for 10 
minutes. As shown in Figs. 43a and 43b, there were no micro-size particle 
aggregation, but volume distribution was more broad compare to the non-
exfoliated suspension (Fig. 43). The large volume of particles ranging from 8 to 




Figure 43a. The particle size distribution of SWN suspension exfoliated using ultrasound. 
The suspension at a concentration of 6 mg/ml of clay was sonicated at amplitude of 85% 























Figure 43b. The particle size distribution of SWN suspension exfoliated using ultrasound. 
The suspension at a concentration of 6 mg/ml of clay was sonicated at amplitude of 85% 
for 10 minutes. The graph shows x-axis from 0 to 80 nm size. 
 
3.1.3.3.4. Exfoliation of SWN suspension through blending 
 
SWN suspension was treated using the Tefal blender. The uniform and exfoliated 
SWN suspension was achieved by using the blade of the coffee grinder at speed 
1 for 10 minutes. As shown in Figs. 44a and 44b, there was one peak of each 
volume and number distribution, where 90% of particles were 2.5 nm, which 
represent 79% of the total volume. This means that the Tefal blending technique 
























Figure 44a. The particle size distribution of SWN suspension exfoliated using the coffee 
grinder. The suspension at a concentration of 6 mg/ml of clay was blended using the 
coffee grinder of the Tefal blender for 10 minutes at speed 1. The graph shows x-axis 
from 0 to 3000 nm size. 
 
Figure 44b. The particle size distribution of SWN suspension exfoliated using the coffee 






































coffee grinder of the Tefal blender for 10 minutes at speed 1. The graph shows x-axis 
from 0 to 80 nm size. 
 
3.1.4. Effect of exfoliation of clay on BC growth on a small scale 
 
The effect of exfoliation of clay on BC growth was studied on a small scale as 
described in Section 2.4.3. Non-exfoliated and exfoliated Cloisite Na+ and SWN 
clay suspensions produced by the Tefal blender were added into HS medium 
prior to the inoculation of bacteria. Clay concentration inside the medium was 
ranging from 0 (no particles) to 3 mg/ml. G. xylinus at a concentration of 7.9´107 
CFU/ml was inoculated using HS medium with and without particles at 30oC for 
48 hours. Fig. 45 shows the mass of dried BC produced with non-exfoliated 
Cloisite Na+ and SWN suspensions, respectively, on a small scale. As shown in 
Fig. 45, non-exfoliated Cloisite Na+ clay suspension at a concentration of 1.5 and 
3 mg/ml has reduced the growth of BC, the dried mass of which dropped to 0.01 
and 0.02 grams, respectively. The mass of dried BC decreased to 0.01 grams 
using 1.5 mg/ml concentration of non-exfoliated SWN clay suspension. In 
addition, there was no synthesis of cellulose using 3 mg/ml concentration of non-
exfoliated SWN. 
 






Figure 45. Effect of non-exfoliated Cloisite Na+ and SWN clay suspensions on the growth 
of BC on a small scale. Bacteria were inoculated at 7.9´107 CFU/ml concentration in HS 
medium containing clay at a final concentration from 0 to 3 mg/ml and incubated for 48 
hours at 30°C. Data shown represent the mean of three experiments with error bars of 
standard deviation. The treatments were compared to the controls (0 mg/ml of clay). The 
data are not significantly different.  
 
The effect of 16 minutes exfoliated Cloisite Na+ and 10 minutes exfoliated SWN 
suspensions produced by the Tefal blender on BC growth was analysed, 
respectively (Fig. 46). As shown in Fig. 46, the mass of dried BC formed with 
exfoliated Cloisite Na+ clay suspension decreased to 0.3 grams at clay 
concentrations ranging from 0.38 to 1.5 mg/ml. It was possible to obtain the 
pellicle in the presence of exfoliated SWN suspension at concentration of 3 mg/ml 
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Figure 46. Effect of exfoliated Cloisite Na+ and SWN clay suspensions on the growth of 
BC on a small scale. Bacteria were inoculated at 7.9´107 CFU/ml concentration in HS 
medium containing clay at a final concentration from 0 to 3 mg/ml and incubated for 48 
hours at 30°C. Data shown represent the mean of three experiments with error bars of 
standard deviation. The treatments were compared to the controls. The data are not 
significantly different. 
 
Consequently, the exfoliation and concentration of the clay suspensions could 
affect the synthesis of cellulose, but the difference in mass was not statistically 
significant. Non-exfoliated suspensions of both types of the clay reduced the 
mass of dried BC at concentration of 3 mg/ml. A possible reason behind this might 
be ability of the clay to form physically self-cross-linked gel structures. The 
images of BC formation with non-exfoliated and exfoliated Cloisite Na+ and SWN 
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Figure 47. Images of BC synthesised under different treatments. The clay was used at 
concentration of 3 mg/ml at either non-exfoliated or exfoliated state for 48 hours at 30°C. 
The gel formed by SWN clay can be detected by comparing the surface of the 
suspension to the control. In addition, a smaller yield of cellulose was obtained 
using non-exfoliated Cloisite Na+ compare to the control.  
A gel formation of non-exfoliated and exfoliated Cloisite Na+ and SWN 
suspensions was investigated using a rheometer as described in Section 2.4.2. 
Clay suspensions were mixed with HS medium at concentration of 3 mg/ml, 
respectively. The viscoelastic properties of clay/medium suspensions were 
studied at 0 and 48 hours (Figs. 48-49). As shown in Figs. 48-49, SWN showed 
higher elastic and viscous modulus compare to Cloisite Na+ after 48 hours. The 















The viscosity of non-exfoliated SWN increased from 0.2 to 1Pa after 0 and 48 
hours, respectively. Exfoliated SWN showed relatively high elastic (13Pa) and 
viscous (1Pa) modulus at both 0 and 48 hours. Whereas, Cloisite Na+ had 
relatively low elastic and viscous modulus after 48 hours. The elastic modulus of 
non-exfoliated and exfoliated Cloisite Na+ was 5Pa and 6Pa, respectively, with 
the viscosity being 0.07Pa and 0.05Pa, respectively. This means that no gel 
formation of Cloisite Na+ occurred after 48 hours. 
 
 
Figure 48. Elastic modulus of non-exfoliated and exfoliated Cloisite Na+/medium and 
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Figure 49. Viscous modulus of non-exfoliated and exfoliated Cloisite Na+/medium and 
SWN/medium suspensions after 0 and 48 hours. 
This means that a physical self-cross-linked gel of SWN might result. A gelation 
could occur through the formation of micro-flocculation, where individual particles 
of clay can aggregate into clot-like masses due to the electrostatic attraction 
between the negatively charged parts of particles and the positively charged 
edges[212]. 
 
3.1.5. Synthesis of BC in clay environment on a large scale 
 
The effect of exfoliated and non-exfoliated Cloisite Na+ and SWN clay on the 
growth of BC was analysed on a large scale as described in Section 2.4.4. There 
was no growth of BC using 3 mg/ml concentration of non-exfoliated SWN 
suspension. Nonetheless, it was possible to synthesis BC with 3 mg/ml of non-
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Figure 50. The synthesised BC with 3 mg/ml of non-exfoliated Cloisite Na+ clay 
suspension. Bacteria was inoculated at a concentration of 7.9´107 CFU/ml and 
incubated at 30°C for 48 hours. 
It was possible to synthesise BC with both exfoliated Cloisite Na+ and SWN at 3 
mg/ml concentration of the clay. Fig. 51 shows wet BC produced on a large scale 
using exfoliated Cloisite Na+ (a) and SWN (b) suspensions. As shown in Fig. 51, 
BC/Cloisite Na+ composite was denser compare to BC/SWN. 
 
 
Figure 51. The synthesised BC in the presence of 3 mg/ml of exfoliated Cloisite Na+ (a) 
and SWN (b) clay suspensions. Bacteria was inoculated at a concentration of 7.9´107 
CFU/ml and incubated at 30°C for 48 hours. 
b a 





As shown in Fig. 52, the mass of wet pure BC was 74.89 grams, whereas the 
mass of BC/Cloisite Na+ was 87.22 grams. However, the lightest cellulose was 
BC/SWN composite with a mass of 29.87 grams. The mass of wet BC/Cloisite 
Na+ composite was heavier than both pure BC and BC/SWN.  
 
 
Figure 52. Mass of wet, centrifuged pure BC, BC/Cloisite Na+ and BC/SWN produced 
with exfoliated clay, respectively. The BC was produced using an inoculum of 
approximately 7.9 x 107 CFU/ml and HS medium containing exfoliated Cloisite Na+ and 
SWN suspensions, respectively, at a concentration of 3 mg/ml. The bacteria were 
incubated for 48 hours at 30°C. Data shown represent the mean of a single experiment. 
The large volume of the medium and sufficient depth of the dish for incubation 
could be beneficial for the synthesis of BC. Furthermore, the results obtained on 
the large scale clearly shown that the synthesis of BC/clay composite was 
dependent on the exfoliation state of the clay, clay type and aspect ratio.  
 
3.1.6. Leaching behaviour of clay 
 
The leaching behaviour of clay was investigated as described in Section 2.4.5. 

























respectively, were obtained (Figs. 53-54). The purpose of the calibration curves 
was to quantify the concentration of clay leached from the composite during the 
washing process. As shown in Figs. 48-49, R2 was 99%, which means that the 
almost ideal linear relationships were obtained.  
 
 
Figure 53. The relationship between absorbance and concentration of Cloisite Na+ 
































Figure 54. The relationship between absorbance and concentration of SWN suspension. 
The absorbance was measured at wavelength of 211 nm. 
The concentration of leached Cloisite Na+ and SWN clay from BC/Cloisite Na+ 
and BC/SWN composites was calculated, respectively, using the calibration 
curves. BC/Cloisite Na+ and BC/SWN composites were washed with 20 ml of 
distilled water for 24 hours as described in Section 2.4.5. Fig. 55 shows the 
concentration of each clay leached from the composites from 0 to 24 hours. As 
shown in Fig. 55, Cloisite Na+ started to leach after 3 hours of washing. The 
concentration of Cloisite Na+ leached was 0.1 mg/ml after 24 hours. SWN clay 
started to leach after an hour of the washing. The concentration of SWN leached 
was 2.5 mg/ml after 24 hours.  
 
SWN started to leach faster with the concentration leached being higher than 
Cloisite Na+. This might be due to smaller aspect ratio, which resulted in weaker 
attachment of clay particles to BC fibres, whereas high aspect ratio of Cloisite 

































Figure 55. The concentration of leached clay of BC/Cloisite Na+ and BC/SWN, 
respectively, from 0 to 24 hours. 
 
3.1.7. Characterisation of in situ synthesised BC/clay composites 
 
In order to evaluate the incorporation of exfoliated particles into BC, BC/clay 
composites were analysed using UV-VIS-NIR spectroscopy after the washing. 
The ultraviolet region covers the range from 200 to 400 nm of the electromagnetic 
spectrum, whereas the visible region is from 400 to 700 nm[213]. The used 
spectrometer was also able to detect peaks in near IR (NIR) region from 800-
2500 nm. The evaluation of incorporation was based on the detection of the 
characteristic peaks of clay.  
 
3.1.7.1. UV-VIS-NIR analysis of BC/Cloisite Na+ composites 
 
UV-VIS-NIR spectrum of BC/Cloisite Na+ composites, which were synthesised in 
situ using the exfoliated clay, were compared to the spectra of both pure BC and 
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nm, whereas both the composite and pure BC had peaks at 215, 263 and 283 
nm[214]. According to Fig. 56, the composite showed the spectrum similar to pure 
BC. The peak of the clay was not detected inside the composite. The reason for 
this might be the reflective nature of the equipment, where the light reflected from 
the surface. Clay may not be present on the surface after the washing process, 
but it may remain inside BC. In this case the equipment cannot detect clay in the 
samples.    
 
 
Figure 56. UV-VIS spectra of BC/Cloisite Na+ composite, pure BC and Cloisite Na+.  
The presence of the clay, however, was detected in the composite in NIR spectra 
(Fig. 57). As shown in Fig. 57, BC/Cloisite Na+ composite had the characteristic 
peak of Cloisite Na+ clay at 1041 and 1426 nm due to the Si-O. Pure BC and 
BC/Cloisite Na+ showed a similar peak of the cellulose at 1921 nm[214].  
 
According to Figs. 56-57, the composite showed predominant cellulose structure. 
However, the presence of the characteristic peak of the clay at 1426 nm indicated 


























Figure 57. NIR spectra of BC/Cloisite Na+ composite, pure BC and Cloisite Na+. 
 
3.1.7.2. UV-VIS-NIR analysis of BC/SWN composites 
 
UV-VIS-NIR spectrum of BC/SWN composite was compared to spectra of pure 
BC and SWN clay (Figs. 58-59). As shown in Fig. 58, the composite had 
predominant BC peaks at 263 and 281 nm. BC/SWN composite had the broad 
peak at 211-215 nm, which made the detection of the clay difficult in UV region.  






























Figure 58. UV-VIS spectra of BC/SWN, pure BC and SWN clay powder.  
The NIR spectrum of the BC/SWN composite was compared to SWN clay and 
pure BC (Fig. 59).  
 
 
Figure 59. NIR spectra of BC/SWN composite, pure BC and SWN clay powder. 
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The characteristic peak of SWN at around 1400 nm was clearly visible inside 
the composite. This result indicated that SWN was incorporated into BC matrix 
during in situ synthesis of the composite. In addition, the peak of the cellulose 
was observed inside BC/SWN composite at 1950 nm. 
 
3.1.8. Antibacterial activity of non-exfoliated clay suspensions 
 
The antibacterial activity of non-exfoliated Cloisite Na+ and SWN suspensions at 
a concentration of 3 mg/ml against MRSA (NCTC 10418) and E. coli (NCTC 
12493), respectively, was investigated as described in Section 2.7.3.1. Fig. 60 
shows the antibacterial effect of non-exfoliated clay against MRSA. The control 
was PBS-resuspended MRSA without any treatment.  
 
 
Figure 60. Antibacterial activity of non-exfoliated Cloisite Na+ and SWN suspensions 
against MRSA (NCTC 10418). The bacteria were incubated with Cloisite Na+ and SWN 
suspensions at 3 mg/ml concentration of clay, respectively, for 24 hours at 37°C. The 
control was PBS-resuspended MRSA without any treatments. Data shown represent the 



























As shown in Fig. 60, there was a little reduction of bacterial growth to 97% of 
control values using non-exfoliated Cloisite Na+, whereas non-exfoliated SWN 
clay increased the growth of MRSA to 109%. 
 
Fig. 61 shows the antibacterial activity of non-exfoliated Cloisite Na+ and SWN 
suspensions at a concentration of 3 mg/ml against E. coli. The control was PBS-
resuspended E. coli without any treatment. Both non-exfoliated Cloisite Na+ and 
SWN clay did not show any antibacterial activity. The growth of E. coli increased 
to 129% and 115% of control values using Cloisite Na+ and SWN clay 
suspensions, respectively.  
 
 
Figure 61. Antibacterial activity of non-exfoliated Cloisite Na+ and SWN suspensions 
against E. coli (NCTC 12493). The bacteria were incubated with Cloisite Na+ and SWN 
suspensions at 3 mg/ml concentration of clay, respectively, for 24 hours at 37°C. The 
control was PBS-resuspended E. coli without any treatments. Data shown represent the 
mean of a single experiment. 
 
It has been reported that natural unmodified MMT clay does not show any 


























exfoliated clay did not possess any antibacterial activity against either MRSA or 
E. coli.  
 
3.1.9. Antibacterial activity of exfoliated clay suspensions 
 
The antibacterial activity of exfoliated Cloisite Na+ and SWN clay suspensions at 
a concentration of 3 mg/ml was investigated against MRSA and E. coli as 
described in Section 2.7.3.1. As shown in Fig. 62, Cloisite Na+ possessed 
antibacterial activity against MRSA. The bacterial growth was reduced to 27.8% 
compare to the control, whereas SWN reduced the control values to 80%. SWN 
showed the highest antibacterial activity against E. coli, where the growth of 
bacteria decreased to 5% of control values (Fig. 63). Cloisite Na+ reduced the 
control values of E. coli to 29%.  
 
 
Figure 62. Antibacterial activity of exfoliated Cloisite Na+ and SWN suspensions against 
MRSA (NCTC 10418). The bacteria were incubated with Cloisite Na+ and SWN 
suspensions at 3 mg/ml concentration of clay, respectively, for 24 hours at 37°C. The 
control was PBS-resuspended MRSA without any treatments. Data shown represent the 


























Figure 63. Antibacterial activity of exfoliated Cloisite Na+ and SWN suspensions against 
E. coli (NCTC 12493). The bacteria were incubated with Cloisite Na+ and SWN 
suspensions at 3 mg/ml concentration of clay, respectively, for 24 hours at 37°C. The 
control was PBS-resuspended E. coli without any treatments. Data shown represent the 
mean of two independent experiments with error bars of standard deviation.  
 
According to Figs. 62-63, SWN showed stronger antibacterial activity against E. 
coli than MRSA, whereas Cloisite Na+ was effective against both bacteria.  
 
3.1.10. Antibacterial activity of in situ synthesised BC/clay 
composites 
 
As exfoliated clay showed antibacterial activity, the effect of both BC/SWN and 
BC/Cloisite Na+ composites, which were produced on a large scale, was 
investigated using MRSA and E. coli as described in Section 2.7.3. Bacteria at a 
concentration of 0.1 OD600 were added to the surface of either BC or BC/clay 
composites, covered with a sterile plastic lid and incubated for 24 hours at 37°C. 
























growth of bacteria using pure BC and BC/clay composites, respectively. As 
shown in Figs. 64-65, pure BC did not possess any antibacterial activity. This 
indicated that pure BC as can also increase the growth of the bacteria, which 
causes infections of wounds. Moreover, pure BC promoted the growth of E. coli.  
 
 
Figure 64. Antibacterial activity of BC/Cloisite Na+ and BC/SWN against MRSA. The 
control was PBS-resuspended MRSA without any treatments, which was placed on the 
surface of the empty petri dish and covered with a lid. The bacteria and different types 
of BC were incubated for 24 hours at 37°C. Data shown represent the mean of two 
experiments with error bars of standard deviation.  
 
However, BC/Cloisite Na+ composite inhibited the growth of both MRSA and E. 
coli, where control values of bacteria were reduced to 1.4% and 14.6%, 
respectively. BC/SWN composites showed the reduction of the control values of 
MRSA to 4.8% and of E. coli to 16.8% respectively. Therefore, in situ synthesised 
BC/clay composites showed antibacterial activity against both MRSA and E. coli 
despite BC alone did not affect the bacteria. The antibacterial activity of the 
BC/clay composites was stronger against MRSA than E. coli. According to Figs. 
























composite. This might be due to a better interaction of bacteria and clay inside 
the matrix of BC rather than in aqueous PBS environment. According to P-value, 
there was no significant difference in the growth of bacteria.  
 
 
Figure 65. Antibacterial activity of BC/Cloisite Na+ and BC/SWN against E. coli (NCTC 
12493). The control was PBS-resuspended E. coli without any treatments, which was 
placed on the surface of the empty petri dish and covered with a lid. The bacteria and 
different types of BC were incubated for 24 hours at 37°C. Data shown represent the 
mean of two independent experiments with error bars of standard deviation.  
 
3.1.11. Cytotoxicity of Cloisite Na+ and SWN clay 
 
The cytotoxicity of both Cloisite Na+ and SWN clay was investigated using non-
exfoliated and exfoliated clay suspensions. Clay particles were either mixed with 
the tissue culture medium and were then considered as non-exfoliated or 
exfoliated using the Tefal blender as described in Section 2.4.1.1 prior to the 


























3.1.12. Cytotoxicity of non-exfoliated clay  
 
Sterile Cloisite Na+ and SWN raw particles were mixed with the tissue culture 
medium at a concentration from 0.09 to 6 mg/ml. The suspensions were 
incubated with NIH 3t3 cells for up to 72 hours at 37°C.   
 
3.1.12.1. Effect of non-exfoliated Cloisite Na+ clay on 3t3 cells 
 
Fig.  66 shows the effect of non-exfoliated Cloisite Na+ clay suspensions on 3t3 
fibroblast cells. As shown in Fig. 66, Cloisite Na+ affected the MTT reduction of 
the cells within first 24 hours. The highest percent of MTT reduced cells was 95%, 
which was observed using 0.19 mg/ml concentration of clay. The MMT reduction 
of 3t3 cells decreased with increasing the concentration of the clay and finally 
dropped to 40% using a concentration of 6 mg/ml. However, the overall MTT 
reduction of the cells increased after 48 hours. The level of MMT reduced cells 
raised over the control and reached 115% and 105% by using 0.09 and 0.19 
mg/ml concentration of clay. In 48 hours, the percent of metabolically active cells 
decreased to 84% by using 1.5 mg/ml concentration of Cloisite Na+. Then, the 
level of MMT reduction of the cells continuously decreased to 46% by using 6 
mg/ml concentration of the clay particles. After 72 hours, the overall percent of 
MMT reduced cells under the treatment reduced from a maximum of 57% to a 
minimum of 15% by using 0.09 and 6 mg/ml clay, respectively.  
 






Figure 66. The effect of non-exfoliated Cloisite Na+ suspensions at 3t3 cells. Cloisite Na+ 
at a concentration of 0.09-6 mg/ml was incubated with NIH 3t3 cells for 24, 48 and 72 
hours at 37°C. The control was the cells without any treatment at each tested time. Data 
shown represent the mean of two independent experiments of MTT assay with error bars 
of standard deviation. Treatments were compared to the controls. Regarding 24 hours 
of incubation, the data obtained after 24 and 48 hours using the concentration of 3 mg/ml 
are significantly different from the control with P-value <0.05. After 72 hours, the 
treatments with concentrations of 0.09 and 0.38 mg/ml are different from the control (P-
value <0.05), whilst 0.019, 0.075, 1.5, 3 and 6 mg/ml concentrations showed significant 
difference from the control with P-value <0.01, respectively.  
 
 
3.1.12.2. Effect of non-exfoliated SWN clay on 3t3 cells 
 
Sterile SWN particles at concentrations from 0.09 to 6 mg/ml were incubated with 
3t3 cells for 24, 48 and 72 hours at 37°C. According to Fig. 67, the level of MTT 
reduction of cells decreased within all treatments. Increasing the concentration of 
SWN in the medium led to a decrease in the MTT reduction of 3t3 cells from 93% 
to 32% using 0.09 and 6 mg/ml of the clay after 24 hours, respectively. Similarly, 
























concentration of clay, respectively, after 48 hours. However, the level of MTT 
reduction varied from 69% to 72% within 0.09 and 0.75 mg/ml after 72 hours. 
Starting from 1.5 mg/ml concentration of clay, MTT reduction of the cells 
significantly decreased to 34%. The lowest percent of MTT reduction obtained 
after 72 hours was detected to be 18% of control values at 6 mg/ml. 
As shown in Fig. 67, SWN could inhibited the metabolic activity of 3t3 cells in a 
time- and concentration-dependent manner. This might be due to the ability of 
the particles to disrupt the cell membrane, which then leads to either apoptosis 
or necrosis[215].  
 
 
Figure 67. The effect of SWN/medium suspension on 3t3 cells. The suspension at a 
concentration of 0.09-6 mg/ml was inoculated with NIH 3t3 cells and incubated for 24, 
48 and 72 hours at 37°C. The control was the cells without any treatment at each tested 
time. Data shown represent the mean of three independent experiments of MTT assay 
with error bars of standard deviation. Treatments were compared to the controls. 
Regarding 24 hours of incubation, the data obtained using the concentrations of 0.19, 
0.38, 0.75, 1.5, 3 and 6 mg/ml are significantly different from the control with P-values 
<0.05, <0.001, <0.05, <0.01, <0.05 and <0.01, respectively. After 48 hours of incubation, 
the treatments with concentrations of 1.5 and 3 mg/ml showed significant difference from 
























are significantly different in comparison with the control after 72 hours (P-values are 
<0.05 and <0.001, respectively). 
 
3.1.13. Cytotoxicity of exfoliated suspensions 
 
The cytotoxicity of exfoliated Cloisite Na+ and SWN clay suspensions was 
analysed using 3t3 cells, respectively. The cytotoxicity assay was carried out as 
described in Sections 2.12.1 and 2.12.3. The suspensions at a final concentration 
from 0 to 1.5 mg/ml were added to the tissue culture medium. The cells were 
incubated in the presence of the exfoliated clay suspensions for 24, 48 and 72 
hours. As the medium was diluted and, therefore, the amount of the essential 
nutrients decreased, the effect of medium reduction on the metabolic activity of 
3t3 cells was investigated prior to the experiment involving clay. 
 
3.1.13.1. Effect of time on MTT reduction in 3t3 cells 
 
The analysis of the cytotoxicity of the clay started with an investigation of levels 
of MTT reduction of 3t3 cells within different time frames. In order to achieve this, 
the cells were incubated for 24, 48 and 72 hours. The control was 24 hours. The 
effect of time on the MTT reduction of cells is shown in Fig. 68, the level of MTT 
reduction of 3t3 cells increased to 114% and 123% of the control values after 48 
hours and 72 hours, respectively. Once the whole surface of the flask is covered, 
the growth of cells can decrease. This is called contact inhibition [216]. However, 
it was not the case in the current results. This specific cell line was identified by 
the supplier as transformed cells that continue proliferating even after they reach 
confluence.  
 






Figure 68. The effect of time of incubation on the MTT reduction in 3t3 cells after 24, 48 
and 72 hours at 37°C. The control was obtained after 24 hours. Data shown represent 
the mean of three independent experiments of MTT assay with error bars of standard 
deviation. 
 
3.1.13.2. The effect of the reduction of the medium on MTT reduction in 3t3 
cells 
 
Prior to the cytotoxicity assay with the clay suspensions, sterile PBS was used to 
dilute the medium from 100 to 75%, which corresponded to the volume of further 
added suspensions. The diluted medium was then incubated with the 3t3 cells 
from 24 to 72 hours at 37°C. As shown in Fig. 69, the MTT reduction of 3t3 cells 
gradually decreased from 100 to 61% by diluting medium from 99 to 75%, 
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Figure 69. The effect of reduction of the medium on the MTT reduction in 3t3 cells. 
Culture medium was diluted with PBS from standard 100 to 75%. The control 
represented cells without any treatments after 24, 48 and 72 hours, respectively, at 37ºC. 
Data shown represent the mean of three independent experiments of MTT assay with 
error bars of standard deviation. The treatments were compared to the controls. Values 
of 94% and 75% are significantly different from the control after 24 hours (P-value <0.05). 
After 48 hours, treatments of 88% and 75% are significantly different from the control (P-
value<0.05), whereas 97% and 75% showed significant difference in comparison with 
the control after 72 hours with P-values <0.001 and <0.05, respectively. 
 
The level of MTT reduction of cells continuously decreased as medium was 
diluted. The lowest percentage of MTT reduction was observed using 75% of the 
medium after 48 hours, where the control values of the 3t3 cells significantly 
dropped to 54%. The level of MTT reduction of 3t3 cells slightly increased to 64% 
by diluting the medium to 75% after 72 hours. Such a decrease in MTT reduction 
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3.1.13.3. Cytotoxicity of exfoliated Cloisite Na+ clay suspensions  
 
The toxicity of exfoliated Cloisite Na+ clay suspensions, which were produced by 
16 minutes of Tefal blending at a concentration from 0.09 to 1.5 mg/ml on 3t3 
cells, was investigated after 24, 48 and 72 hours. A separate control was set up 
and inoculated within each time frame. As shown in Fig. 70, all clay 
concentrations increased the MTT reduction of cells. After 24 hours, the percent 
of MTT reduced cells reached a maximum of 139% using 0.09 mg/ml clay 
suspension. Then, there was a slight decrease to 100% using both 0.19 mg/ml 
and 0.38 mg/ml clay concentration. The level of MTT reduction increased again 
to 114% and 133% of control values by further increasing the concentration of 
Cloisite Na+ to 0.75 mg/ml and 1.5 mg/ml.  
 
The MTT reduction in 3t3 cells firstly increased to 142% and 138% of control 
values by using 0.09 mg/ml and 0.19 mg/ml concentrations of the clay, 
respectively, after 48 hours. Then, there was a decrease of MTT reduced cells to 
76%, 63% and 71% of control values using 0.38, 0.75 and 1.5 mg/ml of the clay, 
respectively. The percent of MTT reduced 3t3 cells went down to 22% at a clay 
concentration of 0.75 mg/ml after 72 hours. The decrease in MTT reduction could 










Figure 70. The effect of exfoliated Cloisite Na+ clay suspension on a level of MTT 
reduction in 3t3 cells. The cells were inoculated with clay suspensions at a concentration 
of 0.09-1.5 mg/ml and incubated for 24, 48 and 72 hours, respectively, at 37ºC. The 
control the cells without any treatment after each time frame. Data represent the mean 
of two independent experiments of MTT assay with error bars of standard deviation. 
Controls were compared to the treatments obtained after 24, 48 and 72 hours. The data 
are not significantly different after both 24 and 48 hours. However, after 72 hours, the 
concentrations of 0.19, 0.38, 0.75 and 1.5 mg/ml are significantly different from the 
control with P-values <0.05, <0.01, <0.001 and <0.05, respectively.  
Exfoliated Cloisite Na+ suspensions were not toxic for NIH 3t3 cells within 24 
hours, whereas starting from 48 hours, the clay showed concentration-dependent 
toxicity on fibroblasts. However, such a decrease of the levels of MTT reduction 
of the cells was not statistically significant. It should also be noted that reducing 
the concentration of medium alone could result in the drop of metabolically active 


















Concentration of Cloisite Na+, mg/ml





3.1.13.4. Cytotoxicity of exfoliated SWN clay suspensions 
 
The cytotoxicity of exfoliated SWN clay suspensions at the concentration from 
0.09 to 1.5 mg/ml was also investigated using 3t3 cells (Fig. 71). As shown in Fig. 
71, the level of MTT reduction of cells decreased from 105% to 56% of control 
values by using the concentration of SWN from 0.09 to 1.5 mg/ml, respectively, 
after 24 hours. In addition, 143% was the maximum percent of MTT reduced cells 
at 0.09 mg/ml concentration of the clay after 24 hours.  
 
 
Figure 71. The effect of exfoliated SWN clay suspension on a level of MTT reduction in 
3t3 cells. The cells were inoculated with clay suspension at a concentration of 0.09-1.5 
mg/ml and incubated for 24 hours at 37ºC. The control represented the cells without any 
treatment. Data represent the mean of two independent experiments of MTT assay with 
error bars of standard deviation. The treatments were compared to the controls. The 
concentration of 1.5 mg/ml is significantly different from the control after 72 hours (P-
value <0.05).  
 
The level of MTT reduction of cells at the concentration of 1.5 mg/ml of the clay 
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cells dropped to a minimum of 34% of the control values at the highest 
concentration of the clay after 72 hours. The maximum number of MTT reduction 
was 80% at the lowest concentration of SWN after 72 hours.  
 
Table 1 shows the level of MTT reduction of cells obtained after 24, 48 and 72 
hours by using 75% diluted culture medium, Cloisite Na+ and SWN exfoliated 
suspensions at concentration of 1.5 mg/ml, respectively. As shown in Table 1, 
the levels of MTT reduction of the 3t3 cells was higher in the presence of clay 
after 24 and 48 hours, respectively. Then, the percent of MTT reduced cells 
decrease after 72 hours. Therefore, the clay was not toxic for the 3t3 cells within 
48 hours. A possible reason behind the decrease of MTT reduced cells in a clay 
environment after 72 hours need to be further investigated. 
 
Table 1. The comparison of MTT reduction in cells under different treatment after 24, 48 
and 72 hours. Standard deviation is shown in the brackets. 
Treatments at the highest used 
concentration/dilution 
 
Time of incubation, hours 
24 48 72 
MTT reduction in 3t3 cells (%) 
Medium diluted with PBS  
(75%) 
61 (±23) 55 (±3) 65 (±13) 
Exfoliated Cloisite Na+  
(1.5 mg/ml) 
133 (±54)  71 (±23) 37 (±14) 
Exfoliated SWN  
(1.5 mg/ml) 












The optimal conditions for the growth of BC were investigated on both small and 
large scales. It was possible to introduce antibacterial activity to BC through 
synthesis in situ by using exfoliated Cloisite Na+ (NaMMT) and SWN 
suspensions. Non-exfoliated clays did not show any antibacterial activity against 
either MRSA or E. coli, whereas exfoliated clay reduced the growth of bacteria. 
The used concentration of clay of 3 mg/ml had no statistically significant effect on 
the MTT reduction in 3t3 cells.  
 
3.2.1. Growth of pure BC in HS medium 
  
There are factors that could affect the growth of pure BC. The formation of BC 
could be associated with a bacterial response to the temperatures studied. It has 
been reported elsewhere that temperatures below 20°C and above 35°C resulted 
in the lack of bacterial replication and, therefore, less extent of growth[217]. 
Furthermore, the temperature over 35°C could lead to a reduction in bacterial 
multiplication through damaging the proteins in the cell wall[217]. A number of 
studies stated that the highest yield of BC was observed in the range of 28-
30°C[218, 219]. This agrees with the results obtained in the current study. Moreover, 
the synthesis of BC did not decrease beyond 48 hours on a large scale as was 
observed on a small scale. A possible reason might be the effect of the volume 
of the medium as well as the size of the trays used. As the bacterial growth 
increases, and, therefore, the number of cells increase, a suitable depth of the 
medium might be beneficial for the growth of thick cellulose. Another study has 
observed the limit of BC formation on a large scale after 14 days, where the 
synthesis of BC was much faster within the first 7 days using a 250 ml flask with 
HS medium[220]. This might be due to exhaustion of medium. Similar results were 
obtained by other researchers. It has been reported that the maximum bacterial 
growth at the log phase was observed to be after 48 hours, which then decreased 
after 72 hours using 24-well plates at 30°C[221, 222].  
 





Another possible reason for such a reduction in BC growth after 72 hours on a 
small scale might be insufficient amount of carbon and nitrogen sources left for 
bacterial survival after 48 hours. For instance, study elsewhere has continued to 
synthesise BC for 96 hours using 24-well plates at 30°C and stated that the 
growth of BC was completely stopped after 96 hours[217]. Thus, the decrease in 
concentration of glucose could be another reason for poor BC formation. Glucose 
is utilised by bacteria in several ways. Glucose is used as an energy source as 
well as the cellulose precursor. The glucose is converted into (keto)gluconic 
acids, so that the concentration of glucose could decrease progressively during 
the fermentation process[128]. In another study, the percentage of glucose used, 
and glucose converted into cellulose was found to be directly proportional to the 
production of BC[217]. The yield of BC has been increased in parallel with 
increasing the initial glucose concentration[128]. Therefore, exhaustion of the 
medium might be another reason why the growth of BC decreases after a long 
incubation period. Therefore, BC could require 48 hours in order to grow 
sufficiently for the subsequent experiments on both small and large scales. 
 
3.2.2. Swelling and exfoliation of clays 
 
As was described previously in Section 1.3.1.1, both Montmorillonite and SWN 
have 2:1 structure, where two tetrahedral sheets are sandwiching one octahedral 
sheet[83]. These sheets are negatively charged and, thus, the charge is balanced 
by exchangeable cations such as Na+[83]. In a dry state, the attractive interaction 
of both van der Waals and electrostatic forces can hold Na+ cations and clay 
sheets together[83]. However, in the aqueous environment, exchangeable cations, 
which form a double layer between the particles, do not interact strongly and can 
flow independently[223]. When the clay gets in contact with water, which enters 
the interlayer space, hydration of Na+ cations occurs[224]. This leads to the 
swelling and delamination of particles. The exchangeable cations could attract 
water molecules in the interlayer space. As a result of the hydration, the 
exchangeable cations may expand in volume[224]. The interaction between Na+ 





cations and water results in the formation of a solvation shell around the 
cations[224]. This means that the interactions of Na+ cations and the clay particles 
could decrease. It has been reported that Na+ cations reside near the siloxane 
surface by moving to the middle plane of the interlayer space after hydration in 
the presence of 3 water molecules[225]. This resulted in the opening of the 
interlayer space to 1.38A[225]. However, once Na+ cations absorbed 5 molecules 
of water, the interlayer space increased to 15.35A[225]. This means that the 
hydration plays an important role in the exfoliation of Cloisite Na+. The simulation 
obtained elsewhere has shown that the hydration of Na+ cations could lead to 
their relocation to the centre of the interlayer space of NaMMT in up to 200 
picoseconds[226, 227]. 
 
The shear force can increase the delamination of clay particles if just the 
interlayer space of clay is hydrated. Nanoparticles may be randomly delaminated 
from the stacks of initial clay. The delamination is a disconnection between layers 
followed by the deconstruction of chemical bonds, whereas the exfoliation means 
that chemical bonds between the clay layers are broken with the result that clay 




Figure 72. Schematic representation of exfoliation of clay particles[223]. 
Magnetic stirring, ultrasonication and Tefal blending techniques were used for the 
exfoliation of both Cloisite Na+ and SWN suspensions. However, the Tefal 
blending was the most successful technique for the exfoliation of clay. A possible 





reason why magnetic stirring not being successful in exfoliation of both Cloisite 
Na+ and SWN suspensions might be the shear stress applied was insufficient for 
exfoliation. The mechanism of the magnetic stirring is based on the external 
magnetic field that rotates the magnetic bars inside the mixture, which results in 
a vortex effect and subsequent stirring of the suspension through the collision of 
particles[228]. The turbulent flow of the stir could be enough to separate the 
aggregations of the micro-particles. However, the shear force might not be 
sufficient to fully exfoliate the clay and to separate the layers.  
 
Furthermore, complete exfoliation was not achieved for either Cloisite Na+ or 
SWN suspensions using the ultrasound.  A possible reason could be the duration 
of ultrasonication. It has been reported elsewhere that particles exposed to longer 
duration of sonication showed increased levels of breakage[196]. As the 
ultrasonication was performed by an elongated tip, which was placed in the 
middle of the suspension, the size of particles at this location could be smaller 
than the size of particles located at the edges of the beaker. As another research 
study pointed out, the effective zone of dispersion of particles was observed near 
the tip[196]. Furthermore, the volume of a suspension plays a crucial role in the 
exfoliation of clay. Increasing the volume of the suspension might lead to an 
increase in both final size of particles and time required for achieving the 
exfoliation[196]. Another possible reason might be that the amplitude used could 
not be efficient for breaking all aggregations. It was found that at higher 
amplitudes more reduction in the size of particles was observed[196]. Furthermore, 
the power of sonication influences the level of cavitation in the liquid[196]. This 
means that high levels of power could increase the number of cavitation bubbles, 
which break the aggregations. However, the high power of ultrasonication could 
also damage the structure of nanosheets[72]. Nevertheless, ultrasonication was 
found to be effective in exfoliation of most layers of the clay[197], agglomerations 
of particles being observed even using the highest amplitude[196]. However, it was 
clearly not the case in this study. In this particular case, the condition applied was 





not only ineffective to exfoliate clay layers, but also failed to separate micro-
particle aggregations. 
 
The total Tefal blending method was the most effective technique for the 
exfoliation of clay. The mechanism of the blending could be based on the circular 
whirring motion that created a vortex. The vortex caused the blades to pull the 
particles towards the middle and then out to the sides. A combination of 
circulation, cavitation and shearing forces resulted in uniform exfoliation of the 
clay. The coffee grinder was more effective than the chopper for the exfoliation 
of the clay. Such a result might be due to the shape of the blades. A possible 
reason for the better exfoliation achieved using the coffee grinder could be narrow 
space between the flat blade and surface resulting in enhanced laminar flow. The 
shear stress in laminar flow might be much higher than in turbulent flow. Any 
particles that may possibly settle underneath the blade were pushed out to the 
sides by the vortex effect. Furthermore, such a structure could lead to the almost 
vertical tornado-like stirring of the suspensions. Oppositely, a distance between 
one side of the blade of the chopper was larger than another. This may result in 
slightly dislocated stirring towards one side of the bowl. Thereby, the best 
technique for the exfoliation of Cloisite Na+ was blending the suspension using 
the coffee grinder at speed 1 for 16 minutes. 
 
The exfoliation of clay in aqueous liquid is currently a challenge[229]. However, the 
exfoliation of clay was successfully achieved using the coffee grinder in this study. 
The result demonstrated that this method could be a simple and low-cost 
technique for the exfoliation of clay in an aqueous environment.  
 
3.2.3. Growth of BC in clay environment 
 
The increased viscosity of SWN seems to be a possible reason for the poor 
growth of BC/SWN composites. The viscosity could prevent bacteria from 
reaching oxygen and, therefore, it may be challenging for them to produce BC. 





Aeration is one of the most important processes of the cultivation. As G. xylinus 
are highly aerobic bacteria, a suitable oxygen supply is crucial[230]. The gel could 
block the access of oxygen and, therefore, lead to a reduction in the bacterial 
growth. The gel could also result in restriction of bacterial movement within the 
liquid. A possible reason behind the increased viscosity of SWN might be the 
ability of the clay to form physically self-cross-linked gel structures. This might be 
due to a disordered network of particles dispersed throughout its volume[212]. It 
has been reported that the concentration of Laponite, which is a synthetic clay, 
above 1 wt.% might lead to blocking clay particles into a stable structure known 
as an equilibrium gel[212]. It has been concluded elsewhere that a concentration 
of Laponite below 1 wt.% could lead to gel formation after a few months[212]. 
However, the results showed that 0.3 wt.% of SWM started to form a gel after 24 
hours. The gelation might occur through a formation of micro-flocculation, where 
individual particles of clay can aggregate into clot-like masses due to the 
electrostatic attraction between the negatively charged parts of particles and the 
positively charged edges[212]. This can result in a card-house structure[212]. 
 
Another reason for the poor synthesis of BC in a non-exfoliated clay environment 
might be pH. As the pH of the final medium/clay suspension was adjusted to pH5 
prior to the experiment, the pH of the clay suspensions itself was not able to affect 
the synthesis of BC at the beginning. However, during the cultivation and 
formation of the cellulose, the bacteria produced gluconic acid, which resulted in 
a decrease to about pH4-3[230].  It has been reported that a decrease in pH could 
lead to a decrease in negative zeta potential, which may affect the dispersion of 
particles[231]. The dispersion of clay has been found to be better at alkaline rather 
than acidic pH[232]. Therefore, clay may not be well-dispersed in an acidic 
environment created by the bacteria. In addition, as non-exfoliated clay had large 
aggregation of particles, these aggregations could even increase in a size during 
the growth of BC.  
 
  





3.2.4. Antibacterial activity of natural clay  
 
Natural dry clay did not show any antibacterial activity; however, clay might be 
antibacterial when it is hydrated[233]. Exchangeable cations, which are located in 
the interlayer space could be released upon the hydration of the clay and affect 
growth of bacteria[234]. The exact mechanism of the antibacterial action of natural 
exfoliated clay is not well understood[234]. However, a mechanism of the 




Figure 73. A proposed antibacterial mechanism of NaMMT[234]. 
As shown in Figs. 72-73, during the exfoliation, Na+ cations, which are hidden 
between layers of the clay, could be exposed on the surface[223, 224]. There are 
approximately 18, 000 ions per nanolayer[235]. As was described in Section 
1.2.3.1., the negative charge of Gram-negative bacteria such as E. coli appears 
due to the presence of phospholipids and LPS inside the outer membrane, 
whereas Gram-positive MRSA carries a negative charge due to the presence of 
teichoic acids[236-238]. Thus, an electrostatic interaction between Na+ cations and 
the negatively charged membrane of bacteria could occur. This may lead to 
permeabilisation and burst release of the components of a bacterial cell wall[239]. 
For instance, it has been reported elsewhere that the cell walls of E. coli were 
shrunk and degenerated after being in the exfoliated clay environment for 24 





hours[239]. Furthermore, ionic charges of nanoparticles could attract polar organic 
molecules and, subsequently, adhere to a bacterial cell wall followed by creating 
a “blockade effect”[234]. It has been reported that the diameter of E. coli  and S. 
aureus cells is about 1.5−2 μm and 0.5−1 μm, respectively, whereas the 
dimensions of a nanoparticle are about 100 nm × 100 nm × 1 nm[240]. This means 
that the particles may cover the surface of bacteria. This might interfere with 
crucial biological functions such as sodium-ion transport and quorum sensing. 
Furthermore, such an attachment of the Na+ cations to a bacterial cell wall could 
affect osmosis and lead to the dehydration of bacterial cells. This might explain 
why non-exfoliated clays did not show any antibacterial activity against both 
MRSA and E. coli, whereas exfoliated clay reduced the growth of bacteria. 
 
In the current study, the exfoliated Cloisite Na+ and SWN clay showed 
antibacterial activity against both MRSA and E. coli. It has been reported 
elsewhere that the exfoliated NaMMT nanoparticles decreased the growth of E. 
coli by 99% after 24 hours[240]. SEM results have shown accumulation and 
association of exfoliated clay particles around the cell wall of E. coli, which 
appeared rough[240]. In another study, Salmonella cells that were incubated with 
0.1 wt.% of clay nanoparticles for 24 hours and tended to bind together that can 
be associated with the motion of their flagella[234]. The surface of Salmonella cells 
appeared shrink and dehydrated after contacting clay for 24 and 48 hours[234]. 
Furthermore, it has been reported that exfoliated nanoparticles of NaMMT at a 
concentration of 0.3 wt.% showed antibacterial effects against both S. aureus and 
E. coli after 24 hours, whereas non-exfoliated NaMMT clay did not possess any 
antibacterial activity[240]. The results obtained in the current study are in 
agreement with these reports. SEM results elsewhere have shown that the 
nanoparticles covered the cell walls of both S. aureus and E. coli after 24 
hours[240]. Another study has concluded that nanosized silicate particles that were 
obtained from natural silicate clay minerals had antibacterial activity through 
physical trapping mechanism[235]. This means that clay particles might exhibit 
antibacterial activity externally without penetrating a cell wall. Moreover, it has 





been stated that nanoparticles could inhibit the growth of Gram-positive MRSA, 
S. aureus and Streptococcus pyogenes as well as Gram-negative E. coli and P. 
aeruginosa through generating ROS[235]. In addition, it has also been concluded 
elsewhere that an increase in surface area by exfoliation might be a key factor in 
boosting antibacterial activity[240]. 
 
The antibacterial effect of exfoliated nanoparticles could be time-dependent. As 
time of the incubation increased, some hollow spaces around particles were 
observed[240]. This might mean that the bacteria could be dead. It has been 
reported that the overall count of E. coli decreased during the increasing time of 
incubation with 1 wt.% of nanoparticles from 24 hours, when the concentration of 
bacteria treated with clay was close to the control values, to 72 hours, when the 
CFU of treated bacteria reduced up to 50% compared to the control[240]. Both 
duration of incubation and concentration of nanoparticles can affect the 
interaction between the anionic components of the cell walls and the positively 
charged exchangeable cations[240].  
 
In addition, no growth of Salmonella typhimurium strains was observed in the 
presence of exfoliated nanoparticles elsewhere[241]. However, particles have not 
shown any effect on the mutagenicity in 5 different Salmonella 
typhimurium strains[241]. Also, there was no increase in the frequency of 
micronuclei and no chromosomal damage after treatment with nanoparticles[241]. 
This means that exfoliated nanoparticles might not able to penetrate the cell wall 
of Gram-negative bacteria such as Salmonella. Another study, however, 
concluded there was no difference in inhibiting the growth of both Gram-positive 
and Gram-negative bacteria[240].  
The antibacterial activity could also be dose-dependent. It has been reported 
elsewhere that a concentration of 0.3 wt.% of nanoparticles inhibited 85% of the 
growth of E. coli in saline buffer[235]. However, no antibacterial activity of 
nanoparticles has been observed in lysogeny broth[235]. Furthermore, non-
exfoliated NaMMT did not show any antibacterial activity at a concentration of 1 





wt.% either in the saline solution or in lysogeny broth[235]. In addition, another 
study has reported that showed that exfoliated clay inhibits the growth of bacteria 
just in a PBS environment, whereas no significant antibacterial activity was 
observed in the medium[234]. This might be due to the polar interaction of 
nanoparticles with proteins in the medium, which prevents the adherence of 
particles on the surfaces of cells. This might explain why G. xylinus was able to 
synthesise BC in the exfoliated clay environment.   
Some experiments have been performed with separated DNA and NaMMT clays 
elsewhere[242, 243]. It has been reported that DNA could be absorbed by NaMMT 
and SWN through electrostatic interactions and ligand exchange, where 
phosphate groups at the end of a DNA molecule and hydroxyl groups of the 
ribose can be absorbed to the clay[242, 243]. It has been found that NaMMT can 
intercalate single-stranded DNA to the interlayer space. However, the results 
elsewhere have shown that the binding of DNA to NaMMT was weak in water[242, 
243]. Thereby, the mechanism of antibacterial action of the exfoliated clay and 
possibility of particles to enter bacterial cells need to be further investigated. 
 
3.2.5. Effect of clay on MTT reduction in 3t3 cells 
 
Both Cloisite Na+ and SWN suspensions decreased the levels of MTT reduction 
in 3t3 cells in time- and concentration-dependent manners. It has been stated 
elsewhere that Cloisite Na+ could inhibit the proliferation of mammalian cells at 
high concentration and over long periods of exposure[244]. A concentration of 6 
mg/ml of the non-exfoliated SWN suspension significantly reduced the metabolic 
activity of 3t3 cells after 24 hours. Clay particles could bind to negatively charged 
components inside the membrane of cells and affect either cell proliferation or life 
cycle[244]. For example, it has been reported elsewhere that particles of the clay 
could penetrate cells of the epithelium[244]. Furthermore, in another study, 
particles of Cloisite Na+ have accumulated in the perinuclear region; however, 
they have not penetrated the nuclear membrane[244]. Moreover, clay may diffuse, 
settle and eventually aggregate in solution. These processes can, thus, lead to 





the development of physicochemical stress over the cells[24]. An interaction of 
Cloisite Na+ clay with the growth medium could lead to either intercalation or 
absorption of substances that are present in the medium. These adsorbed 
molecules might attract the cells to adhere to the surface of Cloisite particles. A 
high concentration of clay might lead to intensive interaction between the 
negatively charged cell surface and positively charged cations between layers of 
the clay. Alternatively, negatively charged components of the medium could bind 
to the particles, which would possibly restrict access of the cells to nutrients after 
72 hours. Following this reasoning, aggregates of the clay could settle down on 
the bottom of the wells, interact with the cells and, as a consequence, clay-cell 
compounds might be washed out during the MTT assay. 
 
Furthermore, it has been reported elsewhere that small sized particles might 
enter mammalian cells, which may die after 24 hours[215]. However, the data 
obtained in the current study showed that the level of MTT reduction by the cells 
increased after 48 hours. It has been stated elsewhere that exfoliated clay 
particles did not affect the MTT reduction in both human gingival fibroblasts and 
blood endothelial cells after 24 hours[240]. Moreover, the MTT reduction in the 
blood endothelial cells treated with 0.3 wt.% of exfoliated silica nanoparticles was 
similar to the control after 72 hours[240]. This experiment has been carried out 
elsewhere using 24-well plates, where the clay suspensions were added directly 
to the culture medium[240]. The cells were incubated for 24, 48 and 72 hours and 
then monitored by MTT assay[240].  
 
A time-dependent uptake of the clay by cells might occur at doses over 1 mg/ml 
after 48-72 hours[244, 245]. It has been observed elsewhere that concentrations 
over 1 mg/ml can change the viscosity of the medium and subsequent 
penetration of oxygen[106]. This might explain why the levels of MTT reduction in 
3t3 cells dropped after 48 and 72 hours using concentrations over 1 mg/ml of the 
clays. However, a concentration up to 31 μg/ml of non-exfoliated NaMMT 
suspension did not show any cytotoxicity towards Caco-2 and HepG2 (liver) cell 





lines in previous studies[101-103, 105]. The viability of human umbilical vein 
endothelial cells (HUVEC) in the presence of 0-125 μg/ml ultrasound-treated 
NaMMT suspension has been observed elsewhere[104]. The results showed that 
NaMMT did not exhibit any cytotoxicity[104].  It has also been reported that NaMMT 
inhibited HepG2 cell growth, which then resulted in cell necrosis at all used 
concentrations starting from 1 to 1000 μg/ml[105].  
 
Regarding exfoliated clay suspensions, one reason for low levels of MTT 
reduction in 3t3 cells could be exhaustion of the medium. The starvation of cells 
played a crucial role in the analysis of the toxicity of clay suspensions. The 
possibility of exhaustion of the medium was overcome by using non-exfoliated 
clay suspensions that were mixed with the culture medium. However, the main 
limitation of such a method is the swelling behaviour of the clay. As the clay was 
added in the form of powder, the interlayer space expanded and liquid from the 
medium started to penetrate between the layers. Furthermore, positively charged 
components of the medium and bioactive molecules could interact with the clay 
by ion exchange reactions. This means that the adsorption capacity of Cloisite 
clay might reduce the amount of nutrients available. Therefore, mammalian 
toxicity of clay should be investigated further.  
 





Chapter 4. Ex situ synthesis of BC/clay composites 
 
Another technique for the incorporation of clay into BC matrix was ex situ 
modification using the vacuum self-assembly method as described in Section 
2.6.3.1. SWN, Cloisite Na+ and Cloisite 10A, 15A, 20A, 30B and 93A organoclay 
were impregnated ex situ into pure BC. The antibacterial activity of the BC/clay 
composites was investigated against MRSA, E. coli (NCTC 12493) and P. 
aeruginosa. The mammalian cytotoxicity behavior of organoclay and synthesised 
composites was analysed using 3t3 cells. 
 
4.1. Results  
4.1.1. Ex situ synthesised BC/Cloisite Na+ and BC/SWN composites 
 
Ex situ synthesised BC/Cloisite Na+ and BC/SWN composites were prepared 
through vacuum self-assembly method using 6 mg/ml of each exfoliated clay 
suspension, respectively, as described in Section 2.6.3.1. The composites were 
analysed for their antibacterial and cytotoxicity properties. The antibacterial 
activity of the BC/clay composites was investigated on MRSA, E. coli and P. 
aeruginosa.  
 
4.1.2. Antibacterial activity of ex situ modified BC/SWN and BC/Cloisite 
Na+ composites 
 
Fig. 74 shows the antibacterial activity of pure BC and ex situ modified BC/SWN 
and BC/Cloisite Na+ composites against MRSA. As shown in Fig. 74, pure BC did 
not possess any antibacterial activity and increase the growth of MRSA nine fold 
compare to the control values. This might be due to the water-holding capacity of 
BC. However, the BC/Cloisite Na+ composite showed antibacterial activity and 
decreased the growth of MRSA to 40% of the control values. The BC/SWN 
composite inhibited strong bacterial activity and significantly reduced the growth 
of MRSA to 6% of control values. 






Figure 74. Antibacterial activity of pure BC, BC/Cloisite Na+ and BC/SWN against MRSA 
after 24 hours. The exfoliated clay at a concentration of 6 mg/ml was pumped inside the 
matrix of BC. The control was PBS-resuspended MRSA, which was placed on the 
surface of the empty petri dish and covered with a lid. Data represent the mean of four 
independent experiments with error bars of standard deviation. The treatments were 
compared to the control. Pure BC, BC/Cloisite Na+ and BC/SWN are significantly 
different from the control (P-value <0.01). 
The antibacterial activity of ex situ synthesised BC/Cloisite Na+ and BC/SWN 
composites were investigated against E. coli. As shown in Fig. 75, both 
BC/Cloisite Na+ and BC/SWN possessed antibacterial activity against E. coli and 
reduced its growth to 15% and 13%, respectively.  
 
According to Figs. 73 and 75, the antibacterial activity of ex situ and in situ 




























Figure 75. Antibacterial activity of BC/Cloisite Na+ and BC/SWN against E. coli after 24 
hours. Each type of exfoliated clay at a concentration of 6 mg/ml was pumped inside the 
matrix of BC, respectively. The control was PBS-resuspended E. coli, which was placed 
on the surface of the empty petri dish and covered with a lid. Data represent the mean 
of six independent experiments with error bars of standard deviation. The treatments 
were compared to the control. All treatments outcomes are not significantly different from 
the control. 
 
As shown in Fig. 76, BC/Cloisite Na+ were not effective against P. aeruginosa, 
which had the growth of 130% of the control values. However, BC/SWN reduced 





























Figure 76. Antibacterial activity of BC/Cloisite Na+ and BC/SWN against P. aeruginosa 
after 24 hours. Each type of exfoliated clay at a concentration of 6 mg/ml was pumped 
inside the matrix of BC, respectively. The control was PBS-resuspended P. aeruginosa, 
which was placed on the surface of the empty petri dish and covered with a lid. Data 
represent the mean of three independent experiments with error bars of standard 
deviation. The treatments were compared to the control. All treatments outcomes are not 
significantly different from the control. 
According to Figs. 74-76, BC/Cloisite Na+ was the most successful in inhibition of 
E. coli. However, this composite did not show any antibacterial activity against 
Gram-negative P. aeruginosa. Furthermore, pure BC promoted the growth of all 
tested bacteria.  
 
4.1.3. Cytotoxicity of BC/clay composites  
 
The mammalian cytotoxicity of ex situ synthesised BC/Cloisite Na+ and BC/SWN 
composites were investigated using 3t3 cells (Fig. 77). The cells were seeded on 
the top of each type of BC and incubated for 24 and 48 hours as described in 



























frame. As shown in Fig. 77, pure BC promoted the level of MTT reduction in cells 
to over 485% compare to the control values after 24 hours.  
 
 
Figure 77. The effect of pure BC, BC/Cloisite Na+ and BC/SWN composites on MTT 
reduction in 3t3 cells. Cells at a concentration of 25´103 cells/ml were seeded on the top 
of the composites and incubated for 24 and 48 hours, respectively, at 37°C. The control 
showed the MTT reduction in cells without any treatment for each time frame. Data 
represent the mean of three independent experiments with error bars of standard 
deviation. The treatments were compared to the controls. All treatments were compared 
to the each of the control. Both BC and BC/Cloisite Na+ are different from the control after 
24 hours with P-value being <0.01, respectively. After 48 hours, BC, BC/Cloisite Na+ and 
BC/SWN are different compared to the control (P-value <0.05), respectively.  
 
This can be due to the healing properties of BC, which are based on the ability to 
keep and retain moisture. However, the levels of MTT reduction in cells with pure 
BC decreased from 485% to 255% after 48 hours.  
 
The percent of MTT reduced cells was 235% using BC/Cloisite Na+ after 24 























percent of MTT reduced cells reached 331% using BC/SWN composite after 24 
hours. Then, the level of MTT reduction in cells with the composite decreased to 
320% of control values after 48 hours.  
 
4.1.4. Ex situ synthesised BC/organoclay composites 
 
Cloisite 10A, Cloisite 15A, Cloisite 20A, Cloisite 30B and Cloisite 93A organoclay, 
at a concentration of 6 mg/ml were incorporated ex situ into pure BC using the 
vacuum self-assembly technique. The antibacterial activity of synthesised 
BC/organoclay composite was investigated against MRSA, E. coli and P. 
aeruginosa. The mammalian cytotoxicity of the composites was analysed using 
3t3 cells after 24 and 48 hours.  
 
4.1.4.1. Antibacterial activity of organoclay 
 
The antibacterial activity of organoclay was investigated by zone inhibition assay 
due to their organophilic nature. This means that the organoclay could not be 
dispersed in water. Therefore, 2 grams of each type of organoclay were pressed 
into a disc, sterilised and placed on the top of TSA agar with freshly spread 
bacteria. As shown in Fig. 78, the largest zones of inhibition of 50, 40 and 45 mm 
were observed with Cloisite 10A against MRSA, E. coli and P. aeruginosa, 
respectively. Cloisite 30B had also shown 15 and 9 mm zones of inhibition against 
MRSA and E. coli, respectively. Cloisite 15A and 20A possessed stronger 
antibacterial activity against E. coli than other bacteria.  However, the zone of 
inhibition of Cloisite 93A was 0.5 mm for all types of bacteria.  
 






Figure 78. The zones of inhibition of Cloisite organoclay against MRSA, E. coli and P. 
aeruginosa. Data shown represent the mean of two independent experiments with error 
bars of standard deviation. The treatments were compared to the control (no zones of 
inhibition). Both 10A and 30B clays are significantly different from the MRSA control (P-
value<0.001). Regarding E. coli and P. aeruginosa, just Cloisite 10A is significantly 
different in comparison with the control (P-value<0.001). 
Leaching behaviour of organoclay could be a reason for the difference in 
antibacterial activity obtained in the zone of inhibition assay. Thereby, the 
leaching behaviour of organoclay was investigated using a drop shape analyser 
(DSA). 
 
4.1.4.2. Investigation of leaching behaviour of organoclay 
 
The leaching behaviour of organoclay was investigated using a DSA. Each type 
of organoclay in amounts of 2 grams were pressed into discs. The contact angle 
between the surface of organoclay and a drop, which contained 4 µl of distilled 
water, was measured. Figs. 79-83 show the measurement of time-dependent 
contact angles for all organoclay. According to Fig. 79, Cloisite 10A did constantly 
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71.6 θ to 60.4 θ. Regarding Cloisite 15A, the contact angle was unstable within 
the first 4 seconds and varied from 172 θ to 3 θ, but starting from 4 until 100 
seconds, it was stable at 0 θ (Fig. 80). 
 
 
Figure 79. The time-dependent contact angle of Cloisite 10A.  Distilled water in a volume 
























Figure 80. The time-dependent contact angle of Cloisite 15A.  Distilled water in a volume 
of 4 µl was placed on a surface of hand-made Cloisite 15A discs. 
As shown in Fig. 81, the contact angle of Cloisite 20A was similar to Cloisite 15A. 
Both Cloisite 20A and Cloisite 15A have the same organic modifier, therefore 
similar wettability was observed. According to Fig. 81, the contact angle went up 
to 180 θ within the first 2 seconds and then decreased to 0.1 θ after 3 seconds. 
The contact angle stabilised after 6 seconds at 77.3 θ and then remained the 
same until 100 seconds. The methyl groups of Cloisite 15A and 20A could make 























Figure 81. The time-dependent contact angle of Cloisite 20A.  Distilled water in a volume 
of 4 µl was placed on a surface of hand-made Cloisite 20A discs. 
According to Fig. 82, Cloisite 30B had also leached within the first 6 seconds. 
Then, from 6 to 100 seconds, the contact angle was in the diapason of 68-63 θ. 























Figure 82. The time-dependent contact angle of Cloisite 30B.  Distilled water in a volume 
of 4 µl was placed on a surface of hand-made Cloisite 30B discs. 
Regarding Cloisite 93A, the contact angle went down from 140 θ to 74 θ within 
the first 6 seconds and remained stable until 100 seconds (Fig. 83).   
 
 
Figure 83. The time-dependent contact angle of Cloisite 93A.  Distilled water in a volume 







































As shown in Figs. 79-83, Cloisite 10A showed the highest leaching behaviour 
compared to other organoclay. Moreover, Cloisite 30B also showed the ability to 
leach, whereas Cloisite 93A had the lowest variation between contact angles and, 
thus, the strongest organophilic properties. This agrees with the results of the 
zone inhibition assay, where the largest inhibition zones were observed with both 
Cloisite 10A and Cloisite 30B clay.  
 
4.1.5. Antibacterial activity of ex situ synthesised BC/clay composites 
 
Clay were pumped through pure BC at a concentration of 6 mg/ml using a 
vacuum self-assembly method as described in Section 2.6.3.1. The antibacterial 
properties of ex situ synthesised BC/clay composites were analysed using Gram-
positive MRSA and Gram-negative E. coli and P. aeruginosa (Figs. 84-87).  
 
4.1.6. Antibacterial activity of ex situ synthesised BC/organoclay 
composites 
 
As organoclay suspensions were prepared in acetone, acetone was pumped 
through pure BC and threated the same way as the other composites. According 
Fig. 84, BC treated with acetone did not show any antibacterial activity, whereas 
all of BC/organoclay composites showed an antibacterial effect. The most 
effective composites were BC/Cloisite 30B and BC/Cloisite 10A, where the 
growth of MRSA went down to 0.01% and 0.14% of control values, respectively. 
BC/Cloisite 15A and BC/Cloisite 20A possessed antibacterial activity and 
reduced the growth of MRSA to 1.8% and 45%, respectively, compare to the 
control. The least effective was BC/Cloisite 93A composite, which reduced MRSA 










Figure 84. Antibacterial activity of BC/organoclay composites against MRSA. 
BC/organoclay composites were prepared by pumping 6 mg/ml of organoclay into BC 
matrix. Each BC/organoclay composite was placed on the surface of empty, without agar 
petri dish. PBS-resuspended MRSA was placed on the top of each BC/organoclay 
composite, covered with a lid and incubated for 24 hours at 37ºC. The control was PBS-
resuspended MRSA that was placed on the surface of empty, without agar petri dish. 
Data shown represent the mean of three independent experiments with error bars of 
standard deviation. Treatments were compared to the control. Pure BC, BC/Cloisite 10A, 
BC/Cloisite 15A and BC/Cloisite 30B are different from the control with P-value<0.05, 
respectively. 
 
As shown in Fig. 85, BC/Cloisite 10A, BC/Cloisite 15A and BC/Cloisite 30B 
showed antibacterial activity against E. coli, where the control values went down 
to 0.2%, 0.3% and 0.1%, respectively. However, BC/Cloisite 20A and BC/Cloisite 
93A were not that effective. The growth of bacteria was not reduced and 
remained at 101% using BC/Cloisite 93A. Furthermore, BC/Cloisite 20A 
increased the control values of E. coli to 267%. In addition, both pure BC and BC 
treated with acetone promoted bacterial growth, which means that pumped 










































Figure 85. Antibacterial activity of BC/organoclay composites against E. coli. 
BC/organoclay composites were prepared by pumping 6 mg/ml of organoclay into BC 
matrix. Each BC/organoclay composite was placed on the surface of empty, without agar 
petri dish. PBS-resuspended E. coli was placed on the top of each BC/organoclay 
composite, covered with a lid and incubated for 24 hours at 37ºC. The control was PBS-
resuspended E. coli that was placed on the surface of empty, without agar petri dish. 
Data shown represent the mean of three independent experiments with error bars of 
standard deviation. Treatments were compared to the control. BC/Cloisite 10A, 
BC/Cloisite 15A and BC/Cloisite 30B are different from the control with P-value<0.001, 
respectively. 
 
Pure BC increased the control values of P. aeruginosa to 419%, whereas BC 
treated with acetone decreased the growth of the cells to 45% (Fig. 86). This 
might be due to the non-complete washing of acetone from the matrix of the 
cellulose. Nonetheless, the control values of the bacteria reduced by remaining 
acetone inside BC, BC/organoclay composites showed a stronger reduction of 
the bacterial growth. As shown in Fig. 86, BC/Cloisite 10A, BC/Cloisite 15A, 







































P. aeruginosa to 1.1, 1.6, 1.4 and 0.4%, respectively. BC/Cloisite 93A increased 
the control values to 123%. 
 
 
Figure 86. Antibacterial activity of BC/organoclay composites against P. aeruginosa. 
BC/organoclay composites were prepared by pumping 6 mg/ml of organoclay into BC 
matrix. Each BC/organoclay composite was placed on the surface of empty, without agar 
petri dish. PBS-resuspended P. aeruginosa was placed on the top of each 
BC/organoclay composite, covered with a lid and incubated for 24 hours at 37ºC. The 
control was PBS-resuspended P. aeruginosa that was placed on the surface of empty, 
without agar petri dish. Data shown represent the mean of three independent 
experiments with error bars of standard deviation. Treatments were compared to the 
control. BC/Cloisite 10A, BC/Cloisite 15A, BC/Cloisite 20A and BC/Cloisite 30B are 
different from the control with P-value<0.001, respectively. 
Consequently, the most effective composites against all three types of bacteria 
were BC/Cloisite 10A, BC/Cloisite 15A and BC/Cloisite 30B. This means that 
such BC/organoclay composites were effective against both Gram-positive and 
Gram-negative bacteria. This agrees with data obtained from the zone of 









































4.1.7. Mammalian cytotoxicity of organoclay 
 
The cytotoxicity assay of organoclay was carried out using the clay/medium 
suspensions as described in Section 2.12.2. Each type of organoclay such as 
Cloisite 10A, Cloisite 15A, Cloisite 20A, Cloisite 30B and Cloisite 93A at a 
concentration of 0.09 to 6 mg/ml was mixed tissue culture medium. The 3t3 cells 
were incubated with clay/medium suspensions for 24, 48 and 72 hours at 37°C.  
 
Fig. 87 shows the MTT reduction in 3t3 cells in a presence of Cloisite 10A after 
24, 48 and 72 hours. The control represented the percent of MTT reduction in the 
cells without any treatment at each time frame. As shown Fig. 87, maximum 
increase of control values was 174% using 0.09 mg/ml of Cloisite 10A, whereas 
the minimum percent of MTT reduction was 52% at 3 mg/ml concentration of the 
clay after 24 hours. The level of MTT reduction by cells then increased after 48 
hours. The concentration of up to 0.75 mg/ml of Cloisite 10A promoted the level 
of MTT reduction in 3t3 cells to a maximum of 155% of control values after 48 
hours. Starting from 1.5 mg/ml concentration, the percent of MTT reduction in the 
cells decreased to 60%. The drop to 37% in percent of MTT reduced cells was 
observed at 6 mg/ml of the clay. The level of MTT reduction by the cells increased 
to 132% of control values just in the treatment with 0.09 mg/ml of Cloisite 10A 
after 72 hours. The lowest percent of MTT reduction by cells was 36% of control 
values using 6 mg/ml of the clay after 72 hours. The concentration from 1.5 mg/ml 
of Cloisite 10A was detected to reduce the level of MTT reduction in cells after 
48 hours. This might be the limit where the clay started to possess toxicity and 
affect the membranes of the cells. 
 






Figure 87. The effect of Cloisite 10A/medium suspension on the level of MTT reduction 
in 3t3 cells. Cloisite 10A at a concentration of 0.09-6 mg/ml was mixed with the culture 
medium. The cells were incubated with the medium for 24, 48 and 72 hours at 37°C. The 
control represented the MTT reduction in cells without any treatment for each time frame. 
Data shown represent the mean of three independent experiments of MTT assay with 
error bars of standard deviation. Treatments were compared to the controls. The data 
obtained using 3 mg/ml concentration of clay after 24 hours are significantly different in 
comparison with the control (P-value<0.5), whereas there is no significant difference 
between the treatments and the control after 48 hours. The treatments with a 
concentration of 6 mg/ml are significantly different from the control after 72 hours (P-
value<0.05).   
 
Fig. 88 shows the cytotoxicity results of Cloisite 15A/medium suspension at a 
concentration from 0.09 to 6 mg/ml on the MTT reduction in 3t3 cells at 24, 48 
and 72 hours, respectively. The concentration of the clay at 0.09 and 0.19 mg/ml 
promoted the growth of 3t3 cells to 147% and 116% of the control values, 
respectively, after 24 hours. Then, the level of MTT reduction decreased from 
83% to 60% by increasing the concentration of the clay from 0.38 to 3 mg/ml. The 
minimum percent of MTT reduction in cells was 38% of control values using 6 
























after 48 hours using 0.09-1.5 mg/ml of the clay. The maximum percent of MTT 
reduction by the cells was 217% of control values at the lowest concentration of 
the clay, which then decreased to 51% by increasing the clay to 3 mg/ml.  As 
shown in Fig. 88, the concentration of the Cloisite 15A at 6 mg/ml resulted in a 
drop of MTT reduction in the cells to 42% compare to the control values. The rise 
in MTT reduction was detected at both 0.09 and 0.75 mg/ml concentration, where 
the percent of the cells increased to 103% and 129% of the control values, 
respectively, after 72 hours. Starting from 1.5 mg/ml concentration of Cloisite 
15A, the level of MTT reduction in 3t3 cells dropped to 75%. The percent of MTT 
reduction in the cells decreased to 43% and 14% of the control values using 3 
and 6 mg/ml concentration of the clay, respectively, after 72 hours. Similar to 
Cloisite 10A, the lowest cytotoxicity of the clay was observed after 48 hours. A 
low limit for the cytotoxic concentration of Cloisite 15A could be 3 mg/ml.  
 
 
Figure 88. The effect of Cloisite 15A/medium suspension on the level of MTT reduction 
in 3t3 cells. Cloisite 15A at a concentration of 0.09-6 mg/ml was mixed with the culture 
medium. The cells were incubated with the medium for 24, 48 and 72 hours at 37°C. The 
control represented the MTT reduction in cells without any treatment for each time frame. 
























error bars of standard deviation. The data obtained using 3 mg/ml concentration of clay 
after 24 hours are significantly different in comparison with the control (P-value<0.05). 
The treatments with a concentration of 6 mg/ml are significantly different from the control 
after 48 and 72 hours with P-values<0.05 and <0.001, respectively.   
 
The mammalian cytotoxicity of Cloisite 20A/medium suspensions at 
concentrations from 0.09 to 6 mg/ml was analysed (Fig. 89). As shown in Fig. 89, 
the lowest percentage of control value for MTT reduction in 3t3 cells was 93% at 
a concentration of 0.38 mg/ml of the clay after 24 hours. The maximum MTT 
reduction was 153% of using 0.09 mg/ml of Cloisite 20A. Furthermore, the drop 
in the level of MTT reduction in the cells was detected just at 0.75 mg/ml after 48 
hours, where the percent of the cells decreased to 89% of the control values. 
After 72 hours, the MTT reduction by the cells was up to of 80%, 86% and 67% 
by using 0.38, 3 and 6 mg/ml of the clay, respectively. Cloisite 20A has not 
significantly affected the MTT reduction by the cells within 48 hours, whereas the 
maximum decrease of metabolically active cells was detected at 6 mg/ml of the 
clay after 72 hours. The results indicated that Cloisite 20A did not show strong 
cytotoxicity effects on 3t3 cells.  
 
 
Figure 89. The effect of Cloisite 20A/medium suspension on the level of MTT reduction 
























medium. The cells were incubated with the medium for 24, 48 and 72 hours at 37°C. The 
control represented the MTT reduction in cells without any treatment for each time frame. 
Data shown represent the mean of three independent experiments of MTT assay with 
error bars of standard deviation. The treatment outcomes are not significantly different 
in comparison with the controls. 
 
Fig. 90 shows cytotoxicity of Cloisite 30B on 3t3 cells after 24, 48 and 72 hours. 
Cloisite 30B clay exhibit higher cytotoxicity than Cloisite 10A, 15A and 20A. The 
MTT reduction in cells did not go higher than 90% of control values at 1.5 mg/ml 
concentration within the first 24 hours. The lowest percent of MTT reduction in 
3t3 cells was 30% at 6 mg/ml concentration of the clay. The percent of MTT 
reduction in the cells increased to 113% of control values at 0.09 mg/ml of the 
clay after 48 hours, whereas there was a drop in the percent of metabolically 
active cells compare to the control values starting from 0.38 to 1.5 mg/ml 
concentration of Cloisite 30B.  
 
 
Figure 90. The effect of Cloisite 30B/medium suspension on the level of MTT reduction 
in 3t3 cells. Cloisite 30B at a concentration of 0.09-6 mg/ml was mixed with the culture 
























control represented the MTT reduction in cells without any treatment for each time frame. 
Data shown represent the mean of three independent experiments of MTT assay with 
error bars of standard deviation. The treatments were compared to the controls. After 24 
hours, the treatments with concentrations of 0.09 and 6 mg/ml are different from the 
control (P-value<0.05). The data obtained using 0.38, 0.75 and 6 mg/ml concentrations 
of clay are significantly different in comparison with the control (P-value<0.05) after 48 
hours. The treatments with concentration of 1.5 mg/ml are different from the control after 
48 hours with P-value<0.001. After 72 hours, concentrations of 0.75 and 6 mg/ml are 
different compared to the control with P-value<0.001. Furthermore, 1.5 and 3 mg/ml 
concentrations are different from the control after 72 hours (P-value<0.05).   
 
The level of MTT reduction in cells slightly increased from 56 to 57% within 48 
hours using a concentration of 1.5 mg/ml of Cloisite 30B. The increase in the 
percent of MTT reduction was also observed in 6 mg/ml concentration of the 
treatment, where it increased to 44% of the control values after 48 hours. 
However, all concentration of the clay resulted in decreasing of levels of MTT 
reduction in the cells after 72 hours. The lowest percent of MTT reduction in the 
cells was 25% using 6 mg/ml concentration of Cloisite 30B. 
 
The MTT reduction in cells increased to 166% of control values at 0.09 mg/ml 
concentration of Cloisite 93A clay within 24 hours (Fig. 91). The drop in the MTT 
reduction activity can be observed within all other concentrations after 24 hours 
of incubation. The lowest percent of MTT reduction activity in 3t3 cells was 35% 
using 6 mg/ml concentration of Cloisite 93A. However, the level of MTT reduction 
in cells increased to 155%, 170%, 118% and 121% of the control values at 
concentration of 0.09, 0.19, 0.38 and 1.5 mg/ml, respectively, after 48 hours. 
Cloisite 93A decreased the MTT reduction activity in the cells to 74% at a 
concentration of 0.75 and 3 mg/ml, respectively. The lowest concentration of 
Cloisite 93A did not affect the levels of MTT reduction in the cells, which remained 
100% after 72 hours. However, the reduction of the MTT activity in cells could be 
observed within concentrations higher than 0.19 mg/ml. The lowest percent of 
the cells was 24% of the control values using 6 mg/ml of Cloisite 93A. 





Consequently, the highest concentration of 6 mg/ml of Cloisite 93A was much 
less compared to other tested Cloisite clay.  
 
 
Figure 91. The effect of Cloisite 93A/medium suspension on the level of MTT reduction 
in 3t3 cells. Cloisite 93A at a concentration of 0.09-6 mg/ml was mixed with the culture 
medium. The cells were incubated with the medium for 24, 48 and 72 hours at 37°C. The 
control represented the MTT reduction in cells without any treatment for each time frame. 
Data shown represent the mean of three independent experiments of MTT assay with 
error bars of standard deviation. The treatments are not significantly different from the 
control after 48 hours. After 24 hours, treatments of 0.38 and 6 mg/ml clay concentrations 
are significantly different in comparison with the control (P-value<0.05). Regarding 72 
hours of incubation, the treatments of 0.38 mg/ml clay concentration are significantly 
different from the control (P-value<0.05). 
  
4.1.8. Cytotoxicity assays on 3t3 cells using clay coated cover glass 
 
Due to their organophilic nature, organoclay were not fully dispersed in the 
medium. Therefore, another method for evaluation of mammalian cytotoxicity of 
the clay was proposed. The cytotoxicity of organoclay was investigated using a 
























concentration of 6 mg/ml and subsequently dried and sterilised using UV-Ozone 
as described in Section 2.12.4. The cells were seeded on the top of a dry sterile 
cover glass coated with the clay, covered with medium and incubated for 24 hours 
at 37°C. Fig. 92 shows the cytotoxicity effect of organoclay on 3t3 cells. The 
control represented the cells growing on the surface of the 6-well plate without 
any treatment. This control was compared to the cells that grew on the surface of 
the clean cover glass without the clay. As shown in Fig. 92, the MTT reduction in 
the cells on the clean cover glass reduced to 78% of the control values. The effect 
of Cloisite 30B on the cells was observed, where the level of MTT reduction in 
the cells significantly decreased to 22%. Cloisite 10A decreased the MTT 
reduction activity in the cells to 44%, whereas Cloisite 15A, 20A and 93A 
increased the percent to 290%, 173% and 128% of the control values, 
respectively. Therefore, Cloisite 10A and Cloisite 30B showed the strongest 
cytotoxicity than other organoclay. This supports the results, which were obtained 
in Section 4.1.9. 
 
 
Figure 92. The effect of Cloisite 10A, 15A, 20A, 30B and 93A at a concentration of 6 
mg/ml on 3t3 cells. The control represented the viably of cells without any treatment that 
































suspension and dried by UV-Ozone. Cells were seeded on the top of each cover glass, 
covered with medium and incubated for 24 hours at 37°C. Data shown represent the 
mean of two independent experiments of MTT assay with error bars of standard 
deviation. 
 
4.1.9. The mammalian toxicity of BC/organoclay composites 
 
The cytotoxicity of synthesised ex situ BC/organoclay composites was 
investigated using NIH 3t3 cells after 24, 48 and 72 hours (Fig. 93). The cells 
were seeded on the top of pure BC and each of BC/clay composites and 
incubated at 37°C as described in Section 2.12.6. As shown in Fig. 92, both pure 
BC and BC/clay composites promoted the MTT reduction in 3t3 cells compare to 
the control values. The MTT reduction activity in the cells with pure BC increased 
to 357% of control values after 24 hours. Furthermore, the MTT reduction activity 
cells raised to 235%, 225%, 189%, 329% and 142% of the control values using 
BC/Cloisite 10A, BC/Cloisite 15A, BC/Cloisite 20A, BC/Cloisite 30B and 
BC/Cloisite 93A, respectively. 
 
 
Figure 93. The effect of pure BC and BC/organoclay composites on 3t3 cells after 24 of 






























treatment. Data shown present the mean of three independent experiments of MTT 
assay with error bars of standard deviation. The treatments were compared to the 
control. Pure BC, BC/Cloisite 30B and BC/Cloisite 93A are significantly different in 
comparison with the control with P-values <0.01, <0.05 and <0.01, respectively.  
 
The level of MTT reduction in 3t3 cells was higher than the control after 48 hours. 
Fig. 94 shows the cytotoxicity of pure BC and BC/organoclay composites after 48 
hours. The control represented the MTT reduction in 3t3 cells without any 
treatments after 48 hours. According to Fig. 94, pure BC promoted the metabolic 
activity of the cells to 248% compare to the control. BC/Cloisite 10A, BC/Cloisite 
15A, BC/Cloisite 20A, BC/Cloisite 30B and BC/Cloisite 93A have also increased 
the MTT reduction activity in 3t3 cells. 
 
 
Figure 94. The effect of pure BC and BC/organoclay composites on 3t3 cells after 48 of 
incubation at 37°C. The control shows the MTT reduction in the cells without any 
treatment that grow on the glass. Data shown represent the mean of three independent 
experiments of MTT assay with error bars of standard deviation. Pure BC and BC/Cloisite 































The MTT reduction activity of 3t3 cells reached 327% of control values using pure 
BC after 72 hours (Fig. 95). The percent of MTT reduction increased to 186%, 
197%, 264%, 255% and 220% by using BC/Cloisite 10A, BC/Cloisite 15A, 
BC/Cloisite 20A, BC/Cloisite 30B and BC/Cloisite 93A composites, respectively. 
 
 
Figure 95. The effect of pure BC and BC/organoclay composites on 3t3 cells after 72 of 
incubation at 37°C. The control shows the MTT reduction in the cells without any 
treatment. Data shown represent the mean of three independent experiments of MTT 
assay with error bars of standard deviation. The treatments outcomes are not 
significantly different in comparison with the control. 
 
The incorporation of organoclay into BC resulted in generation of antibacterial 
material with enhanced levels of MTT reduction in mammalian cells. Table 2 
summaries the MTT reduction activity in the cells in the presence of synthesised 















































MTT reduction, % 
24 357 235 225 189 329 142 
48 248 203 194 174 222 225 




4.2.1. Attachment of clay to BC 
 
Particles of Cloisite clay could penetrate a matrix of BC, fill empty spaces 
between BC fibres and physically attach to them. Moreover, it has been reported 
that an interaction of silicate particles with the OH groups of BC might also occur 
through a hydrogen bonding[246]. This means that the presence of hydroxyl groups 
in both BC and NaMMT clay may lead to a weak organic-inorganic interaction[112]. 
For instance, FTIR results, which have been reported elsewhere showed two 
sharp peaks in the OH stretching of BC/NaMMT composite, which could indicate 
hydrogen bonding between BC and both Mg(OH) and Al groups of NaMMT 
clay[112]. In addition, the presence of merging bands of Si/MgO in MMT and OH 
groups in BC, respectively, has been observed elsewhere in FTIR specta[112]. 
Thus, the particles of Cloisite clay could be attached to BC through both in situ 
and ex situ synthesis. However, there might be a better penetration of the 
exfoliated clay particles into BC during the formation in situ, because forced 
incorporation of clay through the vacuum self-assembly method might result in 
both uneven penetration and distribution of clay particles followed by a leaching 
of clay out of BC. The presence of nanoparticles inside the matrix and on the 
surface of BC has been observed by SEM elsewhere[112]. It has been concluded 
that the amount of absorbed NaMMT clay by both BC surface and matrix could 
increase with increasing a concentration of clay. However, a high concentration 





of clay may lead to particle agglomeration that can adversely affect properties of 
the composite[116]. Non-exfoliated clay particles might also result in insufficient 
load between the matrix and the nanofillers[116]. For instance, the effect of 1 wt.%, 
2 wt.% and 4 wt.% clay concentration has been studied in the synthesis of 
BC/NaMMT composites. The results showed that BC absorbed 25.72%, 40.36% 
and 45.06% of NaMMT suspension containing 1 wt.%, 2 wt.% and 4 wt.% clay 
concentration, respectively[112]. However, the effect was reported to be more 
permanent with a clay concentration up to 2 wt.%[112]. This might be due to 
particle agglomeration and subsequent lack of proper binding to BC fibres, which 
then resulted in a clay leaching. 
 
4.2.2. Antibacterial activity of synthesised ex situ composites 
 
There are a number of reasons for the antibacterial activity of organoclay. Firstly, 
the surfactant of organoclay has quaternary ammonium compounds (QAC) that 
can possess antibacterial activity[87]. Due to the presence of the positively 
charged surfactants, organoclay has a positive zeta potential, whereas bacterial 
cells have a negative zeta potential[247]. In order to express antibacterial activity, 
QAC need to be in a contact with a bacterial cell wall. Therefore, the leaching 
behaviour of organoclay could also play a crucial role in the inhibition of bacterial 
growth. 
 
4.2.2.1. Quaternary ammonium compounds 
 












Table 3. Properties and structure of commercially available organoclay layered silicates 
supplied by Southern Clay Products, Inc[92]. 
Commercial 
Name 
Organic Modifier Molecular structure 
Cloisite® 10A  Dimethyl benzyl hydrogenated 
tallow quaternary ammonium 
 [248] 
Cloisite® 15A  Dimethyl dehydrogenated 
tallow quaternary ammonium 
 [89] 
Cloisite® 20A  Dimethyl dehydrogenated 
tallow, quaternary ammonium 
[89] 
Cloisite® 30B  Methyl tallow bis-2-hydroxyethyl 
quaternary ammonium 
 [87] 




QAC are a major class of cationic surfactants, which have at least one 
hydrophobic hydrocarbon linked to a positively charged nitrogen atom. As shown 
in Table 3, QAC are composed of a charged nitrogen “head” bearing four 
bonds[250]. A proposed mechanism for the antibacterial action of QAC is based 





on the electrostatic interaction between QAC and bacterial cell walls that leads to 
the formation of surfactant-bacteria complexes[251]. For instance, QAC could act 
by the cationic head groups, which face outwards and bind to the anionic head 
groups of acidic phospholipids in bacterial cell walls[251]. Moreover, the 
hydrophobic tails of QAC may also be inserted into the lipid bilayers of a bacterial 
cell[251]. QAC could interact with Gram-positive bacteria through binding to 
teichoic acids[252]. An interaction of QAC with bacteria leads to increased 
permeability of the cell wall. Furthermore, QAC may form aggregates with the 
hydrophobic cell wall and solubilise it. For instance, an alkyl chain of QAC reacts 
with fatty acid chains of lipids of a cell wall and destabilises interactions between 
phospholipids and proteins[98]. QAC might first pass the outer membrane of 
Gram-negative bacteria by lysis, interact with the inner cell wall and subsequently 
with intracellular components[253]. After contact with QAC, bacterial cells have 
been found to exhibit progressive leakage of cytoplasmic materials[251]. The lysis 
of cells could occur when the outer membrane of the cell is broken down or 
destroyed followed by a release of intracellular materials such as proteins, 
organelles, RNA and DNA[253]. It has been reported that QAC might also affect 
DNA, which then loses its ability for multiplication[253]. Contact between QAC and 
a cell wall can be identified by ATP leakage[253]. Thereby, the mechanism of QAC 
involves absorption, disorganisation, disruption of cell walls, releasing of vital cell 
content, a possible penetration into a cell wall followed by intracellular 
degradation of nucleic acids[98, 100, 253, 254]. 
 
Low concentrations of QAC could lead to both damage and leakage of 
cytoplasmic constituents, whereas high concentrations might cause coagulation 
of the cytoplasm presumably through denaturation of proteins[98, 251]. Moreover, it 
has been found that the positively charged QAC may also prevent the formation 
of biofilms and impede the elongation that is necessary for the division of Gram-
negative bacteria[255]. It has been reported elsewhere that organoclays show 
antimicrobial activity against both Gram-positive and Gram-negative bacteria[101, 
103, 105].  In other studies, it was found that Cloisite 10A, Cloisite 15A, Cloisite 20A 





and Cloisite 30B showed strong antibacterial activity against Gram-positive S. 
aureus and Gram-negative E. coli [97, 99]. P. aeruginosa could be less susceptible 
for QAC than other bacteria due to the presence of OprF membrane porin, 
because the diffusion of different molecules through this porin is approximately 
two orders of magnitude slower than through OmpA porin in E. coli [50]. However, 
the results in the current study showed that BC/Cloisite 10A, BC/Cloisite 15A, 
BC/Cloisite 20A and BC/Cloisite 30B successfully inhibited the growth of P. 
aeruginosa.  
 
A strong correlation between the length of an alkyl chain and antibacterial activity 
was found elsewhere[252, 256]. Alkyl groups are mostly short-chain substituents 
such as methyl or benzyl groups[256]. It has been observed that alkyl chains that 
consist from 12 to 16 carbons could possess an optimal antibacterial activity[250]. 
For instance, the length of C16 of the hydrophobic tail was found to be more 
effective against Gram-negative bacteria than shorter-chain compounds due to a 
stronger interaction of C16 with the fatty acid portion of Lipid A in LPS[252]. The 
tested organoclay could be divided into two groups based on their molecular 
structure of QAC. Cloisite 10A and Cloisite 30B consist of a single long tail of 
hydrogenated tallow, whereas Cloisite 15A, Cloisite 20A and Cloisite 93A have 
two long tails of hydrogenated tallow (Table 3). It has been shown that the most 
effective antibacterial activity was observed using Cloisite 10A and Cloisite 30B 
organoclay, whereas the least was with Cloisite 93A[257]. The results obtained in 
the current study are in agreement with this report. Furthermore, it has been 
reported that cationic surfactants that contain one long tail can be more effective 
against bacteria than those QAC containing only short aliphatic tails[257]. This 
might explain why Cloisite 10A and Cloisite 30B showed stronger antibacterial 
activity than other organoclay. 
 
In addition, the tested organoclay contains different amount of surfactants. For 
instance, even though Cloisite 15A and Cloisite 20A have the same cationic 
surfactant, Cloisite 15A, which exhibits stronger antibacterial activity, has a higher 





concentration of the surfactant[257]. This might be a reason why BC/Cloisite 15A 
showed stronger antibacterial activity against MRSA and E. coli than BC/Cloisite 
20A.  
 
4.2.2.2. Effect of zeta potential on the antibacterial activity of 
organoclay  
 
Each layer of MMT clay has a net charge from 0.2 to 0.9 per formula unit due to 
isomorphous substitution such as Mg2 + for Al3 + in the octahedral sheet or Al3 + for 
Si4 + substitution in the tetrahedral sheet. In the octahedral sheet, the charge is 
delocalised on both top and bottom of the structure[258]. The substitution in the 
tetrahedral sheet is more localised, where a charge is present only on one 
surface[258]. The negative charge of clay particles is compensated by the 
exchangeable Na+ cations[258]. The zeta potential of MMT clay was found to be 
−39.0 mV, which means that the surface of the particles is negatively charged[258].  
The pH condition might affect the zeta potential of unmodified NaMMT clay. It 
has been reported that zeta potential was –28mV at pH2 and became more 
negative as pH values increases[259]. The replacement of Na+ by H+ can occur at 
a low pH and lead to an increase in the concentration of sodium, electrical 
conductivity of the suspension and numbers of H+ on the surface[259]. 
Furthermore, dissolution of MMT structure could arise through the breakage of 
bridging oxygen bonds (Si–O–Al) at a low pH. This leads to the release of Al and 
then Si atoms into the suspension. Al3+ might displace the Na+ cations, reside 
between the layer and neutralise the negative surface more effectively than Na+. 
This then results in an increase in zeta potential. At pH10, zeta potential 
decreased to –48mV and remained stable[259]. The net negative charge of 
NaMMT could be associated with better dispersion of clay particles. A negative 
charge of a single particle might be greater than that of clay aggregates.   
The zeta potential might also vary within different clay structures. The 
modification of MMT clay with cationic QAC leads to an increase in zeta potential 





in a positive direction[260]. It has been found that zeta potential for organoclay was 
higher than for unmodified clay due to the stronger binding of organic than 
inorganic cations to the clay layers[260]. Furthermore, the addition of C16 leads to 
an increase in the charge of MMT, which becomes positive in acidic or neutral 
solution and decreases when the concentration of hydroxyl ions increases. 
Moreover, an increase in the length of alkylammonium cations might result in 
better absorption of cations outside the surfaces of the clay through cation 
exchange and hydrophobic binding[261]. Thus, QAC with a benzyl group was 
found to have zeta potential around +22.7mV, whereas the zeta potential of MMT 
clay modified with other QAC was around +14.4 mV[247]. Due to the organic cation 
saturation, Cloisite 10A is highly organophilic and not homogeneously dispersed 
in water[262]. Therefore, it is challenging to measure zeta potential of organoclay 
consistently. The values of Cloisite 30B were found to be lower than Cloisite 15A, 
which means that Cloisite 30B suspension is more stable[263]. 
The surface of a bacterial cell is negatively charged and is balanced by positively 
charged cations present in the surrounding medium. Zeta potential values of S. 
aureus have been found to be -35.6 mV, whereas that for E. coli was -44.2 mV[57]. 
Another study reported zeta potential values of MRSA and P. aeruginosa being 
–17mV and –13.4mV, respectively[264, 265]. It has been stated elsewhere that the 
neutralisation of the surface charge of a cell could lead to membrane 
permeability[266]. The electrostatic interaction between various agents and the 
bacterial surface might affect zeta potential, which can, subsequently, cause not 
just greater permeability of the cell surface, but also might lead to cell death. In 
addition, the cationic compounds might interfere with membrane bound ATPase, 
which are responsible for membrane potential through the regulation of 
movements of H+ across the membrane, and disturb the ion transport[266].  
4.2.2.3.  Leaching behaviour of organoclay 
 
In order to inhibit antibacterial activity by contact, the cationic surfactant, which is 
located between the clay layers, needs to be exposed to the surface of a material. 





Therefore, the leaching ability of organoclay could be another possible reason for 
the antibacterial activity. The leaching behaviour was analysed by measuring the 
contact angle between hand-made pressed discs of Cloisite 10A, Cloisite 15A, 
Cloisite 20A, Cloisite 30B and Cloisite 93A and a drop of water, respectively. The 
contact angle represents the tendency of a fluid to spread over the solid surfaces. 
Wettability refers to the degree of dispersion of fluids on the surface of solid 
materials. A contact angle that is less than 90° indicates that a solid has a wetting 
(hydrophilic) behaviour, whereas a contact angle, which is greater than 90°, 
shows that a solid has a non-wetting (hydrophobic) property[267]. Therefore, an 
increase in a contact angle leads to increasing hydrophobicity of a material. The 
advancing contact angle is referred to a state when a drop touches the surface 
and spreads just after making contact. This angle is more sensitive to 
hydrophobic surfaces. The receding contact angle is the smallest state of the 
angle[268]. Furthermore, the equilibrium contact angle is defined when the system 
has the absolute minimum free energy[268]. The measurement of wettability might 
be challenging due to the liquid absorption and roughness of the hand-made 
discs. The porosity of hand-made discs could also influence contact angle 
measurements. It has been reported that the pore volume of NaMMT clay 
decreased from about 4 nm to about 3 nm after loading of surfactants of 
organoclay[269]. Porous materials can be either partially-wetting or complete 
wetting. Regarding a partial-wetting process, once a drop of water touches a 
porous material, the contact angle decreases almost linearly from the initial to a 
static contact angle[270]. During this stage, the base of a droplet does not 
move[270]. Then, the contact angle remains stable. However, in the case of 
complete wetting, the contact between a droplet and a porous surface is initially 
stable, where the spreading of a droplet almost stops[270]. Then, the droplet starts 
to soak into a porous material leading to a rapid decrease in a contact angle[270]. 
According to the results obtained in the current study, the contact angle between 
Cloisite organoclay and the drops of water showed a pattern similar to partially-
wetting porous materials. However, both Cloisite 10A and Cloisite 30B did not 
completely reach static contact angles after 900 and 100 seconds, respectively. 





Due to the hydrophilicity of Cloisite Na+, the drop of water was not sufficiently 
stable to measure a contact angle. 
 
An increase in the amount of an organic modifier leads to a change in the clay 
from being hydrophilic to organophilic[259]. Organophilic property of organoclay 
could be influenced by the length of an alkyl chain, where the longer the chain is, 
the more organophilic is the clay[271]. Depending on the surfactant, long carbon 
chains might be arranged as mono, bilayers or pseudotrimolecular layers 
between the clay sheets parallel to the clay surface[262]. D-space increases with 
surfactants that contain two long tails. For instance, Cloisite 10A has a d-space 
of 19.13A and a pseudotrimolecular orientation of alkylammonium cations in the 
interlayer space[262]. Furthermore, benzyl substitute groups in QAC result in 
superhydrophobic surface and water non-wettability, whereas clay that is 
modified with QAC without benzyl substitute group becomes more hydrophilic 
and water-wettable[247].  
 
Moreover, the static angle was about 80θ for both Cloisite 20A and Cloisite 93A. 
This might indicate a similar wettability of both clays. The contact angle of Cloisite 
30B was not stable and had the values of 70θ ± 10θ. A study elsewhere has 
reported that the contact angle values for Cloisite 30B were 73θ, 60θ or 81θ[268]. 
These values are in agreement with the results obtained in the current study. 
Furthermore, it also has been stated that static contact angles for Cloisite 10A, 
Cloisite 20A and Cloisite 30B compacted discs were not different[268]. However, 
in the current study, Cloisite 10A did not reach a static contact angle after 900 
seconds where the values of the angle constantly dropped.  
The measurements of contact angle elsewhere have shown that leaching of 
surfactants used for the preparation of Cloisite 10A and Cloisite 30B was quicker 
compared to Cloisite 15A, Cloisite 20A and Cloisite 93A[257]. It was found that 
Cloisite 93A leached the least among others[257]. These results agreed with the 
current study, where Cloisite 10A and Cloisite 30B leached the most, whereas 
the leaching behaviour of Cloisite 93A was the least pronounced compared to 





other organoclays. Cloisite 15A contains the same type of surfactant as Cloisite 
20A, but in a higher amount, which results in a smaller increase in d-spacing 
compared to Cloisite 20A[257]. Therefore, a difference in leaching behaviour might 
occur. 
Organophilic property of the clay could lead to the antibacterial activity by 
attracting the bacterial surfaces[272]. It has been reported that S. aureus has 
hydrophobic characteristics with the contact angle of the cell wall being 72θ due 
to the presence of lipoteichoic acids[272]. Hydrophobic cells might have a 
preference for hydrophobic surfaces, where bacteria may get attracted to 
organoclay and, subsequently, be inhibited by the free QAC surfactant[272].  
 
4.2.2.4. Comparison of antibacterial activity of BC/clay composites 
 
Both QAC and leaching behaviour could be major reasons for the antibacterial 
activity of organoclay. The variation of CFU reduction could be explained by the 
leaching behaviour of tested organoclay. Cloisite 10A and Cloisite 30B showed 
greater leaching behaviour compared to others. Furthermore, BC/Cloisite 20A 
showed antibacterial properties against both MRSA and P. aeruginosa, but did 
not affect the growth of E. coli. As Cloisite 15A and Cloisite 20A are similar in 
chemical structure, Cloisite 20A would have also possessed antibacterial activity 
against E. coli. A possible reason for this might be an uneven distribution of either 
bacteria or Cloisite 20A within the matrix of BC. In addition, Cloisite 93A was the 
least effective composite in terms of antibacterial activity in both zone inhibition 
assay as well as inside the BC/Cloisite 93A composites. BC/Cloisite 93A reduced 
the growth of MRSA, but did affect either E. coli or P. aeruginosa. As was 
observed from the experiments on the contact angle of Cloisite 93A, the leaching 
behaviour of the clay was less pronounced than the leaching activity of Cloisite 
10A and Cloisite 30B. This might have an impact on the attachment of the 
bacteria to the clay and subsequent binding of the clay to the bacterial cell wall. 
 





The antibacterial activity of organoclays, mainly Cloisite 10A and Cloisite 30B, 
was stronger than Cloisite Na+ and SWN clay without surfactants. It has been 
concluded elsewhere that both the charge and hydrophobic nature of organoclay 
could be associated with their antibacterial activity[272]. The organoclays were 
more effective against P. aeruginosa compared to Cloisite Na+ and SWN clay. 
However, the antibacterial activity of organoclay was associated with the QAC 
and leaching behaviour, whereas the antibacterial activity of the natural clay was 
possibly due to the release of Na+ cations in the exfoliated state. 
 
Similar results were obtained in another study, where BC/NaMMT, which was 
synthesised ex situ through immersion using 1 wt.% of clay, showed antibacterial 
activity against S. aureus and E. coli, but did not inhibit P. aeruginosa[239]. 
Previous studies have reported a very slow release of ions from BC composites, 
which resulted in a strong antibacterial effect through physical attachment with 
bacteria[125]. As a current method for the antibacterial assay is based on placing 
the bacteria inside the composite, such attachment might be successfully 
achieved. Furthermore, the bacterial death could be due to the destruction of the 
cell walls, change in cellular pathways or due to the ability of sodium to destabilise 
the permeability of the bacterial cell wall (Section 3.2.4). BC/SWN, however, 
showed antibacterial activity against three tested organisms and especially 
strong inhibition of growth was observed with MRSA. This might be due to the 
low aspect ratio, which allowed better dispersion within the BC matrix and, 
therefore, interaction with the bacterial cell walls with subsequent penetration of 
SWN inside the bacteria. Moreover, the stronger antibacterial activity of SWN 
against MRSA might be because Gram-positive bacteria have a single cell wall, 
whereas Gram-negative bacteria have the additional outer membrane as 
described in Section 1.2.3.1[273].  
Pure BC promoted the growth of all tested bacteria. This might lead to a spread 
of pathogens within the wounds. It has been reported elsewhere that common 
bacterial species that cause wound infections are S. aureus, P. aeruginosa and 
MRSA[119, 120]. The incorporation of exfoliated clay resulted in the antibacterial 





activity of BC, which might overcome the issues associated with wound 
infections. 
4.2.3. Effect of organoclay on 3t3 cells 
Both Cloisite 10A and 30B organoclays alone possessed cytotoxic behaviour; 
however, as shown in Table 2, all BC/organoclay composites increased the levels 
of MTT reduction in 3t3 cells. The level of MTT reduction of the cells was the 
highest in the presence of pure BC after 24 hours. The MTT reduction activity of 
the cells increased after 72 hours using BC/Cloisite 20A and BC/Cloisite 93A 
composites.  
 
Nonetheless, the percent of metabolically active cells inside the matrix of pure 
BC was higher than inside the composites after 24 hours, the levels of MTT 
reduction in 3t3 cells dropped to about 50% less compared to the control values 
using pure BC after 48 hours. A possible reason behind this might be the 
reduction of nutrients, which could be consumed by a large number of cells, and, 
therefore, due to insufficient amount of nutrients after 48 hours cells exhibit low 
metabolic activity. Oppositely, BC/clay composites might stabilise the 
overpopulation of the cells. However, the MTT reduction activity of 3t3 cells 
decreased after 72 hours in the presence of BC/Cloisite 10A, BC/Cloisite 15A 
and BC/Cloisite 30B. This might be due to the leaching behaviour. Due to their 
organophilic nature, the clay might not be properly dispersed inside the tissue 
culture medium, which could lead to agglomeration of particles with subsequent 
settling down at the bottom of the wells. This might also influence the proliferation 
of cells. In order to evaluate the current method for analysis of cytotoxicity, a new 
method using a cover glass coated with the pre-suspended clay was proposed. 
Such a method allowed better interaction of the clay with the cells. 
 
However, there was a variation of MTT reduction in 3t3 cells within three 
experiments at 6 mg/ml concentration of the clay after 24 hours. A possible 
reason for this might be that 6 mg/ml was too high a concentration, which could 





negatively affect the proliferation of the cells. It has been reported that Cloisite 
20A did not show any cytotoxicity towards Caco-2 and HepG2 cell lines at a 
concentration of up to 0.065 mg/ml after 24 and 48 hours[101]. A concentration of 
Cloisite 30B over 0.19 mg/ml affected the MTT reduction in 3t3 cells. The damage 
of DNA of Caco-2 cells by Cloisite 30B at 0.17 mg/ml after 24 hours has been 
reported elsewhere[102, 104]. Furthermore, Cloisite 30B has shown cytotoxicity at a 
concentration of 0.125 mg/ml against HepG2 cells[102]. Another study has shown 
that a 0.226 mg/ml concentration of Cloisite 30B induced 40% cytotoxicity in 
Caco-2 cells[102]. In addition, 0.250 mg/ml of Cloisite 30B has been reported as 
toxic for HUVEC cells[104]. The lowest concentration of Cloisite 93A did not affect 
the metabolic activity of 3t3 cells, which remained at 100% of the control values 
after 72 hours. However, the decrease in the MTT reduction in the cells could be 
observed within concentrations higher than 0.19 mg/ml. The lowest percent of 
metabolically active cells was 24% of the control values using 6 mg/ml of Cloisite 
93A. Consequently, the highest concentration of 6 mg/ml of Cloisite 93A affected 
MTT reduction in 3t3 cells much less compared to other tested Cloisite clay. This 
might be due to the highly organophilic nature of the clay. Similar results were 
obtained in another study, which stated that Cloisite 93A reduced the viability of 
human monocytic U937 cells at over 1 mg/ml concentration after 24 hours [106].  
 
A connection between antibacterial activity and cytotoxicity of the Cloisite clay 
used can be observed. Organoclay with a high ability to leach could exhibit 
cytotoxicity towards fibroblasts. Thereby, Cloisite 10A and Cloisite 30B clay, 
which showed the strongest antibacterial activity and leaching behaviour, also 
induced a decrease in MTT reduction in 3t3 cells. Whereas Cloisite 93A, which 
showed the weak antibacterial activity, was not as toxic as other clay to 3t3 cells 
even at the highest concentration. This might raise concerns regarding the use 
of Cloisite 10A and Cloisite 30B in wound healing systems. Both BC/organoclay 
and BC/natural clay without surfactants induced an increase in the metabolic 
activity of the 3t3 cells compared to the control values. 
 





Chapter 5. Incorporation of chitosan into BC through synthesis in situ 
 
Bacterial cellulose was synthesised in situ in the standard HS medium containing 
a solution of widely-available (WA) chitosan (MW 161 kDA, 90% DDA) as 
described in Section 2.5.2. The chitosan solution was prepared using 0.1M of 
acetic acid and 0.5 wt.% of chitosan followed by magnetic stirring for 24 hours. 
The solution was then added to the medium to a final concentration of 0.25 wt.%.  
The pH of the medium was adjusted to pH5. G. xylinus at an inoculum 
concentration of approximately 7.9 ´ 107 CFU/ml was mixed with HS medium, 
which already contained both 2 wt.% glucose and 0.25 wt.% of the chitosan 
solutions, and incubated for 48 hours at 30°C. The synthesised composite was 
then characterised by UV-VIS-NIR spectroscopy. The antibacterial properties of 
the composite were analysed using MRSA and E. coli. The cytotoxicity of 
chitosan was investigated using the 3t3 cell line. 
 
5.1. Results 
5.1.1. In situ synthesis of BC/chitosan composite involving glucose 
5.1.1.1. Characterisation of in situ produced BC/chitosan composite 
 
The formation of the pellicle was observed using WA chitosan after 48 hours. Fig. 
96 shows synthesised BC/chitosan composite. The composite was weak 
compare to the original BC. Similarly, another study reported inhibition of 
synthesis of BC in the presence of 0.1 wt.% of chitosan in the medium[138]. A 
possible reason for this might be viscosity, which can increase in a higher 
concentration of chitosan. This appears due to the presence of ionic groups that 
result in expansion of the polymer chains and causing an increase in viscosity.  
However, during synthesis, chitosan can establish hydrogen bonds with BC and 
with water molecules[180]. This might result in strong physical binding of chitosan 
to the matrix of BC.  
 






Figure 96. A photograph of the synthesised BC/chitosan composite. BC was produced 
using inoculum of G. xylinus and HS medium containing both glucose solution and WA 
MW chitosan solution at 2 wt.% and 0.25 wt.%, respectively, at pH5 on a large scale. 
Bacteria was incubated for 48 hours at 30°C. 
 
5.1.1.2. Leaching behaviour of BC/chitosan composite 
 
The leaching behaviour of chitosan was investigated as described in Section 
2.5.2.2. Prior to the experiment, the calibration curve of chitosan at characteristic 
peak at wavelength of the 325 nm[274] was obtained (Fig. 97). The purpose of the 
calibration curve was to quantify the concentration of chitosan leached from the 
composite during the washing process. As shown in Fig. 97, R2 was 99%, which 
means that the good linear relationships were obtained.  
 






Figure 97. The relationship between absorbance at wavelength of 325 nm and 
concentration of chitosan. 
BC/chitosan composite in amount of 6 grams was placed into a centrifuge tube 
containing 20 ml of distilled water and washed from 1 to 80 hours. The 
concentration of chitosan leached was determined by UV-VIS and calculated 
using the calibration curve. Fig. 98 shows the concentration of chitosan leached 
from BC/chitosan composite from 1 to 80 hours. As shown in Fig. 98, the 
concentration of chitosan leached within first 3 hours was 0.01, 0.04 and 0.05 
mg/ml, respectively. Then, the leaching amount of chitosan increased to 0.85 
mg/ml after 75 hours. BC/chitosan composite started to break and fall apart at 
this point. Therefore, other peaks after 75 hours might be due to the disturb 






























Figure 98. The concentration of chitosan leached from the composite during washing 
from 1 to 80 hours. 
 
5.1.1.3. UV-VIS-NIR analysis of synthesised in situ BC/chitosan 
composite 
 
After treatment with NaOH and washing, BC/chitosan composite was analysed 
by UV-VIS-NIR spectroscopy (Figs. 99-100). The UV-VIS-NIR spectrum of the 
composite was compared to those of both chitosan powder and pure BC.  
 
As shown in Fig. 99, BC/chitosan composite had predominant peaks of BC. The 
characteristic peak of chitosan at 325 nm were not detected inside the 
composite[274]. This might be due to either washing of chitosan out of BC/chitosan 
composite or the presence of chitosan inside the composite, but not on a surface 
of a material that made it hard to detect. However, the presence of chitosan inside 
the composite might be detected in the NIR spectrum, where both chitosan and 
BC/chitosan composite had peaks in a range of 1404-1660 nm (Fig. 100). 
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of O-H and N-H groups in chitosan leads to strong chemical binding to BC[177]. 
This can result in broader peak at 1404-1660 nm, which included separate peaks 
of both BC and chitosan.  
 
Figure 99. UV-VIS spectra of medium MW chitosan, pure BC and BC/chitosan 
composite. 
 





















































5.1.1.4. Antibacterial activity of chitosan 
 
The effect of pure chitosan on a bacterial growth was investigated using MRSA 
and E. coli as described in Section 2.7.3.3. Figs. 101-102 show antibacterial 
activity of chitosan solution at a concentration of 0.5 wt.%. The control was PBS-
resuspended either MRSA or E. coli without any treatment.  According to Figs. 
101-102, chitosan showed antibacterial activity against both tested bacteria. 




Figure 101. Antibacterial activity of chitosan against MRSA. The bacteria were incubated 
for 24 hours at 37◦C. The control was MRSA without any treatment after 24 hours. Data 
represent the mean of two independent experiments with error bars of standard 


























Figure 102. Antibacterial activity of chitosan against E. coli. The bacteria were incubated 
for 24 hours at 37◦C. The control was E. coli without any treatment after 24 hours. Data 
shown represent the mean of two independent experiments with error bars of standard 
deviation. WA chitosan is significantly different in comparison with the control (P-
value<0.01). 
5.1.1.5. Antibacterial activity of BC/chitosan composite 
 
The antibacterial activity of the BC/chitosan composite was investigated against 
MRSA, E. coli and P. aeruginosa as described in Section 2.7.3 (Fig. 103-105). 
The control for each experiment was PBS-resuspended MRSA, E. coli or P. 
aeruginosa, respectively, that was placed on the surface of the empty petri dish 
without agar and covered with the plastic lid. As shown in Fig. 103, pure BC did 
not show any antibacterial activity against MRSA, where the growth of the 
bacteria was the same as the control. Whereas the control values were 
significantly lower and decreased to 0.003% with BC/chitosan composite. This 
result indicated that chitosan was successfully incorporated into BC through 
biosynthesis in situ. BC/chitosan composite showed strong antibacterial activity 


























Figure 103. Antibacterial activity of BC/chitosan composite against. The control was 
PBS-resuspended MRSA, which was placed on the surface of the empty petri dish 
without agar and covered with a lid. The bacteria were incubated for 24 hours at 37◦C. 
Data shown represent the mean of two independent experiments with error bars of 
standard deviation. BC/Chitosan composite is significantly different from the control (P-
value<0.001).  
Furthermore, pure BC promoted the growth of E. coli after 24 hours (Fig. 104). 
The control values increased to 151% with pure BC. However, BC/chitosan 
composite significantly decreased the growth of E. coli to 40% of control values. 
In addition, BC/chitosan composite did not show any antibacterial activity against 
P. aeruginosa (Fig. 105). As a consequence, the BC/chitosan composite was 



























Figure 104. Antibacterial activity of BC/chitosan composite against E. coli. The bacteria 
were incubated for 24 hours at 37◦C. The control was PBS-resuspended E. coli, which 
was placed on the surface of the empty petri dish without agar and covered with a lid. 
Data shown represent the mean of two independent experiments with error bars of 
standard deviation. BC/Chitosan composite is significantly different from the control (P-

























Figure 105. Antibacterial activity of BC/chitosan composite against P. aeruginosa. The 
bacteria were incubated for 24 hours at 37◦C. The control was PBS-resuspended P. 
aeruginosa, which was placed on the surface of the empty petri dish without agar and 
covered with a lid. Data shown represent the mean of two independent experiments with 
error bars of standard deviation.  
 
5.1.1.6. Mammalian cytotoxicity of chitosan 
 
The cytotoxicity of chitosan on 3t3 cells was investigated using two methods as 
described in Section 2.12.5. Firstly, chitosan powder at a concentration of 5 
mg/ml was mixed with the tissue culture medium and incubated with 3t3 cells for 
24, 48 and 72 hours at 30°C. Secondly, a glass cover slip was coated with 0.5 
wt.% chitosan solution that was dissolved at pH3, dried and sterilise by UV-
Ozone. The cells were seeded on the top of both clean cover glass and the cover 
glass coated with the chitosan solution, covered with tissue culture medium and 



























5.1.1.6.1. Evaluation of toxicity of chitosan powder 
 
The cytotoxicity of WA chitosan at a concentration of 5 mg/ml in the growth 
medium was investigated using 3t3 cells after 24, 48 and 72 hours (Fig. 106). 
The control represented the cells without any treatment after each time frame. 
WA chitosan was mixed with medium and incubated with cells at 37°C. As shown 
in Fig. 106, the level of MTT reduction by cells increased to 370% of control 
values by using chitosan after 24 hours. Then, the percent of MTT reduction 
decreased to 147% and 91% of control values after 48 and 72 hours, respectively. 
 
 
Figure 106. The effect of chitosan powder on 3t3 cells after 24, 48 and 72 hours. 
Chitosan at a concentration of 5 mg/ml was mixed with growth medium. Cells were 
incubation at 37°C. The control represented the cells without any treatment after each 
time frame. Data shown represent the mean of three independent experiments of MTT 
assay with error bars of standard deviation. Data obtained after 24 and 48 hours are 
significantly different to the control (P-value<0.001).   
 
The main issue with this method was insolubility of chitosan at neutral pH. The 
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dissolved in the medium and, therefore, the interaction of chitosan with the cells 
could not occur. In order to overcome this issue, another method for evaluation 
of cytotoxicity of chitosan was proposed (Section 2.12.5.2). 
 
5.1.1.6.2. Cytotoxicity assay using cover glass coated with 
chitosan 
 
Another method for the evolution of cytotoxicity of chitosan was based on using 
the glass coverslip coated with 0.5 wt.% of WA chitosan solution as described in 
Section 2.12.5.2. The glass was subsequently dried and sterilised by UV-Ozone. 
The 3t3 cells were seeded on the top on it, covered with tissue culture medium 
and incubated for 24 and 48 hours at 37°C. As shown in Fig. 107, the level of 
MTT reduction of cells increased in the presence of chitosan. The level of MTT 
reduction was 332% and 249% of control values after 24 and 48 hours, 
respectively. 
 
The data obtained using the glass coverslip coated with chitosan agreed with the 
results in Fig. 106. Chitosan increased level of MTT reduction in the cells. 
According to Figs. 106-107, MTT reduction in 3t3 cells was higher using the glass 
coverslip coated with chitosan rather than chitosan powder after 48 hours. This 
means that the proposed method can provide a better interaction of chitosan with 
the cells.  
 
 






Figure 107. The effect of chitosan coated coverslips on MTT reduction in 3t3 cells. The 
cover slips were coated with 0.5 wt.% of WA chitosan solution and dried by UV-Ozone. 
Cells were seeded on the top of each cover glass, covered with medium and incubated 
for 24 and 48 hours at 37°C. Data shown represent the mean of two independent 
experiments of MTT assay with error bars of standard deviation.  
 
5.1.2. In situ synthesis of BC-CH using chitosan as the main carbon 
source 
 
Another method of synthesis in situ of BC was based on the complete 
replacement of the main carbon source. Glucose was replaced with 0.5 wt.% of 
WA chitosan solution, which was prepared using 10 vol.% distilled vinegar. G. 
xylinus was incubated in the modified medium for 48 hours at 30°C. The 
synthesised material is a completely new type of material and temporarily named 
as “bacterial chitosan” (BC-CH) before the chemical structure of the material is 
understood. The synthesis of BC-CH started with an investigation of pH on BC-
CH growth. Then, BC-CH was characterised using UV-VIS-NIR, FT-IR and X-ray 
spectroscopy. The antibacterial activity of the material was investigated against 
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5.1.2.1. Effect of pH on the synthesis of BC-CH  
 
As chitosan must be dissolved in an acidic environment, the modified medium 
was adjusted from pH6 to 2 using either 0.1M of sodium hydroxide in order to 
increase the pH or 0.1M of hydrochloric acid for decreasing the pH, as described 
in Section 2.5.2.1. Fig. 108 shows the images of the synthesised and treated BC-
CH after 48 hours of incubation at different pH values from 6 to 4.  
 
   
BC-CH produced at pH6 BC-CH produced at pH5 BC-CH produced at pH4 
Figure 108. Photographs of BC-CH growth at pH6, 5 and 4 on a large scale. There was 
no BC-CH growth at pH 3 and 2.  
 
Bacteria did not produce any BC-CH at pH3 and pH2. As shown in Fig. 108, the 
greater yield of BC-CH was obtained at pH5, which is the standard for the 
synthesis of BC. The material produced at pH4 was weaker than others. BC-CH 
synthesised at pH6 had a relatively high yield, but was not robust for further 
treatments.   
 
Fig. 109 shows the mass yield of wet BC-CH produced at pH4-6 and centrifuged. 
The greater BC-CH yield was obtained at pH5 and reached 3.7 grams, whereas 
BC-CH produced at pH6 and pH4 was 3.5 grams and 1.5 grams, respectively.  
 






Figure 109. The mass of wet BC-CH produced in situ. BC-CH was produced with 0.5 
wt.% WA MW chitosan as the main carbon source using approximately 7.9 x 107 CFU/ml 
bacterial concentration for 48 hours at 30◦C in a large scale. Data shown represent the 
mean of a single experiment. 
 
5.1.3. Understanding the structure of BC-CH  
 
The characterisation of BC-CH started with the morphology of the synthesised 
BC-CH using SEM. As seen in Fig. 110, BC-CH showed a porous structure with 
randomly and ununiformly oriented fibres compare to BC. The size of the pores 
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Figure 110. SEM micrograph of BC-CH (left image) and pure BC (right image). The bars 
represent a distance in 1µm. 
 
5.1.4. Solubility of BC-CH  
 
Due to the fact that chitosan is soluble in acidic environments, the solubility of 
BC-CH was investigated. In order to study the solubility of the material, 3 grams 
of BC-CH were placed in 20 ml of pure vinegar at pH2 for 48 hours as described 
in Section 2.5.3. Fig. 111 shows the blue centrifuge tube with BC-CH inside the 










Figure 111. The centrifuge tube containing 3 grams of BC-CH inside the pure vinegar at 
pH2 after 48 hours. 
The vinegar liquid from the tube was then analysed by using UV-VIS for the 
presence of any chitosan that might possibly leach and dissolve from BC-CH after 
48 hours (Fig. 112). If chitosan leaches and dissolves in vinegar, UV-VIS can 
detect the presence of it. As shown in Fig. 112, the washing vinegar, which was 
vinegar that contained BC-CH for 48 hours, did not show the characteristic peak 
of chitosan. This means that BC-CH not only did not leach, but also cannot be 
dissolved in acid.  
 






Figure 112. UV-VIS spectra of washing vinegar liquid, which contained BC-CH for 48 
hours, chitosan and pure vinegar. 
 
5.1.5. UV-VIS-NIR analysis of BC-CH  
 
Synthesised BC-CH was compared to pure BC and chitosan powder using UV-
VIS-NIR spectroscopy (Fig. 113). According to Fig. 113, chitosan powder, pure 
BC and BC-CH had peaks of 211, 216 and 220 nm, respectively. The 
characteristic peak of chitosan at 325 nm[275] was slightly detectable inside BC-
CH. Furthermore, BC-CH and chitosan shared the similar peaks of 1437 nm in 
NIR region. This might be evidence of the presence of NH2 inside the BC-CH[275]. 
In addition, the peak at around 2000 nm seems to be larger in the composite than 




























Figure 113. UV-VIS-NIR spectra of chitosan powder, pure BC and BC-CH. Arrows 
indicate characteristic peaks of chitosan. 
 
5.1.6. Analysis of BC-CH using FT-IR 
 
The structure of BC-CH was studied using infrared (IR) spectroscopy. According 
to Fig. 114, BC-CH had predominantly cellulose peaks. The peak at 1158 cm-1 is 
due to C-O-C stretching vibrations in pure BC matrix[276]. The peak of 1643 cm−1, 
which is corresponded to the glucose carbonyl, was similar to both BC-CH and 
pure BC. Chitosan had the peaks of around 1531 cm-1, which showed N-H 
bending vibration of protonated amine groups[277], 1640 cm-1 corresponded to C-
O bending of the acetyl group[275] and 3270 cm-1 that is corresponded to N-H 
stretch could be seen in BC-CH. The peaks of 2921 cm-1 and 2867 cm-1 are due 
to the C-H stretching in chitosan[275]. Moreover, peaks at 1580 cm-1 and 1425 cm-




















































































The peak of 3350 cm−1 of BC-CH was similar to both BC and chitosan indicated 
O─H stretching[276]. The widening of O-H stretching could be due to overlapping 
the N-H stretching 3500-3000 cm-1 of chitosan and O-H stretching vibration of 
cellulose[180]. As BC-CH had predominantly the structure of BC, the peaks of 
chitosan could be overlap with the peaks of cellulose, and, therefore, were hardly 
detectable. However, due to the presence of two characteristic peaks of chitosan 
inside the composite, it might be possible to confirm the presence of chitosan 
inside BC-CH. However, the resolution of attenuated total reflection (ATR) FTIR 
might not give enough resolving powder to distinguish the difference in structure.  
 
5.1.7. X-ray diffraction analysis of BC-CH  
 
The XRD patterns of BC-CH, pure BC and chitosan are shown in Fig. 115. The 
purpose of X-ray was to investigate the crystalline structure of BC-CH. As shown 
in Fig. 115, synthesised BC-CH had two peaks at a 2q angle of 14° and 22° 
corresponded to crystalline plate 110 and 002, respectively. These peaks of BC-
CH were similar to pure BC indicating that BC-CH was cellulose type Iα[113, 278]. 
The difference between BC-CH and pure BC peaks was the intensity. The 
intensity for BC-CH was higher with first peak being at 64 and the second at 86, 
respectively, whereas the intensity of the first and second peaks of pure BC was 
34 and 55 counts, respectively.  
 
Chitosan had two peaks at 10° and 20°, which correspond to the crystallographic 
planes (002) and (101), respectively. These data ware in agreement with the 
results of other work[279]. These peaks were not detected in BC-CH. This means 



































































5.1.8. Antibacterial activity of BC-CH  
 
Antibacterial activity of BC-CH was investigated against both MRSA and E. coli.  
As shown in Fig. 116, BC-CH showed significant antibacterial behaviour against 
MRSA and reduced the growth of the bacteria to 0.0003% of control values. BC-
CH reduced the control values of E. coli to 1.7% (Fig. 117).  
 
According to Figs. 101-102 and 116-117, BC-CH was more effective against both 
MRSA and E. coli than pure chitosan, which reduced the percent of the control 
values of MRSA and E. coli to 1.7% and 4% of control values, respectively. It may 
further indicate a new material has been formed that is different from both BC 
and chitosan.  
 
 
Figure 116. Antibacterial properties of BC-CH composite against MRSA. The bacteria 
were incubated for 24 hours at 37°C. The control was PBS-resuspended MRSA placed 
on the surface of the empty petri dish without agar and covered with a lid. Data shown 





























Figure 117. Antibacterial properties of BC-CH composite against E. coli. The bacteria 
were incubated for 24 hours at 37°C. The control was PBS-resuspended E. coli placed 
on the surface of the empty petri dish and covered with a lid. Data shown represent the 




It was possible to incorporate chitosan into BC through synthesis in situ. The 
novel BC-CH was synthesised by replacing glucose with chitosan in HS medium. 
UV-VIS-NIR and FT-IR analysis indicated the presence of chitosan inside BC-
CH. Furthermore, BC-CH expressed strong antibacterial activity against both 
MRSA and E. coli, which was further evidence for the presence of chitosan inside 
BC-CH. However, X-ray diffraction showed the unchanged crystalline structure 
of the cellulose of BC-CH. There are two possible reasons behind the results 
obtained. First, bacteria that consumed chitosan can synthesise original BC, but 
with the physical attachment of chitosan to BC fibres. Alternatively, the bacteria 
synthesised BC with chemically attached chitosan. This would make chitosan 

























5.2.1. Attachment of chitosan to BC 
 
Chitosan could penetrate the pores of BC and, subsequently, interact with 
fibrils[180]. The mechanism of attachment of chitosan has been described 
elsewhere. Both BC and chitosan have the similar structures with β-glycoside 
linkages[280]. However, BC has hydroxyl groups, whereas chitosan has primary 
amine groups at the C2 position[280]. Chitosan and BC might interact by hydrogen 
bonds that are formed between the functional groups. The intramolecular 
hydrogen bonds could be formed between the chemical groups in chitosan (-OH 
and NH2) and BC (-OH). This may lead to restricting motions of the matrix and 
promote rigidity. It has been reported elsewhere that the intramolecular hydrogen 
bonds in BC could break down in order to form hydrogen bonding between BC 
and chitosan[138, 140]. Therefore, the widening of -OH stretching, which was 
observed inside BC-CH could be evidence for the presence of chitosan in BC. 
Furthermore, chitosan could coat fibres of BC and, in this case, subsequently 
leach. BC/chitosan composite produced using both glucose and chitosan as 
carbon sources showed a leaching behaviour. This means that the attachment of 
chitosan to BC might not be permanent. In contrast, BC-CH did not exhibit 
leaching of chitosan even in vinegar. Therefore, BC-CH could not be dissolved in 
acid.  
5.2.2. The dependence of microbial growth on medium  
Microbial growth is referred to an increase in the number of cells. The microbial 
growth depends on factors such as temperature, pH, oxygen and the composition 
of the medium. Microbial growth undergoes several phases. Firstly, the lag phase 
can be characterised as a period of adjustment of cells to new conditions with 
little or no increase in population[281]. The next phase of growth is a logarithmic 
(log) phase, where cells begin to divide followed by a period of rapid growth, 
where the number of cells produced is higher than the number of cells that die[281]. 
The third phase is the stationary phase, during which a population of cells begins 
to stabilise, the cell number does not increase, and cell division starts to slow 





down. The last phase is the decline or death phase. The “growth curves” have 
the following shape: no growth is detected at the lag phase followed by 
exponential growth, then the growth slows down and ends with a period of no net 
growth, which is the stationary phase[282]. Slow bacterial growth can be due to 
poor nutrients present in medium. As a result, cells do not achieve the metabolic 
state that is necessary to allow exponential growth[282]. Starvation of bacteria 
could result in a decrease in the size of the cells, which appear almost spherical. 
Such a reduction might improve the survival of cells[282]. A condensation of 
cytoplasm could occur followed by an increase in the volume of periplasm as well 
as deposition and changes to subcellular compartments. In order to generate 
agglomeration, the membrane might become less permeable and more 
hydrophobic[282].  
The lag phase represents the beginning of the growth curve, where an inoculum 
is added to a fresh medium. During this phase, cells are metabolically active and 
synthesise proteins that are needed for cells to grow within a medium. The 
duration of this phase is determined by many factors including composition of the 
medium. There are different types of medium, which can serve a variety of 
purposes. The culture medium is a nutrient material that is prepared for microbial 
growth. Some media such as tryptic soy broth (TSB) is considered all-purpose 
media and can support a growth of a large variety of microorganisms including 
S. aureus, E. coli and P. aeruginosa[283]. Bacterial growth is a process that 
includes a number of anabolic, for instance, synthesis of cell metabolites and 
constitutes as well as catabolic, which is breaking down cell constitutes and 
metabolites, reactions[283]. These reactions result in a cell division. The log phase 
occurs when the cells are dividing actively by binary fission, thus, the number of 
cells increases exponentially[283]. The bacterial growth refers to a large population 
of cells (≥107)[283].  
G. xylinus is a strictly aerobic, catalase-positive and oxidase-negative Gram-
negative bacterium[284]. HS medium is the optimal growth medium for G. xylinus. 
In order to grow, bacteria need a minimum of nutrients including water, carbon 





source, nitrogen source and minerals[285, 286]. Water plays a crucial role in 
hydrolysis reactions, transporting and solubilising nutrients[285]. Carbon is 
essential for bacteria to produce carbon molecules such as carbohydrates, fats 
or organic sources such as alcohols and sugars[285]. Nitrogen source is used by 
bacteria in the synthesis of their proteins[285]. Phosphorus is required for nucleic 
acid, synthesis of phospholipids and ATP, whereas sulphur is crucial for amino 
acids and vitamins[285]. Micronutrients such as K+, Mg2+, Fe2+ and Ca+ are needed 
for enzymes, to stabilise membrane, ribosomes and electron transport systems. 
However, the minimal medium cannot be enough for the growth of bacteria that 
need specific elements[285]. Therefore, a medium may be supplied with additional 
elements. Thereby, enrichment medium is a medium for a growth of desired 
microorganisms in an inoculum. Growth factors, which are the elements that 
bacteria are unable to synthesise using just minimal medium, could be added to 
such an enrichment medium. For instance, purine and pyrimidine bases are 
necessary for nucleic acids, amino acids and synthesis of proteins and vitamins. 
There is also another type of medium, which is a selective medium that is used 
to grow specific bacteria from an inoculum. This medium can contain a variety of 
antibiotics, antiseptics, ethanol, etc[285]. 
 
G. xylinus is a mesophilic organism with an optimum temperature for growth 
being 30ºC and pH5-6.5, but the bacterium might grow at a lower pH[284]. In the 
presence of oxygen, G. xylius can oxidise sugars, alcohols, aldehydes or sugar 
alcohols by primary dehydrogenases that are located on the outer surface of the 
cytoplasmic membrane[284]. Glucose is a preferred carbon source for the growth 
of G. xylinus[287]. The effect of different carbon sources such as sucrose, glucose, 
fructose, lactose, xylose and glycerol on a growth of G. xylinus has been 
evaluated elsewhere. It has been reported that BC synthesised in the standard 
HS medium containing glucose can reach a concentration of 4.1 g/l, whereas the 
concentration of BC produced in a sucrose-based HS medium was 4.9 g/l[286]. It 
has been found that lactose and xylose were not efficiently metabolised by G. 
xylinus resulted in low BC production with concentrations of 1.7 g/l and 1.6 g/l, 





respectively[286]. G. xylinus could oxidise xylose to d-xylonic acid, but this led to 
the accumulation of xylonate in the medium followed by lowering the pH that 
could subsequently inhibit the growth of bacteria and, therefore, BC production. 
Furthermore, G. xylinus does not have the gene that encodes the β-galactosidase 
enzyme, which is responsible for hydrolysis of lactose[286]. It has been reported 
that BC produced in a fructose-based HS medium showed the highest 
concentration of BC of 5.65 g/l[286]. Glycerol can also be used for the growth of G. 
xylinus, but the concentration of BC decreased to 3.4 g/L[286].  
 
As a result, products of oxidation could accumulate in the medium. There are two 
main phases of oxidation by G. xylinus. Firstly, G. xylinus can oxidise ethanol to 
acetic acid by two sequential catalytic reactions. Ethanol is oxidised to 
acetaldehyde, which is then catalysed by membrane-bound pyrroloquinoline 
quinone, and which dependents on alcohol dehydrogenase (ADH)[284]. The 
acetaldehyde is then oxidised to acetate by membrane-bound aldehyde 
dehydrogenase (ALDH), which is located near ADH[284]. Both ALDH and ADH 
form a multienzyme complex in the bacterial cell wall with the function to produce 
acetic acid from ethanol. The acetic acid then released into the growth medium 
to a maximum of 10-20%[284]. An exhaustion of acetate may be observed after 
this phase. This means that the medium needs to be supplemented with acetate 
for further growth of the bacteria. G. xylinus could be resistant to acetic acid due 
to the presence of specific proteins, which associate the protons and conjugate 
a base of the dissociated acid, which renders it in the undissociated form and, 
thus, decreases toxicity level[284]. Therefore, the bacteria are able to adjust to the 
acidic condition of the medium. Furthermore, it has been found that a crystallite 
size of BC produced is less in the presence of acetic acid is lower than of BC 
produced in the original HS medium containing citric acid[287]. The second phase 
is an assimilation of sugars[288]. It has been reported that an increase in pH could 
be an indicator that the amount of glucose depletes. This could be accompanied 
by a major augmentation of the yield of BC in the medium[289].  
 





G. xylinus cells are able to form cellulose with acetate, but in the presence of 
sugars. The acid did not affect the sugar consumptions[287]. It has been reported 
that the yield of BC produced without glucose, but with acetate decreased from 
0.2 mg to 0.1 mg[287]. It has been stated that HS medium containing acetic acid 
instead of the glucose showed a slight decrease in pH within first 10 hours of 
incubation[287]. The results reported elsewhere stated that bacteria were able to 
grow without glucose by using other carbon sources such as citric acid, amino 
acids and vitamins that come from yeast extract and peptone[287]. The growth of 
BC does not start immediately after the incubation of cells, because, at the 
beginning, bacteria may colonise the surface and start to change the physical 
properties of the air-broth interface. A primary cellulosic biofilm starts to appear 
at the air-broth interface by clustering biomass, fibrils of BC and other bioproducts 
at an early stage of incubation[287].  
 
Based on the above comments, a possible reason why pH5 was the best 
condition for the synthesis of BC-CH might be the nature of the acetic acid 
bacteria. G. xylinus needs acidic conditions for the growth and synthesis of 
cellulose, which it creates during the cultivation. During the cultivation and 
synthesis of BC, the bacteria secrete gluconic acid and 5-keto-gluconic acid, 
which results in a decrease in pH[231]. However, an excessive amount of acidity 
could inhibit the growth of bacteria. Thus, the inoculation of the bacteria at pH3 
or pH2, which then decreases during the cultivation, could lead to bacterial cell 
death. In addition, a decrease in pH during the cultivation might be beneficial due 
to the solubility of chitosan in an acidic environment (Section 1.4.2.1). As a 
consequence, the growth of BC-CH might be due to the presence of acetic acid 
in vinegar, to the composition of HS medium and/or to consumption of chitosan 
as a carbon source by the bacteria. Further investigation of the mechanism of 









5.2.3. Antibacterial activity of chitosan 
 
BC-CH could inhibit the growth of Gram-positive MRSA and Gram-negative E. 
coli. The difference in antibacterial activity against Gram-positive and Gram-
negative bacteria could be due to the different structures of the cell walls as 
described in Section 1.2.3.1. 
 
The exact mechanism of chitosan as an antimicrobial agent is not well 
understood, although different hypotheses have been proposed[152]. The 
proposed mechanisms of the antibacterial action of chitosan are described in 
Section 1.4.3.1. The most accepted theory is based on a mechanism involving 
electrostatic interaction between positively charged chitosan and negatively 
charged bacterial cell walls. The structure of Gram-positive bacteria carries a 
large net negative charge due to phosphate groups in teichoic acids, whereas 
LPS are negatively charged in the outer membrane of Gram-negative bacteria[43]. 
The electrostatic interaction between chitosan and the bacterial cell wall could 
lead to either changes in the permeability of the bacterial cell wall followed by 
internal osmosis imbalance or hydrolysis of the peptidoglycan in walls, which 
could then lead to the leakage of intracellular components[131].  
 
Chitosan becomes soluble in an acidic aqueous environment, where the high 
cationic nature of the amine group is protonated and, therefore, is positively 
charged. This means that the –NH2 groups are converted to a soluble protonated 
form −NH3+[46]. The interaction of positively charged amine groups of chitosan 
and negatively charged teichoic acids of MRSA might result in the leakage of 
intracellular constituents[132, 153, 154]. Furthermore, an imbalance in osmosis could 
be one reason behind the reduction of the growth of MRSA[131]. Another reason 
might be the ability of chitosan to form a layer over a bacterial cell wall that may 
subsequently affect the absorption of nutrients[132]. Moreover, cell walls of Gram-
negative bacteria consist of LPS, phospholipids and lipoproteins that are 
connected by electrostatic interactions with divalent cations, which are required 





to stabilise the outer membrane[53]. Amine groups could bind to the negatively 
charged O-specific oligosaccharide units of LPS and, thus, disturbing the integrity 
of the outer membrane[53]. A permeability barrier of the outer membrane of E. coli 
is formed by cross-bridging of lipid A molecules and divalent cations (calcium 
or/and magnesium). Amine groups could also bind either to lipid A or divalent 
cations[53]. 
 
BC-CH showed stronger antibacterial activity against MRSA than E. coli. This 
might be due to the additional outer cell wall of Gram-negative bacteria. Chitosan 
may not cross the outer membrane of Gram-negative bacteria, but could affect 
E. coli externally[168]. P. aeruginosa showed high resistance to the BC/chitosan 
composite. This might be due to the stronger outer membrane of this bacterium, 
which has porins different from E. coli. 
 
5.2.4. Mammalian cytotoxicity of chitosan 
 
Chitosan increased the level of MTT reduction compared to control values in 3t3 
cells after 24, 48 and 72 hours. The increase in MTT reduction suggests that 
chitosan may increase the metabolic activity of 3t3 cells. This might be due to 
decomposition and release of N-acetyl-β-D-glucosamine from chitosan, which 
has been found to also increase the proliferation of fibroblasts[290]. 
 
The effect of chitosan powder was evaluated. However, the main issue with this 
method was the insolubility of chitosan at neutral pH. The pH of the tissue culture 
medium was pH7. This means that chitosan might not be dissolved in the medium 
and, therefore, the interaction of chitosan with the cells could not occur. In order 
to overcome this issue, another method for evaluation of cytotoxicity of chitosan 
was proposed (Section 2.12.5.2). The results from the experiment which was 
based on using glass cover slips coated with 0.5 wt.% chitosan also suggests 
that chitosan increased the levels of MTT reduction in 3t3 cells.   
 





The cytotoxicity of BC/chitosan composites has also been investigated 
elsewhere. The cytotoxicity of the BC/0.6 wt.% chitosan composites, which were 
synthesised by the immersion method, were analysed using mouse skin 
fibroblast cells (L929) in the presence of DMEM medium containing 10% FBS[180]. 
It was reported that BC/chitosan composites did not affect the cell viability[180]. It 
has been shown that the adhesion and spreading of fibroblasts cells on a 
BC/chitosan composite was better than on pure BC[181]. Furthermore, the 
attachment of 3t3 cells to the fibres of both pure BC and BC/chitosan composite, 
which was produced by immersion of BC into 1 wt.% chitosan solution followed 
by seeding the cells on the surface of the composite in DMEM for 48 hours has 
been investigated elsewhere[183]. The results of that study have shown that the 
cells attached to BC/chitosan proliferated and spread almost completely over the 
surface, whereas 3t3 cells remained round-shaped inside the matrix of pure 
BC[183]. This might be due to better biocompatibility of BC/chitosan composite 
than pure BC. Therefore, BC-CH could be an ideal material for biomedical 
applications due to lack of cytotoxicity, strong antibacterial activity and cheaper 
synthesis compared to the pure BC. 
 
 





Chapter 6. Ex situ integration of chitosan into BC matrix  
 
Widely available (WA) (161 kDA, 90% DDA), low (50-190 kDa, 75-85%DDA) and 
medium (200-800 kDa, 75-85%DDA) molecular weight (MW) chitosan at a 
concentration of 0.5 wt.% was incorporated ex situ into non-oxidised (non-ox) BC 
and oxidised BC (ox BC), which was obtained by using sodium metaperiodate as 
described in Section 2.6.1. The incorporation ex situ of chitosan into BC was 
carried out through immersion and vacuum self-assembly methods. The 
immersion was based on placing pure oxidised and non-oxidised BC into 0.5 
wt.% of each of WA, low and medium MW chitosan solutions, respectively, for an 
hour. Vacuum self-assembly method implied the forced incorporation of chitosan 
into BC using a vacuum pump. The synthesised BC/chitosan composites were 
analysed using UV-VIS-NIR and FT-IR. Antibacterial activity of synthesised 
composites was investigated against MRSA, E. coli and P. aeruginosa, 
respectively.  
 
6.1. Results  
6.1.1.  Comparison of oxidised and non-oxidised BC 
BC was oxidised to dialdehyde cellulose by using sodium periodate. The 
mechanism of oxidation is described in Section 6.2.1. During the oxidation, 
aldehyde groups (-CHO) of the oxidised BC were grafted with amine groups of 
chitosan by a Schiff’s base reaction[291]. At the end of the oxidation reaction, the 
hydroxyl groups are replaced with aldehyde groups[292].  
The characterisation of the composites started with the comparison of oxidised 
(ox BC) and non-oxidised (non-ox) BC using UV-VIS-NIR and IR spectroscopies 
(Figs. 118-120).  As shown in Fig. 118, non-ox and ox BC had similar peaks in 
regions of 203-215, 240-258 and 397-417 nm. However, ox BC showed an 
additional peak in the UV region at 356 nm wavelength, which was not present in 
original BC. Both types of BC had a significant peak at 1950 nm and a smaller 
peak at 2090 nm in NIR region. Ox BC differs from non-ox BC with a sharper 





peak at 2096 nm, which suggest that oxidation led to minor differences in 
structure.  
 
Figure 118. UV-VIS-NIR spectra of non-oxidised and oxidised BC. Arrows indicate 
additional peaks of ox BC. 
FT-IR spectra obtained from non-ox and ox BC are shown in Figs. 119-120. It 
has been reported that the process of oxidation occurs in the bulk material[292]. 
Therefore, the aldehyde groups could be detectable in FT-IR spectrum. It has 
been stated that a peak, which is corresponding to a symmetrical stretching of 
C=O bond, can be assigned to the aldehyde group that was inserted in the 
structure by the periodate oxidation process[292]. The peak around 1738 cm-1 
appeared in the oxidised cellulose due to the stretching vibration of C=O double 
bond of the aldehyde group[291]. As shown in Figs. 119-120, this peak is much 
more intense in the spectrum of ox-BC than non-ox BC. This means that BC was 
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Regarding similarities, non-ox and ox BC shared peaks of 915-924, 1146 and 
1192-1198 cm-1 that indicated the presence of the C-O-C chemical bonding. The 
peak at around 800 cm-1 is corresponded to out-of-plane bending of C─O─H in 
BC matrix[276]. The peaks of 1351, 1410-1416 cm-1 showed the chemical bonding 
between carbon and hydrogen (C─H bonding)[276]. Other peaks at 1086-1093, 
1503-1509, 2048 and 3017 cm-1 were also present in both types of BC. The broad 
peaks of 3350 cm−1 and around 3400–3500 cm−1 indicated O─H stretching.  
 

























Figure 120. IR spectrum of oxidised BC. 
 
6.1.2. Comparison of different types of chitosan  
 
Once the differences between the two types of BC were observed, three types of 
chitosan powder were compared (Figs. 121-122). Firstly, chitosan low, medium 
and WA chitosan powder were analysed using UV-VIS-NIR. Fig. 123 shows that 
the spectra of the three types of chitosan powders were very similar. Chitosan 
had a characteristic peak at 325 nm[275]. The characteristic peak of chitosan in 
UV region could also be observed inside all three spectra. Chitosan also showed 
characteristic peaks in a range of 1460-1540 nm in the near IR region due to the 
presence of NH2, the other peaks unique to the chitosan powders were at 1953 
and 2031 nm[275]. Therefore, UV-VIS-NIR spectra was similar for WA, low and 
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Fig. 122 shows IR spectra of WA, low and medium MW chitosan. Three types of 
chitosan had similar IR spectra. Chitosan had the peaks between 3200 cm-1 and 
3400 cm-1 that indicated N-H stretch. Furthermore, chitosan had the peaks of 
around 1580 cm-1, which showed N-H bending vibration of protonated amine 
groups[277, 293] and 1640 cm-1 corresponded to C-O bending of the acetyl 
group[275]. The peaks of 2921 cm-1 and 2867 cm-1 are due to the C-H stretching 
in chitosan[275, 276]. The characteristic peaks for chitosan are indicated by arrows 
in Fig. 122. Further assessment of BC/chitosan composites will be based on 
identification of these characteristic peaks of chitosan in BC/chitosan composites. 
According to the results obtained from UV-VIS-NIR and FT-IR, the three types of 
chitosan had very similar structure. The main differences between these three 
types of chitosan were molecular weight and degree of deacetylation (DDA). 
Molecular weight of WA, low and medium chitosan was 161 kDA, 50-190 kDA 
and 190-310 kDA, respectively. WA chitosan had the highest degree of 
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6.1.3. Modification ex situ of BC through immersion 
 
The modification of BC was obtained through immersion of non-ox and ox BC 
into each of 0.5 wt.% solution of WA, low and medium MW chitosan, respectively, 
for an hour. The materials were either air-dried for 24 hours at 25ºC when 
analysed by UV-VIS-NIR and FT-IR or sterilised using autoclave at 121ºC for 15 
minutes and were used in the antibacterial assay experiments. 
 
6.1.4. Non-oxidised BC/chitosan composites 
 
Non-ox BC was immersed into 0.5 wt.% of WA, low and medium MW chitosan 
solutions, respectively, for 30 minutes at 25°C as described in Section 2.6.3.2. 
After air-drying, each type of synthesised non-ox BC/chitosan composite was 
firstly analysed by UV-VIS-NIR (Fig. 123). As shown in Fig. 123, the peaks of the 
composite were similar to pure BC. BC character was predominant in the UV-
VIS-NIR spectrum, which might be due to overlapping of chitosan peaks.  
 
The non-ox BC/WA and BC/Medium MW chitosan composites did not show the 
characteristic peak of chitosan at about 325-340 nm. Whereas BC/Low MW 
chitosan composite had a small peak around 347 nm. This might be due to the 
presence of chitosan inside the structure, but not on the surface of BC. 
Alternatively, chitosan might not be incorporated into BC. 
 






Figure 123. UV-VIS-NIR spectra of non-ox BC/WA, non-ox BC/Low and non-ox 
BC/Medium MW chitosan composites. 
The composites were then compared to both non-ox BC and chitosan powder 
using FT-IR (Fig. 124). The O-H peak of BC can be seen at 3340 cm-1 [276]. The 
incorporation of chitosan let to broad hydrogen bonding between BC (O-H) and 
N-H stretching of chitosan[276]. This resulted in a widening of the O-H region in 
the composite[276]. Therefore, BC/chitosan composites had the wider region with 
O-H peaks than pure BC. As the composite’s spectrum was dominated by BC 
peaks, chitosan peaks might not be identified. In addition, the characteristic N-H 
bend at 1580 cm-1 and N-H stretch at 3270 cm-1 of chitosan were not clearly 


































Figure 124. IR spectrum of non-ox BC/WA chitosan composite using FT-IR equipment. 
However, non-ox BC/Low MW chitosan and non-ox BC/Medium MW chitosan 
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Figure 126. The FT-IR spectrum of non-ox BC/Medium MW chitosan composite. 
According to Figs. 124-126, chitosan was either hidden by the predominant peaks 
of BC or incorporation of chitosan was not achieved. The spectrum of UV-VIS 
showed the presence of chitosan peak in BC/Low MW chitosan composite, 
whereas the peaks of chitosan inside other two composites were not detected. 
The wide region of both O-H and N-H stretching peaks might be due to 
overlapping these peaks in BC/chitosan composite. It has been stated that the 
broad peak corresponded to the multiple absorption of hydrogen bonds that could 
overlap the absorption peaks of the N-H and O-H stretching vibration[291]. This 
can lead to moving to the high wavenumber compare to pure BC. The peak 
indicating N-H stretch was found inside the spectrum of both non-ox BC/Low MW 
chitosan and non-ox BC/Medium MW chitosan composites. 
6.1.5. Ox BC/chitosan composites 
 
Ox BC was immersed into each of 0.5 wt.% solution of WA, low and medium MW 
chitosan, respectively, for an hour at 25ºC. The synthesised ox BC/chitosan 
composites were compared to both ox BC and chitosan in order to evaluate the 
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VIS-NIR and FT-IR spectroscopies. Fig. 127 shows UV-VIS-NIR spectra of ox 
BC/WA, ox BC/Low and ox BC/Medium MW chitosan composites.  
 
 
Figure 127. UV-VIS-NIR spectra of ox BC/WA, ox BC/Low and ox BC/Medium MW 
chitosan composites. 
 
According to UV-VIS-NIR spectra shown in Fig. 127, all three types of the 
composites had predominant peaks of BC. However, the peaks of chitosan at 
around 325 can be seen in the all synthesised composites. In addition, the peak 
of chitosan in NIR spectra was detected in ox BC/Low MW chitosan composite. 
 
The N-H bend of chitosan at 1580 cm-1 can be detected in ox BC/Low MW 
chitosan composite in IR spectra as shown in Fig. 128. Whereas N-H stretch of 
chitosan at 3270 cm-1 can be seen just in ox-BC/Medium chitosan composite (Fig. 
128). This might be because the characteristic peak of WA chitosan overlapped 
with the peaks of BC. As stated previously, the broadening of O-H peak at 3270 
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As a consequence, the most successful incorporation of chitosan could be 
observed in the oxidised BC/chitosan composites. The presence of chitosan was 
detected inside the UV spectra of all composites, whereas the characteristic 
peaks of chitosan can be seen just in ox BC/Low MW chitosan and BC/Medium 
MW chitosan composites in IR spectra. However, as was stated above, the peaks 
of WA chitosan might overlap the non-ox BC composites. Therefore, it was 
challenging to fully evaluate the incorporation of all three types of chitosan inside 
non-ox BC. However, due to the two detectable peaks of chitosan inside ox BC 
in UV-VIS and NIR regions, it could be possible to state that oxidation of BC might 
have improved attachment of chitosan.  In addition, the IR spectrum of oxidised 
and non-oxidised BC/chitosan prepared via immersion showed similarities.  
 
6.1.6. Incorporation of chitosan into BC using vacuum self-assembly 
method  
 
Another method for incorporation ex situ of chitosan into the ox and non-ox BC 
was vacuum self-assembly technique, where pure BC was placed on the Buchner 
funnel. Each solution containing 0.5 wt.% of WA, low and medium MW chitosan 
was pumped through the matrix of non-ox and ox BC, respectively. Then, each 
type of BC/chitosan composite was air-dried at 25°C for 48 hours and analysed 
by UV-VIS-NIR and FT-IR.  
 
6.1.7. Analysis of synthesised ex situ non-ox BC/chitosan composites 
 
Fig. 129 shows the SEM image of BC/WA chitosan composite synthesised using 
vacuum self-assembly method. As shown in Fig. 129, the fibres of BC were 
coated with chitosan. This might indicate the successful incorporation of chitosan 
inside non-ox BC using the pumping-based method. 
 
 






Figure 129. SEM image of BC/WA chitosan synthesised using vacuum self-assembly 
method.  
 
Fig. 130 shows UV-VIS-NIR spectra of non-ox BC/chitosan composites 
synthesised using the vacuum pump. Three types of non-ox BC/chitosan had 
predominantly BC peaks at 265, 860 and 1948 nm. Chitosan peak at 325 nm was 
detected just in BC/WA chitosan composite.  






Figure 130. UV-VIS-NIR spectra of non-ox BC/WA, non-ox BC/ Low MW and non-ox 
BC/Medium MW chitosan composites. 
 
Three types of the composites were analysed by FT-IR (Fig. 131). N-H bend at 
1570 cm-1 of chitosan were not seen in all composite, whereas N-H stretch could 
be observed in non-ox BC/WA composite. Regarding O-H stretching, non-ox 
BC/Medium MW chitosan composite had O-H stretch peak of 3340 cm-1 at a 
transmittance of 91%, whereas the other two composites had such peak at a 





























Figure 131. IR spectra of non-ox BC/WA, non-ox BC/ Low MW and non-ox BC/Medium 
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6.1.8. Analysis of synthesised ex situ ox BC/chitosan composites 
 
Fig. 132 shows UV-VIS-NIR spectra of ox BC/chitosan composites prepared 
using the pump. While UV-VIS analysis of the composites showed all peaks of 
BC, sharp chitosan peaks at around 325-350 nm can also be observed in all three 
types of the composites.  
 
 
Figure 132. UV-VIS-NIR spectra of ox BC/WA, ox BC/Low and ox BC/Medium MW 
chitosan composites prepared using the pump. 
 
Fig. 133 shows IR spectra of ox BC/chitosan composites prepared using the 
pump. According to Fig. 133, the composites synthesised with low MW chitosan 
had the best integration into BC. The sharp peak of N-H stretch could be identified 
at 3260 cm-1. This peak was also slightly visible in other tested BC/chitosan 
composites. Originally, the peak of N-H stretch was at 3270 cm-1 in the chitosan 
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Figure 133. IR spectra of ox BC/WA, ox BC/Low and ox BC/Medium MW chitosan 
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Therefore, BC/chitosan composites prepared via the vacuum self-assembly 
method showed that the incorporation of chitosan was more successful using ox 
BC than non-ox BC. The characteristic peaks of the chitosan were pronounced 
in the oxidised samples, which is likely due to a reduction in the crystallinity of the 
BC during oxidation. 
 
6.1.9. Antibacterial activity of synthesised ex situ BC/chitosan composites 
 
The antibacterial activity of synthesised ex situ BC/chitosan composites was 
investigated against MRSA, E. coli and P. aeruginosa, respectively, as described 
in Section 2.7.3. The control for each antibacterial assay was PBS-resuspended 
MRSA, E. coli and P. aeruginosa, respectively, that was placed on the surface of 
the empty petri dish without agar and covered with the sterile plastic lid.  
 
6.1.9.1. Antibacterial activity of non-ox BC/chitosan composite 
produced through immersion 
 
The antibacterial activity of non-ox BC/chitosan composites produced through 
immersion ex situ method along with BC treated with 0.1M acetic acid was 
investigated against MRSA, E. coli and P. aeruginosa (Figs. 134-136).  
 
According to Fig. 134, the growth of MRSA was reduced to 94% and 85% of 
control values by using BC/WA chitosan and BC/Low MW chitosan composites, 
respectively. Non-ox BC/Medium MW chitosan composite decreased the control 
values to 73%.  
 






Figure 134. Antibacterial activity of non-ox BC/chitosan composites against MRSA. The 
control represented PBS-resuspended MRSA that was inoculated on the surface of the 
empty petri dish without any treatment and covered with a lid. Data shown represent the 
mean of two independent experiments with error bars of standard deviation. 
 
Fig. 135 shows antibacterial activity of non-ox BC/chitosan composites against 
E. coli. As shown in Fig. 135, non-ox BC/WA chitosan composite decreased the 
control values to 10%, whereas BC/Medium MW chitosan composite increased 
the growth of E. coli to 304% compare to the control, which was double than pure 












































Figure 135. Antibacterial activity of non-ox BC/chitosan composites against E. coli. The 
control represented PBS-resuspended E. coli that was inoculated on the surface of the 
empty petri dish without any treatment and covered with a lid. Data shown represent the 
mean of two independent experiments with error bars of standard deviation.  
However, BC/Low MW chitosan affected the growth of P. aeruginosa and 
decrease it to 67% of the control values, whereas both BC/WA chitosan and 
BC/Medium MW chitosan promoted the bacterial growth to 150% and 260% 
compare to the control values, respectively (Fig. 136). Furthermore, both pure 
BC and BC treated with 0.1M of acetic acid increased the growth of the bacteria 









































Figure 136. Antibacterial activity of non-ox BC/chitosan composites against P. 
aeruginosa. The control represented PBS-resuspended P. aeruginosa that was 
inoculated on the surface of the empty petri dish without any treatment and covered with 
a lid. Data represent the mean of two independent experiments with error bars of 
standard deviation.  
 
6.1.9.2. Antibacterial activity of non-ox BC/chitosan composites 
prepared through vacuum self-assembly technique  
 
The antibacterial activity of non-ox BC/chitosan composites synthesised using 
vacuum self-assembly method was investigated (Fig. 137-139). According to 
Figs. 137-139, all three types of composites showed significantly strong 
antibacterial activity. The BC/WA chitosan composites reduced the growth of 
MRSA, E. coli and P. aeruginosa to 0.3%, 0.002% and 0.8% of control values, 
respectively. BC/Low MW chitosan decreased the control values of MRSA, E. coli 
and P. aeruginosa to 0.8%, 0.006% and 1.8%, respectively. BC/Medium MW 
chitosan composite reduced the growth of MRSA, E. coli and P. aeruginosa to 
0.7%, 0.5% and 1.8% of control values, respectively. As shown in Figs. 137-139, 




































types of bacteria. In addition, pure BC did not affect MRSA and increased the 




Figure 137. Antibacterial activity of non-ox BC/CH composites prepared through vacuum 
self-assembly technique against MRSA. The control represented PBS-resuspended 
MRSA that was inoculated on the surface of the empty petri dish without any treatment 
and covered with a lid. Data shown represent the mean of three independent 
experiments with error bars of standard deviation. The treatments were compared to the 
control. BC/WA, BC/Low MW and BC/Medium MW chitosan composites are significantly 
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Figure 138. Antibacterial activity of non-ox BC/chitosan composites prepared through 
vacuum self-assembly technique against E. coli. The control represented PBS-
resuspended E. coli that was inoculated on the surface of the empty petri dish without 
any treatment and covered with a lid. Data shown represent the mean of three 
independent experiments with error bars of standard deviation. The treatments were 
compared to the control. BC/WA, BC/Low MW and BC/Medium MW chitosan composites 
are significantly different from the control (P-value<0.01). 
 
  
Figure 139. Antibacterial activity of non-ox BC/CH composites prepared through vacuum 






























































resuspended P. aeruginosa that was inoculated on the surface of the empty petri dish 
without any treatment and covered with a lid. Data shown represent the mean of three 
independent experiments with error bars of standard deviation. The treatments were 
compared to the control. BC/WA, BC/Low MW and BC/Medium MW chitosan composites 
are significantly different from the control (P-value<0.01). 
 
6.1.9.3. Antibacterial activity of ox BC/chitosan composites 
synthesised through vacuum self-assembly technique 
 
The antibacterial properties of pumped-synthesised oxidised BC/chitosan 
composites were analysed against MRSA, E. coli and P. aeruginosa (Figs. 140-
142). According to Fig. 140, all three composites showed strong antibacterial 
activity against MRSA. The bacterial growth reduced to 0.0009% of control values 
using ox BC/WA chitosan, to 0.005% using ox BC/Low MW chitosan and to 0.6% 
using BC/Medium MW chitosan.  
 
 
Figure 140. Antibacterial activity of ox BC/chitosan composites prepared through 
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resuspended MRSA that was inoculated on the surface of the empty petri dish without 
any treatment and covered with a lid. Data shown represent the mean of three 
independent experiments with error bars of standard deviation. Ox BC is different from 
the control with P-value<0.01. Ox BC/WA, ox BC/Low MW and ox BC/Medium MW 
chitosan composites are significantly different from the control (P-value<0.001). 
 
The ox BC/chitosan composites also showed antibacterial activity against E. coli. 
The growth of the bacteria significantly decreased to 2% and 1.8% of control 
values using ox BC/WA chitosan and ox BC/Medium MW chitosan composites, 
respectively (Fig. 141). Ox BC/Low MW chitosan composites reduced the growth 
of E. coli to 3.5% of control values. Both pure BC and BC treated with 0.1M acetic 
acid increased control values to 163% and 115%, respectively. 
 
 
Figure 141. Antibacterial activity of ox BC/chitosan composites prepared through 
vacuum self-assembly technique against E. coli. The control represented PBS-
resuspended E. coli that was inoculated on the surface of the empty petri dish without 
any treatment and covered with a lid. Data shown represent the mean of three 
independent experiments with error bars of standard deviation. The treatments were 
compared to the control. Ox BC/WA, ox BC/Low MW and ox BC/Medium MW chitosan 


































As seen in Fig. 142, the weakest antibacterial activity was observed with ox 
BC/Medium MW chitosan, which decreased the growth of P. aeruginosa to 2.7%, 
whereas BC/Low MW chitosan and BC/WA chitosan reduced bacterial growth to 
0.005% and 0.13% of control values, respectively. However, all treatments shown 
statistically significant differences. 
 
 
Figure 142. Antibacterial activity of ox BC/CH composites prepared through vacuum self-
assembly technique against P. aeruginosa. The control represented PBS-resuspended 
P. aeruginosa that was inoculated on the surface of the empty petri dish without any 
treatment and covered with a lid. Data shown represent the mean of three independent 
experiments with error bars of standard deviation. All treatments are significantly 
different from the control. P-value for ox BC and ox BC/Low MW chitosan is <0.01, 
whereas P-value for other treatments is <0.05.   
 
6.2.  Discussion 
 
BC/chitosan composites prepared via the vacuum self-assembly method showed 















































BC. The characteristic peaks of chitosan were pronounced in the oxidised 
samples, which is likely due to a reduction in the crystallinity of the BC during 
oxidation. 
 
6.2.1. Oxidation of BC 
Oxidation of BC using sodium periodate (NaIO4) resulted in the introduction of 
aldehyde groups to the structure (Fig. 143). This reaction is characterised by 
cleaving of C2 and C3 bonds between hydroxyl groups of a glucose unit. This 
results in the formation of two aldehyde groups (–HC=O) per unit[292].  
Figure 143. Periodate oxidation of cellulose [294]. 
 
At the end of the oxidation reaction, the hydroxyl groups were replaced with the 
aldehyde groups. It has been reported that the process of oxidation occurs in the 
bulk material[292]. Therefore, the aldehyde groups could be detectable in the FT-
IR spectrum. According to the FT-IR result, it was possible to achieve oxidation 
of BC by using sodium periodate.  
The aldehyde groups (-CHO) of the oxidised BC were grafted with amine groups 
of chitosan by a Schiff’s base reaction. In the presence of chitosan, the aldehyde 
groups could bind to the amino group (-NH2) of chitosan and form an imine bond 
(–C=NR), which is subsequently rearranged to a stable amine (-C-NHR)[292]. As 
was discussed in Section 5.2.1, chitosan could interact with non-ox BC through 
the intramolecular hydrogen bonds that may be formed between the chemical 
groups in chitosan (-OH and NH2) and BC (-OH). It has been reported that the 
intramolecular hydrogen bond can break down in order to form BC-chitosan 
hydrogen bonding[138, 140]. In addition, chitosan could also coat BC fibres by 
physical attachment[291].  





It has been reported that oxidised BC and oxidised BC/chitosan composites have 
a more amorphous structure than pure BC[295]. This might be due to the oxidant, 
which could destroy the hydrogen bonding and subsequently the crystal structure 
of ox BC. In addition, it has been stated that the surface charge of BC changed 
from negative -8.3 ueq/g to more negative during oxidation −11.4 ueq/g[291]. 
However, ox BC has shown positive charge of +34.4 ueq/g in the presence of 
chitosan[291].  
Oxidation of BC could be beneficial for the chemical interaction with chitosan. 
However, such a modification of BC may not improve the attachment of clay, 
because the interaction between clay and BC occurs when silicate particles bind 
to the OH groups of BC thorough hydrogen and/or weak organic-inorganic 
bindings[112, 246].  
6.2.2. Antibacterial activity of BC/chitosan composites 
 
The incorporation of chitosan into BC using the immersion method seemed to be 
uneven. According to the results obtained from UV-VIS and FT-IR, the BC/WA 
chitosan composite did not show any peaks of WA chitosan inside BC; however, 
the antibacterial assay exhibits improved antimicrobial properties of the 
composite and, therefore, incorporation of chitosan. A possible reason behind 
this might be the relatively short time of the actual immersion, resulting in a low 
concentration of chitosan penetrating the matrix of BC. It has been reported 
elsewhere that immersion for 12 hours allowed proper incorporation of 0.6 wt.% 
of chitosan solution, which resulted in inhibition of 99% of the growth of both E. 
coli and S. aureus[180]. According to UV-VIS and FT-IR results, BC/Medium MW 
chitosan composite showed more evidence of the presence of chitosan inside the 
matrix. However, as shown in Figs. 135-136, BC/Medium MW chitosan 
composite increased bacterial growth, which suggested that chitosan was not 
fully incorporated into the BC matrix. Alternatively, this might also be because of 
the lower antibacterial activity of medium MW chitosan[170]. The antibacterial data 
obtained were very different from pure chitosan, which might be due to the non-





effective penetration of chitosan inside the matrix, where a very small extent of 
chitosan was in the BC structure in the materials produced through immersion. 
 
Furthermore, BC treated with 0.1M acetic affected the growth of both MRSA and 
E. coli. The growth of MRSA and E. coli was reduced to 51% and 21% of control 
values, respectively, using BC treated with 0.1M acetic acid. The results might 
suggest that either BC treated with 0.1M acid was not completely washed after 
the pumping method or due to porosity of BC, acid could remain inside the matrix 
and release during the treatment. However, the growth of the bacteria was much 
lower with the composites than with BC treated with acetic acid. This means that 
acetic acid was not responsible for the reduction in bacterial growth. In addition, 
P. aeruginosa did not show any sensitivity to BC treated with 0.1M acetic acid as 
the control values of bacteria increased to 192% (Fig. 139).  
 
The composites synthesised through the immersion showed the least 
antibacterial activity compared to the composites produced through the vacuum 
self-assembly technique. Ox BC/chitosan composites synthesised using the 
vacuum self-assembly technique showed incorporation of chitosan in UV-VIS-
NIR and IR spectra as well as strong antibacterial activity. Within all types of 
synthesised composites, BC/WA chitosan showed the strongest antibacterial 
activity against MRSA, E. coli and P. aeruginosa. This might be due to differences 
in both MW and DDA.  
 
DDA might affect the antimicrobial property of chitosan due to the number of 
amine groups, which are directly involved in the antibacterial mechanisms that 
are described in Section 1.4.3.1. WA chitosan had the highest DDA of 90%, 
whereas WA and low MW chitosan had DDA of 75-85%, respectively. It has been 
reported elsewhere that an increase in DDA leads to a stronger antimicrobial 
activity[132, 157]. In another study, chitosan with 82% DDA reduced the viability to 
0.0625% of control values of both E. coli and S. aureus after 24 hours[157]. It has 
been also stated that increasing DDA of chitosan from 75% to 95% leads to 





increased antimicrobial activity against S. aureus and E. coli through nucleotide 
leakage[158].  
 
The molecular weight of chitosan is another possible factor that may affect 
antibacterial activity. It has been reported elsewhere that low MW chitosan could 
enhance antibacterial properties against Gram-negative bacteria[164]. Low MW 
chitosan might penetrate bacterial cell walls and enter bacterial cells[161]. It has 
also been reported that chitosan with high MW might showed reduced 
antibacterial activity against E. coli due to the strong binding of intramolecular 
hydrogen bonds that prevents amine groups from being available to attach 
bacterial cells[151]. Furthermore, it has been found that a decrease of MW of 
chitosan increases the antibacterial activity. As MW decreased chitosan can pass 
through the channels into the cell[166]. Low MW chitosan might also be able to 
affect DNA and inhibit RNA replication[46]. Inside a bacterial cell, low MW chitosan 
can bind to DNA electrostatically and reduce a mobility of nucleic acids[132, 162]. 
Whereas, high MW of chitosan may form a dense polymer film on the surface of 
cells and prevent nutrients and oxygen from passing through. This might inhibit 
the growth of aerobic bacteria[46]. The present findings confirmed those reports. 
WA chitosan with the highest 90% DDA and low MW was the most effective, 
whereas medium MW chitosan showed a weaker antibacterial activity. 
 
The antibacterial activity of the BC/chitosan composites synthesised through the 
vacuum self-assembly method was much stronger than that of pure chitosan. A 
possible reason for this might be an experimental error, bacterial adaptation or 
synergistic effect of chitosan and BC together. A combination of chitosan and BC 
might lead to increased antibacterial activity[296]. It has been reported that both 
antibacterial activity and solubility of chitosan could be increased when chitosan 
coupling with other materials by a Schiff base reaction[296]. Schiff base 
derivatives, where carbonyl groups or aldehyde efficiently coupled with 
NH2 groups of chitosan and, subsequently, form the corresponding chitosan 
Schiff base consisting of the characteristic imine group (-RC=N-), possess 





stronger antibacterial activity than pure chitosan due to enhancement of 
hydrophilicity of chitosan, altering chitosan molecular structure and increasing a 
number of positively charged cations[297]. Furthermore, the solubility of chitosan 
might be improved due to the introduction of groups that could reduce interaction 
of intramolecular hydrogen bonds[296]. For example, it has been observed 
elsewhere that BC/PVA/chitosan composites, which were prepared by magnetic 
stirring using 0.3 wt.% of chitosan nanoparticles with DDA at 85-90%, showed an 
increase in both swelling behaviour and solubility in water[293]. Furthermore, 
BC/PVA/Chitosan composite has shown higher antibacterial activity against S. 
aureus and E. coli than pure chitosan[293, 298]. Moreover, it has been reported that 
the combination of ox BC and chitosan (1 wt.%, 200 kDa MW, 90% DDA) could 
result in the improved antibacterial activity that inhibited growth by 99.9% in S. 
aureus and E. coli, respectively[293]. Such a synergistic effect was observed 
elsewhere, where chitosan has shown improved antibacterial activity against S. 
aureus in a composite with streptomycin[296].  
 
6.2.3. Cytotoxicity of BC/chitosan composites 
 
Both spreading and adherence of mammalian cells on a surface of BC might 
provide an insight into its biocompatibility. It has been reported that fibroblasts 
hardly adhere on a surface of ox BC after 1, 2 and 3 days, whereas the addition 
of 1 wt.% of chitosan led to both normal morphology and strong proliferation of 
the cells on a surface of ox BC/chitosan composite with the number of cells being 
2 fold more than just on ox BC after 3 days of incubation[292]. According to MTT 
results obtained elsewhere, there were 97.7% of metabolically active fibroblasts 
adhered to the ox BC/chitosan composite after 24 hours[292]. Ox BC might have 
a low pH due to free carboxyl groups, which can result in inhibition of the 
mammalian cells[292]. However, this effect can be neutralised by the amine groups 
of chitosan in ox BC/chitosan composite.  
Furthermore, fresh blood has been placed on a surface of both non-ox and ox 
BC/chitosan composites elsewhere in the blood clotting assay. It has been 





observed that ox BC/chitosan composite induced whole blood clotting 2 fold 
faster with a low number of cells adhered compare to the non-ox BC/chitosan 
composite[293]. Such an increase in the rate of blood clotting might be due to the 
amine groups that can interact with blood, for instance, with the cell membrane 
of erythrocytes, through electrostatic binding. However, as has been stated 
elsewhere, the morphology of erythrocytes and platelets adhered to ox 
BC/chitosan composite remained normal[293]. Moreover, chitosan can increase 
expression of integrin β3, but inhibit the adhesion of fibroblasts by reorganisation 
of the actin and integrin β1 network[299].  
Furthermore, it has been concluded that BC could not support the adherence of 
cancer cells, whereas chitosan can rapidly promote the progression of cancer 
cells showing better biocompatibility than BC[299]. Effect of non-ox BC/chitosan 
composite on the adhesion of A2780 (ovarian cancer) cell lines has been 
analysed elsewhere by culturing the cells on the composite for 1, 3, 5, and 7 
days[299]. It has been observed by phase-contrast microscopic analysis that the 
cells were very strongly attached to the fibres of BC/chitosan composite, which 
were produced by immersion of non-ox BC into 2 wt.% chitosan solution[299]. The 
formation of A2780 cell aggregates occurred inside the matrix of pure BC from 
the 1st day[299]. It has been reported that the size of the aggregates of A2780 cells 
on a surface of pure BC and BC/chitosan composite was 281 ± 3.5 and 
133 ± 2 μm, respectively[299]. It was concluded that the BC/chitosan composite 
supported the adherence of the cancel cells more than pure BC indicating a high 
tumorigenic activity of the composite towards the A2780 cells in vitro[299]. 
Thereby, the addition of chitosan to BC could lead to enhancing the 
biocompatibility of pure BC in terms of proliferation and adhesion of cells[299]. 
There are might be two possible reasons for the stronger adhesion of cells as 
well as a lower number of cell aggregates with BC/chitosan composite. A 
BC/chitosan composite might show a strong cell-fibre interaction through 
electrostatic binding between chitosan and membranes of cancer cells[299]. In the 
case of pure BC without chitosan, cells might interact with each other more 





strongly than with fibres of BC. In addition, chitosan could produce N-acetyl-β-D-
glucosamine upon a degradation causing a synergistic effect with BC by 
improving the wound healing ability followed by the reduction in the scar 
formation[299]. 
 
Therefore, both ox and non-ox BC/chitosan composites could increase the 
proliferation and adhesion of different cells such as fibroblasts, A2780 and blood 
cells.  





Chapter 7. Synthesis of BC/chitosan hybrid gel through chemical 
attachment 
 
The novel hybrid of BC gel and chitosan hydrogel was produced using genipin as 
a crosslinker. Genipin was used due to its low toxicity towards mammalian 
cells[300]. Firstly, 0.5 wt.% of WA chitosan was dissolved using 10 vol.% of distilled 
vinegar at a final pH3. Then, gepin was introduced to the chitosan solution as 
detailed in Section 2.6.2.3. 
 
7.1. Results  
7.1.1. Synthesis of BC/chitosan hybrid gel through chemical attachment of 
chitosan 
 
The chemical binding between chitosan and genipin cross-linked chitosan to form 
the hydrogel is as shown in Fig. 144.  
 
 
Figure 144. Schematic image of genipin crosslinks with chitosan[301]. 
As seen in Fig. 144, two chains of chitosan, which are shown on right side of the 
picture, react covalently with genipin to form the hydrogel[301].  The hydrogel was 
then either settled or incorporated into BC matrix using the vacuum self-assembly 
technique. Subsequently, BC/chitosan (BC/CH) hybrid was then analysed using 





UV-UIS-NIR spectroscopy. Antibacterial activity of the hybrid was investigated 
against MRSA, E. coli and P. aeruginosa, respectively.  
 
7.1.2. Analysis of BC/CH hybrid 
 
Fig. 145 shows the appearance of chitosan hydrogel (a) and BC/CH hybrid gel 
(b) after 24 hours. As seen in Fig. 145a synthesised chitosan hydrogel was dark 
blue colour due to the presence of genipin. Once the hydrogel was incorporated 
into BC, the gel formation appeared inside the BC structure. BC/CH hybrid gel 
was slightly green colour (Fig. 145b). 
 
 
Figure 145. The appearance of chitosan hydrogel (a) BC/CH hybrid gel (b) after 24 hours. 
 
Fig. 146 shows SEM image of BC/CH hybrid gel. As seen in Fig. 146, chitosan 
hydrogel spread through the matrix and completely covered fibres of BC. 










Figure 146. SEM image of BC/CH hybrid gel. 
 
7.1.3. UV-VIS-NIR spectroscopy of BC/CH hybrid gel 
 
BC/CH hybrid gel was analysed using UV-VIS-NIR spectroscopy. In order to 
investigate the presence of genipin, BC/Genipin composite was observed using 
UV-VIS spectroscopy (Fig. 147). The characteristic peak of genipin, which is 
about 683 nm[301] was not detected inside the composite. Furthermore, Fig. 148 
shows UV-VIS spectrum of BC/CH/Genipin hybrid. The double peak of cellulose 
was detected around 213 nm and 264 nm. The peak of both chitosan at 325 nm 
and genipin were also not seen inside the hybrid. This might be due to presence 
of chitosan and genipin inside BC, which was challenging to detect.  
 






Figure 147. UV-VIS spectrum of BC/Genipin composite. 
 
Figure 148. UV-VIS spectrum of BC/CH/Genipin hybrid. 
Nonetheless, NIR spectrum of the BC/CH hybrid gel had predominantly BC 
structure with two characteristic peaks of cellulose at 1940 nm, the peak of 
chitosan at around 1430-1488 nm might be detectable inside the BC/CH hybrid 












































Figure 149. NIR spectrum of BC/CH/Genipin hybrid. 
 
7.1.4. Introduction of exfoliated Cloisite Na+ to BC/CH hybrid  
 
Once chitosan hydrogel was successfully incorporated into BC, exfoliated Cloisite 
Na+ clay was introduced to the hybrid. Chitosan at concentration 0.5 wt.% was 
dissolved using vinegar at pH3. Then, chitosan solution was mixed with 0.6 wt.% 
exfoliated suspension of Cloisite Na+ suspension in the ratio of 1:1, which leaves 
a final clay concentration of 3 mg/ml. Subsequently, the suspension of chitosan 
and clay was then pumped through pure BC using the vacuum self-assembly 
technique. The detailed method of developing BC/CH/Cloisite Na+ composite is 
described in Section 2.6.2.4. The analysis of BC/CH/Cloisite Na+ composite was 
carried out using UV-VIS-NIR spectroscopy.  
 
Fig. 150 shows UV-VIS spectrum of BC/CH/Genipin/Cloisite Na+ composite. As 
shown in Fig. 144, the BC/CH/Cloisite Na+ composite contained the peaks of both 
clay and the cellulose in a range of 209-211 nm. The separate peak of the 
cellulose at 279 nm was present. The peaks of both genipin and chitosan were 





























Figure 150. UV-Vis spectrum of BC/CH/Genipin/Cloisite Na+ composite. 
 
Fig. 151 shows NIR spectrum of BC/CH/Genipin/Cloisite Na+ composite. As seen 
in Fig. 151, the peak of 1912-1950 nm corresponded to BC. The broad peak 
around 1400-1500 nm might be due to the presence of both chitosan and clay. 
Therefore, the presence of clay and chitosan might be detected inside the final 


























Figure 151. NIR spectrum of BC/CH/Genipin/Cloisite Na+ composite. 
 
7.1.5. Antibacterial activity of BC/CH hybrid and BC/CH/Cloisite Na+ 
composite 
 
Antibacterial properties of synthesised BC/CH hybrid and BC/CH/Cloisite Na+ 
composites were investigated against MRSA, E. coli and P. aeruginosa, 
respectively, with the results shown in Figs. 152-154. The control represented 
PBS-resuspended bacteria, which was inoculated on the surface of an empty 
petri dish without agar and covered with a sterile plastic lid as described in 
Section 2.7.3. In order to investigate the possible antibacterial activity of vinegar 
and genipin, each of the solutions was pumped through pure BC. 
 
As shown in Fig. 152, the highest number of MRSA was observed with pure BC, 
where the growth of the bacteria reached 194% of control values. Both 
BC/Vinegar and BC/Genipin increased the bacterial growth to 103% and 116% 
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to MRSA. BC/CH hybrid reduced the growth of MRSA to 9% of control values, 
whereas BC/CH/Cloisite Na+ composite showed a reduction to 0001%. 
 
 
Figure 152. Antibacterial activity of synthesised BC/CH hybrid and BC/CH/Cloisite Na+ 
composite against MRSA. The control represented PBS-resuspended MRSA that was 
inoculated on the surface of the empty petri dish without agar and covered with a lid. 
Data shown present the mean of three independent experiments with error bars of 
standard deviation. BC/CH hydride and BC/CH/Cloisite Na+ are different from the control 
(P-value<0.001).  
As shown in Fig. 153, pure BC, BC/Vinegar and BC/Genipin increased the growth 
of E. coli to 131%, 102% and 136% of control values, respectively. This means 
that vinegar and genipin were not responsible for the reduction of growth obtained 
from the hybrid and the composite. BC/CH/Cloisite Na+ composite was more 
effective than BC/CH hybrid and reduced the growth of E. coli to 0.5% of control 
values. BC/CH hybrid decrease the bacterial growth to 50% of control values, 
which indicated that hybrid was more effective against Gram-positive MRSA than 































Figure 153. Antibacterial activity of synthesised BC/CH hybrid and BC/CH/ Cloisite Na+ 
composite against E. coli. The control represented PBS-resuspended E. coli that was 
inoculated on the surface of the empty petri dish without agar and covered with a lid. 
Data shown present the mean of three independent experiments with error bars of 
standard deviation. BC/CH/Cloisite Na+ is different compared to the control (P-
value<0.001). 
Regarding P. aeruginosa, BC/CH/Cloisite Na+ composite slightly reduced the 
growth of the bacteria to 93% of control values, whereas BC/CH hybrid promoted 
the growth of P. aeruginosa compared to control values (Fig. 154). The highest 
level of bacterial growth was observed using BC/Vinegar (299%). Pure BC and 
BC/Genipin promoted the bacterial growth and increased it to 132% and 108% of 

































Figure 154. Antibacterial activity of synthesised BC/CH hybrid and BC/CH/Cloisite Na+ 
composite against P. aeruginosa. The control represented PBS-resuspended P. 
aeruginosa that was inoculated on the surface of the empty petri dish without agar and 
covered with a lid. Data shown represent the mean of three independent experiments 
with error bars of standard deviation. BC/Vinegar is different to the control (P-
value<0.05). 
 
7.2.  Discussion 
7.2.1. Cross-linking of chitosan by genipin 
Chitosan can be cross-linked using ionic cross-linkers such as sulphates and 
phosphates. The cross-linking of chitosan could be achieved by the formation of 
chemical bridges between reactive amine groups of a polymer chain[302]. 
However, a synthesised hydrogel might possess limited stability due to the nature 
of its chemical bonds, which are based on relatively weak interactions such as 
dipole–dipole, electrostatic and hydrophobic interactions[302]. Alternatively, 
covalent cross-linkers such as formaldehyde and glutaraldehyde could produce 

























glutaraldehyde is a chemical cross-linking agent that covalently reacts with 
primary amine groups. The final hydrogel possesses resistance to crush, 
solubility and the efficacy of metallic cation absorption[303]. However, 
glutaraldehyde could exhibit cytotoxicity to mammalian cells[303].  
It has been reported that genepin, which is a natural extract from Gardenia 
Iasminoides ellis fruit showed reduced toxicity towards mammalians compared to 
glutaraldehyde and formaldehyde[302, 303]. Genipin could react with chitosan 
through a Schiff base reaction leading to the formation of a polymeric network 
(Fig. 144). A molecule of genipin cross-links two chains of chitosan and, 
subsequently, creates both a tertiary amine and a mono-substituted amide[304]. 
Genipin attacks the primary amine groups on the olefinic carbon atom at C3[304]. 
Then, the dihydropyran ring opens followed by a formation of the secondary 
amine group[304]. Subsequently, amine groups of chitosan get attacked by the 
carboxyl group of genipin followed by the formation of amide[304]. This last 
reaction could be a relatively slow.  
The oxygen radical-induced polymerisation of genipin can occur between genipin 
molecules that are already linked to amine groups of chitosan. During the 
polymerisation, the hydrogel has both low cross-linking degree and a low number 
of covalent bonds[305]. This means that the hydrogel has a long length of chitosan 
chains between the links and, therefore, less force is required to deform the 
hydrogel. As the number of the cross-links increases, the network is tightened, 
which could lead to a stiffer hydrogel[305]. Furthermore, a fragile membrane occurs 
if the degree of cross-linking is low, whereas a high degree of cross-linking leads 
to an excessively long period of degradation and reduced hydrolysis[41, 305, 308]. It 
has been reported that cross-linking degree of hydrogels increases when 
increasing the concentration of genipin[305]. For example, it has been stated that 
the degree of cross-linking using 0.05, 0.10, 0.15 and 0.20 wt.% of genipin was 
30%, 32%, 42% and 40, respectively[311]. The degree of cross-linking could also 
depend on pH values. For example, it has been reported elsewhere that the 





degree of crosslinking of chitosan/genipin was 39.9%, 96%, 45% and 1.4% at 
pH5, pH 7.4, pH9 and pH13, respectively[303].  
Chitosan is soluble in acidic aqueous solutions that are lower than pH6[306]. 
Therefore, an acidic environment can negatively affect chitosan-based 
hydrogels. In an acidic environment, the links between chitosan and genipin are 
short, whereas, at alkaline pH, links are long[306]. At the neutral pH, the cross-
linking degree is the highest, whereas the swelling behaviour is the lowest[306]. 
The swelling behaviour of a hydrogel occurs at pH values lower than pH3 and 
higher than pH11 followed by a hydrolysis of amide linkages[306]. This may lead 
to a regeneration of amine groups and carboxyl acid in the hydrogel network[306]. 
It has been reported elsewhere that formation of the hydrogel can be influenced 
by DDA of chitosan, as effective formation was observed with a low DDA[307]. 
Furthermore, it has been found that CH/Genipin hydrogels show the highest 
swelling behaviour at pH1 and pH2. This is due to the protonation of amine 
groups in the chains of chitosan that depend on the pH of the environment[304]. 
The number of protonated amine groups might increase by decreasing the pH 
values of an external solution. At pH1, all amine groups are protonated, which 
results in a fully charged network[302]. Protonation of amine groups could also lead 
to both extension and repulsion of a chain. This may increase the amount of water 
that enters the polymeric network. An increase in pH of the external solution leads 
to a decrease in the number of protonated amine groups[309, 310]. This means that 
ionic contribution to the swelling capacity decreases. A hydrogel shows negative 
swelling values at pH6-11[302].  
7.2.2. Antibacterial activity of BC/chitosan hybrid gels  
 
BC/CH and BC/CH/Cloisite Na+ were more effective against Gram-positive 
MRSA than Gram-negative E. coli and P. aeruginosa. This might be due to the 
presence of an outer membrane in Gram-negative bacteria, which makes it 
difficult to inhibit. BC/CH/Cloisite Na+ showed stronger antibacterial activity than 





BC/CH hybrid. A possible reason why could be that the cross-linking reaction that 
made the amine groups hidden and ineffective. It has been reported that genipin 
can decrease the number of residual amine groups[300]. However, the stronger 
antibacterial activity of the hybrid was obtained after introducing Cloisite Na+ clay. 
Some amine groups might attach to the negatively charged surface of the clay 
and not participate in the cross-linking reaction. This could have resulted in the 
expansion of free movement of the intercalated amine groups. This might lead to 
enhanced antibacterial properties. 
 
7.2.3. Mammalian toxicity of genipin 
Genipin does not possess any cytotoxicity against mammalian cells[304, 308, 311]. It 
has been reported that no difference was observed in the proliferation of either 
hMSCs (human mesenchymal stem cells) or MG63 (human immortalized 
osteosarcoma) in vitro using genipin[308]. Moreover, L929 fibroblasts have shown 
good viability on the surfaces of crosslinked CH/Genipin hydrogels (88.4%–
90.9%) and chitosan films (92.8%) after 48 hours[304]. It has been observed 
elsewhere that the viability of TSA cells was not significantly affected by the 
presence of 0.20 wt.% of genipin[311]. In addition, it has also been observed that 
a degree of cross-linking of 36% of the genipin-gelatin hydrogel can ensure nerve 
regeneration by developing perineural and epineural organisations, whereas 
24% and 51% cross-linking might cause irritation and compression of nerves by 
the remaining tube walls[304]. BC/CH/Cloisite Na+ composite, which showed the 
high antibacterial activity against Gram-positive MRSA and Gram-negative E. coli 
was not toxic to mammalian cells and might be a potential material for wound 
healing applications. 
 





Chapter 8. Kombucha cellulose as an alternative to the conventional BC 
 
The use of Kombucha cellulose (KC) as an alternative to the conventional BC 
was investigated. KC was synthesised by the isolated microorganisms (IM) 
obtained from symbiotic culture of bacteria and yeast (SCOBY) on both small and 
large scales using either glucose or WA chitosan as the main carbon source. 
Exfoliated Cloisite Na+ and SWN clay were in situ incorporated into KC, 
respectively, during the formation. The synthesised KC/Clay, KC/Chitosan and 
KC/Chitosan/Clay composites were analysed by UV-VIS-NIR spectroscopy. The 
antibacterial activity of synthesised composites was investigated against MRSA, 
E. coli and P. aeruginosa, respectively. 
 
8.1. Results 
8.1.1. Optimisation of growing conditions of KC on a small scale  
 
The optimal conditions for cultivation of KC were investigated on a small scale. 
The synthesis of KC started with isolation of microorganisms from SCOBY as 
described in Section 2.8. The SCOBY contained a symbiotic culture of acetic acid 
bacteria including species of genera of Gluconacetobacter and Acetobacter, 
lactic bacteria and yeasts in unknown proportions. The effect of different 
concentration of IM on the formation of KC was analysed. As the main broth for 
the cultivation of Kombucha was found to be sugared tea[312], black tea containing 
2 wt.% of glucose was used as the tea broth for inoculation of IM.  
 
The tea broth was adjusted to pH5 and 3.8 RIU (optical reflective unit) of optical 
reflective index prior to the inoculation. The volume of 100 µls of PBS diluted IM 
was added to the tea broth, where IM was ranging from 0.1 to 2 OD600, and 
incubated subsequently for 48 hours at 25°C.  The mass of wet KC produced by 
IM at concentration ranging from 0.1 to 2 OD600 was measured with the results 
shown in Fig. 155. 





According to Fig. 155, the mass of wet KC was greater for 2 OD600 and 
corresponded to 0.24 grams, whereas the mass of KC decreased to 0.18 and 
0.12 grams using 1 and 0.1 OD600, respectively. 
 
 
Figure 155. The effect of IM density ranging on the mass of wet KC after 48 hours. KC 
was produced on a small scale using 2 wt.% of glucose solution and inoculum ranging 
from 0.1 to 2 OD600 at 25°C for 48 hours. Data shown represent the mean of three 
independent experiments with error bars of standard deviation. OD of 0.1 was compared 
to either 1 OD or 2 OD. Mass obtained at 2 OD is significantly different in comparison 
with 1 OD (P-value<0.05).  
 
Therefore, the concentration of PBS-resuspended IM was chosen to be 2 OD600. 
The effect of temperature on KC growth was investigated as detailed in Section 
2.8.3. Fig. 156 shows the mass of wet KC formed at 25°C, 30°C and 37°C using 
2 OD600 concentration of IM after 48 hours. As shown in Fig. 156, the most 
effective temperature for KC growth was 25°C with the mass reaching 0.23 
grams. The mass of wet KC decreased to 0.8 grams at 30°C, whereas no 
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Figure 156. The mass of wet KC produced at 25°C, 30°C and 37°C temperature. KC was 
produced on a small scale using 2 OD600 concentration of IM and incubated for 48 hours. 
Data shown represent the mean of three independent experiments with error bars of 
standard deviation. The data obtained at 25°C are significantly different from 30°C (P-
value<0.001). 
 
The effect of pH on the formation of KC was investigated with the results shown 
in Fig. 157. As seen in Fig. 157, the most effective pH for KC growth was pH4, 
which corresponded to the mass of 0.7 grams. KC produced at pH3 and pH2 was 
0.62 and 0.6 grams, respectively. The mass of wet KC decreased to 0.23 and 
0.24 grams at pH6 and pH5, respectively. There was no cellulose observed at 





























Figure 157. The effect of pH on KC growth. KC was produced using 2 OD600 of IM source 
at pH ranging from pH6 to pH1 at 25°C for 48 hours. Data shown represent the mean of 
three independent experiments with error bars of standard deviation. Mass produced at 
pH4 was compared to mass synthesised at other pH values. The data obtained at pH5 
and pH6 are significantly different from pH4 (P-value< 0.001).  
 
The effect of tea concentration on the formation of KC was investigated. The 
stock of the tea broth was diluted using sterilised distilled water. The control 
represented the inoculum containing 100% of the non-diluted tea broth. The 
volume of the tea was reduced from 100% to 0%, where the tea broth was 
completely replaced with distilled water. The pH of tea was adjusted to pH4 using 
sterile 0.1M HCl. Fig. 158 shows the mass of wet KC synthesised using different 
concentrations of the tea broth at pH4 with 2 OD600 of IM source at 25°C after 48 
hours. According to Fig. 158, the mass of wet KC was the heaviest with 75% of 
the tea broth and reached 0.24 grams. The mass of wet KC produced with 100% 
of the tea broth was 0.21 grams. The mass of wet KC was continuously 
decreasing with reducing the concentration of tea. KC was formed without tea, 
but the cellulose was not robust and hardly weighable. The mass of synthesised 
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KC might depend on the tea environment. The concentration of the tea broth was 
chosen to be 75% for further experiments. 
 
 
Figure 158. The effect of the concentration of tea broth the mass of wet KC. KC was 
produced at pH4 using 2 OD600 of IM source at 25°C for 48 hours. Data shown represent 
the mean of three independent experiments with error bars of standard deviation. The 
control (100% broth) was compared to other broth concentrations. The data obtained 
using 50%, 25%, 6%, 3% and 0% concentrations are significantly different from 100% 
(P-value <0.05 for 50% and <0.01 for 25-0%).  
 
The parameters for the synthesis of KC were optimised on a small scale. The 
chosen concentration of IM was 2 OD600. The incubation of PBS-resuspended IM 
was carried out using 75% of the tea broth adjusted to pH4 at 25°C temperature 
for 48 hours for further experiments.  
 
8.1.2. Synthesis of KC on a large scale involving glucose 
 
After optimisation of KC growing conditions on a small scale, KC was synthesised 
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KC using the optimised parameters such as 75% of tea broth adjusted to pH4 
and containing 2 wt.% of glucose as the main carbon source with 2 OD600 of IM 
incubated at 25°C for 48 hours. As seen in Fig. 159, it was possible to produce 




Figure 159. Image of KC produced. KC was inoculated using 75% tea broth at pH4 
containing 2 wt.% of glucose as the main carbon source with 2 OD600 of IM concentration 
and incubated at 25°C for 48 hours. 
 
Fig. 160a shows the SEM image of KC produced on a large scale, which was 
synthesised using all optimised parameters. As seen in Fig. 160a, KC had a 
porous matrix similar to the conventional BC (Fig. 160b), but the orientation of 
fibres of KC was more random compare to the pure BC.  






Figure 160. SEM image of KC (a) and pure BC (b) produced on a large scale, 
respectively. The bars represent a distance in 1µm. 
 
In order to investigate the dependence of the formation of KC on the tea 
environment on a large scale, 2 OD600 of IM were inoculated in distilled water, 
which was adjusted pH4, using 2 wt.% glucose as the main carbon source and 2 
OD600 of IM concentration at 25°C for 48 hours (Fig. 161). As shown in Fig. 161, 
the mass of wet KC synthesised with distilled water was much lower than the 
mass of KC produced using 75% of the tea broth and corresponded to 19.87 
grams. Whereas the mass of wet KC synthesised with 75% of black tea reached 
56 grams. This agrees with the results obtained from the small scale experiment. 
It means that the formation of KC was dependent on the tea environment.  
a b 






Figure 161. The mass of wet KC produced using either tea or distilled water. KC was 
produced using 75% of the tea broth and sterile distilled water, respectively, containing 
2 wt.% of glucose as the main carbon source and 2 OD600 of IM concentration at 25°C 
for 48 hours. Data shown represent the mean of a single experiment.  
 
8.1.3. In situ incorporation of clay into KC on a small scale 
 
The possibility of in situ incorporation of clay into KC was firstly investigated on a 
small scale.  Non-exfoliated and exfoliated by the Tefal blender Cloisite Na+ and 
SWN suspensions were added into the tea broth at the concentration of 3 mg/ml, 
respectively, prior to the incubation with IM as described in Section 2.9.1. 
 
Fig. 162 shows the mass of wet KC produced with non-exfoliated and exfoliated 
Cloisite Na+ and SWN clay, respectively. The control represented pure KC 
produced without clay. According to Fig. 162, non-exfoliated SWN suspension 
has reduced the growth of KC, the wet mass of which was 0.7 grams. Whereas, 
the mass of wet KC produced with exfoliated SWN increased to 1.82 grams. The 
non-exfoliated and exfoliated Cloisite Na+ increased the mass of KC to 1.48 and 
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Figure 162. The effect of non-exfoliated and exfoliated Cloisite Na+ and SWN clay 
suspensions on a mass of KC. KC was produced using clay suspensions at the 
concentration of 3 mg/ml, respectively, and 2 OD600 PBS-resuspended IM with 75% the 
tea broth at pH4 and incubating at 25°C for 48 hours on a small scale. The control was 
pure KC produced without clay. Data shown represent the mean of a single experiment.  
 
8.1.4. In situ incorporation of clay into KC on a large scale 
 
The synthesis of KC/Clay composites was obtained on a large scale. Fig. 163 

































Figure 163. Images of KC/Exfoliated Cloisite Na+ (a) and KC/Exfoliated SWN (b) 
composites. The composites were produced using 2 OD600 PBS-resuspended IM 
incubated with 75% of the tea broth containing 3 mg/ml of each exfoliated clay 
suspension adjusted subsequently to pH4 for 48 hours at 25°C on a large scale. 
 
The effect of exfoliation of the clay on the mass of KC was investigated on a large 
scale with the results shown in Fig. 164. As seen in Fig. 164, the mass of both 
KC/Exfoliated Cloisite Na+ and KC/Exfoliated SWN increased from 56 grams of 
pure KC to 65% and 82%, respectively. This might indicate successful 
incorporation of the clay inside KC. The mass of wet KC/Non-exfoliated Cloisite 
Na+ was 43 grams. However, KC/Non-exfoliated SWN composite reached 80 
grams after 48 hours.  
a b 






Figure 164. The effect of non-exfoliated and exfoliated Cloisite Na+ and SWN clay 
suspensions on a mass of wet KC. KC was produced using clays at the concentration of 
3 mg/ml, respectively, and 2 OD600 PBS-resuspended IM and 75% the tea broth at pH4 
and incubating at 25°C for 48 hours on a large scale. The control was pure KC produced 
without clay. Data shown represent the mean of a single experiment. 
 
8.1.4.1. UV-VIS-NIR analysis of synthesised KC/Clay composites 
 
KC/Cloisite Na+ and KC/SWN composites, which were produced with exfoliated 
clay, were analysed using UV-VIS-NIR spectroscopy with the results shown in 
Figs. 165-166. According to Fig. 165, KC/SWN composites had predominantly 
KC pattern.  The presence of the clay at 211 nm wavelength was not detected in 
the composites. However, KC/SWN composite showed the peak for SWN at 
around 1167 nm in NIR region. In addition, UV-VIS spectrum of pure KC was 
similar to pure BC that was shown in Fig. 56. According to Figs. 57 and 165, pure 






































Figure 165. UV-VIS-NIR spectra of pure KC, SWN powder and KC/SWN composite. 
 
According to Fig. 166, KC/Cloisite Na+ composites had predominantly KC pattern 
with a broad peak around 1400 nm, which might indicate both KC and the clay. 
The clay might be present inside KC, but due to reflective operation of the 
equipment, such characteristic peaks of the clay were not detected. 
 
 

























































8.1.4.2. Antibacterial activity of synthesised KC/Clay composites 
 
Antibacterial properties of KC/Cloisite Na+ and KC/SWN composites prepared 
using the exfoliated by the Tefal blender clay suspensions were tested against 
MRSA, E. coli and P. aeruginosa, respectively, as described in Section 2.9.3. The 
control represented PBS-resuspended bacteria without any treatment that was 
placed on the surface of the empty petri dish without agar and covered with a 
sterile lid. Fig. 167 shows antibacterial activity of the composites against MRSA. 
As seen in Fig. 167, pure KC increased the growth of MRSA to 227% of control 
values, whereas KC/Cloisite Na+ and KC/SWN composites reduced the control 
values to 2% and 3%, respectively. This means that pure KC can promote the 
growth of the bacteria in a similar fashion to pure BC. The results indicated that 
clay was successfully incorporated inside the matrix of KC.  
 
 
Figure 167. Antibacterial activity of pure KC, KC/Cloisite Na+ and KC/SWN composites 
against MRSA. The control represented PBS-resuspended MRSA that was inoculated 
on the surface of the empty petri dish without agar and covered with a lid. Bacteria were 
incubated with treatments for 24 hours at 37°C. Data shown represent the mean of three 
























compared to the control. Pure KC and KC/Cloisite Na+ and KC/SWN are significantly 
different from the control with P-values <0.05, <0.01 and <0.01, respectively. 
  
Antibacterial activity of synthesised KC/Clay composites against E. coli is shown 
in Fig. 168. KC/SWN was more effective than KC/Cloisite Na+ and reduced the 
growth of bacteria to 48% of control values. KC/Cloisite Na+ decreased the growth 
of E. coli to 55% of control values. Pure KC slightly increased the bacterial growth 
to 106% of control values.  
 
The antibacterial activity of KC/Cloisite Na+ and KC/SWN composites were 
weaker compare to the in situ synthesised BC/Cloisite Na+ and BC/SWN 
composites, which reduced the growth of E. coli to 14.6% and 16.8% of control 
values, respectively, as shown in Fig. 65. This might be due to not complete 
penetration of clay particles inside KC during the formation.  
 
 
Figure 168. Antibacterial activity of pure KC, KC/Cloisite Na+ and KC/SWN composites 
against E. coli. The control represented PBS-resuspended E. coli that was inoculated on 
the surface of the empty petri dish without any treatment and covered with a lid. The data 
























deviation. The treatments were compared to the control. KC/SWN is significantly 
different from the control (P-value<0.05). 
 
Furthermore, synthesised KC/Clay composites did not show any antibacterial 
activity against P. aeruginosa. As seen in Fig. 169, all three types of tested KC 
materials promoted bacterial growth. Pure KC increased the growth of P. 
aeruginosa to 175% of control values. KC/Cloisite Na+ and KC/SWN composites 




Figure 169. Antibacterial activity of pure KC, KC/Cloisite Na+ and KC/SWN composites 
against P. aeruginosa. The control represented PBS-resuspended P. aeruginosa that 
was inoculated on the surface of the empty petri dish without any treatment and covered 
with a lid. Bacteria were incubated with treatments for 24 hours at 37°C. Data shown 
represent the mean of three independent experiments with error bars of standard 
deviation. The treatments were compared to the control. Pure KC and KC/Cloisite Na+ 

























KC/Cloisite Na+ and KC/SWN composites showed stronger antibacterial activity 
against Gram-positive MRSA than Gram-negative E. coli and P. aeruginosa. This 
might be due to the presence of outer cell wall in Gram-negative bacteria, which 
made it difficult to inhibit. 
 
8.1.5. In situ synthesis of KC/Chitosan using chitosan as the main carbon 
source on a large scale  
 
Another method of in situ synthesis of KC was based on the complete 
replacement of the main carbon source. Glucose was replaced with 0.5 wt.% of 
WA chitosan solution, which was prepared using 10 vol.% of distilled vinegar at 
pH3. IM at concentration of 2 OD600 were incubated in the either modified tea 
broth or distilled water for 48 hours at 25°C. Then, KC/Chitosan was 
characterised using UV-VIS-NIR spectroscopy. The antibacterial activity of the 
material was investigated against MRSA, E. coli and P. aeruginosa, respectively. 
Fig. 170 shows the image of the produced KC/Chitosan.  
 
 
Figure 170. Image of the produced KC/Chitosan using tea. The composite was produced 
using 75% of the tea broth at pH4 containing 0.5 wt.% of WA chitosan as the main carbon 
source and 2 OD600 of IM concentration at 25°C for 48 hours on a large scale. 






KC/Chitosan was then synthesised using sterile distilled water containing 0.5 
wt.% of WA chitosan solution as the main carbon source with 2 OD600 of IM 
concentration for 48 hours at 25°C (Fig. 171). As shown in Figs. 170-171, 
KC/Chitosan formed in distilled water was more robust compared to KC/Chitosan 
synthesised using the tea broth.  
 
 
Figure 171. Image of the produced KC/Chitosan using sterile distilled water. KC/Chitosan 
was produced at pH4 containing 0.5 wt.% of WA chitosan as the main carbon source 
and 2 OD600 of IM concentration at 25°C for 48 hours on a large scale. 
 
The mass of wet KC/Chitosan produced with 75% of tea and sterile distilled water, 
respectively, is shown in Fig. 172. According to Fig. 172, KC/Chitosan 
synthesised with distilled water was heavier with the mass reached 42 grams, 











Figure 172. The mass of wet KC/Chitosan produced with either tea broth or distilled 
water. KC/Chitosan was produced with 75% of the tea broth and sterile distilled water, 
respectively, at pH4 using 0.5 wt.% WA chitosan as the main carbon source and 2 OD600 
of IM concentration at 25°C for 48 hours. Data shown represent the mean of a single 
experiment.  
 
8.1.5.1. UV-VIS-NIR analysis of in situ synthesised KC/Chitosan  
 
KC/Chitosan was analysed using UV-VIS-NIR spectroscopy in order to 
investigate the presence of chitosan. Fig. 173 shows UV-VIS-NIR spectra of pure 
KC, WA chitosan powder and KC/Chitosan. According to Fig. 173, KC/Chitosan 
showed a broad peak around 320-400 nm, which might correspond to 
characteristic peak of chitosan at 325 nm. The peak of chitosan around 1500 nm 
might overlap with the peak of KC, thus it was difficult to detect the presence of 
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Figure 173. UV-VIS-NIR spectra of pure KC, WA chitosan powder and KC/WA chitosan 
composite. 
 
8.1.6. Synthesis of KC/Chitosan/Clay composites  
 
The synthesis of KC/Chitosan/Clay composites started on a small scale by 
adding 3 mg/ml of non-exfoliated and exfoliated Cloisite Na+ and SWN 
suspensions, respectively, into Kombucha inoculum along with 0.5 wt.% of WA 
chitosan as the main carbon source. Fig. 174 shows the effect of exfoliated and 
non-exfoliated clay on the mass of wet KC, respectively. As seen in Fig. 174, the 
mass of wet KC/Chitosan/Clay composites was increased with exfoliated clay 
suspensions. Wet KC/Chitosan/Exfoliated Cloisite Na+ composite had a mass of 
2.38 grams, whereas the mass of KC/Chitosan was 1.2 grams. The mass of 
KC/Chitosan/Non-exfoliated Cloisite Na+ composite was 1.6 grams. As shown in 
Fig. 174, the mass of KC/Chitosan/Exfoliated SWN and KC/Chitosan/Non-




























Figure 174. The mass of wet KC/Chitosan, KC/Chitosan/Cloisite Na+ and 
KC/Chitosan/SWN composites on a small scale. The composites were produced with 
non-exfoliated and exfoliated Cloisite Na+ and SWN clay suspensions at the 
concentration of 3 mg/ml, respectively, using 2 OD600 PBS-resuspended IM, 75% the tea 
broth containing 0.5 wt.% of WA chitosan at pH4 and incubated at 25°C for 48 hours on 
a small scale. Data shown represent the mean of a single experiment. 
 
The mass of KC/Chitosan/Clay composites using exfoliated and non-exfoliated 
clay suspensions, respectively, was obtained on a large scale (Fig. 175). As 
shown in Fig. 175, the mass of the wet KC/Chitosan/Clay composites was heavier 
than KC/Chitosan. The mass of wet KC/Chitosan/Non-exfoliated Cloisite Na+ and 
KC/Chitosan/Non-exfoliated SWN composites was 15.43 and 26.54 grams, 
respectively. The mass of KC/Chitosan/Clay composites produced with exfoliated 
clay suspensions was significantly higher and reached 25.46 grams with Cloisite 
Na+ and 36.57 grams with SWN, respectively. This might indicate that the 
incorporation of the clay was successfully achieved. As shown in Figs. 174-175, 
the exfoliation of the clay affected the formation of KC. Non-exfoliated state of the 

































Figure 175. The mass of wet KC/Chitosan, KC/Chitosan/Cloisite Na+ and 
KC/Chitosan/SWN composites produced on a large scale. The composites with non-
exfoliated and exfoliated Cloisite Na+ and SWN clay suspensions at the concentration of 
3 mg/ml, respectively, using 2 OD600 PBS-resuspended IM, 75% the tea broth containing 
0.5 wt.% of WA chitosan at pH4 and incubated at 25°C for 48 hours on a large scale. 
Data shown present the mean of a single experiment.  
 
8.1.7. Antibacterial activity of synthesised KC/Chitosan and 
KC/Chitosan/Clay composites 
 
The antibacterial activity of KC/Chitosan, KC/Chitosan/Cloisite Na+ and 
KC/Chitosan/SWN composites prepared with exfoliated clay suspensions were 
investigated against MRSA, E. coli and P. aeruginosa, respectively, with the 
results shown in Figs. 176-179. As seen in Fig. 176, pure KC increased the 
growth of MRSA to 302% of control values, whereas KC/Chitosan decreased the 
growth of the bacteria to 53%. The growth of MRSA was reduced to 12.7% and 





































Figure 176. Antibacterial activity of synthesised pure KC, KC/Chitosan, KC/Cloisite Na+ 
and KC/SWN composites against MRSA. The control represented PBS-resuspended 
MRSA that was inoculated on the surface of the empty petri dish without any treatment 
and covered with a lid. Bacteria were incubated with treatments for 24 hours at 37°C. 
Data shown represent the mean of three independent experiments with error bars of 
standard deviation. The treatments were compared to the control. KC/Chitosan/Cloisite 
Na+ and KC/Chitosan/SWN are significantly different from the control (P-value<0.05). 
 
Similarly, pure KC increased the growth of E. coli to 183% of control values (Fig. 
177). KC/Chitosan reduced the growth of bacteria to 73% of control values. This 
indicated the presence of chitosan inside KC/Chitosan composite. Furthermore, 
KC/Chitosan/Cloisite Na+ and KC/Chitosan/SWN composites decreased the 
growth of E. coli to 54% and 46% of control values, respectively. This means that 
introducing exfoliated clay to already antibacterial material resulted in increased 































Figure 177. Antibacterial activity of synthesised pure KC, KC/Chitosan, KC/Cloisite Na+ 
and KC/SWN composites against E. coli. The control represented PBS-resuspended E. 
coli that was inoculated on the surface of the empty petri dish without agar and covered 
with a lid. Bacteria were incubated with treatments for 24 hours at 37°C. Data shown 
represent the mean of three independent experiments with error bars of standard 
deviation. The treatment outcomes are not significantly different in comparison with the 
control. 
 
As shown in Fig. 178, only KC/Chitosan/Cloisite Na+ showed antibacterial activity 
against P. aeruginosa, the growth of which was reduced to 78% from control 
values. Pure KC, KC/Chitosan and KC/Chitosan/SWN increased the growth of P. 



































Figure 178. Antibacterial activity of synthesised pure KC, KC/Chitosan, KC/Cloisite Na+ 
and KC/SWN composites against P. aeruginosa. The control represented PBS-
resuspended P. aeruginosa that was inoculated on the surface of the empty petri dish 
without agar and covered with a lid. Bacteria were incubated with treatments for 24 hours 
at 37°C. Data shown represent the mean of three independent experiments with error 
bars of standard deviation. Pure KC and KC/Chitosan/Cloisite Na+ are significantly 
different from the control (P-value<0.05).  
 
8.2.  Discussion 
 
It was possible to synthesise KC using IM from the SCOBY. The parameters for 
the growth of KC were optimised on both small and large scales. The greater 
mass of wet KC at a higher optical density of IM might be due to a large number 
of bacteria, which were responsible for the formation of cellulose. It was possible 
to obtain KC just in 48 hours using 2 OD600, whereas, according to the literature, 
the formation of the pellicle requires approximately 7 to 21 days by using 
SCOBY[313]. This might be due to the novelty of the method used in the current 


























method of isolation of microorganisms might be beneficial for the synthesis of KC 
in a relatively short period of time. 
 
It has been reported that 25°C was the ideal temperature for the synthesis of 
Kombucha[312]. Similar to the formation of the conventional BC, the temperature 
above 37°C could lead to inhibition of the growth of acetic acid bacteria through 
the lack of bacterial replication due to the damaging of cell proteins[217]. 
Furthermore, KC did not grow at pH1. The mass of KC produced was lower at 
pH2 and 3 than at pH4. This might be due to the decrease in pH during cultivation. 
Acetic acid bacteria secrete gluconic acid and 5-keto-gluconic acids, which result 
in the decrease of pH[230]. An excessive amount of acidity could inhibit the growth 
of bacteria. Thus, the inoculation of bacteria at pH1 could lead to the death of 
bacteria. In addition, a possible reason behind the lower mass of KC obtained 
from the stock of the tea broth might be that the stock was too concentrated, 
which slightly inhibited the growth of the bacteria. 
 
The effect of the exfoliation state of the clay was similar to the results obtained 
with the original BC in Section 3.1.10. As was discussed in Section 3.2.3, a 
possible reason behind the better growth of the cellulose in the exfoliated SWN 
clay environment could be a gel formation of non-exfoliated SWN. The viscosity 
increase during gel formation might restrict the oxygen supply for the bacteria, 
which were responsible for the formation of KC. Non-exfoliated particle 
aggregations could also block the access to oxygen supply and, therefore, lead 
to the reduction in the growth of the bacteria. Moreover, as synthesis of KC was 
performed at low pH, the number of aggregations of the clay might increase in 
the acidic environment.  
 
The growth of KC/Chitosan was affected by the tea broth, whereas the mass of 
KC/Chitosan was heavier in distilled water. Black tea has tannic acid, which could 
be used as a cross-linker of chitosan. It has been reported that stirring 1 wt.% 
chitosan with 2, 5, 10 and 20 vol.% of tannic acid led to the formation of hydrogel 





due to a reaction between the amine groups of chitosan and OH groups of tannic 
acid[314]. This might make chitosan less amenable for bacteria to consume, and, 
therefore, the formation of KC/Chitosan decreased. 
 
Regarding the antibacterial activity of synthesised KC-based materials, due to 
exposure of Na+ ions during the exfoliation process, the exfoliated clay might be 
able to inhibit the growth of the bacteria by binding to the negatively charged 
components of the cell wall (Section 3.2.4.). The antibacterial activity of 
KC/Cloisite Na+ and KC/SWN composites were similar to the synthesised in situ 
BC/Cloisite Na+ and BC/SWN composites, respectively.  
 
Therefore, it was possible to synthesise KC from IM of SCOBY on both small and 
large scales. Similar to the conventional BC, pure KC does not possess any 
antibacterial activity; However, antibacterial activity can be introduced by in situ 
modification using exfoliated Cloisite Na+ and SWN as well as chitosan. KC can 
be synthesised with chitosan as the main carbon source. KC/Chitosan and 
KC/Chitosan/Clay composites showed stronger antibacterial activity against 
MRSA than E. coli. The incorporation of exfoliated clay into KC/Chitosan material 
resulted in improved antibacterial properties. These findings strongly suggest the 
potential for using KC with incorporated clay and chitosan as a natural and low-
cost antibacterial wound healing system. 
 





Chapter 9. Final discussion 
 
9.1. Summary of mechanisms of antibacterial action 
 
The main mechanism for the antibacterial action of the materials synthesised in 
the current study was based on the electrostatic interactions between positively 
charged clay or chitosan and the negatively charged bacterial cell wall. Cell walls 
of Gram-positive and Gram-negative bacteria are negatively charged due to the 
presence of teichoic acids and LPS, respectively (Section 1.2.3.1)[132, 151]. 
Whereas, organoclay and chitosan have positively charged QAC surfactants and 
amine groups, respectively[151, 250, 256]. Furthermore, natural clay showed the 
antibacterial activity in its exfoliated state. As was discussed in Section 3.2.4., 
this might be due to the release of Na+ cations, which were hidden between layers 
of Cloisite Na+ clay[233]. Thereby, such an electrostatic interaction could lead to 
permeability and disruption of a cell wall, leakage of vital cell content and the 
possible penetration of positively charged components of either clay or chitosan 
through the bacterial cell wall followed by binding to the negatively charged 
DNA[254]. 
 
However, the mechanism of antibacterial action of clay and chitosan might 
depend on a number of factors such as a chemical composition of organoclay 
surfactants, concentration of positively charged compounds, MW and DDA of 
chitosan, pH of the environment, etc. For instance, C16 hydrophobic tail of QAC 
was found to be more effective against Gram-negative bacteria than shorter-
chain compounds due to the stronger interaction of C16 with the fatty acid portion 
of Lipid A[252]. It has been reported that monoalkyl QAC may bind to bacterial 
surfaces through an ionic interaction of the cationic head groups and hydrophobic 
connection via hydrophobic tails that could be inserted into lipid bilayers[252]. This 
can cause re-arrangement of a bacterial cell wall and subsequent leakage of 
intracellular constituents[251]. Furthermore, low concentrations of QAC could lead 





to damage of the bacterial cell wall, whereas high concentrations of QAC might 
cause coagulation of the cytoplasm possibly through denaturation of proteins[98].  
 
Regarding the antibacterial action of chitosan, amine groups could interact with 
LPS and teichoic acids causing increased permeability of the bacterial cell 
wall[132]. For instance, an interaction of chitosan and the outer membrane of 
Gram-negative bacteria may result in vesicle formation that causes disruption of 
the outer membrane and the loss of its barrier properties[53, 152]. Chitosan could 
bind to metal ions such as Ni2+, Fe2+, or Cu2+ that are present in the cell wall and 
play an essential role in viability[132]. The ability of chitosan to penetrate bacterial 
cell walls might depend on DDA and MW. Increased DDA has been reported to 
give increased antimicrobial activity due to the presence of free amine groups[132]. 
Chitosan with high DDA showed quicker ability to bind and form a stable complex 
with DNA[156]. An interaction of chitosan and DNA could lead to DNA 
dehydration[156]. Furthermore, the MW of chitosan may also affect its antibacterial 
activity. As MW decreases chitosan could pass through the channels into a 
bacterial cell[161, 166]. Low molecular weight chitosan might also affect DNA and 
inhibit RNA replication[46, 132, 162]. Whereas, high MW of chitosan may form a 
dense polymer film on the cell surface and prevent entry of nutrients and 
oxygen[46]. This might inhibit the growth of aerobic bacteria[46]. In addition, it has 
been found that Gram-positive bacteria could be more sensitive to antibacterial 
agents than Gram-negative bacteria (Section 1.2.3.2)[251].  
 
9.2. Ex situ and in situ synthesised materials and their significance for 
antibacterial action 
 
The antibacterial activity of all synthesised materials is presented in Table 4.  
 
Table 4. The antibacterial activity of all tested materials against MRSA, E. coli and P. 
aeruginosa. The bold data represents bacterial growth which was less than 1% of control 
values. 





Materials Growth of bacteria,  
% of the control values 
MRSA E. coli P. aeruginosa 
Pure BC 400 261 300 
Pure KC 227 183 126.65 
Ox BC 378 163 N/A 
BC treated with acetone 190 525 45 
BC treated with 0.1M of acetic acid 56 98 192 
BC/Cloisite Na+ in situ 1.4 14.6 N/A 
KC/Cloisite Na+ in situ 2.17 55.09 172.54 
BC/Cloisite Na+ ex situ 40 15.7 130 
BC/Cloisite SWN in situ 4.8 16.8 113 
KC/SWN in situ 3.03 48.42 N/A 
BC/Cloisite SWN ex situ 6.53 13.7 58.27 
BC/Cloisite 10A ex situ 0.14 0.2 1.1 
BC/Cloisite 15A ex situ 1.86 0.3 1.6 
BC/Cloisite 20A ex situ 45 267 1.4 
BC/Cloisite 30B ex situ 0.012 0.1 0.4 
BC/Cloisite 93A ex situ 69 101 123 
BC/chitosan in situ <0.1 40 337 
BC-CH in situ 0.003 1.6 N/A 
KC/Chitosan in situ 53.51 73.47 N/A 
KC/Chitosan/Cloisite Na+ in situ 12.75 54.06 78.49 
KC/Chitosan/SWN in situ 3.74 48.4 160.61 
BC/WA chitosan ex situ (immersion) 94 10 150 
BC/Low MW chitosan ex situ (immersion) 85 101 67 
BC/WA chitosan ex situ (immersion) 73 304 260 
BC/WA chitosan ex situ (pumped) 0.3 0.002 0.85 
BC/Low MW chitosan ex situ (pumped) 0.8 0.006 1 
BC/Medium MW chitosan ex situ (pumped) 0.7 0.58 1.8 
Ox BC/WA chitosan ex situ (pumped) 0.0009 2.05 0.13 
Ox BC/Low MW chitosan ex situ (pumped) 0.005 3.05 0.005 
Ox BC/Medium MW chitosan ex situ 
(pumped) 
0.6 1.8 2.77 
BC/CH hybrid 9.5 60.22 128.66 
BC/CH/Cloisite Na+ composite 0.0017 0.58 93.11 
 
As shown in Table 4, the strongest antibacterial activity against MRSA was 
exhibited by BC/Cloisite 10A, BC/Cloisite 30B, all non-ox and ox BC/chitosan 
composites synthesised ex situ using the vacuum self-assembly method, 





BC/CH/Cloisite Na+ composites as well as BC-CH. E. coli was inhibited the most 
by using BC/Cloisite 10A, BC/Cloisite 15A, BC/Cloisite 30B, non-ox BC/chitosan 
composites produced ex situ by using the vacuum self-assembly method and 
BC/CH/Cloisite Na+ composites. In addition, BC/Cloisite 30B, non-ox and ox 
BC/WA chitosan and ox BC/Low MW chitosan composites, which were modified 
ex situ using the vacuum self-assembly method, inhibited the growth of P. 
aeruginosa the most.  
 
Nonetheless, BC-based composites synthesised ex situ showed higher 
antibacterial activity than materials produced in situ. The antibacterial activity of 
BC/clay composites synthesised ex situ could depend on either Na+ cations or 
QAC. The antibacterial activity of organoclay, mainly Cloisite 10A and Cloisite 
30B, was stronger than Cloisite Na+ and SWN clay without surfactants. This might 
be due to both a positive charge and hydrophobic nature of QAC in 
organoclay[272]. The organoclays were also more effective against P. aeruginosa 
compared to Cloisite Na+ and SWN clay. However, the antibacterial activity of 
organoclay was associated with the QAC and leaching behaviour, whereas the 
antibacterial activity of the natural clay was possibly due to the release of Na+ 
cations in the exfoliated state. BC/SWN, however, showed antibacterial activity 
against the three tested organisms and especially strong inhibition of growth was 
observed with MRSA. This might be due to the low aspect ratio, which allowed 
better dispersion within the BC matrix and, therefore, interaction with the bacterial 
cell wall with subsequent penetration of SWN inside the bacteria. Moreover, the 
stronger antibacterial activity of SWN against MRSA might be because there is a 
single cell wall in Gram-positive bacteria, whereas Gram-negative bacteria have 
an additional outer membrane[273]. Even though BC/clay composites produced ex 
situ showed stronger antibacterial activity than BC/clay composites synthesised 
in situ, the attachment of the additives might not be permanent. The exception 
could be BC/CH/ Cloisite Na+ composite that was synthesised by the chemical 
attachment of chitosan to BC. In other cases, the leaching activity of the additive 





materials such as organoclay might raise health and safety concerns due to 
cytotoxicity to fibroblasts. 
 
Antibacterial activity was introduced to BC by incorporation of chitosan both in 
situ and ex situ. BC-CH showed stronger antibacterial activity against MRSA than 
E. coli. Chitosan may not cross the outer membrane of Gram-negative bacteria, 
but could be able to bind to the negatively charged LPS in E. coli [168]. P. 
aeruginosa showed high resistance to the BC/chitosan composite. This might be 
due to the stringer outer membrane of those bacteria, which have different porins 
from E. coli. 
 
BC composites synthesised ex situ via immersion showed lower antibacterial 
activity compared to the composites produced through vacuum self-assembly. Of 
all types of synthesized composites, BC/WA chitosan possessed the strongest 
antibacterial activity against MRSA, E. coli and P. aeruginosa. This might be due 
to differences in both MW and DDA. WA chitosan had the highest DDA of 90%, 
whereas WA and low MW chitosan had DDA of 75-85%, respectively. It has been 
reported elsewhere that increasing DDA of chitosan from 75% to 95% leads to 
increased antimicrobial activity against S. aureus and E. coli through nucleotide 
leakage[158]. The strong antibacterial activity of BC/chitosan composites 
synthesised through the vacuum self-assembly method suggests that this 
technique could be considered more successful than immersion. A major 
drawback of BC/chitosan synthesised ex situ is the ability of chitosan to leach in 
an acidic environment. However, BC-CH synthesised in situ could not be 
dissolved in acid and, therefore, might overcome the issues associated with the 
leaching behaviour of chitosan. 
 
BC/CH and BC/CH/Cloisite Na+ were more effective against Gram-positive 
MRSA than Gram-negative E. coli and P. aeruginosa. BC/CH/Cloisite Na+ 
showed stronger antibacterial activity than BC/CH hybrid. A possible reason 
behind this could be the cross-linking reaction that made the amine group hidden 





and ineffective. It has been reported that genipin can decrease the number of 
residual amine groups[300]. However, a stronger antibacterial activity of the hybrid 
was obtained after introducing Cloisite Na+ clay. Some amine groups might attach 
to the negatively charged surface of the clay and not participate in the cross-
linking reaction. This could have resulted in the expansion of free movement of 
the intercalated amine groups and lead to enhanced antibacterial properties.  
 
9.3. Antibacterial correlation of materials synthesised to other 
antibacterial agents 
 
As was described in Section 1.2.3.2., different antibacterial materials might affect 
a bacterial growth through electrostatic interactions and/or inhibition of nucleic 
acids’ activity.  Nanoparticles such as silver (Ag), gold (Au), zinc oxide (ZnO), 
silica (SiO2), titanium dioxide (TiO2), alumina (Al2O3), and iron oxides (Fe3O4, 
Fe2O3) have been used elsewhere as antibacterial agents[22, 42, 47, 67, 69, 315, 317]. 
For instance, copper is a broad-spectrum biocide and can inhibit the growth of 
bacteria such as Salmonella typhimurium (S. typhimurium), Listeria 
monocytogenes (L. monocytogenes), Salmonella enterica (S. 
enterica) and Campylobacter jejuni (C. jejuni) fungi[42].  Furthermore, silver 
nanoparticles showed antibacterial activity against pathogens such as S. aureus, 
Bacillus subtilis (B. subtilis), Klebsiella pneumoniae (K. pneumoniae), E. coli and 
P. aeruginosa[19, 22, 41, 69, 315, 317]. The mode of antibacterial action of this variety of 
agents is similar to the mechanisms of both organoclay and chitosan used in the 
current study. The mechanism of antibacterial action of the materials used is 
summarised in Section 9.1. Regarding other antibacterial agents, the mechanism 
of silver ions is also based on the binding of silver to the bacterial cell wall, 
damaging proteins or altering bacterial function as well as interacting with thiol 
groups on enzymes and proteins; thus, affecting bacterial cells from inside[61]. 
Moreover, silver ions may inhibit the growth of both S. aureus and E. coli by 
binding to functional groups of enzymes, causing the release of K+ ions from 
bacteria[62]. In addition, silver ions can penetrate the cell wall of Gram-positive 





bacteria and bind to DNA, which then loses its replication ability, and to cellular 
proteins leading to protein denaturation[55]. Furthermore, TiO2 nanoparticles 
might adhere to the surface of bacterial cells and produce ROS followed by 
damaging the structure, composition of the cell wall and leakage of cellular 
contents[47]. TiO2 nanoparticles could also penetrate the cell wall of bacteria and 
affect DNA degeneration, fragmentation and compression[47].  
 
The antibacterial activity of nanoparticles might depend on their size, surface 
morphology, zeta potential and pH of the environment[47]. Metal oxide 
nanoparticles can show high stability over a range of pH. For instance, one of the 
main advantages of ZnO is antibacterial activity at pH7[68]. The shape of ZnO 
nanoparticles can also influence their antibacterial mechanism. For example, 
rods and wire shape nanoparticles might penetrate bacterial cell walls more 
easily than spherical ZnO nanoparticles, whereas flower-shaped nanoparticles 
showed stronger antibacterial activity against both E. coli and S. aureus than 
spherical nanoparticles[68]. The size of particles could also play a crucial role in 
antibacterial activity. It has been reported elsewhere that smaller size ZnO 
nanoparticles (less than 10 nm) showed stronger antibacterial activity than larger 
particles against S. aureus, E. coli, and B. subtilis[69]. Furthermore, small size 
silver nanoparticles (<10 nm) might pass through the pores in a cell membrane[63]. 
In addition, exfoliation of clay to nanoparticles could improve their antibacterial 
activity against both Gram-positive and Gram-negative bacteria. 
 
Antibacterial agents might be combined with other materials in order to enhance 
their antibacterial activity. For example, the antibacterial activity of NaMMT has 
been enhanced by replacing exchangeable Na+ cations with silver ions between 
the layers of MMT clay[318]. It has been observed that the growth of anaerobic 
mesophilic bacteria has been decreased from the control by 6.7 log CFU/g to 
6.3 log CFU/g using both 10 and 15 mg of AgMMT, whereas 20 mg of AgMMT 
reduced bacterial growth to 4.5 log CFU/g of control values[318]. Furthermore, it 
has been reported that the antibacterial activity of TiO2/chitosan nanocomposite 





was enhanced by introducing chitosan, which is non-toxic to mammals[316]. 
Therefore, this nanocomposite might also be an optimal material for bone 
regeneration and reconstruction due to its biocompatible nature[316].  
 
In order to introduce antibacterial properties to pure BC, different nanoparticles 
could be incorporated into its matrix. For example, antimicrobial properties have 
been introduced into BC by incorporating silver nanoparticles through 
immersion[63]. The material produced showed antibacterial activity against both 
E. coli and S. aureus[63]. Furthermore, BC/silver composites, which have been 
synthesised through immersion elsewhere, inhibited E. coli and S. aureus by 
100% and 99.99%, respectively[64]. Moreover, BC/sodium alginate with silver 
sulfadiazine composites showed high antimicrobial properties against both E. coli 
and S. aureus bacteria as well as Candida albicans (C. albicans) yeast[65]. The 
bacterial cell wall showed a significant increase in permeability, incapability of 
regulating transport through the wall followed by cell death[47, 66]. It has been 
reported elsewhere that BC/Ag composites, which have been synthesised 
through immersion of pure BC into 10−2 M suspension of AgNO3 overnight, 
reduced the control values of E. coli from 0.75x108 CFU/ml to approximately 
0.01x108 CFU/ml[276]. Moreover, BC/Ag composites have been placed either in 
the medium containing bacteria or on the top of the LB plate for 24 hours. The 
zones of inhibition of S. aureus by Ag/BC composites have been reported to be 
6.5 nm due to the release of Ag+ ions from the BC[276]. Furthermore, it has been 
stated elsewhere that BC/Ag composite showed antibacterial activity greater than 
99.99% against both E. coli and S. aureus[29, 319]. It has been observed that BC 
synthesised with copper and copper alloy (CuxOy) nanoparticles by immersion 
possessed antimicrobial activity against E. coli, S. aureus, S. enterica and C. 
albicans[42]. Moreover, it has been shown elsewhere that cellulose films coated 
with 0.046M Cu/NH3 solution reduced the growth of both S. aureus and E. coli by 
50%, respectively, within an hour of incubation[278]. Therefore, an antibacterial 
activity of BC/nanoparticle composites could depend on a leaching behaviour in 
a similar manner as BC/organoclay synthesised in the current study. In addition, 





the immersion technique used in the current study showed that the incorporation 
of chitosan was uneven, whereas the BC/chitosan composites synthesised 
through the vacuum self-assembly technique showed stronger antibacterial 
activity than pure chitosan against MRSA, E. coli and P. aeruginosa. 
 
The main advantages of inorganic oxides are their stability, robustness, and long 
shelf life compared to organic antimicrobial agents[19, 69, 315]. However, most of 
inorganic oxides could be toxic to mammalian cells. For instance, it has been 
found that TiO2 can penetrate the membrane of mammalian cells and could 
present in the plasma membrane of epithelial cells after 10 days of exposure[316]. 
It has been reported that ZnO could be toxic to mammals and may affect both Fe 
and glucose transports in Caco-2 and HT29-MTX cells[316]. In addition, 
organoclay with a strong ability to leach could also exhibit mammalian 
cytotoxicity[102, 104], whereas the natural clay and chitosan did not show cytotoxic 
behaviour to 3t3 cells in the current study.  
 
Furthermore, there are a number of antibiotics that are used against a variety of 
bacteria. For instance, ceftaroline could inhibit the growth of both Gram-positive 
bacteria such as Streptococcus pneumoniae, S. aureus and Streptococcus 
pyogenes as well as Gram-negative species such as Moraxella catarrhalis and 
Haemophilus influenzae[320].The mechanism of β-lactam derivatives is based on 
the interaction of antibiotics and the peptidoglycan enzymes[58]. Both 
glycopeptide and β-lactam antibiotics can interfere with bacterial cell wall 
synthesis by either mimicking the peptide stem of peptidoglycan subunits 
followed by blocking the action of periplasmic transpeptidase enzymes, which are 
essential for forming and modifying the cell wall or by binding to the peptide stem 
of precursor molecules and, subsequently, preventing their incorporation into the 
cell wall[321]. In Gram-positive bacteria, β-lactam antibiotics may disrupt the 
peptidoglycan layer followed by the release of teichoic acids[50-52, 59]. Furthermore, 
antibiotics such as aminoglycosides, tetracyclines and macrolides could pass 
through porins in Gram-negative bacteria[321]. Inside a bacterial cell, antibiotics 





such as glycopeptides, oxazolidinones, aminoglycosides, pleuromutilins, 
tetracyclines and macrolides may also bind to RNA[320].  
 
However, the main issue is the development of resistance of bacteria to different 
antibiotics.  Organisms that have shown resistance to antibiotics through biofilm 
production are S. aureus, P. aeruginosa, Escherichia coli, Pseudomonas 
pseudomallei, and Streptococcus sanguis[320]. Such a formation of biofilm may 
protect bacteria from different antibiotic effects. However, nanoparticles have 
been found to inhibit a biofilm formation. It has been reported that nanoparticles 
might be able to prevent the formation of biofilm of Acinetobacter baumannii, P. 
aeruginosa and MRSA[320].  
 
9.4. Mechanical properties of the materials synthesised 
 
BC exhibits high porosity, water holding and release capacities as well as 
elasticity[3, 15]. Mechanical properties of BC could be further reinforced via the 
incorporation of different materials, in order to improve thermostability, barrier 
and mechanical properties of BC such as strength and toughness, NaMMT 
particles have been introduced to a matrix elsewhere[112, 113, 118]. Such an 
incorporation of NaMMT clay into BC could restrict the mobility of the polymer 
chains and, therefore, increase the toughness and mechanical strength of the 
final BC/NaMMT composite[112]. One study has reported that BC/NaMMT 
composites, which were synthesised by immersion of pure BC into 1 wt.% and 2 
wt.% of exfoliated NaMMT suspensions, respectively, showed an increase in the 
tensile strength from 151.3 MPa for pure BC to 191.2 and 209.6 MPa, 
respectively[112]. Whereas, the strain of BC/NaMMT composites decreased from 
6.66% of pure BC to 4.51 and 4.45 using 1 wt.% and 2 wt.% of NaMMT 
suspensions, respectively[112]. Moreover, the incorporation of clay particles may 
reduce BC porosity, which then leads to a denser and more compact matrix of 
BC/NaMMT composites[29, 112, 113]. This might be due to penetration of 
nanoparticles into pores of the BC matrix and to BC fibres. Furthermore, it has 





been stated that water holding capacities of BC increased from the original 692% 
to 1923, 2653 and 3460% using 0.5 wt.%, 1 wt.% and 2 wt.% of NaMMT clay, 
respectively[325]. Such an increase of water holding capacity might be due to the 
organophilic nature of NaMMT[325]. 
 
Moreover, the fibres of BC could become thicker when they are coated with high 
MW chitosan[138]. This might lead to a decrease in the elastic modulus[138]. For 
instance, elasticity of pure BC decreased from 6 GPa to 5.2 GPa in the presence 
of 0.75 wt.% (MW of 80kDA) chitosan[180, 323]. The addition of a high concentration 
of chitosan to pure BC could lead to a decrease in the tensile strength of the final 
composite[280]. It has been reported that an increase in concentration of low MW 
chitosan from 12 wt.% to 45 wt.% led to a decrease in the tensile strength from 
160MPa (pure BC) to 130 MPa and 54MPa of final BC/chitosan composites, 
respectively[322]. In another study, the tensile strength of a BC/chitosan composite 
reduced to 82 MPa[180]. This might be due to stronger intermolecular interactions 
between OH groups of BC and OH and NH2 groups of chitosan. However, the 
concentration of 0.5 wt.% of chitosan used in the current study might not be 
enough to decrease the tensile strength significantly. In addition, the tensile 
strength of ox BC was reported to be 30% lower than pure BC[292]. This might be 
due to a reduction of interfibrillar interaction caused by the insertion of two 
additional aldehyde groups. 
 
9.4.1. O2 diffusion through BC/clay and BC/chitosan composites 
 
Incorporation of different materials into a matrix of BC might cause an increase 
in barrier properties of the final composite. Such barrier properties of BC can be 
enhanced by the incorporation of clay particles that have a sufficient aspect ratio 
to be able to alter the diffusion path of gas molecules that penetrate the matrix[323]. 
The main challenge is to obtain an exfoliation and effective dispersion of clay 
particles[323]. The presence of exfoliated nanoparticles may slow down the 
diffusion of gas molecules and increase tortuosity[323]. An increase in tortuosity 





could lead to an extended travelling pathway of diffused gas through the BC 
matrix[323]. In addition, the incorporation of clay particles into the matrix of BC may 
result in a decrease in the available free volume for gas diffusion[324]. BC/NaMMT 
composites have been prepared elsewhere by adding 0.5 wt.%, 1 wt.% and 2 
wt.% of dispersed NaMMT suspensions, which were exfoliated using ultrasound 
at an amplitude of 20% for 60 minutes, into HS medium and incubated for 13 
days at 30ºC[325]. It was reported that the porosity of BC loaded with 0.5 wt.%, 1 
wt.% and 2 wt.% of NaMMT decreased from 12% to 11.8, 9.8 and 6.3%, 
respectively[325]. This means that MMT clay particles can be captured inside the 
matrix of BC and, subsequently, result in a compact structure of BC[325]. In 
addition, it has been observed elsewhere that the oxygen permeability of 
polypropylene decreased from around 56% to 27% by adding 15 wt.% of Cloisite 
20A organoclay[326]. Therefore, the incorporation of MMT clay might lead to a 
reduction in oxygen permeability. However, the concentrations of both Cloisite 
Na+ and SWN suspensions used in the current study to synthesise BC/clay 
composites were not higher than 0.6 wt.%. This concentration might not 
dramatically affect the porosity of BC/clay composites.  
 
Furthermore, it has been observed that the porosity of BC/chitosan composite, 
which has been prepared ex situ, was 80 ± 1% and 74 ± 2% using 1.5 wt.% and 
2 wt.% of chitosan, respectively[327]. The diameter of pores in BC/chitosan 
composite prepared using 1.5 and 2 wt.% of chitosan was found to be 2.5 ± 1 μm 
and 1.4 ± 1 μm, respectively[327]. Therefore, the incorporation of chitosan into the 
BC matrix resulted in the formation of a more compact structure of BC with a 
lower porosity, which could lead to a lower O2 permeability. The results presented 
in Fig. 129 showed that the fibres of the BC/WA chitosan composite synthesised 
ex situ through the vacuum self-assembly technique were coated in chitosan, 
which subsequently might result in a decrease in pore size. However, as seen in 
Fig. 110, BC-CH had a porous structure similar to pure BC. This means that 
porosity of BC-CH may not be greatly affected. 
 





Regarding ox BC, the oxidation could lead to a high aggregation of nanofibrils. 
The diameter of pure non-ox BC fibres is about 8-100 nm, whereas the oxidation 
of BC led to a compact BC matrix with the width of fibres being 140-300 nm[1, 291, 
292]. It has been stated elsewhere that the porosity of ox BC was reduced by 
36%[292]. Furthermore, the oxidation caused in the shortening of BC fibrils[292].  
 
To summarise, mechanical properties of pure BC could be increased by 
incorporation of exfoliated clay that might be beneficial in applications such as 
food packaging and bone regeneration. On the other hand, the incorporation of 
chitosan into ox BC might lead to both a decrease in mechanical strength and 
reduced porosity. A reduction in a porosity might influence the diffusion of oxygen 
though the gel structures. However, a decrease in porosity might result in an 
increase in water release capacity. Furthermore, porosity might not be 
significantly decreased in BC-CH due to similarity in structures of both pure BC 
and BC-CH. This means that water holding capacity might be similar for both pure 
BC and BC-CH. In addition, BC/clay composites synthesised in situ using a 
concentration of 0.3 wt.% of exfoliated clay might exhibit increased mechanical 
strength without affecting the diffusion of oxygen. Therefore, BC/clay composites 
and BC-CH synthesised in situ could be beneficial materials for wound healing 









Chapter 10. Conclusion 
 
Significant findings were obtained during this research. Firstly, natural Cloisite 
Na+ and synthetic SWN with antibacterial activity at the exfoliated state, 
respectively, were identified. The further incorporation of these exfoliated clay 
into BC let to the final BC/clay composite exhibiting antimicrobial properties 
against both MRSA and E. coli.  
 
Secondly, the novel BC-based material, which was named bacterial chitosan 
(BC-CH), was developed from chitosan using bacteria as template to produce a 
new material that has effective antimicrobial properties against MRSA and E. coli 
but cannot be dissolved in acid. This attribute can solve the problem associated 
with using chitosan in antibacterial applications due to solubility in acidic 
environment. It could be ideal for not only wound healing but also future textile 
applications. 
 
The third major finding was the enhancement of the antibacterial activity of 
BC/chitosan hybrid gels by using the exfoliated Cloisite Na+ clay. These findings 
are novel and based on 100% natural materials that are both non-toxic for 
mammalian cells and effective against MRSA and E. coli. The non-biocidal 
leaching behaviour of these new materials will widen the application of BC in 
medical, food and drink sectors.  
 
Furthermore, antibacterial activity was provided to KC using natural biocides. 
This demonstrates that the new materials can be produced in domestic 
environments, which may offer potential for future commercialisation and the 
creation of new industries. 
 
There were other results obtained involving the clay with traditional surfactants 
as biocides as well as micro-formed clay. Although some of synthesised materials 
were effective in inhibiting the growth of bacteria, they may have potential 





concerns on health and safety due to the structure of the surfactant and biocidal 
leaching. Therefore, these developments were less important in comparison to 
those three major findings. In addition, the work provided a solid fundamental 















Chapter 11. Future work 
 
The characterisation of the synthesised in situ BC/clay composites should be 
continued. In order to completely investigate the penetration of clay inside the 
matrix, SEM, FT-IR and X-ray analysis of the composite may be obtained[325]. The 
content of incorporated clay inside the matrix of BC could be measured using 
thermogravimetric analysis (TGA). TGA heats a sample and measures the 
changes in weight of as a function of temperature and time[328]. The 
crystallographic structure of the composite needs to be obtained by differential 
scanning calorimetry (DSC), which measures the heat flow during thermal 
changes as a function of temperature and time[328].  
 
The characterisation of BC-CH should be continued. Firstly, the nature of fibres 
produced by the bacteria using chitosan as the main carbon source needs to be 
investigated. The consumption of chitosan followed by the production of the fibres 
by the bacteria might lead to a presence of chitosan in the chemical structure of 
the final material. Atomic force and confocal microscopies could offer a better 
understanding of the structure of the material.  The characterisation of BC-CH 
might also be taken further in an analysis of pore size and size distribution inside 
the cellulose using the equipment such as Quontochrome.  
 
The mechanism behind the antibacterial activity of exfoliated clay could be 
analysed, because non-exfoliated clay did not show any antibacterial activity. 
Such an investigation could include the observation of bacteria under clay 
treatment using SEM[325]. If the inhibition is caused by dehydration, the cell 
membrane would appear shrunken. In addition, the binding of the clay to the 
bacterial cell wall or even penetration of particles inside the cell can be 
investigated using either atomic or confocal force microscopies.  In addition, if 
antibacterial activity of exfoliated clay and chitosan is the result of binding to 
bacterial cell wall, the lysis, which is the breaking down of a cell wall, might be 
possible to detect by DNA release[329].  





In order to identify changes in cellular proteins and obtain insight into cellular 
signals, a proteomic approach could be carried out. The proteomic analysis would 
consist of sample and protein preparation followed by a protein identification[333]. 
The most common proteomic analysis involves either identification of specific 
proteins by, for instance, mass spectrometry following separation by two-
dimensional polyacrylamide gel electrophoresis (2D-PAGE)[330, 334]. Proteins 
could be purified by ion exchange, affinity or size exclusion chromatography. The 
analysis of selected proteins may also be obtained by enzyme-linked 
immunosorbent assay (ELISA) or western blotting [331]. ELISA is a plate-based 
assay that is designed for detecting and quantifying proteins, proteins, antibodies, 
hormones, etc[335]. However, these techniques might also be used just to analyse 
selected proteins in cell extracts. Whereas, protein microarrays or chips allow the 
analysis of protein expression[331]. In order to determine an amino acid sequence 
of a particular protein, Edman degradation method could also be used[334].    
 
Cell-impedance sensing techniques such as real-time cell analysis (RTCA) could 
also be investigated. RCTA is a technique in vitro that is based on monitoring 
changes in impedance, which is generated by the adherence of cells to 
microelectrodes to the bottom of microelectronic wells[332]. This technique might 
help to monitor cellular changes in real-time without any dyes or labels. Changes 
in impedance could represent differences in cell proliferation, adhesion or 
morphology that are caused by exposure to toxic materials over time[330]. RCTA 
might be more effective than MTT reduction assay in order to determine a 
chemical toxicity of organoclay.  
 
In order to investigate the interaction of either clay or chitosan with DNA, comet 
and micronucleus assays could be performed. The comet assay is known as 
single cell gel electrophoresis (SCGE) or microgel electrophoresis (MGE)[333]. 
This assay could be used to evaluate the genotoxicity of clay in both mammalian 
and bacterial cells[333]. Furthermore, the comet assay could be helpful to detect 
and visualised the breaks in DNA strands[333]. In addition, the micronucleus assay 





may be used to detect both breakage and loss of chromosomes that might occur 
due to chemical treatment in somatic cells[333]. 
 
The proliferation of the 3t3 cells inside the hydrogels synthesised might also be 
investigated using CCK-8 and confocal microscopy. The level of expression of 
genes could be determined by the real-time reverse transcriptase-polymerase 
chain reaction (RT-PCR)[334]. The total RNA from the cells, which are embedded 
in the gels, could be extracted by, for instance, trizol reagent. Then, cDNA could 
be obtained from RNA by reverse transcription[334]. The expression of the proteins 
may also be analysed by immunostaining and visualised by fluorescence 
microscopy[334]. In addition, serial analysis of gene expression (SAGE) and DNA 
microarray technology might also be obtained. 
 
In order to measure oxidative stress and damage of cells caused by clay particles, 
protein, lipid and DNA oxidation might be analysed. For instance, the oxidation of 
lysine, proline, arginine and threonine might lead to a formation of carbonyl 
groups on a protein side of chains[335]. Therefore, the detection and visualisation 
of protein carbonyl might be carried out by ELISA or by Western blot analysis [331].  
 
Regarding cytotoxicity assays, the lactate dehydrogenase assay, which is 
another type of colorimetric assay can be performed. Lactate dehydrogenase is 
an enzyme that is present in the cytoplasm and could be released as a result of 
damage to the plasma membrane[336]. Furthermore, ATP measurements through 
luciferase activity could be investigated by CellTiter-Glo Luminescent Cell 
Viability Assay (Promega) in order to investigate the metabolic activity of cells.  
 
Next, the cytotoxicity of KC and KC-based materials should also be investigated. 
The investigation of potential healing and antibacterial activity of Kombucha 
beverage needs to be taken further.  The healing properties of the developed 
materials should be analysed using a scratch assay. The attachment of cells 
inside the matrix, which may indicate the healing nature of the composite. can be 





studied using SEM.  In addition, the mechanical properties of the synthesised 
composites might be investigated using dynamic mechanical testing. Evaluation 
and comparison of tensile strength and Young’s modulus of the composites to 
the original BC need to be studied.  
 
In order to further investigate the potential of the synthesised materials in medical 
applications, an animal model can be introduced.  Structural damage of the skin 
of an animal with the subsequent measurements of reepithelisation and 
granulation of wounded area might provide a better understanding on healing 
properties of a material[337]. Swabs from the wounds for any contaminations can 
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